,0
recombinant virus produced e2 protein,0.00155141261143568
vectored mucosal vaccine,0.0015169150889352083
consensus heptameric intergenic sequence,0.0014304638469047285
linear genetic map,0.0013990220717511519
homologous rna recombination,0.0013707946443790964
interpretation,0.0013259192031082302
consensus heptameric intergenic sequence uacucaaac,0.0013164381042191906
reverse transcriptionpolymerase chain,0.001283093788796419
diagnostic tests vaccines,0.0012774469772464036
laboratoryconfirmed merscov infection,0.0012391162609212715
s3,0.0011875070026674997
simple antibody test methods,0.0011866908406393435
older individuals,0.0011330021343056757
hepatic inflammation,0.0011214247163921225
immunisation,0.0011026974027615875
comparator group,0.001093581817579104
lethal lower respiratory tract infection34,0.0010885113394232767
wildtype di rna ne1 rna,0.001066857920926069
betacoronavirus genomes,0.0010511928885395087
protein coding genes,0.0010480284924484315
laboratory monitoring,0.0010408420555756714
military medical city,0.001038047956177137
glutathione stransferase fusion proteins,0.0010379219714661784
core leader transcriptionregulating sequence ltrs forms sl3,0.0010264535419436615
sarscov protein 6,0.001020827930972497
peplomer glycoprotein,0.0010205761022329472
cns tissue,0.001018094768216785
coronavirus sarsassociated coronavirus sarscov,0.0010041151081102346
crosssectional serosurvey,0.0010000339930732593
ace1,0.0009988938701859464
feline viral infections,0.0009757029779864579
heart,0.0009729526989937166
mucosal surface,0.000970568679016424
antifeline coronavirus fcov antibodies recombinant fcov nucleocapsid protein rnp,0.0009581882580985974
immunoprecipitation,0.0009528592136947324
polyprotein chain orfs 1a,0.0009480442555974538
engineering,0.0009459148872401643
heterotypic vaccination,0.0009357777745658835
entire coding region,0.0009264501262976785
granulomas,0.0009251874256601817
deletion mutant viruses,0.0009219268654945851
free receptor binding domain,0.0009149122837489702
fibroblasts,0.0009032834966719704
molecular regulation,0.0009012266791756825
individuals1,0.0009010996159729821
viruslike particles expression vectors,0.0008993330626976455
controlling,0.0008938923894631401
intensification,0.0008915073174382541
batcov hku9 hku9rbd,0.0008771662747412972
merscovspecific immunofluorescence assay ifa,0.0008765693433647595
mrna mrna 7 sequence,0.0008759226883163878
doi101038nature12328,0.000872065867743623
sequence insertion,0.0008692102290361274
bilateral abnormalities,0.0008653045854440187
immunologically crossreactive hcvoc43,0.0008603116094761273
cellpenetrating peptide cpp,0.0008581495486627544
indoor,0.0008581044619775536
feline leukaemia virus,0.0008570915068400186
mouse hepatitis virus mhv di rna,0.0008558054566583658
serinearginine srrich motif,0.0008533955825410179
virus origin virus,0.0008499173482330924
immunological screening tests,0.0008462997488476283
upper respiratory tract disease,0.0008458545161480644
di rna species,0.0008450798641444616
crystal structures,0.0008447391883196989
radiological infiltrates,0.0008415132824876675
tracheobronchial lymph node,0.0008396630702840219
realtime surface plasmon resonance,0.0008392473645859897
ion channel inhibitor,0.0008391573797043806
st cells elongation factor 1alpha ef1a,0.0008359874821503405
aerosolisation,0.0008321858335195868
cisacting sequences,0.0008251175883927418
membranes,0.0008244945302137678
putative functional domains,0.0008214061000675956
indoor ventilation systems,0.0008136376228052335
reverse genetic system,0.0008087812383416852
hvr,0.0008076252363518848
encoded,0.0008073581205781697
slaughterhouse,0.0008034480236674182
assessment,0.0008021037610839284
continual,0.0007979323863339194
serologic testing,0.0007937325244174216
usefulness,0.0007887310309225887
neural cell cultures,0.0007795439479281584
persistently,0.0007769718707532011
regional,0.0007720003526606966
synthetic peptide p2,0.0007713108503690124
aggressive lung disease,0.0007677138190913322
evolutionary lineages,0.0007671739078004876
sequence alignment,0.0007664965911460479
chemokine ligand 2 ccl2 monocyte chemoattractant protein1,0.0007606364331143725
brushborder membrane protein,0.0007605207009860393
subcutaneous pegylated interferon,0.0007575219689751418
healthcareassociated merscov infections,0.0007563179864703367
chicken respiratory tract,0.0007522802856313828
endogenous hdpp4 promoter,0.0007521906076480993
heterozygous,0.0007519791338498468
multinucleated syncytia,0.000750029554830448
laboratoryconfirmed primary middle eastern respiratory syndrome,0.0007458179447854099
mouse hepatitis virus mhv di rna ne1,0.000745296848984721
sarslike covs slcovs,0.0007433586173124409
lung fibroblasts,0.0007393662430694347
carboxylterminal half,0.0007388498431445968
camel age,0.000737581235184635
aromatic arylmethyl substituent,0.0007352189090202126
pseudoknot structure,0.0007318130331649241
rtcproximal host,0.0007308690429155955
huh7 cells antibodies,0.0007282048509213827
aromatic substituent,0.0007274603874987356
coding sequences,0.0007272857406163571
cd8,0.0007251820599447628
serum samples,0.0007207825804804427
7a protein activated p38 mitogenactivated protein kinase mapk,0.000720449456502271
coronavirus merscov infections,0.0007193728145955666
protein forms ion channels,0.0007190743049143239
genomes sequencing,0.0007167705643624591
multivariate sensitivity analyses,0.0007155356418999161
tiaubein differential management,0.0007132178481128441
high rate,0.0007114954542663754
murine cells,0.0007101837148464657
7oarylmethylquercetin derivatives,0.0007090750433610309
hcovemc dpp4,0.0007050814359189792
doublestrandedrnaactivated protein kinase pkr,0.0007048381545142836
shamvaccinated control,0.0006984229365401496
coronavirus avian,0.0006982876026102021
camel urine,0.0006976663461499457
ceacam proteins,0.0006969978258509503
poor agreement,0.0006951317802186416
particle variability,0.0006928011005235474
cell cultureadapted fipv strains,0.0006923445537037114
genetically modified,0.0006917916335540759
hong kong china,0.0006907825104293881
mixed rhinoviruscoronavirus 229e infection 1,0.0006861345393291998
immunohistochemistry viral rna,0.0006839791475573338
clinical data virus,0.0006810877013271777
short hydrophilic amino terminus,0.0006803878506434976
general population,0.0006796885838123497
letter,0.0006796097230950387
chicken eggs,0.0006794665935031187
immunopathological damage,0.0006794583759515192
alphacoronaviruses,0.0006776453036456719
quantitative rtpcr approaches,0.0006774306222657063
erfibs,0.000677095574859957
techniques,0.0006762027550226125
single nucleotide deletion,0.0006748274558645249
nterminal finger,0.0006747603179179229
sarscoronavirus s m,0.0006713154768748284
luciferasebased reporter plasmid,0.0006710897130518937
humanmouse hybrids,0.0006707368881636672
hcov229e hcovoc43 hcovnl63,0.0006706459065693693
localization studies,0.0006692505947065355
ammoterminal sequencing,0.0006672590307482387
dengue infections,0.0006666828995514582
di rnas,0.0006647857478412974
lewis rats,0.0006646875834772708
replacement fibrosis,0.0006633782401006594
gfpexpressing reporter virus,0.0006609180004968436
cov replication,0.0006599083653473077
reversetranscriptase polymerase chain reaction rtpcr,0.0006582512585935176
cell lines sarscov infection,0.0006579815429416275
sarscov epitopes,0.0006567097796297468
dna immunization,0.0006545627450354526
intracellular membranes,0.0006535415518065656
merscov sitedirected mutagenesis,0.0006527089134058193
mutated virus,0.0006513365572422329
histopathology,0.0006497464580453653
nasal mucosa trachea bronchi bronchioli,0.000648623317254882
porcine teschovirus 2a peptide,0.0006467505952198313
parainfluenza virus type 3 hpiv3,0.000646731847229101
disease serological,0.0006464656206629525
predisposed,0.0006424467097879825
fibrillaringreen fluorescent protein fusion protein,0.0006419068856954733
large open reading frame,0.0006404723385210361
monoclonal antibodybased antigen capture elisa,0.0006398892221803796
biomedical factors,0.0006392228786803158
tropism1 transmissible gastroenteritis virus tgev,0.0006392016714544366
bioisosteric relationship,0.0006391510561139406
oronasal inoculation mild diarrhoea,0.0006387757606626527
hyaline membranes type 2 pneumocyte hyperplasia,0.0006382605177000676
myelin proteins,0.0006364044364257484
ne1 di rna replication sequence analysis,0.0006363249450822188
nuclear polyhedrosis baculovirus acnpv,0.0006354596099964119
conserved structural elements stem loops sl 1 2 4 and 5,0.0006309952075168102
nosocomial transmission,0.0006308936077953328
substrate recognition,0.0006306839285126762
molecular pathogenesis,0.0006305464052365593
epidemiologic investigation,0.0006294761519510401
highdensity oligonucleotide arrays caco2,0.0006290724112886976
south koreas mers outbreak,0.0006290109877030972
mild upper respiratory tract disease,0.0006283090627224986
f73 r84 w86 r310 d331 g333 p335 y368,0.0006280491973819489
s1 domain s1 s1foldon,0.0006274372130946448
pancreatitis,0.0006255017832008476
host cell factor,0.0006253842802611089
e2 peplomer glycoprotein,0.0006253162743254928
corticosteroids hypoalbuminemia,0.000620858088956134
pigs virusspecific lymphocyte,0.0006194930988157308
glutathione stransferase hgst,0.0006153561190117962
pathogenesis structural proteins,0.0006148142762355619
parainfluenza virus bhpiv3,0.0006146399450317391
myelin basic protein,0.0006133439731479299
kbp,0.0006133037733616443
natural coronavirus infection,0.0006124394679134881
transcriptional gene silencing,0.0006115990252380907
interferon alfa2a,0.0006110607413598819
expression vectors,0.0006092870085892999
highthroughput analysis,0.0006083767240641404
lung lesions,0.0006072908511601131
rna chaperone activity,0.0006059960801530514
coronavirus n proteins,0.0006049951806105426
enc,0.0006048817504631949
protein hsp70,0.0006026062916817394
neuroinflammation,0.0006000080134236828
mannose receptor,0.0005977157331328375
mode,0.0005974135927739639
human 293 renal epithelial cells pseudoparticles,0.0005972291273408705
subgenomic mrnas mrna3,0.000597134601108847
chimeric and truncated spike proteins,0.0005956156956588536
mitochondrial cytochrome c,0.0005951703789582763
methyltransferase activity,0.0005944623296223915
nonsegmented linear pluspolarity rna virus,0.0005943144983804233
immunoreactivities,0.0005936414136418438
core leader transcriptionregulating,0.00059294745974556
jhmvspecific major neutralizing epitopes,0.000592924051821851
mucosal immune responses,0.0005922082004375293
cytoplasmic domains,0.0005922012876252574
propia mucosa,0.000591463687016225
genetic susceptibility,0.0005902707478658755
quantifying,0.0005897225848956985
cognate ace2 receptor,0.0005861143001808269
apoptotic induction,0.0005853991450413737
accessory genes 3a 3b 5a,0.0005853058430197837
respiratory pathogen,0.0005839044988336291
fujian china,0.0005837424421628603
nb nbms10,0.0005832640895885381
recombinant fcov nucleocapsid protein rnp,0.0005832572679556831
serogroups,0.0005831770527866619
coronavirus strains sequencing,0.0005829644941572642
chronic cardiac disease,0.0005815041891354578
rna metabolism,0.0005803351795154291
coding sequence,0.0005798067934291749
hightomoderate codon,0.0005793287700498642
protein pattern,0.0005780396213303665
environmental contamination,0.000577769791645877
deisgylase activity,0.000576020364919823
paradigm,0.0005747301217978201
intergenic sequence,0.0005743039304107832
coronaviridae,0.0005742272719374266
residues 538 591 and 543,0.0005741368808843217
virion nucleocapsid,0.0005732152664512334
protective tcell response,0.0005727186983001323
block infection,0.0005713026270326737
mutated messenger rna 4,0.0005694078557606906
complement system,0.0005690098880347263
capped guanine,0.0005687338067556964
antigenic stimulation,0.0005673895599774492
nucleocapsid protein of sarscov,0.0005670240198664634
junction sequences,0.0005660190182946916
cellsurface metalloprotease,0.0005655842479102697
sarscov viroporins,0.00056540338479485
viral genome analysis,0.0005649297702009806
plasmid dna,0.0005632119859124474
similarities,0.0005631344504279977
clinical radiological,0.0005630566757587745
mixed infection,0.0005624543064701693
ages,0.0005600933298643733
human glioblastoma u87,0.0005596168213275303
electron cryomicroscopy cryoem,0.0005594837142957917
id50,0.000559278353339282
compartment ergic,0.0005590809419200995
eukaryotic mrnas,0.0005588627193300674
conserved hexanucleotide core,0.0005579239893183784
murine coronavirus jhmv,0.0005577036575862807
translational machinery,0.0005576054409811113
upper respiratory tract infections1,0.0005568424451240271
neutralizing nb nbms10,0.0005557761771708854
active surveillance,0.0005554527330143404
mouse central nervous system cns,0.000555273652237166
b 85 enteroviruses 40,0.0005529180967765336
hematopoietic stem cell transplant,0.0005526089004357662
human coronavirus 229e hcv 229e rna polymerase,0.0005525458182516886
microenvironment,0.0005521453328835049
dissected,0.0005515075212808811
isogenic viruses,0.0005514273207746174
merscov proteins,0.0005503444358833677
peroxidase antiperoxidase staining technique,0.0005500278103698584
biochemical methods,0.000550024229421991
virus and brain antigens,0.0005496983516994589
retrospective analysis,0.0005476766943897651
resultant,0.0005470662266452345
processing bodies,0.0005446299813871782
inflammatory demyelinating disease,0.0005440950778424932
thrombocytopenia 17 36,0.0005436800400153231
postfusion stage,0.0005434274467951103
sarslike illness,0.0005420082665279141
porcine respiratry coronavirus,0.0005400383586223126
protein antip2 antibodies,0.000539460808953907
protein kinase r,0.0005391618665724731
coronavirus regulatory processes,0.0005391257350858053
cytokine interleukin,0.0005386566698451843
recombinants,0.000537109361271924
bronchial bln lymph nodes,0.0005368759549933317
elderly,0.0005356870766771684
comorbid medical disorders,0.0005356223504240192
7aminoacid insert,0.0005349210290956851
proximal and distal elements,0.0005347084140535856
frameshifting 3b product,0.0005340229074013265
transmissible gastroenteritis virus tgev infection,0.0005333476648106064
abattoirs,0.0005324862495513016
fulllength genome sequence,0.0005323838284400885
carcinoembryonic antigenrelated cell adhesion molecule ceacam,0.0005314021180492492
merscov assembly,0.0005285210944841724
intestinal tract kidney,0.0005263446364900723
nl63 19,0.0005259448779025881
cap analog m7gpppa,0.0005235513197367074
nucleoside triphosphate hydrolase,0.0005234668299133378
pathogenic variants,0.000523197120389857
ccr5 signaling,0.0005202677391120305
hrvs,0.0005200828689782475
conserved site,0.0005199845493359123
m41,0.0005172741463060131
quarantine facilities,0.0005165508502357275
recombinant s protein fragments,0.0005153525191676603
elisabased antibody tests,0.0005147188135346774
stranddominated,0.0005139520779316944
endonucleolytic rna cleavage function,0.0005117141123232926
mnt merscov neutralizing antibodies,0.0005112433171312121
viral replicasetranscriptase,0.0005106328071367298
multifocal lymphocytic hepatitis,0.0005106257767433635
peplomer protein epitope,0.0005101519271623205
genome leadermrna junction sequences,0.0005084386859531534
canonical rossmann fold,0.0005076599081711175
epithelial necrosis serosanguineous exudate formation,0.000507654910699011
oral l casei vaccine,0.0005074191407608546
rna polymerase gene products,0.0005072604064623564
respiratory aspirates,0.0005070671830582472
sarsrrhbatcov genome epidemiology,0.0005044616869713892
research articles,0.0005032439754331755
nmdinducing,0.0005013050943367247
anticov plpro enzyme inhibitors,0.0005011247688915526
antitransmissible gastroenteritis virus,0.000500723137259251
recombinant rshdpp4,0.000500040642745156
hepatitis b virus,0.0005000245328314569
research german research council,0.0004999535766481323
genomic level,0.0004989857571461303
targeted rna recombination,0.0004957072984820246
mhv resistance,0.0004955695402327845
hyaline membranes type 2 pneumocyte,0.000494826540030635
batcov hku9,0.000494793075287993
secondary occurring,0.0004947401421897477
immune pathways,0.0004930467257486422
coronavirus jhm omp1 murray,0.0004916016446188394
monomeric form,0.0004915850399971369
ic,0.0004911249843510212
nasopharyngeal swabs,0.0004910208940411584
immobilized,0.0004904153708930752
euthanized,0.0004895379404799052
animal markets,0.0004894108731590326
therapeutic regimens,0.0004894019301657366
type i interferon responses,0.0004893393400477371
sspecific immunoglobulin g antibody,0.0004891375874967002
receptor first,0.00048732326133323154
intestinal tract,0.0004865784518451871
feline immunodeficiency antibodies,0.0004862684404856975
family specific,0.0004861906480813977
sudden cardiac death,0.0004860252279008772
human 293 renal epithelial cells,0.00048560207787689164
balt bronchial lymph nodes bln,0.00048484091010734815
antinucleocapsid protein,0.00048452330982947723
protein expression,0.00048389926590977297
laboratoryconfirmed merscov disease,0.0004835981404828864
interferoninducible antiviral factor,0.00048266152604499923
mcp1,0.00048254042757884434
mrna mrna 7 sequence analyses,0.0004822823775410743
upstream consensus sequence,0.00048165799702729577
measure,0.00048134963735283804
nosocomial amplification,0.00048128552082926944
central hydrophilic region,0.00048067150356714887
stat interactor,0.000478856050840327
cd8 tcell,0.00047750422846812773
orally,0.00047712477789857964
control mice,0.00047632615654789857
statistically significant,0.0004759477018808306
humanfcfused version,0.0004754354831813931
pathogenetic,0.00047512731080981245
parenchyma virusspecific t cells,0.0004747155480399084
merscov interpretation,0.000473366736080862
nucleocapsid and spike proteins,0.00047278209370881706
nucleotide homology,0.00047270407987679236
hcv229e virus infection,0.0004724202325819069
39-,0.00047175359116191575
reverse transcription polymerase chain reaction,0.0004711838692362032
sarscov12345,0.0004685889704128975
open reading frames 3a 3b and 3c,0.0004679628315327351
mhv4mhva59,0.0004674816130587347
viral rna 5370,0.00046634033199101306
heptad repeat 2,0.0004657237847549517
immune environment,0.0004652169509571413
coronavirus rna recombination,0.000464857368096765
sarscov receptor human angiotensin 1converting enzyme 2 hace2,0.00046457792514802365
frankfurt university germany,0.00046361245237335445
multifocal mononuclear cell interstitial pneumonitis,0.0004625392392762559
seasonal incidence,0.00046207577800336453
7a7b orf7a7b,0.00046187632608350764
43450 single strand rna probes,0.00046134633534766724
old age,0.0004610658380924848
platform,0.00046092392442230034
antibody response,0.0004604409263983599
virus and host factors,0.00045980747923253377
coronavirus mouse hepatitis virus jhm,0.0004591409390710961
farms,0.00045854685368857
betacov rbds,0.0004585318328006488
nucleocapsid n n protein,0.00045806778977149716
serial passages,0.00045727625557410003
zoonotic pathogen,0.00045703499435350724
tdrs,0.00045699403953093675
infected target cells,0.00045680015486133024
middle east respiratory syndromecoronavirus merscov infections,0.00045599853035048564
site b residues 97 and 144 site c residues 50 and 51 and site,0.00045572874624861604
human airway epitheliumderived a549,0.0004554933784430485
spike regions,0.00045417429579525857
single virus infections,0.00045384050516412023
single-tube rt-pcr assay,0.00045340221762573443
glucoseregulated protein grp78,0.00045256926197571456
published fcov sequences,0.0004524809955743895
etiological agent,0.00045125232596596204
dna vaccine,0.0004512287395783632
viral structural protein,0.00045026954028647875
lifethreatening,0.00045011882756739005
zoonotic covs,0.00044996764860317807
med virol,0.0004494553701518871
protective response,0.0004480623902658749
bioactive,0.000447194048264482
translation initiation factors,0.0004470180780235907
cameltohuman,0.0004468117136907248
respiratory faecal,0.00044640479002782616
galt lymphoid tissues,0.00044617666458785855
natural hosts,0.0004454943364499824
complementary proximal and distal elements,0.0004454033281925217
small membrane protein,0.00044474736297273645
western blot approach,0.0004446863334212987
pharyngitis coryza fever,0.0004446654897301974
cc chemokine ligand 2 ccl2 monocyte chemoattractant protein1,0.0004441330983237315
genetic recombination techniques,0.0004438330724039964
nonsensemediated,0.00044181808320153113
merscov strains,0.00044071871806945594
recombination frequency,0.0004403181666616344
mouse hepatitis virus mutant mhvs,0.00043998492823526505
tgev neutralizing antibodies,0.0004399193946514311
conserved human grp78,0.00043977905630275093
batorigin,0.0004395160571941425
serum thelper type 1,0.0004390058998882832
putative leaderbody junction,0.00043842318481780127
antimerscov antibodies,0.00043839672229949893
hospitalacquired infections,0.00043778549926832443
allhydrocarbon stapling,0.0004374682051415368
hightiter virus,0.0004373742139837687
internal termination codons,0.0004372400576756562
coronavirus particles,0.0004372053137674806
clinical manifestations,0.0004368105355084214
small envelop e membrane m,0.00043676824577131235
early control,0.0004363423503397644
iaha,0.0004361191852814161
realart hpa cov rtpcr assay artus,0.0004360328792190439
human cov 229e exon activesite mutants,0.000435559977987551
orf4b,0.0004349063865511386
saudi nationals,0.0004346834375556673
scotophilus kuhlii,0.0004346596639797339
mtase domain,0.00043442991940384625
hemagglutininesterase he proteins of the variant viruses,0.0004343833032712025
pdcov survival,0.00043349393632994497
molecular switch,0.00043326925465006174
amino acid homology,0.0004325361841424846
deisgylating activities,0.0004322965763951398
cap guaninen7methyltransferase n7mtase,0.00043144720382413927
viral cultures,0.00042870382244778376
hcov229e fusion core,0.00042857909272501625
costeffective,0.00042852072977727013
autoreactive t lymphocytes,0.0004282150687365108
cloned gene strain,0.0004272062397023476
primary,0.00042720305050021054
mass spectra,0.00042650759388903286
camel populations,0.00042641996520375474
oligodendroglia,0.0004259152273011522
antigenic properties,0.0004258466349275223
region molecular,0.0004258348007850642
coactivator crebbinding protein cbp,0.0004254718686543322
type 2 denv2 cinanserin hydrochloride,0.0004246310270842373
spread2,0.0004246080971212548
transmissible gastroenteritis coronavirus tgev,0.0004238398301139746
photochemical treatment,0.00042316840618243656
plasma membrane protein,0.0004230423939386299
cytopathic viral infection,0.00042182415974796004
cofactor,0.0004213745972238154
high mortality rates,0.00042092898829919833
highest,0.00041974991110579684
mitogen-activated protein kinases,0.0004189710964445305
randomized trials,0.0004187412347217692
chain antibody scfv,0.0004184467033109893
nongrouping,0.0004177454127284482
epsteinbarr virus,0.00041632903825197283
genomic characterization,0.0004159040157686682
virusspecific,0.00041559305002381594
dipeptidyl peptidase 4 dpp4,0.000415490023171995
bovine coronavirusspecific antibodies,0.0004153877893533588
retrospective cohort study,0.00041522985266105285
cellular translation,0.00041405547746258377
virus neutralization,0.0004129411503290271
merscov spike protein receptorbinding domain,0.0004123503036531263
coronavirus envelope,0.00041232764072254136
turkey coronavirus tcov antigens,0.0004110969300906915
kinetic behavior,0.0004106282415571965
multiple rnas,0.0004105691115016447
cross-species transmission,0.0004105054260453783
hcov229e cell death,0.00040997116766348105
pulmonary lesions,0.00040989576473652445
sarscovinfected macrophages,0.0004095134537181214
biological processes,0.00040948159245790235
loss,0.00040944691100259866
rbdspecific antibodies,0.0004090910088245933
proofreading activity,0.0004085645150232796
casei,0.00040847020696662794
mers outbreak,0.0004076495861913481
recombinant baculovirus system,0.00040637084772906926
singledomain antibodies,0.0004058169259609145
sarsassociated coronavirus infection,0.000405412032550599
hipposiderid bats,0.0004053067117124839
nsp1mt protein sarscovmt,0.00040516141627276395
biophysical analysis,0.00040502039316499115
funding,0.0004043160865466995
t cell chemoattractant chemokine cxcl10 interferoninducible protein 10 kda,0.00040323696802258924
cysteine proteases,0.0004029910310237241
orf1a fragment 940 nucleotides,0.0004029461357045122
mebus-induced antibodies,0.0004025073262888314
lactate dehydrogenase 23 49,0.0004023983676610104
huh7 and mdck lines,0.00040228167984585837
submicromolar,0.0004021421106941131
co-localized,0.0004017813798448943
external receptor binding motif region,0.0004015869036915137
rbcv infections,0.00040158579580734427
feed,0.00040132728781965156
merscov s1,0.00040031020991165595
interfering rna sirna inhibitors,0.00040027383850460124
rpha method,0.00040024310184526865
antiviral response genes,0.0004001261576254048
high yield,0.00039955317060959836
primary sensor,0.00039953582123237525
recombinant attenuated parainfluenza virus bhpiv3,0.000399456217146696
ribosomes cellulaires,0.00039937941137188404
fip pathogenesis,0.00039918447626951424
genetic elements,0.0003988332908471191
immunoglobulin heavychain,0.00039794341708032497
viral fusion proteins,0.0003978318375013058
repeat chr,0.00039757102562806563
bias,0.0003974501329782192
strains vaccine platforms,0.0003970829686047103
virus neutralisation,0.000396722524838345
oxygen requirement,0.00039622771567791724
glycoprotein mutations,0.00039620559235252495
heart weighttobody weight ratios,0.0003955949382078143
mitochondria,0.00039544002096589714
consensus transcriptional initiation sequence,0.0003950349546228645
primary chick kidney ck cells,0.00039481745910206403
halflife,0.0003947087112693926
oral lactobacillus casei,0.0003942473880619752
genomic rna templates,0.00039419642161083037
oligonucleotides pcr,0.0003935726907272178
pantropic canine coronavirus,0.0003932612036155483
ovo,0.0003927857293036888
camelexposed,0.0003926830070327125
enzyme 2 ace2 receptor,0.000392529902701727
sars-cov-infected vero e6 cells,0.0003923781909190507
tgevneutralizing antibodies,0.0003918935313021056
viral assembly,0.00039163266698380195
molecular events,0.0003913883110960298
homologous interference,0.0003913863714700065
mouse hepatitis virus isolates,0.00039097710844203647
hematologic malignancies,0.00039072867597626386
transportation,0.00039053478468971826
hr2p spanning residues,0.0003904093152483272
spike s gene,0.0003901335227267176
sixhelix bundle fusion core structure,0.00038987231559303005
pharmacophore modeling study,0.00038962821468573256
pcdna 31 mammalian expression vector,0.0003889779213923553
mtase,0.00038833521022893714
uvinactivated sarscov,0.0003879163297772412
die,0.0003877886763631459
haemadsorptionelutionhaemagglutination,0.00038745288023147364
confluent,0.0003873268207248961
immunosuppressive factor,0.0003872014403276206
immune cell,0.00038675465658063047
conformational epitope,0.0003866817241771896
angiotensin,0.00038649712305425317
proinflammatory cytokine interleukin il6,0.0003861320531701785
fulllength ectodomain,0.00038608388705383735
nexocendo conformation,0.0003859000089846561
middle east respiratory syndrome coronaviruses,0.0003856726488663239
phosphorylation,0.00038538927095128835
luciferase activity,0.0003852821052700026
dominant neutralization epitope,0.000384828139848928
mouse hepatitis coronavirus mhv a59 e,0.0003846980820199273
tissue tropism1,0.00038461783339132353
biotin,0.0003843370690347233
pair,0.0003835108897422548
group virus,0.0003834116089132811
immunoglobulin heavychain variable region ighv169derived heavy chain,0.00038341095981804665
viral activity,0.00038303261699535374
baculoviruses,0.00038284944078153
swine testes st cells elongation factor 1alpha,0.0003825935583779457
distant upstream site,0.00038256217521236987
adenovirus 2,0.0003825194500896067
43 hydrophobic heptad repeat regions,0.00038245762817782573
hepatic impairment,0.000382119837773067
granulomatous necrotizing,0.0003820521904089841
research priorities methods,0.00038198310171066286
hek293t cells,0.0003816043058534377
glycosylation sites,0.0003815543176159789
feed additives,0.00038145917618441136
virus replication cycle recombination,0.0003812982336649094
nursing stations,0.00038108010127730675
cubic membrane structures,0.0003810520188851111
coronavirus 229e antibodies,0.00038103277924076383
bat hosts,0.00038069889402974266
lethal viral,0.0003805173600707366
transfected 293ft cells,0.0003804677602958283
early endosome antigen 1,0.0003800831801497221
biochemical analyses,0.00038002331123670487
small intestine distal,0.00037991103569836454
gc3  curve,0.0003797481741555755
glycoprotein ectodomain,0.00037956210965086576
subclinical illness,0.0003790610402445305
networks,0.0003787260911747139
american type culture collection,0.0003783333419401956
neurovirulent mhva59,0.0003782625159852713
kinome,0.00037823170529538045
autographa cafifornica nuclear polyhedrosis baculovirus acnpv,0.00037769233687175353
prokaryotic expression system,0.0003771748844565279
129svev stat1,0.00037707198131429283
cofactor nsp10,0.00037704400502150957
experimental support,0.0003768983166240058
virus genomic sequence,0.00037657803646655013
bcvly138,0.0003763793520806525
merscov mersn,0.0003762042490942851
fecov,0.00037587861508435336
natural selection,0.0003755281980385434
5aminomethyl coumarin,0.0003750305576086229
virusbinding hotspot,0.00037494799109837377
host immunity,0.00037424708713703226
negativestrand antimrna,0.0003740546333582124
sendai virus rna,0.00037403755706970923
result,0.0003736609750187115
fcov-infected cats,0.0003735871439029216
nasopharyngeal aspirates npa,0.00037336980934807014
multiple healthcare facilities,0.00037314965291110856
nucleotide mutation,0.0003731438112799642
mers cov infection,0.00037308702224799346
viral genomic rnas image,0.0003730331149895202
middle east respiratory syndrome coronavirus mers cov,0.0003724338090450419
open reading frames 7a,0.0003723054679537759
created substitution mutants,0.00037230405890833844
purified sarscov plpro amino acids aa1507 to 1858,0.00037218186613835664
monocyte chemoattractant protein mcp1,0.0003721654313742822
tgev orf3 sequences,0.0003720467146546485
continental,0.00037177922446939693
vaccination programmes,0.00037175819915258567
logistic regression modeling,0.0003716701920017459
eighth open reading frame orf8,0.0003716302792524308
virusneutralizing,0.00037139538670926206
hexatantalum dodecabromide,0.000370991388055482
fusion des villi,0.0003709456749611502
microorganisms,0.00037048959143350606
membranefusion structure,0.0003701094850736563
receptor binding domain protein vaccine,0.00036940844328397387
n2 20,0.00036909406560658406
viral rnasynthesising machinery,0.00036891421932792846
continuation,0.00036879267053471646
merscov spike protein receptorbinding domain rbd,0.0003687372694113247
peptidesspecific antibodies,0.00036868017642842555
clinically significant,0.0003686705812832143
ccl2monocyte chemoattractant protein 1,0.00036834116037945185
turkey tissues,0.000368332972574685
glycosylated envelope glycoproteins,0.0003681316644758942
dihydrorhodamine 123,0.0003680846130401771
vaccinated animals,0.00036805784616184993
mean body mass index,0.00036782053747722704
recirculation,0.00036778816180932605
inactivate,0.0003676739213890666
outpatient clinic,0.0003675403362610055
aij,0.0003673844589993832
serotype i,0.00036705450588981426
capability,0.00036686651238708185
mouse central nervous system these viruses,0.0003667463105606985
alkyl halogeno nitro,0.0003665995727988803
serosal surfaces granulomas,0.00036629415516132284
gene 7 products,0.000366034577167098
lower respiratory disease,0.00036592812646850126
differentiating,0.00036582333160555837
site b residues,0.0003657551688514645
human cell culture model,0.00036572682653291283
virus isolates,0.00036512625805658317
genotype c,0.00036495615949462865
active domain,0.0003645862759526527
fulllength n protein of sarscov,0.00036450387960718816
circulation,0.00036372063231003706
host pathways,0.00036355995000408165
sars chest radiographs,0.0003635376379257985
replicasetranscriptase open reading frames,0.00036352357586986474
internal membrane proteins,0.00036336954320800315
human merscov strains,0.0003632936230262716
viral rna replicase polyproteins,0.0003631444389158563
ccl2monocyte chemotactic protein 1,0.0003630990125357739
time of,0.000362399469450382
xray structure,0.0003623282436673406
reverse transcriptionpolymerase chain reaction rtpcr,0.00036213780372366906
adenovirus type 5 ad5s vaccines,0.0003613343570783916
12nucleotide nt ambermutation linker,0.00036121548791789133
phylogentic analysis,0.0003603005384803377
host population,0.0003599957781778132
theilers murine encephalitis,0.00035996939459553574
replicative structures,0.00035965929444952446
jhmvinfected mouse cells,0.00035933572243667495
genome expression,0.0003593057039106835
antigenic site,0.00035864001450521926
cell cycle control,0.0003586018262066028
decreases,0.00035854058409211774
hcov229e hcovoc43,0.0003583096098172429
virusbased pseudovirus system,0.000358229905975251
sarscov rna copiesml,0.00035819490650442707
nonrespiratory tract disease,0.00035812858779097424
baculovirus polyhedrin promotor,0.00035792540167650823
positive antibodies,0.000357450333329291
no rna recombination,0.00035720601936410233
3a,0.0003571774651547
african bats,0.0003571239631170651
effector cells,0.00035701627417329766
wildtype virus,0.0003569151867105156
enteric tgev challenge,0.0003567801015764403
conjunctivitis,0.00035670005694842487
domestic,0.00035669505294136974
unfolded protein response upr,0.0003564827085192853
secov,0.00035592367113911093
antibacterial effects 2,0.0003555453976105782
16s rrna gene sequencing,0.00035535239685157425
putative protein antip2 antibodies,0.00035530045972967183
protein specific,0.0003551872190912219
arylmethyl group,0.0003546521273156341
cov plpros,0.00035451103343127094
108 sarscov rna copiesml,0.0003543307727257348
mitochondriamediated pathway,0.0003543027174657999
pulmonary perivascular hemorrhage,0.00035427852174634586
tuftsin fusion protein mt,0.00035411399311125326
merscov pseudotype,0.0003540842120240591
coronaviral polya tail length,0.00035406228233493526
mtase activity,0.00035396688720670106
rna viruses coronaviruses,0.0003536720000539923
merscov rbd core,0.0003536167676505798
sspecific monoclonal antibodies,0.00035360923430356695
clinical progression,0.00035357904706820293
immunosorbent assay elisa,0.00035339651864015303
systems,0.0003533947550416821
active translation,0.0003533847007697945
antiviral effector responses,0.0003530358230928569
children methods,0.0003526507166123375
admitted to,0.0003525805754558566
basepair fragment flanked,0.0003520792948462491
animal testing,0.0003519957567323576
protein receptor aminopeptidase n,0.00035195936217109
human cov 229e exon activesite,0.0003519161169308852
hcv oc43 surface antigens,0.00035176654915294956
national burdenofdisease study,0.00035169952018489014
mucosal immune responses recombinant,0.0003511399267320918
protein translation,0.0003510770081806692
normal white blood cell count,0.0003508349516833589
nonhuman primate model,0.00035054407554399467
cell nucleus,0.00035036660042289767
human brains,0.00035033415672654645
cellular stress deletion,0.00035012635577065466
cytoskeleton organization macromolecular complex,0.0003496896692264724
lipid analyses,0.00034951129866633217
lvcvs tubular bodies,0.0003493996830136728
pregnancy,0.0003491966456747503
cd8 cells,0.0003490827568427998
cell cycle,0.0003490676477523188
coronavirus sarscov polyproteins,0.00034905163512653634
endosome antigen 1,0.00034886260613588765
embryo,0.00034864113907553766
multiple passages,0.00034860526071997413
nucleolar proteins,0.0003479627265431845
vrp3014 or wildtype vee glycoproteins,0.0003475176843742551
vaccinia virus vectors,0.00034747264985083323
nile virus,0.00034738412378231275
hcovemc infection,0.0003471019083082133
immunopathological mechanism,0.0003470199093501245
coronavirus cov 3clike protease 3clpro,0.00034658501250858407
ag,0.00034652818324990594
phenylsulfonamide scaffold,0.0003460023457580399
geometric mean titer,0.0003459652535811951
antigenic determinants,0.0003458805378487618
preisolation contacts,0.0003456757096500201
form conformational epitopes,0.00034546495760348677
diverse host factors,0.0003451531055158916
cdna subclones,0.00034481826492071773
vaccinia virus system,0.00034468490096313086
autoimmune reaction,0.0003442124665414807
myocardial ace2 system,0.00034401355556628823
epidemiological study,0.0003430542859577238
zisternen aus,0.00034293906220964353
monoclonal antibodybased antigen,0.0003425440017775753
hospital surfaces,0.00034186172158325246
golgi region,0.00034161156269191657
surveillance programs,0.0003413751600684519
non structural protein nsp,0.00034130586545407795
primary target cells,0.00034096093147254755
m41specific neutralizing monoclonal antibody,0.00034073919350846913
human myelin basic,0.00034040031703874154
domain residues,0.00034039991049881867
congestive heart failure,0.0003401472479575633
recover,0.00033995171333998903
type ii transmembrane serine protease verotmprss2 cells,0.00033972395566627436
unfoldedprotein response upr,0.00033945014371328296
7813,0.000339303007945119
cloning escherichia coli,0.0003392821514911299
cell expression system,0.00033925661480107964
assessed,0.0003389337182172725
vrp3000 vaccines,0.0003385431717943501
virology chinese,0.0003384495060356208
material,0.00033834875874995363
nucleic acidbinding function gel shift assays,0.0003383021811687606
microglial cell line chme5,0.0003381980045793362
scientific evidence,0.00033816942752135483
s1s2,0.0003381649687086118
interphase oocytes,0.0003380170962430562
israeli camels,0.0003379471469835802
au,0.000337786431142985
swine testis st porcine cell line j h schickli b d zelus d e wentworth,0.0003374540291666681
productive coughing,0.0003373717455037788
sarscov binding receptor,0.0003369077770866216
convencionales,0.00033679906059507663
camel nose swabs,0.0003367903997641289
wildtype field coronaviruses,0.0003365716588463917
membrane fusion reaction,0.00033656671588460957
environmental triggering,0.0003363420008903641
bat origin,0.0003362775804389401
human aminopeptidase n a cellsurface metalloprotease,0.0003358977531586638
accessory protein 5b,0.00033547143459026964
ferrets,0.00033521225094854915
human ace2 nl63cov rbd,0.00033516463975863587
chemokine ccl2 monocyte chemoattractant protein mcp1,0.0003348763234793655
geographic location,0.0003341303960555763
rna recombinant,0.00033410999352963136
parainfluenza viruses 1 2 3,0.00033404601120955553
silac approach,0.00033387875465852026
fusion activity,0.00033356982160858594
cell culture materials,0.0003335277689831999
glycoprotein rocus183241,0.00033337798299424193
chinese field strains,0.00033337629542057323
oc43 spike protein,0.0003332586324791457
coronaviruses 5 kb,0.00033320128413368314
acute respiratory syndrome sars methods,0.0003323559128306276
immunoreactivity,0.0003322894573625118
bacterial strains,0.00033225003259561585
sarscov m,0.0003322153917817633
extrapulmonary loci,0.00033191792257639504
slcovs,0.00033183644034632295
french guinea fowl virus,0.0003316777553890573
convalescent serum samples,0.00033155403186813066
adenovirus,0.00033116260459948167
ph,0.0003310939375862881
orf1ab replicase polyprotein,0.0003310049159549497
receptorbinding site,0.0003307904539369707
electronic supplementary material,0.00033069202679880704
social impact,0.0003298231677279107
multiple respiratory,0.0003297569269996576
anticytopathic activity,0.00032970047588746365
immune response monoclonal antibody,0.00032865933149955906
singleparticle image analysis,0.0003286196554911897
recombinant lactobacillus,0.0003284628161745384
hcovnl63 strain cbj 037,0.00032832466294870733
haemagglutination-esterase and spike proteins,0.00032822603828855693
ccl2 monocyte chemoattractant protein,0.00032822558644908533
tumour suppressor protein p53,0.00032817167574723246
bupleurum spp heteromorpha spp,0.00032794686425300376
glial fibrillary acidic,0.0003278936740783895
sialodacryoadenitis,0.00032778565560944806
dimeric species,0.0003275672446615424
middle east respiratory syndrome coronavirus merscov nonstructural protein 16 nsp16,0.00032730162436714403
murine encephalitis virus tmev vesicular stomatitis virus,0.0003272429646353223
immune therapeutic,0.00032705668244121426
plasma membrane proteins,0.00032679535774816524
genetic backbone,0.0003264045217558883
sars cov receptorbinding domain amino acids,0.00032634201431496054
replicase gene 1bderived sequences,0.00032609063765518377
transchromosomic cattle,0.0003260702248057984
interstitial pneumonitis,0.0003260596337167563
sars outbreaks,0.00032598506388800317
western immunoblotting,0.0003258202876261719
donors,0.0003255286523262072
antimicrobial activity,0.00032552209434918164
hematopoietic cell transplantation,0.00032539905763914084
hamster rat cat dog monkey,0.0003252559363171245
hcd26dpp4 viral receptor,0.0003248280470405342
stress granule,0.0003244200101657577
inner city,0.00032441188058197163
travelassociated mers infection,0.0003241224274775222
central nervous system tissue,0.00032409951947447787
human rhabdomyosarcoma rd,0.00032362761246453427
celldeath pathways,0.00032361958021510153
domain structure,0.00032356166680879014
293 cells,0.00032344185895408066
tissueculture,0.0003224489383552598
rna drna cd61,0.0003224208518943166
ceacam1a receptor proteins,0.0003222315168255184
merscov receptor dipeptidyl peptidase 4 dpp4,0.00032221589003949576
non structural protein nsp 16,0.0003221746067588462
fever cough shortness,0.0003221107341758336
molecular epidemiology,0.0003220162524004575
lrt illness,0.00032197620336213396
homopolymeric or heteropolymeric sequences,0.0003218747373565167
gliocytes,0.00032172982255475194
foldon domain,0.0003216985646490699
mhv spike protein,0.00032169475370277833
nascent,0.0003216251200000957
antihcov229e antibody s proteins,0.0003215997463833085
hydrophilic residues,0.00032145627493589173
sarscov nucleocapsid protein antibody,0.0003210168928162851
nmd,0.0003207942666485744
nucleocapsid n genes,0.00032061453175003993
acute diffuse alveoli damage,0.00032058597833569845
vero cell culture,0.00032020463252869553
aspartate aminotransferase seven 15,0.0003201025514257086
syndromecoronavirus sarscov nucleocapsid protein n enzymelinked immunosorbent assay elisabased antibody,0.00032000333493775653
tonsillar,0.0003197664016073113
chfjwt2018,0.00031968410293529195
pfuml,0.000319228931584258
smallanimal model,0.0003190475124272992
parental antibody,0.00031900475801301267
sars coronaviruses,0.00031890249459646386
proteosomal,0.0003186989434031361
humans zumla,0.00031864714449832257
attachment,0.00031861642002199036
bioinformatic analysis,0.00031845600989077955
infectious clone,0.00031843619330898873
protocol,0.00031838168698643477
cytokine signaling,0.00031828413323386486
removal,0.0003182614643780761
synthetic peptides,0.00031823748897685415
gene expression synthetic 2123 nucleotide nt small interfering rna,0.00031810852585925067
hcov species hku1 nl63,0.0003180209043908815
mgkg,0.00031790749368383706
cordata,0.00031778422469921496
neurological disease,0.00031777365216211493
humoral,0.0003176705494991975
single prrsv infection,0.0003175406965206469
region of sequence,0.000317473606705284
virion surface,0.00031744205167477224
sarsrrhbatcov strains,0.0003169354388460303
coronavirus human coronaviruserasmus,0.00031674811829740003
hexamerization,0.00031669335164119343
acute respiratory syndromecoronavirus sarscov,0.000316408808773178
wb,0.0003161488809565976
consolidation,0.0003158333226609923
reinfected,0.0003158202942617005
orfs,0.00031574937079495874
rat cell line lbc cell,0.0003157468439882739
proteasome subunit alpha type,0.00031549413542350513
hand hygiene,0.00031543609244987544
team,0.0003152540931702949
trail fasl tumor necrosis factor alpha,0.00031517917662943033
ep4,0.0003150223676490237
primary amino acid sequences,0.000314950983949691
lung spleen,0.00031474327095747535
nonsmoking,0.00031444458008067467
sk,0.00031423808556982493
vimentin retinal dehydrogenase 2,0.000314172574462442
dpp4 protein,0.00031415727416368895
short report,0.00031403237836293804
translation control,0.00031391478298090894
astroviridae,0.0003139072996569639
vesicular transport,0.00031387335510460495
t cell deficient,0.0003138561195375974
randomized clinical trials,0.0003135893822081862
shuttling behavior,0.00031329146783162093
abdominal pain,0.00031319117658539376
phenotype,0.00031313194933742326
cns demyelinating disease,0.0003130835251115537
combination treatment,0.00031298545907181425
clinical signs,0.00031282381586267483
phase of infection,0.00031263021070422256
virus viability,0.0003124159728267206
camostat,0.000312349117197057
virion nucleocapsid protein pp60,0.00031224407747487004
primary endpoint,0.0003122410389316376
serum neutralising antibody,0.00031214092804583243
intestinaler,0.00031208481518635496
abilities,0.0003120438355394507
known viruses,0.0003119519802246517
coronavirus nucleocapsid antigens,0.00031194040524476203
protein metastability,0.0003118973611866241
human immunodeficiency virus type 1sars,0.000311463850331399
respiratory tract disease,0.0003113546621839081
coronavirus rna,0.00031101942786310215
mild clinical disease,0.00031095332564819075
codons enc,0.0003108414580673043
pediatric population,0.0003107386463335668
frscv,0.0003107130002551928
human myelin basic protein,0.0003106545739261636
calu3 human airway cells,0.00031048209466194305
likelihood,0.0003102868857054014
human wi38 cells,0.00031023871531765565
combinations,0.00031017356237742746
postreceptorbinding stage,0.0003100342560352211
exposure rates,0.00031001872889172775
viralinduced demyelination,0.0003097651272324477
serologic reagents,0.0003097261684985802
time lymphocytosis,0.00030937631550294846
hybridoma antibody,0.0003093474437931431
balanced control,0.0003093375313285686
natural mutation,0.00030917367934585246
hepatocytes,0.00030906561063739343
eggs,0.00030902885565363023
green fluorescent protein,0.00030865211874512774
nt primer extension analysis,0.0003086400744360293
inflammatory cytokine,0.0003083874878309744
eukaryotes,0.00030827960645751047
mhv cloning strategy,0.0003081391675524671
section interstitial,0.0003081194174369048
microgram,0.0003081095351467037
lung failure8,0.0003080547505833391
rad5based merscov s1 vaccine,0.00030762934003478697
immune protection,0.0003073233817118046
human coronavirus hcovnl63,0.00030704352221693013
molecular determinants,0.00030694465930307635
mhv pathogenesis,0.0003068532561308182
viral replicase,0.00030627108565997336
rtqpcr,0.000306136557993006
receptor recognition supplementary,0.0003061086967276611
viability,0.0003061019379622659
transfusion transmission,0.00030609474349695793
human lung fibroblasts,0.000305815772077074
multinucleated syncytial cells edema,0.00030567249376444057
brain immunopathology,0.00030551715057228765
ccl2 monocyte chemoattractant,0.0003046402440176423
postviral infections,0.0003044604865254905
clinical episode,0.00030438368883106817
coronavirus sarscov infection,0.0003043235390789699
ace2 molecules,0.00030418451618604675
e and 3a proteins,0.000304137820247966
amplicon ca 16 kb,0.00030408422624318514
nucleocapsid protein of mhv,0.00030394915902564614
king fahd general hospital,0.00030382448402537285
components,0.0003037196235510682
seroresponses,0.00030356477084707534
cov replicative machinery,0.0003034796123270469
myocardial dysfunction,0.0003030216940783129
development time,0.0003028636209117201
immunofluorescence experiments,0.00030256867356168784
pathogenic viruses,0.0003024020305120384
doi101038ncomms4067,0.0003023818180203434
293derived cell line merscov,0.0003023733710935729
coronavirus replication viral proteins,0.0003023287395705171
medical chart review,0.00030209751998373937
organ culture oc,0.00030188763273381633
structural integrity,0.00030186938890457995
sore throat cough,0.00030182270572489816
chest radiographs,0.00030173651561010115
predicted open reading frames orfs,0.00030172073098572335
genomic characterizations,0.000301685170717872
bcov rbcv wd,0.0003015823562027531
transport pathway,0.00030153197359802426
acute respiratory tract disease,0.00030127963585653897
interleukin 6,0.0003012700824058325
oral lactobacillus casei l casei vaccine,0.000301190657301142
noncanonical,0.0003011734602657611
riskbased surveillance,0.0003010384974635106
bootstrap,0.00030099853903162193
cap analogs gpppg gpppa,0.00030095078575277645
enzyme activity analysis,0.0003007203467828526
replication cycle tgev mrna 6,0.0003007131600558692
ergic compartment,0.00030063718958551577
resolution cryoelectron microscopy,0.00030020099128764104
highestaffinity mab,0.00030019210426942276
structurally,0.00030006533080185744
pyruvate kinase,0.00029995968204346937
lymphoproliferative assays lpa,0.00029939018069469187
ileumcecal junction,0.00029934407987094476
prototype strains,0.0002991997090754596
methods survival,0.0002987571090315797
3b proteins,0.00029871133907095426
yeasts,0.000298510050327337
transmissible gastroenteritis virus infection,0.00029849526893752976
coronaviral replicationtranscription complex,0.00029847431022216205
highvirulence biotype,0.00029783939232046837
mammalian-cell activate promoter element,0.0002973126161339895
atlanta ga 30333,0.0002969209547833694
turkeys,0.0002964544545616349
hydrocortisone,0.00029641887134012533
membrane topology,0.0002958701962117354
hyperleucocytosis,0.0002955206672525012
serotype i fecv field,0.000295408612113468
spillover animals,0.0002952365615054193
ciliated cell cultures,0.0002951021003314245
plasmid dna expression vectors,0.00029478208660349304
granulomatous necrotizing vasculitis,0.0002947814279672044
cysteine protease,0.0002945007840283999
yunnan china,0.00029449303347267824
ae,0.0002944679789276006
batcov,0.0002934157029712751
endosomal,0.0002933384702385703
discussions,0.00029310129469506575
bystander tcellmediated demyelination,0.00029304914294561713
b d zelus d r wessner r k williams m n pensiero f t phibbs m,0.0002924548356528938
intracellular viral rna,0.000292403284248524
short interfering rna sirna inhibitors,0.00029215873228473425
open reading frames 1a,0.0002921150089812504
plasma biochemistry,0.00029206927927556274
niches,0.00029195001594817016
dcsign dendritic cellspecific,0.0002918369534336288
inflammatory changes,0.00029166682403795137
immunodominant regions,0.0002913789755839576
intestinal immunity,0.0002913120920522037
nested reverse transcription,0.00029114922026236107
diarrhoeic,0.00029095506051668744
nucleolus nucleoli and proteins,0.0002908994184802962
inositolrequiring protein 1 alpha,0.00029065650901309435
radiological lesions,0.00029038508479285865
antiviral effect,0.00028953670083865633
murine cd3positive cells,0.00028938088019864986
oral,0.0002889554278484853
virus replication complex,0.00028882918781654855
distant virus,0.00028869344828779433
human respiratory coronaviruses hcov,0.0002884622697785501
syndromecoronavirus sarscov avianorigin influenzas h7n9,0.00028845442134687915
prime,0.00028843962490780663
structural polypeptides,0.0002881395182716977
enveloped virus,0.00028812628256794293
smokers,0.0002881189947355884
extracellular signalrelated kinase,0.000287635431002467
pulmonary consolidation,0.00028725469372664663
bone marrow stromal antigen 2 bst2,0.0002870004141520222
virusvermehrung nur i,0.0002867363341323545
sg mrna,0.00028671105188013234
t cell hyperplasia,0.0002866498063533097
twostep conventional,0.00028664323355485737
231aminoacid fragment residues 358,0.00028653537878252117
reverse transcriptionpolymerase chain reaction,0.0002864693324918012
high risk,0.0002864544409329824
google scholar,0.00028644144668783284
mucosae,0.00028638644065976846
brain parenchyma,0.00028633301944998936
polyclonal igg antibodies,0.000286216408031104
thinsection techniques,0.00028612325835124366
medical comorbidities,0.0002860698327863775
histological lesions,0.0002860340616708179
caspase1,0.000285893987909019
sarscov 3clproexpressing human promonocyte cells,0.00028547975359588057
high sequence,0.00028543478704578395
murine hepatitis virus strain 3 mhv3 coronavirus,0.0002854290921979633
lechones,0.0002853754082431136
exonucleolytic activity,0.0002851930282858116
human neural cell,0.00028517878936055004
epithelial layer,0.0002847626163461498
doi101007s1126201106687,0.00028470830274371535
hepatitis coronavirus a59 e protein,0.0002846970194682964
septic shock merscov,0.00028469645285740113
retrospective studies,0.00028420182644810677
enzymelinked immunosorbent assaybased system,0.00028389813060800134
anti-sars-cov humoral responses,0.0002836575425946381
pkr coronaviruses,0.00028364541642866793
coronavirus fcov,0.0002836334899384223
droplets,0.00028347396589169417
venezuelan equine encephalitis virus vee replicon particle,0.00028338024047817065
ntpasehelicase,0.00028321364358791233
infiltrates,0.0002831964285475506
eran,0.0002831449339622105
nl63 hku1,0.0002827518583483114
human cystatin d from,0.0002826487646523819
murine carcinoembryonic,0.00028259719019957483
revaccination,0.00028252654480358724
neutrophil macrophage,0.00028252473229528244
lipid vesicles,0.00028249450392737986
regulating t cell polarization,0.0002823268227063926
subcutaneous,0.00028223495661103845
infectious phase,0.00028219191319612196
primary influenza virus,0.00028198559000761915
enzyme immunoassays,0.00028183909224783126
contrast internal,0.00028183326773680706
commercial lat dipstick,0.00028173339264597454
tdrs 1,0.0002816643839056863
populations disease,0.0002814508484377494
sarscov 3clproexpressing cells,0.00028138570981524227
surface plasmon resonance,0.0002812742238482399
lrti,0.0002812505274891641
hku23 coronavirus,0.00028115741609663727
n-acetyl-l-cysteine,0.00028091976988272384
antibiotics,0.00028079138673961203
shortness of,0.0002807834622082273
sequence comparisons,0.0002807213565043801
country,0.00028055479023988674
ibv spike gene,0.00028052150601797686
adaptive immune system,0.00028022580630734413
autophagyrelated processes,0.00028018201280481474
war,0.00027990402383210386
sab301,0.0002797568402078241
overlapping sequences,0.00027971064268377996
cross-protective vaccines,0.00027967430443559825
preceding globular domain,0.00027950398908615647
organ system,0.00027935652280100304
suckling,0.00027915355284805653
cterminal ublike domains,0.00027914140092310125
functional antigenic sites c,0.000278916527003232
viral particules,0.00027891055156961393
comprehensive analysis,0.0002788712546904445
ribosome subunit,0.0002787684603773067
nasal aspirates,0.00027874542098370336
reverse transcriptionpcr,0.0002787136845469756
neurovirulent mouse,0.00027866421886361904
neuropathogenesis,0.00027863910911738696
indexes,0.00027854281368792986
postprandial,0.0002783502695494025
coronavirus scv,0.0002782211965970553
coronavirus frecv,0.00027799908109446395
antisarscov antibody,0.00027794331715110877
l casei vaccine,0.0002779297090320983
rbds binding,0.00027783344325932964
immunohistochemical studies,0.00027773555513705854
smediated membrane fusion,0.00027770990829321506
swab samples antibodies,0.00027770927605559625
rabbit,0.0002775301545312486
coronavirus mouse hepatitis virus strain jhm jhm,0.0002773253465834549
cell cytoplasm,0.0002773050961907198
monomeric mpro,0.0002772682006994428
coronavirus plp,0.0002772089384246339
recombinant murine coronaviruses expressing green fluorescent protein,0.0002771154521161246
reading frame,0.00027703612321993765
digestive problems,0.0002768144673171614
dimerizationactivity,0.0002765522829547086
immunochromatographic assays,0.00027650880759020935
basic myelin proteins,0.0002764582196944041
small,0.0002762877754089681
nasopharyngeal aspirates npas,0.0002762822985968535
nidovirus,0.00027603758173421313
bovine parainfluenza virus type,0.0002759507682720919
igm,0.00027592302435737286
infected alveolar macrophages,0.0002756190049107653
putative leaderbody junction sites,0.00027559722676967924
cellular receptor angiotensinconverting enzyme 2,0.00027558918237552497
camel workers,0.0002755066397217029
targeted recombination,0.00027548267311682033
membraneanchored fusion subunit s2,0.0002754611662758127
anticoronaviral compounds,0.00027520595816267257
3 e proteins,0.0002752032815554378
klinikum schwabing munich germany,0.000275135485764313
picornavirus rna,0.0002751118351038257
cd8 tcellmediated demyelination,0.0002749325128209964
oesophagus spleen,0.00027469097178930746
viralinduced neurologic disease,0.00027461880024936446
bln,0.00027456645093864646
newly acquired genes,0.00027431848160830685
singledose,0.00027407974217609065
reversetranscription polymerase chain reaction,0.00027404031912228467
polyubiquitin chains merscov plpro,0.00027402528434595233
neurotropism productively infecting neurons,0.00027381268622754556
mockimmunized hamsters,0.0002737418975524147
crossneutralize,0.0002737276819513181
hot-spot cdr mutagenesis,0.00027365177793443163
coronavirus whole genome sequence,0.00027364930721573435
reticulocyte lysate,0.0002735773432600149
rna polymerase chain,0.0002735357927126651
molecular information,0.00027337699797417675
coronavirusinduced dilated cardiomyopathy,0.00027296333772578005
noncanonical transcription,0.0002729110107287247
intra-species transmission,0.00027290848927258196
conditional growth defect,0.0002726270163081611
rtcproximal,0.00027257961127136876
interferon lambda,0.00027244537034157166
genome packaging,0.0002720939815766005
livestock poultry,0.000271973976617982
decades,0.0002719302797397417
living system chickens,0.00027186896444602243
virus origin virus recombination,0.0002717227743692293
human cellular receptor human dipeptidyl peptidase 4,0.0002715791193576928
laboratory diagnosis,0.000271557959615725
tgev orf4 m n,0.00027147974839625136
respiratory coronaviruses hcov,0.00027141040974683106
deduced amino acid homologies,0.0002713932033153217
p38 mitogenactivated protein kinase,0.0002713080831688915
enzymatic activities,0.00027125325467839036
egfr,0.0002712331974686767
singleparticle cryoem,0.0002710373581606119
feline leukaemia virus felv,0.00027094495070741363
molecular aspects,0.0002708908167453273
k48linked polyubiquitin chains,0.0002707320741107703
s1b,0.000270557385192297
ocasiones fibroblastos y,0.00027035849327930716
positive reaction,0.0002701402271459973
antivirals,0.00027005422128534507
regimen,0.000270013523086915
lymphoproliferative responses pigs,0.0002698782348263956
hcovnh infection,0.0002698075486356944
cd4 t cell response,0.00026956203493854386
in vitro system,0.0002693787840767183
cd8 tlymphocyte,0.0002692727012452563
viral dmv formation,0.00026920534369211525
fluorescent antibody tests,0.0002690831630452599
scov s protein,0.00026884383594137325
conserved conformational epitope,0.00026872826734534116
drastic amino acid change gly to asp,0.0002684669351860083
laryngitis,0.0002683457315903773
pcdnam pcdnan,0.00026790918021731
recombinant protein rs268,0.0002678893712414759
viral deisgylase,0.0002678511564358875
poisson regression,0.00026779896695713917
poor communication,0.000267641215776473
europe,0.00026754806298500186
rna processing enzymes,0.00026747965352215094
lesions virus replication,0.00026739757307991756
multivariable models,0.00026713050817612284
blades,0.0002669765272880017
phosphoric acid,0.0002669599921177719
cns glial cell,0.00026660133147010206
relational autonomy,0.0002665076643955357
uda,0.00026617192182233493
merscov plpro a,0.0002661146619200355
multivariable model,0.0002659938865935299
coronavirion,0.0002657688592802998
sirnasilencing,0.0002653707619956914
structural information mutants,0.00026517954670059575
immune communication,0.00026502591929767943
human polyclonal igg,0.00026486057914800474
dromedary camel,0.00026463485348821183
generalized model,0.0002644828117161989
histocompatibility complex class i,0.00026442279736696856
long hydrophobic membrane domain,0.0002644224089070865
enveloped positivestranded rna viruses,0.00026435001125840133
monoclonal antibodies,0.000264240170074253
oligodendroglia cells,0.0002641111899756095
polya tail length,0.00026390611234320733
host cell proteins,0.00026370676305884625
intermediate cleavage,0.0002636408212586357
assay format,0.0002635783587542306
virus vaccine,0.0002634674064959027
publications,0.000263258025439017
nucleocapsid protein n protein,0.00026290711731538266
cov sarscov merscov porcine,0.000262810214717477
host constituents,0.00026273777886671746
neurons,0.0002626842227003951
therapeutic treatments,0.00026259540352140245
11dayold pigs,0.00026235532174204466
autoantibodies,0.0002623299530902982
antiviral therapeutics,0.0002621932585150284
viral mrna,0.00026207188643044744
antigenreactive cells,0.00026186441614469184
chloramphenicol acetyltransferase reporter gene,0.00026172449348084713
apc,0.00026172020653558546
prototype group 2,0.00026168968579925187
grp78,0.00026153027535634807
clone mutant viruses,0.0002614830478517445
umrah,0.0002614664630139903
autographa cafifornica,0.0002614268261915227
provision,0.00026137705324092217
t cell populations,0.00026132237657064313
crossinfection,0.0002613139606357514
antiviral pathways,0.00026125324231569407
neutralising human monoclonal antibody,0.00026044423329827233
sarscoronavirusneutralising serum antibodies,0.00026023929068083937
therapeutic administration,0.0002601041319906625
european turkey coronavirus,0.00026004737067269774
binding motif region,0.00025971513197220485
experimentally virus,0.0002596896093997725
mersn protein,0.0002594726234157687
leptospira interrogans,0.00025933267585202753
selfcleaving,0.0002591114497305791
small intestinal villi lymphoid,0.00025900730426466463
apical membrane,0.0002589641198811276
phosphoprotein phosphoamino acid analysis,0.00025895600854985323
deubiquitinase,0.000258946689233747
serological elisas,0.00025877197716304994
nasopharyngeal secretion cells,0.00025874058723559113
potassium,0.0002585928209573585
haemagglutination-esterase,0.0002582855837430701
lung diffusion abnormities,0.00025819342026901527
respiratory diseases cancer,0.00025805643074376406
negative-pressure rooms,0.0002578932728255994
feline coronavirus fipv strain,0.0002576523972346762
sindbis virus,0.00025764321434519285
autoimmune diseases,0.0002576016458527881
abattoir workers,0.0002574912640330393
y217n,0.00025724495564858273
human cd26dipeptidyl peptidase 4 hdpp4,0.00025717737169726914
body weights,0.00025701660972696737
human specimens,0.00025647762868294383
rm and gnn,0.00025628507431619857
host shutoff,0.0002562794993385567
linezolid,0.00025588253764202717
minnesota,0.00025587247657149275
proteolysis,0.0002557875661012767
octylglucoside,0.0002555880481125313
de virus las modificaciones,0.00025554609043941013
cooh,0.0002554704146197097
mature sarscov replicase proteins,0.0002553581764339709
acute respiratory syndrome cov sarscov mpro,0.00025534952187001393
guts,0.0002553039762579343
twotailed mann whitney u exact tests,0.0002551180544119596
p21s10,0.0002547971903528926
respiratory distress,0.00025452690862509626
cov infection image,0.00025427128002034305
zn2binding domains,0.0002541192310951067
cellular rodent,0.00025406553959975755
cisacting viral proteins,0.00025371255710513076
viral genetic sequences,0.00025353628487004385
disposable gown,0.00025350895707981975
villous enterocytes,0.00025301704757679317
ciliostasis,0.00025258747212742133
plasma serum,0.0002522013419075169
lung specimen recombinant protein 3a,0.0002521337581652906
npu,0.0002520057283281937
doi101038nature02463,0.0002519966598146132
cooler,0.00025198372647131616
vp10 protein of rotavirus,0.00025195945693842054
hypothesisdirected literature,0.00025178543337068984
application,0.00025174457150020955
virus interpretation,0.00025143037147356347
evolutionary analyses,0.0002513966149311196
acute respiratory syndrome sars sars coronavirus cov materials,0.00025134702886732554
expression vector,0.00025121895048877427
diarrea durante las,0.00025121569760975387
biochemical assays,0.000250963308337858
minute amounts,0.0002508980530229161
human aminopeptidase,0.00025084626653728724
nucleocapsid n protein of sarscov,0.000250835098935535
internal initiation,0.0002508114151964771
bronchoalveolar lavage bal hcov strains,0.0002507537655955967
merscov s glycoprotein,0.00025045033170619023
8a,0.0002503328141770154
cats kittens,0.0002503046843255522
guinea pig,0.0002500714279742422
6thioguanine 6tg,0.00025005088117637127
human spleen cdna library,0.00024958519607764477
administration,0.00024952700958082337
citric acid,0.0002495012108622345
aromatic substituents,0.0002494830168771482
influenza vaccines,0.00024935871079987987
postbinding stage,0.0002491503428481065
interleukins 18 p  014 and 1a p  031,0.00024909874694716277
t cell chemoattractant chemokine cxcl10 interferoninducible protein 10,0.0002490481432413262
sars-cov genome,0.0002490139714099434
p6,0.0002489724646235283
pcr array,0.00024895716095379723
partition,0.00024892266137824395
north american tricolored bat perimyotis subflavus,0.0002488443610376944
proteinligand xray structure,0.0002487054779015032
faculty,0.00024858358977487057
rhace2,0.0002485201706662026
cost,0.00024839864855218693
neurological fip,0.000248356085654327
viral rna replicationtranscription,0.0002480957557476408
divergence,0.0002480212166346976
highdose steroids,0.00024779779951984726
acute respiratory syndrome coronavirus papainlike protease sarscov,0.00024777126018424214
protein kinase r pkr coronaviruses,0.0002476682661065446
s1s2 heteromers,0.0002475849192995954
murine glycoprotein receptor,0.00024750018697332853
human tissues,0.0002473733882534981
lat assays,0.0002473494470945589
associated disease,0.0002468825293514432
single hcov infections,0.0002468788905979349
outpatients,0.00024666297044877514
homologous virusneutralising vn antibody,0.0002465870954147649
murine hepatitis virus,0.00024649735871698904
quantitative reverse transcriptionpcr qrtpcr tests,0.0002464212651564461
predilection,0.00024638827185555066
immunofluorescence slides,0.0002462939600952886
v m  ,0.0002462186104903844
chong kh chang hh leung b ling,0.0002461981965980956
intestinal,0.00024618791327882163
heat,0.00024608035020321037
cell culture system,0.00024604497975011383
tricistronic,0.00024597558028010625
cytolytic activity,0.0002457677362547981
sarscoronavirus transmission,0.00024567416720278057
positivestrand rna viruses,0.00024557455042473994
alphacoronavirus,0.0002455385497851965
bat slcov,0.0002451307825891769
hand washing,0.0002450558064647779
dr zhengli shi,0.00024501959611756744
orf 1b region,0.00024499856648824294
glass slides,0.0002447655584235998
possible functional site,0.0002447162383879776
disease manifestation,0.0002446976187186381
hospital records,0.0002445999977949845
essen germany,0.00024419791138659307
vaccination profiles,0.00024392141737348365
deletion mutants,0.00024390338939095946
cellular immune response,0.0002433098652767909
phosphatase activity,0.00024330205417645367
clinical differences,0.000243239159918124
sandwich format enzyme immunoassay,0.00024323164018653765
structural domains,0.00024289143432691004
analysis of variance,0.00024196549389604704
rna alignment,0.00024171134883542412
infectious potential,0.00024119131071266315
sanitized,0.00024114529387413595
nonnative receptor,0.00024107579885900663
eastern province,0.00024105869339315634
glial fibrillary acidic protein,0.00024105697691205515
proapoptotic viral proteins,0.00024093649876668268
phenotypes,0.000240712605149907
interferon lambda ifnl1,0.00024070115918833925
leadermrna junction sequence,0.00024059775166973397
biological activity,0.00024049188706358113
human parainfluenza virus type 2 hpiv2 interferon ifn,0.00024041681911038
deubiquitination,0.000240236370120234
fatal infection virus antigen,0.00024018808345586034
africa methods,0.00024016243775913348
human convalescent sera,0.00024002325855551585
ibvreplicating sites,0.00023986639031955699
positions,0.00023981093182186738
extensiver,0.00023973603286519282
nsp34,0.0002395264154336961
bananin antiviral activity,0.0002393984105727967
howard mueller jhm,0.00023935619288905166
hdpp4 mice,0.00023929235698441875
refolded protein fragment,0.0002392749340341528
m gene,0.0002391046237505562
l386del,0.0002390704124170783
cellular defense,0.00023896859759859148
parkinsons disease,0.00023866005041678568
cov nsp14 exoribonuclease exon,0.00023865698086966315
nanobodies,0.00023836710417476256
endoplasmic reticulum network cellular,0.00023817881476003296
transcription factor 6,0.0002380556678162359
doi101007s1126201208640,0.00023801335371571514
inflammatory demyelinating,0.00023774046106361089
cooh terminus,0.00023773267227559
ecov nsp3 protein,0.00023773200584978582
vn antibody,0.00023765937600787843
genetic material,0.00023743141459992503
bat coronavirus batcov,0.00023742695675967897
neutralising,0.00023726312415417054
translational,0.0002372526191466026
life threatening disease,0.00023709510007936384
saudi arabia ksa 2012,0.0002369798225440684
seasonality,0.00023697252479954484
ultraviolet c uvc,0.000236813117503402
viral rna polymerase,0.00023675929036955616
dnas mvas,0.00023667029772387357
activated t and b lymphocytes expressing cxc,0.00023633705605551197
spanish camels,0.00023624264436981614
gz02 variants,0.00023607239135838617
replicationcompetent propagationdeficient vectors vector,0.00023605923148839749
quantitative realtime rtpcr assay,0.00023579022615460962
virological technique,0.00023572670019719074
1950s genotype b and c,0.00023570825853863362
tgev monoclonal antibodies,0.0002356538773655995
leucinerich polypeptide,0.0002355539871731357
nbs,0.0002349964028290486
hydrogen bonding,0.00023498882761003413
e faecium,0.00023488721901978546
strain-specific nab,0.0002346380703688596
human samples,0.00023458468787019993
bifunctional,0.00023453663292279602
congenic mice,0.0002343903472842342
putative multiple sclerosis,0.00023436829937482985
continents,0.0002343402825942148
pig,0.0002341938796656224
human ciliated airway epithelia hae derived,0.0002341461649591487
asymmetric amplification,0.00023402926086907086
killed,0.00023394693994062198
surface plasmon resonance biacore mass spectroscopic analysis,0.000233844692350995
activity halflife,0.00023372136753195942
guinea fowl coronavirus,0.00023358928575567043
vesicular stomatitis virus,0.00023333019331593484
fusion protein gene,0.00023331351926966985
r menard j virol 7945504551 2005,0.0002332047314360775
delta value,0.00023310529657055988
cxcl8interleukin8 il8,0.0002329796105637395
drinking,0.00023254831137271853
bat coronavirus hku5,0.00023252150153869446
fecal specimens,0.0002325116631649703
merscov receptor dipeptidyl peptidase 4,0.00023250678682242164
genetic subgroup,0.00023242023594596833
dual virus,0.00023240463822698831
fcov electronic supplementary material,0.0002324025912339517
insect cells,0.00023230625892349207
nasal mucosa nasopharynx lung stomach small intestine colon skin lymph nodes thymus bone marrow spleen liver kidney,0.0002322081277321507
nucleoside analogue gs5734 remdesivir,0.00023220092363373078
progress,0.0002320071693279046
epidemiological aspects,0.00023188791372780654
upper respiratory tract infections,0.00023098262382650642
chemokine ligand 2 ccl2 monocyte chemoattractant,0.00023091027819972223
hcov infection,0.00023079841392720945
protein 8ab,0.0002307925868621206
gene 3 transcriptionassociated sequence,0.00023073394229448308
hku4spike,0.00023073376468304562
host factor,0.0002305748525305806
copathogen and host factors,0.00023054892289755378
mouse hepatitis coronavirus mhv a59 e protein alanine scanning insertion,0.00023039282922722974
antisense peptide nucleic acids pnas,0.00023003708334341967
merscov fusion inhibitor,0.00023002657436436294
long hydrophilic carboxyterminal domain,0.00023002627807085238
coronaviruses hcov229e hcovoc43 sarscov hcovnl63,0.00023000056751559708
primary human alveolar epithelial cells,0.00022995127567063012
eukaryotic rna viruses,0.00022983800622451356
lactate dehydrogenase,0.00022936754705344962
sharks,0.00022915743190468407
transcripts,0.00022908380909699848
pulmonary alveolar septae,0.0002290485156113928
resistance,0.00022900345302949706
human astrocytic cell,0.00022877351055346326
herpes simplex virus 1,0.000228760887067882
west nile virus influenza virus norovirus,0.00022841921444300025
sars cov nucleocapsid antigen,0.00022827704749479663
sar,0.00022820407053835069
coronavirus sarscov nucleocapsid proteinbased enzymelinked immunosorbent assay elisa,0.00022796992995171612
murine coronavirus polymerase,0.00022788325530231866
experimentally,0.00022787354740295228
subgenomic mrna species,0.00022786237936322164
block coronavirus infection,0.00022781759414060846
chronic renal disease,0.0002278148340361212
antibodies viral,0.00022774277790576388
cell fusion,0.00022746043834035614
occupational exposure,0.00022741429535092493
therapeutic efficacy,0.00022727327572444325
sars coronavirus sarscov nucleocapsid n protein methods,0.00022717064790861468
depletion,0.00022700392372968964
endemic,0.00022698916866846836
enteroviruses,0.00022694999110754662
immune effector,0.0002268651374971041
viral virulence factor,0.00022673158434642014
wealth,0.00022639902753363104
nl63gfp clones,0.00022633344613431176
mv and foreign antigens,0.0002262413018224095
markers,0.0002259228148709301
sarscov virus,0.00022576707248330103
nucleotide positions,0.00022560719271404314
technologist,0.0002255677575123793
homogenized,0.00022518845677252491
orf9a,0.00022496586054978848
nl63 6,0.00022495690201144013
lspcf fiberoptic biosensor,0.00022493740864796532
viral tissue,0.00022462035692223425
trypsin a single 1 to 2,0.0002245967252470545
early diagnosis,0.00022451460112490174
metagenomic,0.00022443176443077802
analytical methods disease,0.000224106892132434
positive-strand [(+)-strand] coronaviral genome,0.00022408896844437694
acute encephalomyelitis,0.0002240445000343638
bovine coronavirus bcv ns2 protein,0.0002238236379780255
inoculated units,0.00022380719218437626
geographical variability,0.00022380466235643077
virulent tgev,0.00022360088448752222
retrospective review,0.00022357113745042937
human hnrnp a1,0.00022341101009913094
familial caregiving,0.0002232080221385508
female,0.0002231972523348518
rf1,0.00022276456621375586
nsp1nsp2 cleavage site,0.0002226388356321582
neurotropism,0.0002226087827987097
rna cleavageinducing function,0.00022242162041805034
multiple regions,0.00022236099868295597
lymph nodespecific homing receptor,0.00022232781390054174
exon proofreading activity,0.00022216759004980053
coronaviruses mouse hepatitis virus,0.00022211045703496014
tdr  10,0.00022200959068423637
virus purification procedures,0.00022196867660225424
opening reading frames,0.00022175723390315262
mouse hepatitis virus mhv variant mhvbhk,0.00022150629019188157
sick rabbits,0.00022135311397312253
neutralizing epitopes,0.00022115109634143746
characteristic,0.00022074555800972393
viral phosphodiesterases,0.00022067576024070024
anti-inflammatory cytokines,0.00022061865076013004
middle eastern camels,0.0002206128059798579
putative coding sequences,0.00022033774167369712
camelids,0.00022031042458488882
cell line merscov nsp1,0.00022027020882880115
protease inhibitors,0.00022019861385432475
generated unusually group 2 antibodies,0.00022015172355251199
hydrophilic residues sequence,0.00022005768403479762
mocktreated,0.0002197837954205425
membrane permeability,0.00021978221308664673
reverse genetic studies,0.00021978187222545967
cathepsin b ctsb,0.00021927105267337415
peripheral blood samples,0.00021917069488717217
inflammatory response,0.00021903832667157053
alveolar integrity,0.00021896723991124759
coronavirus family,0.00021862661134158099
recombinantdirected expression products,0.00021861462569117983
groupspecific gene cluster open reading frame 3abc,0.00021849696153867124
recombinant virus,0.00021848741574742494
unusually labile spike protein,0.00021807013527383657
human airway cell cultures,0.00021724606086648675
assayed,0.000217129281059322
feline coronaviruses,0.00021705414017736087
dsrna binding protein,0.00021703141666637262
multiple studies,0.00021691687191655149
virusspecific mrnas,0.00021670634774159498
singlesubstitution viruses,0.00021637310191358845
live-attenuated ibv vaccines,0.00021626970499128939
human immunoglobulin,0.00021612234227269775
merscov receptor,0.00021606273659668815
golgi complextargeting signal dissecting,0.00021491178432423862
nlinked sugars,0.00021489778495575808
oligonucleotide resequencing,0.00021486598439910909
late demyelinating encephalomyelitis,0.0002148016416690436
son una entidad muy frecuente,0.00021478932134602792
antigenpresenting cell apc,0.00021475563847907778
knowledge gap,0.00021467681648798696
cellsurface molecules,0.0002144050350820777
systemic coronavirus disease,0.00021437582370501185
sarscov valinomycin glycopeptide,0.00021431840955538943
high secretions,0.00021408963317396927
enveloped viruses,0.00021407973590076282
translation machineries,0.00021404563073415235
consistency,0.00021384442407278262
23kb polymerase region,0.00021383935708797254
cytoplasmic stress granules,0.00021382743175169897
gastrointestinal swine,0.00021381163569864366
xray crystallography electron microscopy,0.00021367863998547284
right-hand fold,0.00021355708721441802
complementarity determining region,0.0002134497500189343
weekly,0.0002133694349055144
bud,0.00021336082579595893
cellular membranes,0.00021332593555471271
nasopharyngeal aspirates nsps,0.00021328980358701724
in situ hybridization,0.00021320568210538804
children testing,0.0002129190803689836
gko,0.0002128608900708882
acute aspiratory syndromecoronavirus sarscov,0.00021233606448494194
furin-like cleavage site,0.0002123132302442629
permissive cell lines,0.00021196312111950943
euthanized daily,0.00021188706620793574
feasibility,0.00021187917744250293
disease realtime assays,0.0002117102970626619
ucuaa sequence,0.00021162365941625375
sars_n/human hnrnp a1,0.00021149247558285
rnabinding protein complex,0.0002114854101484137
coronavirus transcripts arterivirus,0.0002114741583215287
virus receptors,0.0002113224937574947
protein surface,0.00021131286104046794
400 cellular proteins,0.00021130073831147667
betasitosterol ic50,0.0002112122536130882
mhv-jhm 3cpro and flanking hydrophobic domains,0.00021114076633858047
membrane m protein,0.0002111160330235891
expansion,0.00021109778496474052
semiquantitative assay,0.0002110550212638658
orf1b,0.00021085997507593927
pvx,0.00021060003506887442
wildtype viruses,0.00021056232716100043
proc natl acad sci u,0.00021046856204573553
blue line,0.00021043043809426128
diagnostic relevance,0.0002104192085976716
virusinduced,0.00021026110456217497
diabetes mellitus,0.00021017870214788572
virgo consortium,0.00021007810082883477
hcov,0.0002098202518485424
prophylaxis reports,0.0002097980332460012
laboratory analyses,0.0002097588287292081
autophagosome membranes,0.00020971317129841042
simian kidney vero cell,0.00020929097173838135
pulmonary endothelial cells,0.0002091941716840087
attachment stage,0.0002090242180611227
recombinant n protein hgstn,0.00020894690984887403
rna molecule,0.00020856454507366416
normal,0.0002085566342583508
heparinbinding egflike growth factor,0.00020814334267726115
respiratory droplets,0.00020796817687476524
lysosomotropic agents,0.00020795525129561212
infectious peritonitis virus,0.00020791682499457718
coronaviral enteritis,0.00020788353408832016
complement activation,0.00020761826897976407
microwell immunoperoxidase test,0.00020761442239480133
mhvinfected 17cl1 cells,0.00020739774638681767
secondary immune response,0.00020701089178784708
porc,0.00020691545659552618
sarscov rna,0.00020648975666381588
tgev nprotein deletion mutants,0.00020623695516323436
cterminal and nterminal,0.0002062182296553109
lectins,0.00020595457452148334
inflammatory cytokineschemokines,0.0002057564159805789
human neutralizing monoclonal antibodies,0.00020551011026307233
chronic pancreatitis,0.00020550139700019823
sars-cov s-protein receptor-binding domain,0.00020543297968823705
prototype,0.00020538852078915405
sarscov s protein sarscovst19,0.00020537491600952485
human coronavirus nl63 cn060114,0.0002052903977935047
defense,0.0002051817505497508
nonconservative aminoacid change,0.00020515755427801005
nspecific igg,0.00020489940547555296
mixed neuronglia culture,0.00020481804397429353
sepharose 4b,0.0002047876435265324
primary neuronal,0.00020472897594537762
fibrosis,0.00020472550545745047
coimmunoprecipitation assay,0.0002046714476768988
scv antigen,0.0002043981810247479
cysteinerich c terminus,0.0002043716558223551
coexpressed,0.0002043218537853324
problems coronaviruses,0.00020422769258744312
affecting,0.00020415003101020458
betacoronavirus genus,0.00020380419000975386
amino acid substitution,0.0002037903053380891
basal group 2,0.0002035384158205256
multiple virusinduced,0.00020337494748889218
open reading frame 3 orf3,0.00020328989688598404
external subdomain,0.00020322212938167763
tripartite polymerase complex,0.0002030963172968093
perinatal disease,0.00020297140657787787
recombinant ibv,0.0002028929214035911
viral detection,0.0002027351169859232
genotypes western blot assays,0.0002027108057782091
bioinformatics analysis,0.00020269878234111454
picornaviral 3clike protease domain,0.00020269586662652352
ibv accessory proteins,0.00020264960875193653
nonstructural protein nsp 14 bacterially expressed forms,0.00020264273328301675
non-structural protein 15,0.0002024453477833087
wildtype sl form,0.00020242089672658164
blood supply,0.00020237982256601656
human coronavirus nl63 hcovnl63,0.00020214837544447927
primerindependent rna polymerase,0.0002019757285500247
amino acids gly244,0.00020165165275814727
primary replication site,0.00020155809519885478
clinical significance,0.00020113105036910234
reversetranscriptase pcr,0.00020094090691869724
mouse hepatitis coronavirus a59 e,0.0002008415003710324
protein processing,0.00020083900518334073
fusioncore,0.00020076570769895875
membranous elements,0.0002007317687691132
detection rates,0.0002006380651572659
hamster bhk and st cells,0.0002004748275800857
hela cells,0.00020045801068516368
recovery,0.00020041472987316063
angiotensin-converting enzyme2,0.00020025104258351883
apical aacuaaa heptaloop,0.00020002335496817055
boost,0.00019982186814920236
dnsp16,0.00019948573301927598
multiple protein products,0.00019939830379654181
pseudoknot-independent,0.00019933871448396182
spur development,0.00019927949058190118
whole blood serum,0.00019914658790715122
transiently transfected 293ft cells,0.00019909885602643798
european guinea fowl,0.0001990083867225113
mice mice,0.0001988896062402289
antigenically,0.00019885908842262113
merscovspecific,0.000198603998871394
monocyte chemoattractant protein1,0.00019860393401928788
nucleoside,0.00019833198013158415
nsp14 exoribonuclease exon,0.00019790336738353625
nonimmunocompromised,0.00019730870795629985
coronavirus nucleocapsid,0.0001972486915022414
enzymelinked immunosorbent assay,0.0001972473562774326
orf7borf8 region,0.00019707273776118316
immune activation,0.0001970716006799104
nonstructural protein bcv mrnas 5,0.000197040418483671
high dose,0.0001966157806163347
renal cells tracheal epithelial cells,0.00019650223428580615
presenting,0.00019634557808375082
recombinant vv,0.00019624495247142496
calcium binding,0.000196228963143681
mhv replication complex,0.00019612274353480818
transmissible gastroenteritispurdue 115,0.00019605477426907483
liver function,0.00019593875107300616
minigenomes,0.00019593223134868395
recombinant wildtype virus,0.00019591055410392506
eukaryotic,0.0001958314341479265
potentials,0.0001955002874268256
spike glycoprotein ectodomain,0.0001954695582290362
israeli dromedary camels,0.00019532776054279784
coronaviral replicationtranscription complex rtc,0.00019529733254228474
ribonucleoprotein genome,0.00019527849022798474
fip virus fipv mutant,0.0001952739253611187
proofreading pathway,0.00019521894314280505
th2,0.00019520348122840445
chicken hostrelationship,0.00019500492999460474
family coronaviridae,0.00019486279830667396
acidifiers,0.00019459339033826191
human lungbronchial epithelial cells,0.0001944335201883913
nbms10,0.0001941802158632126
aminoterminal 26,0.0001941244824493164
merscov spike protein vaccine,0.00019394929897089156
enveloped singlestranded positivesense rna viruses,0.00019394071672840246
mv and merscovneutralizing antibodies,0.00019393109908957002
tgev orf3 gene,0.0001938503370017265
rna-dependent rna polymerase,0.0001937716954745711
transmembrane anchor,0.00019374705379301738
exposed either,0.00019369204980092608
catalytic nucleophile lys 289 points,0.00019355064615301178
control sera,0.00019350546422930673
membrane m protein mutant,0.00019346770084812436
membrane m protein mutant e proteins,0.00019345149246316058
hydrophobic heptad repeat regions,0.000193394821716867
hong kong 138,0.00019333722335611612
murine dcsign homologue,0.00019290871422271248
dead box rna helicases,0.00019267675588440536
nt,0.00019248176914798932
inhibiting,0.00019240125468811676
mers coronavirus vaccine methods,0.00019233428974193116
periods,0.00019218853318879909
440nt sequence,0.00019218222650322205
renilla luciferase rluc reporter gene,0.00019216217980637807
sa and spike b sb proteins,0.0001920818727168931
dominantnegative,0.0001920544487143999
viral fusion inhibitor,0.00019201380328337668
genetic variability,0.00019196864303360235
necrotizing lesions,0.00019171530634499195
secondary response,0.00019161079345065158
palmitoylated e proteins,0.00019141859179570186
cysteine protease inhibitor k11777 2sn1e3s1benzenesulfonyl5phenylpent1en3yl2e4methylpiperazine1carbonylamino3phenylpropanamide,0.00019128920427916634
contagious gastrointestinal swine disease,0.000191260390536747
orf 1b,0.00019124964874732146
breath,0.00019111487874615905
human coronavirus 229e proteins,0.00018979305278176456
inflammasome,0.00018977850623819648
clinical relevance,0.00018973592509005232
feline coronavirus fcov fcov,0.00018963577443256656
nidoviruses,0.00018959400451786047
fast renal clearance,0.0001895567286416834
human chromosome 15 enzyme markers mannose phosphate isomerase,0.00018947581255457556
matrix metalloproteinases2,0.00018934860322253162
epidermal growth factor receptor,0.0001892637818504683
truncated endodomain reconstruction,0.0001892632550428865
urine clinical diagnosis,0.00018910306596741738
embase cochrane,0.00018888537341500008
chicken embryo kidney cells,0.00018869093788747494
merscov infected airway epithelial cells,0.00018846075352866885
cterminal human,0.0001884037411947937
control virus,0.00018827249690817651
cotton,0.00018808213636452162
sars_cov replication/transcription complex,0.0001880605574956056
persistently infected murine cell cultures,0.00018804850059731882
merscovspecific antibodies,0.000188027908171081
excised,0.00018801773449835682
mucosal antibodies,0.00018799826184651497
recombinant ibv strains,0.00018799081869360143
gene deletion region,0.00018792723986477022
murine dendritic cells merscov,0.00018775249380132293
resialylated,0.0001877061236244512
therapeutic design,0.0001875197058558234
duodenum pyogranulomatous panophthalmitis,0.00018735415892019198
respiratory syncytial virus 61 parainfluenza virus 3 1 influenza virus,0.00018725662502109034
immunofluorescent staining,0.00018721174652506874
receptormediated pathway,0.0001872100050249063
cross-reactivity,0.0001870685636029452
macrophages monocytederivedmyeloid,0.00018696343181672211
chemokine receptor 2,0.00018682649315740607
j.,0.00018673568027406507
immune-mediated demyelination,0.00018661168166832565
sarscov nsp14,0.0001863319024391954
rbcv isolation tests,0.00018622168458520401
mild upper respiratory symptoms,0.00018618496050122114
open reading frames orf,0.00018616122423123144
lamina propria mucosae,0.000186147182566115
proapoptotic proteins bax cytochrome c cytc,0.0001861008317103549
high resolution computerized tomography,0.0001861004721386084
nitric oxide,0.00018592094442278686
igg immunofluorescence assay,0.00018590102137656041
mg1363psecn,0.00018563532274104127
robustness,0.00018553589022094155
coronavirus nonstructural protein 9 nsp9,0.00018502001026763252
receptorexpressing cells,0.00018493817571545
sarscov rbd batsrbd batsrbd,0.00018449994937863958
swine acute diarrhea syndrome coronavirus,0.00018449637826188886
primary healthcare centres,0.00018390659501544776
wildtype titres,0.0001836348276041924
bat coronavirus hku2,0.00018362963335143744
human interferonstimulated gene product 15 hisg15,0.00018352516219728333
acute enteritis,0.0001835139300834811
mers-cov case identification,0.00018341306050268828
pkr,0.00018335032275476815
aggregates,0.0001831049208575457
a31,0.00018309600003543747
chr of middle east respiratory syndrome,0.00018307914466566053
viroporins,0.00018282516264965263
positivestranded,0.00018259040229361284
feline coronavirus fcov infection,0.0001825683672164305
arterivirus,0.00018249084478439068
activation-induced cytidine deaminase,0.00018231208159432178
sister relationships,0.00018224936812592587
double antibody sandwich method,0.0001821472227219418
transmembrane m protein,0.00018209369538978436
seattle children,0.00018158353821991262
functional merscov receptor,0.00018138883124549794
pneumocytes,0.0001813811830215575
3c,0.0001813269581785838
structured,0.00018128825765232335
sars-cov spike protein,0.00018119341325832747
infectious dose,0.00018115374046966148
polya tail,0.00018102021722748464
pkr kinase activity,0.00018088396299725768
antithrombin iii preparation,0.00018076450195699345
sars coronavirus sarscov nucleocapsid,0.00018064328912768436
kdke,0.00018053881646327275
anticoronavirus activities,0.00018030287536583206
neutralizing sarscov,0.00018028959958404968
pbm,0.00018025689287088704
pseudovirus assembly,0.0001800372673422537
trials,0.00018001160576447314
biocontainment facilities,0.00017992890547302432
enzyme labeling,0.00017982368039010595
selective index,0.00017979615225420845
hku9 bcovhku9,0.0001797102135412149
ergic localization,0.00017954522921104755
guinea,0.00017934845887374634
1146nucleotide gene fragment s1b,0.00017931626520635148
mouse central nervous system,0.00017917346372982106
immobilized antibody,0.00017908318729132204
amino acid long proteins,0.00017899626401615568
lectin affinity plasmapheresis lap methods,0.0001785433868124271
gene silencing rna,0.000178524695535853
macro-h2a-like fold,0.00017849632320760745
amino- and carboxy-terminal flanking domains,0.00017848488166343594
realtime quantitative reverse transcriptase pcr,0.00017846897057935724
canine fibrosarcoma cell line,0.00017753792481767306
sitedirected mutants methods,0.00017750363967292503
infectious peritonitis,0.00017742750488392825
ibv structural proteins,0.00017730265817134455
glucoseregulated protein,0.00017729378728594414
multinucleated,0.00017686885536764545
avian coronaviruses avian,0.00017670338967547774
jhmv-specific cd4 t cells,0.00017659786114887933
glycosylation status,0.00017645493823820077
visualized,0.0001764143339216162
sars spike protein,0.0001764077551118075
rectal swabs,0.00017631503632701772
translation membrane biosynthesis,0.00017594746766204332
glycoproteinmediated cell,0.0001758069234458008
peplomeric glycoprotein e2,0.00017563052729084317
virus passages,0.0001753074915483475
kb long,0.00017524030689550498
sars-cov virions,0.00017503291150058696
sars-cov 3b protein,0.00017485578016181137
merscov serological,0.0001746277839797237
murine monoclonal antibody,0.00017461977006380403
cellular attachment receptor,0.00017433566245176154
acute respiratory syndrome sars coronavirus cov a protein fragment sii,0.0001741852597852847
beef cattle,0.00017387999499649377
rnadependent rna polymerase rdrp rna helicase proteases metalbinding proteins,0.00017383549535469732
cubic,0.00017361912744287092
type 1 pneumocytes,0.00017355592398233426
ultrastructural features,0.00017329514550781737
hp,0.0001732088728390405
mouse brain,0.00017316526796025357
vulnerable populations,0.0001730768095732383
positive amplification,0.00017298225930521198
nivalis agglutinin hippeastrum hybrid agglutinin,0.0001728841743338126
cebp homologous protein,0.00017283094190132466
sf,0.00017278325710294956
reticulovesicular network,0.0001725530493396778
ns4a,0.00017244304652209465
participation,0.00017243754901150317
serological analysis,0.00017223132223052952
sarscov receptor ace2,0.00017213899159020194
p70,0.0001721256287714158
golgi retention signal,0.0001717717732192079
pbacoc43fl complementation,0.0001716961138475778
study population,0.00017149984325718622
genebased vaccination,0.00017148377432955607
routes,0.00017145999376457752
il6 il8,0.00017145201783137277
m protein glycosylation,0.00017114107536851618
receptor activator,0.00017105445832321187
trees,0.0001710013159291321
gastroenteritis virus monoclonal antibodies mab,0.00017097036167466298
nuclear ribonucleoprotein a1 hnrnpa1,0.00017071642294094538
crystallographic methods,0.0001704199532090453
nucleic acid isolation,0.00017040856817019816
sudden emergence,0.00017026899545948278
igg1,0.00017025194472003677
aromatic residues,0.00017018730064782727
respiratory viruses primary human monocytederived macrophages,0.00017017563533445592
ethiopia,0.00017015880928260697
l lactisbased mucosal vaccines,0.00017015780424639034
fecal contamination,0.0001699530180744849
dipeptidyl peptidase 4 receptor,0.00016992388558550737
345dimethylthiazol2yl53carboxymethoxyphenyl24sulfophenyl2htetrazolium inner salt mts assay,0.0001698879343606517
serum sars-cov,0.00016979746769867494
canonical rnadependent rna polymerase,0.0001697456482345493
atomic,0.00016973343147542248
mechanistic,0.00016969915312097395
bovine coronavirus bcv,0.00016944775858871063
murine coronavirus polymerase gene,0.00016918797101564333
receptor of,0.0001691806461945912
lymph node bone marrow heart aorta,0.00016913452141590338
chicken tissuespecific protein genes sequences,0.00016896132151538837
intramolecular substitutions,0.00016888128380526966
external,0.00016866719594448796
ty-batcov hku4/pi-batcov hku5,0.00016841826832658224
hr2based fusion inhibitor drugresistant variants,0.00016839710887236613
late stages,0.00016803547564892856
gross,0.00016803481176496643
human intestinal cell lines,0.00016750408693279922
sedimentation behavior,0.0001674019816499614
orf7b transmembrane domain,0.00016722717345321074
bovine coronavirus spike glycoprotein,0.00016706409724276421
chimeric sarscovs,0.00016702260870593016
concatenated fragment,0.00016697761498217202
treatments,0.00016690020969513972
complications,0.0001667182560086907
open reading frame predicted,0.00016662762732586373
human immunodeficiency,0.0001664206702286657
stx1 7,0.00016640462423114308
polymorphonuclear neutrophils pmn,0.00016638332978714782
strain beaudette,0.0001660943886341127
il18 regulate cells,0.00016592948453253567
hcov infections,0.0001658410701832562
immunopathological events,0.00016578680189018567
intranasal infection,0.0001654490946038983
inter-species adaptation,0.00016539327888786772
imino proton solvent,0.00016528142708260917
n321 amino acid 321,0.0001651998591678439
distant coronaviruses,0.0001649135412578264
doi101038nature12005,0.00016484720689872954
cytochrome c cytc,0.0001647874206256774
blot hybridization,0.0001646786987538318
proclamation,0.00016466041128651953
acute diarrhoea,0.00016430863986543313
anticxcl10 neutralizing antibody,0.0001641488376927033
bronchoalveolar fluid,0.00016393174990457076
domestic fowl,0.0001638468464522023
third merscov transmembrane protein nsp6,0.00016368015533814982
nucleolar marker proteins,0.0001632541349161143
authorized,0.00016323812963654806
cytopathological,0.00016310006756266662
coronavirus swine acute diarrhoea syndrome,0.00016301579797937935
augmenting,0.00016288121303469934
resialylated erythrocytes,0.000162827980411747
receptorbinding s1 domain,0.0001625250510118219
rhinovirus coronavirus,0.00016219775685365065
mouse dpp4 locus,0.00016215808516564271
camel sera,0.00016205013119603647
fomites,0.00016191092959467955
chain-shuffling,0.00016134940803706882
cholesterol,0.00016130403795634388
mers-cov replication,0.00016129469707520054
clustal w program,0.0001609627349554752
mouseadapted virus,0.00016067888482333665
polar hydrophilic residues,0.00016065831375008667
solution nmr structure,0.00016047587781716651
oligou stretch,0.00016036935580522504
deubiquitinating enzyme inhibitor,0.0001603070028692474
mouse genome,0.0001601004158486532
syncytia,0.00015999538321062986
vakuolisierung der golgielemente der,0.00015997683559184944
protective effects,0.00015970784766630475
chicken embryo kidney cek cells,0.0001596461220777889
ibv italy,0.00015960654120373045
wt,0.0001594310595174586
cov mrnas,0.0001593599635703878
coronaviruses hku4,0.00015919718298934696
open reading frame orf 1a pcr positive samples,0.00015914575607857567
domain protein,0.00015913224951983286
synonymous codons,0.00015895884439883268
sars-cov urbani strain virus,0.00015892170495265096
golden syrian hamsters,0.00015889552402957423
fcov-positive,0.00015864425607789505
dromedaryegyptnrcehku2702013 nrcehku270,0.00015856143683690943
endoribonuclease domain,0.00015855420397617543
chest radiographs sequence analysis,0.0001584154064817483
stocks,0.0001584046659018866
south korean government,0.00015838223864883555
lrtd,0.00015836859495973543
hafr al-batin region district,0.00015820729207131193
fibrosarcoma cell line,0.00015763285378393572
countermeasures,0.0001576308985245062
virusencoded proteinases,0.00015750652887178954
human coronavirus nl63 cn060114 strain,0.00015738184337658602
interventions,0.0001572354226225106
intermediate precursors,0.00015698725303209943
plaque-purified virus,0.00015697343744337547
n and m genes 2 orf4b,0.00015688496554092283
interferon-related genes,0.00015681077689190425
site-directed mutagenesis,0.00015654605523932104
coronavirusinfected crfk,0.00015641369485436195
slaughterhouse workers,0.0001562979979199584
evaluating,0.0001561186384762665
single-stranded cdna fragments,0.0001558521308726773
live sars-cov,0.0001558494423471652
angiotensin converting enzyme 2 ace2 the,0.00015577449183212512
histologically,0.0001556905228666414
older,0.00015531418905312774
grouping,0.00015526085497227044
3j,0.00015518687677247607
foreign sequences,0.00015506453144618207
recombinant protein fragments,0.00015498004930886795
bulbul cov hku11 bucov hku11,0.00015496190678935583
transcriptionregulatory sequence,0.0001548298014264086
chicken,0.0001548172870497174
coronavirus cov agent,0.00015475262737649513
viral mrnas,0.0001546319411890257
femoral head necrosis,0.00015460234353996196
biocontainment laboratories,0.00015437900419039066
additives,0.00015426884754584814
infusions,0.00015424083787853488
seroprevalences,0.0001542147880640752
coronavirus s1 domains,0.00015405127037868387
open reading frame (orf)1a and orf1b genes,0.0001537819941621554
human airway epithelial cells,0.00015360887538759695
prcv infection,0.00015352870652377782
transgenic drosophila,0.00015307820632593928
clin,0.000152792170399524
diagnostic assay,0.00015269707898047486
upper respiratory tract,0.00015268705893826284
merscov seroprevalence,0.00015264943806396434
407 bp fragment,0.0001525745160887391
prcvpbs pigs,0.0001525645226963831
pathogenic sarscov,0.00015237023345794176
humancivet,0.00015234191490901117
merscov spike protein s2,0.00015232448624572442
sarsinfected cells,0.00015228835933906292
polymerase polyprotein,0.0001522423308196728
secondary transmissions,0.0001521238944061263
radiographic score,0.00015208481190431673
sarscoronavirus spike protein trimeric recombinant proteins,0.00015189322470276828
epizootic,0.0001517205877121767
kozak,0.0001516899274772032
wild asian leopard cats,0.0001513254427941531
"vm, rm",0.00015130880494183984
185-nucleotide deletion,0.0001511292836055048
nonnucleoside hiv-1 rt inhibitors,0.00015109083508348245
merscovspecific microneutralization mnt assay,0.00015107691661180795
mersn,0.00015107352717762468
hcov lrtd,0.00015061429776638022
dissociated s1 monomers,0.00015061007507852304
deadly middle east respiratory syndrome,0.00015058365863929735
acute respiratory syndrome-associated coronavirus,0.0001504952413616465
two-dimensional liquid chromatography-tandem mass spectrometry,0.00015024670382243857
plasmacells producing coronavirusspecific antibodies,0.00015019581534007767
antiviral nucleosides,0.0001500911610784715
isolation methods,0.00014995015306418062
rna capping mechanisms,0.0001498322397307358
bcovinfected hamster kidney21 bhk21 cells,0.00014955640117081848
retrospective chart reviews,0.00014953792606023087
homologous gene,0.00014928750547641258
human immunodeficiency virus1 receptors,0.0001491897213857915
rt-pcr amplification,0.00014906758704878454
leptomeninx,0.00014906488221053446
faculty members,0.00014881398382544036
infectious bronchitis virus nucleocapsid protein,0.0001487537755469203
il23,0.00014871194356862543
burkina faso,0.00014863824838198808
baseline,0.00014831865812031826
itraq-based quantitative approach,0.00014828555058224652
dmvs coexpression,0.00014812347619920643
glycosylation dependent sites,0.00014802862466090335
mothers,0.0001477581029238838
amino terminal s1 subunit,0.00014770324254355783
(fret)-based double-strand (ds),0.00014765080024474738
public health management,0.0001475487800038747
immunofluorescence microscopy,0.00014726243601173643
middle eastern respiratory syndrome coronavirus,0.0001472236090937557
ibv h52,0.0001470329306614918
58-kda proteins,0.00014702007794467706
duplex formation,0.0001469779550410976
swine testis,0.00014688453226649627
sephacryl s1000 chromatography,0.00014686568962554033
neurotropic strain,0.00014668430294595931
flow,0.00014653491564688286
supranuclear cytoplasm,0.00014635873141349268
assays svsvtmdcyt,0.00014625887399193017
intestinal lung,0.00014613646113639128
balbc background,0.00014603655276707628
pc7,0.00014598168072558478
serum sample,0.0001459132325922305
restimulation,0.00014578774853223417
alveolar cells,0.00014577778820944887
students,0.0001457619208628959
conformationdependant,0.0001457221549866037
membranous,0.00014570502181003153
west africa,0.00014564926033028017
bovine fetal spleen bfs cells,0.00014555699048004108
cynomolgus macaques,0.00014539311755422854
regions of sequence,0.00014506098775260017
viral proteinase domain pcp1,0.00014502466677176714
standard serological method,0.0001449883020422862
viral isolates,0.00014483917896320703
coronaviral pl(pro,0.00014480990475607865
swine testicular cells,0.000144778003793219
inhibition hai,0.00014472016416672268
coronavirus transmissible gastroenteritis virus monoclonal antibodies,0.00014455939191487964
influenza virus and piv,0.0001444998949952432
immune miniswine lymphocytes,0.00014436167341190488
cellular homeostasis,0.00014431519354977764
cleavage recognition,0.0001441194446080368
hcovemc spike protein,0.0001440475606943134
nucleosides,0.0001439955901981744
igem technique,0.000143861768649799
bcovinfected,0.0001438025873537233
recombinant his-tagged protein,0.00014365707735780652
cultured human lungbronchial epithelial cells,0.000143490193414683
jhmv-infected glial cultures,0.00014334399869827353
carboxyterminal m protein domain,0.0001432864882303489
host factors,0.0001427294355772309
cov merscov nsp16,0.00014266654024953291
cytopathic effect,0.00014262903828570023
epidemiological investigation,0.0001422833743981178
enteric viruses,0.00014223203224220698
cis-acting elements,0.00014199398609216358
nucleocapsid protein of sars_cov,0.00014194998257149424
nucleoprotein n48 amino acids,0.00014188088459960997
wild-type recombinant ibv,0.0001417744729133812
svsvtmdcyt trimers,0.0001415116026758079
gp210 immunofluorescence analysis,0.0001411893273906377
antiviral genes,0.00014114825004819096
porcine transmissible gastroenteritis coronavirus,0.000141123286820566
planar lipid bilayers,0.0001410923682176235
triggering,0.0001410469610255586
chr,0.00014060288144652615
oncolytic therapy,0.00014060034025135154
m membrane proteins,0.00014052540611541955
lactisbased mucosal vaccines,0.00014038682375414185
clinical findings,0.00014032815796606425
tetrazolium-based colorimetric method,0.00014026309159790136
neuropathological lesion,0.00013981880155646386
intestinal enterocytes,0.00013980547680810635
outbreak iga,0.00013975974345152738
microscopy,0.00013921998420191056
adk,0.00013918525901499015
coronavirus nsp16,0.00013915150712658707
viral diversity,0.00013914647287368656
sspecific monoclonal antibodies mab,0.0001390654170277954
predominant,0.00013893515833201845
recombinant spike polypeptide,0.00013890639702749985
immunotherapy approaches,0.00013880539686095448
b1,0.00013868534795672435
clinicaltrialsgov,0.00013853891031276886
autographa californica nuclear polyhedrosis virus,0.00013840445709119352
protective monoclonal antibody,0.00013792619733615457
secondary infections,0.00013790041547001803
bovine coronavirus bcv spike glycoprotein precursor,0.00013786499106780721
cross-reactive tcc,0.00013771507886399656
affinitypurified antirbd antibodies,0.00013756300075838128
livestock,0.00013745365557118162
infectious bronchitis,0.00013740758925361108
oasrnase l pathways,0.00013731336000681076
rare,0.0001371027559488141
fecvfipv biotype,0.0001369001076101639
downstream open reading frame,0.00013670809266145406
cows,0.0001367035980548612
fetal spleen,0.00013652993089577085
sars-coronavirus nonstructural proteins,0.0001365230138204118
hierarchical mixed generalized,0.00013630889969095278
open reading frame 1a orf1a and spike regions,0.00013627680316914294
aminoterminal gene 1 polyprotein cleavage product p28,0.00013594957723054768
sequences clustered,0.00013589220314726255
membrane hairpin topology,0.00013571582626094772
human coronavirus infections34,0.00013553995790757236
truncated product,0.00013553302640268366
viral maturation,0.00013552456443809906
peritoneal effusions,0.00013546322321654039
virus roots,0.00013545312773496882
medicinal purposes,0.00013508245779826196
lymphoid tissues,0.00013504583232045415
ibvinduced apoptosis,0.00013483883277184147
hyperphosphorylation homodimer,0.00013459975721651893
genetic variation,0.00013437630239752335
chronic hepatitis b virus infection,0.00013419711132235128
loss of cholesterol,0.00013393976361641204
immune response,0.00013358091566077076
heptad repeats,0.00013354098036882112
nucleic acids,0.00013352446128826634
ibv beaudette strain,0.0001334648686469763
tannic acid,0.00013319113864635604
serial,0.0001331418692385993
nucleotide excision,0.00013309193596533866
membrane m glycoprotein,0.00013289593126937838
open reading frame 7a7b orf7a7b,0.0001328087709364229
m-csf levels,0.00013270554605375551
genus betacoronavirus western blotting,0.000132640210316736
immunization procedure,0.0001324780825443957
bcovinfected hrt18 cells,0.00013246166832480718
protein accumulates,0.0001324152464002543
coronavirus prcv mrna species,0.00013211343482747874
oligodeoxynucleotide sets,0.00013202267175803676
immune cell infiltration,0.00013199724220349518
cell entry receptor,0.00013181101753408913
superspreaders,0.0001317156995624033
experimentally reverse,0.00013160465031991826
case,0.00013149639017628464
sarscovinfected vero e6 cells protein 3a,0.00013132648968958591
itraq technology,0.00013128083841056716
locally,0.0001310180152325051
healthy rabbits,0.00013092083918823095
american tcovs the region,0.0001308806066630193
type i viruses,0.0001307719675610733
cell culture supernatant,0.00013073274384207436
tgttt motif predominanted,0.00013062388790657678
attachment factors,0.00013054487186222932
enzyme glutamine synthetase,0.0001304968606676257
turkey coronaviral enteritis,0.0001303780967871523
single trna,0.00013028634197182363
laboratory settings,0.00013021128237004448
industrialized countries,0.0001298576147042972
radioisotopic virus,0.00012985413474465334
protocols,0.00012970254069744646
cell surface structure,0.00012943068847212524
adenovirus type 5,0.00012941836986263172
pol,0.000129193589519043
prcv specific sequences,0.00012917799040929672
viral infectious diseases,0.00012890366252816564
reciprocal coimmunoprecipitation,0.0001288964221638211
real-time sequence-specific verification,0.00012886040163503378
primary household,0.00012868614029383382
replicase complexes,0.00012859340069333654
immunosuppressive agent,0.0001284968402411573
nt test,0.00012820793673298635
coiledcoil,0.00012812541962006405
working group,0.0001277932291700724
acute respiratory syndrome sars envelope,0.00012763971405745068
epidemiological reports,0.00012746372472212527
coronavirus hemagglutinating encephalomyelitis virus,0.0001274335024187459
parvolike viruses,0.0001274309329065716
dayold mice,0.00012719027736189125
protein treatment,0.00012718750193107148
rsars-cov-infected cells,0.0001271738334412532
pc5b the convertase inhibitor,0.00012677536312589126
neurological infections,0.00012675258851359826
virusbeaudette strain,0.00012671192302334566
complement cascade,0.00012669855221435292
recombinant chimeric murinized,0.0001266597239914371
mouse hepatitis virus mhv strain a59 mhva59,0.00012663400868175584
comparisons,0.0001264151552564944
merscov phylogenetic analysis,0.0001263250494972798
modular,0.00012628771750460368
sarsrcov strains,0.00012625893057169172
cell function,0.0001259776993242873
oligosaccharide side chains,0.00012594288168483927
multiple isotopically labeled,0.00012584956144163825
bal samples,0.00012574197347464458
portable point-of-care,0.00012570173895687275
diarrheal disease,0.00012559202483536158
pro- and anti-apoptotic proteins,0.0001254714102009956
serum levels,0.00012525238187329767
k6c,0.00012502885398347813
n-linked glycosylation sites,0.00012501943764975498
sarscov spike glycoprotein s protein,0.00012490101045529802
primary structure,0.00012478726813039515
single nucleotide mutations,0.0001247068472674506
coronaviruses cvs and 2 a virus,0.00012458688865136773
cap methylation,0.0001245156772695091
coronavirusspecific igg,0.00012431839701193447
immunizing,0.0001242343078432882
relatedness,0.0001240278769487157
repeats,0.00012397270485145503
middle east respiratory coronavirus,0.00012392918794015646
mhv negativestrand template,0.00012373979717529874
th17,0.00012373576024401515
sialodacryoadenitis sda virus,0.00012366037096250994
sarscov nucleocaspid protein np amino acids,0.00012344776469540224
palmitoylations,0.0001234464119728628
primary chick kidney cells,0.00012342321834565327
sarscov plpro,0.00012325472963591145
genetic changes,0.00012324428173124833
fast mutagenesis,0.00012323220552904797
gastrointestinal disorders,0.00012316530584587004
infectious clone system,0.00012296410622719347
massachusetts prototype ibv m41 kq6,0.00012288021152958531
molecular virology,0.0001228135621280771
anchoring,0.00012279432129062092
rna replication,0.0001226408785142252
clustered,0.00012259439070374498
h9,0.00012259284049952415
membrane-associated papain-like protease plp2,0.00012247574459745974
persistence/demylinating-negative strain,0.00012236505684804224
published studies analysis,0.00012231888826549025
diarrhea,0.00012226522111588004
ovation method,0.00012211524959311354
type i alphabeta interferon ifn system,0.00012202981324918915
antigenic domain d,0.00012188131270954072
c-terminal hexahistidine tag,0.00012175494467924027
replicationtranscription complexes,0.00012174948728639235
bacterioferritin,0.00012173231979810895
viral plaques,0.00012124565862307017
facility,0.00012121800398160333
nonstructural protein 16 nsp16,0.00012116168052771118
cterminal sequence,0.00012105243462963559
mild enteritis,0.00012104685202245304
endoplasmic reticulum er stress,0.00012090638049136579
vl chain repertoire,0.00012089395455096347
correlation coefficients linear scale,0.00012082694121993263
hn99,0.00012077931060015466
codon-optimized human dipeptidyl peptidase 4,0.00012070861824432195
patient diagnosis,0.00012063271605662523
fecal diagnostic test,0.00012048868616409442
antiviral innate,0.00012029365094244432
cytokine-mediated lymphocyte,0.00012021602068527801
structural gene sequences,0.00011993109154464605
virusinduced cell fusion,0.00011966258767442546
respiratory mucosal epithelium mild nonsuppurative tracheitis,0.00011962178034481395
humoral immunity,0.00011938282439112201
systemic symptoms,0.00011935308611017819
bovine immune serum,0.00011910223175961115
pro- and anti-inflammatory cytokines,0.00011908267602858075
exponential adjustment model,0.00011900616789428114
nonstructural gene 5,0.00011891320713277308
ibv non-structural proteins,0.00011887142854470967
immune modulation,0.00011877197316501039
feline cd14 blood monocytes,0.00011851859384188637
upper respiratory tissues,0.00011833494505841092
inflammatory monocytes,0.0001182504576109774
biases,0.00011820805333017578
wild strains,0.00011819561557886607
intergenic consensus sequence,0.00011813650158235087
isothermal amplification assays,0.00011812309873159988
kidneys,0.00011789363298859741
medical research council,0.00011773625533579965
16 recurrent variant sequences common variant sequences,0.00011773331067402507
older camels,0.00011772729403369841
feces,0.00011754712147727297
lettuce surface,0.00011749150854691511
intracellular genome-length rnp complex,0.00011742796703180706
canadian dollars cdn per test,0.00011702606011398038
multiple structural domains,0.00011682770618636402
mhv counterpart,0.00011663868376273783
g26,0.00011663088543075038
content,0.00011661826156658609
pulmonary function pulmonary hemorrhage,0.0001166145652301337
silencing,0.00011648292110099676
568bp nucleotide fragment,0.00011648256777305901
bhpiv3sarss interpretation,0.0001163399017261856
rna polymerase,0.00011598262237291034
double-stranded product,0.00011596190330480244
catalytic dyad,0.00011595051558782989
rnabinding activity,0.00011593409033937103
anti-lys63 ubiquitin antibodies,0.00011579518559059836
comprehensive review,0.00011574568194027195
biological variation,0.00011570460266242156
sp4 virus growth,0.00011561940756686659
bcv spike gene hypervariable region,0.00011557332456262973
single organ system,0.00011556370044541967
cellular translational machinery,0.00011554620253026939
excellent,0.00011538475859986963
cytolytic animal viruses,0.00011531853201983308
sequence residues,0.00011530923030694889
protein two heptad repeats,0.00011503292043341664
merscov replicase selfcleaving polyprotein fragments,0.00011493892214974966
breast epithelial mcf10a cells,0.0001148726552720733
consensus sequence,0.00011486484408610268
mhvlike progeny,0.00011475197162143772
t cell proliferation,0.00011464426172781522
haploid dna sequencing,0.00011455145499905946
delayedtype hypersensitivity reaction,0.00011451891111689534
respiratory complaints,0.00011449049215526288
full-length gst-rdrp,0.0001144078888146843
protein binding sequence,0.00011425839693286738
cross-reactive antibodies,0.00011413451107983191
slcov s protein,0.00011401383232850692
virus inactivation curves,0.00011397407317984507
conserved genes,0.00011386668125487006
positive-stranded rna viruses,0.00011385032546168198
structural conservation,0.00011383076407546035
hcov-oc43 genotypes,0.00011380247310624821
demographics/symptoms/outcomes,0.00011371743122543373
budding/assembly,0.00011354318625147959
e protein pbm,0.00011337520377337584
5h,0.00011327549496168408
inadequate,0.00011320132614872461
transmembrane or membrane hairpin topology,0.000113130232320521
prcv mrna 2 polymerase chain reaction pcr,0.00011311696625535113
infection spleen cells,0.00011288993824836943
community-acquired pneumonia,0.00011287013386998397
cytokine-associated single nucleotide polymorphisms,0.00011284514290190412
adapter protein,0.0001128037184456081
intranasal inoculation virus replication,0.00011259890968392348
fluorescenceactivated cell sorter analysis,0.00011258341895477996
dna unwinding activity,0.00011249685141513204
virus-infected nasal epithelial cells,0.0001124648728297781
leaderbody junction sites,0.00011224369460265018
california field,0.00011214201795044939
gene 3 transcriptionassociated sequence western blot analysis,0.00011186011050203641
conformational differences,0.00011183341085496989
exocytosis,0.00011174216683419562
non-intubation group,0.00011172963091569524
human h7n9 influenza viruses,0.00011170391184945187
leadermrna junction sequences,0.00011169276129379534
open reading frames 4a,0.00011166173069071666
inositol-requiring protein 1,0.00011165201026389845
antinucleocapsid protein iga antibody,0.0001115203116323313
partial rnadependent rna,0.00011137083065005858
makkah and riyadh regions,0.00011134674164689676
contrast cells,0.00011119997013637154
14 functional open reading frames,0.00011115692811240123
single amino acid polymorphism analyses,0.00011105398229041677
bovine coronavirus isolates,0.00011102524130039156
recombinant mhv receptor cdna,0.0001109656740955785
highest-titer igg antibodies,0.0001109415099655857
coronavirus spike s protein,0.00011078824592232517
type,0.00011075629247813433
hrc1 anti-serum,0.00011055238083453378
enteric coronavirus,0.00011049024948786035
fluorescence signal,0.00011043986908307385
aglycon moiety,0.00011041166310350793
european union european centre,0.00011029214044244337
mers epidemiology,0.00011028064734938304
astrocytes demyelination,0.00011024149169068734
hemagglutination inhibition test,0.00011009509012367634
kennel,0.00011007490663065433
real time reverse transcriptase polymerase chain reaction,0.00010999852143417608
pkr-dependent stress response pathway,0.00010997736257161209
virion assembly,0.00010990552454716468
pathogenic studies,0.00010980369759505742
monoclonal antibody-based nucleocapsid protein-capture,0.00010946910836180734
20 protein,0.00010911935894600012
rna structure elements,0.0001090189539086133
antigen canine,0.0001089325347329863
alanine aminotransferase (alt),0.00010888006545990625
atropine-resistant,0.00010881060473575619
laboratory capacity,0.00010868982132019517
mers upper respiratory tract infection,0.00010849449185175947
piv lrtd,0.0001080577483670914
salmonella infections,0.00010791408707704139
mouse hepatitis coronavirus nonstructural protein 4 nsp4,0.00010790115410695126
2 functional domains,0.00010774494480771613
two-stranded coiled-coil template,0.00010770025776267637
rat kidney cell cultures,0.00010754389917293
nuclear ribonucleoprotein a1,0.0001075174793706839
neutralization epitope,0.00010740605586268332
serotype,0.00010729062770570111
229especific igg antibodies,0.0001071094875677345
vaccine strain,0.00010691119363543331
mers-cov replication inhibitors,0.00010677772389818772
restriction endonuclease,0.00010655452350214847
polygonum multiflorum thunb,0.00010643359466650865
hepatitis c virus (hcv) helicase,0.00010639791379863072
c3,0.00010632492305202686
slipperysequence,0.00010628877193906953
culture fluids,0.00010625534702592386
international mers-cov,0.00010593395949302609
comparative molecular field analysis,0.0001059038956401219
reverse-transcriptase polymerase chain reaction,0.0001059037000549123
amino terminal,0.00010554411875868522
interferonbeta1a leukocytic interferonalpha,0.00010539904567038925
rabbit immune sera,0.00010532371206777083
s6,0.00010517106644625431
spin column method,0.00010513382771721557
haemagglutinating encephalomyelitis virus,0.00010513091823956718
membranous regions,0.00010504973383693525
primary hepatocytes,0.0001048908872898478
central unstructured region,0.0001046879823371194
sars-cov- infected cells,0.00010462355588188125
fulllength e and 3a proteins,0.00010443309908209905
yellow fever virus yfv dengue virus serotype 2,0.00010437176388549961
virus ion channels family,0.00010429635072321466
open reading frames 1a and 1ab spike1,0.00010403292907816422
whole egg yolk,0.00010391873067489355
occursin vitro,0.0001038989384776012
hairpin structure,0.00010356701554563537
d441toarginine,0.00010354269830036623
ct,0.00010342631155011362
charged residues,0.00010335321684168936
developmental maturation,0.00010331504005002468
nucleoprotein mrna species,0.00010331085887816523
physical interaction,0.00010328756626272195
cellular activators of sars-cov,0.00010326161061896598
transcriptiontranslation system,0.00010305029377710587
escherichia coli maltosebinding,0.00010302832493626769
highly conserved core sequence cs,0.00010301656053025445
host-protective,0.0001030153157658426
positivestranded rna genomic rna,0.00010300043805530714
35 kda protein 3clpro,0.00010296065836888498
adhesion kinase,0.00010296009770005248
extrapulmonary mers-cov antigens,0.00010294855726031625
plp-mediated anti-ifn difference,0.00010282188022023337
truncated open reading frame,0.0001028150519150295
critically ill sari,0.00010272436704555038
mers-cov genomic loci,0.0001027165952760797
bcv 95kda protein,0.00010270103878914031
activating nuclear factor kappa b,0.00010267299040046786
structural protein n nucleocapsid protein,0.00010254443529565945
3'-terminal sequences,0.00010253557578295837
enzymes exoribonuclease endoribonuclease,0.00010250427946202193
leadermrna fusion,0.00010248689499913441
recipients,0.00010220829394482832
sarscov spike s glycoprotein,0.00010213671611892555
targetcell membranes,0.00010212837518694939
humantohuman transmission bestfitting arima,0.00010210615876456863
control di vector,0.00010196372196785173
seroprevalent,0.00010164483446727098
ebola envelope,0.00010157984043948734
electron tomography,0.00010140978415080266
fcov-specific immune response,0.00010135111478866008
sarscovinduced disease,0.00010131071998188114
biosafety level bsl 3,0.00010121154720823622
8.8kda,0.00010097385955109787
short stalk purified viruses,0.00010081923487810912
hospital visitors,0.00010078896777741825
eigenvector centrality score,0.00010076978965834163
nasal secretions,0.00010066925617584064
dengue virus ns3 protease,0.00010065130738484404
primary human embryokidney monolayers,0.00010063684948289011
nonstructural proteins 1,0.00010062904210694297
ultrathin sections,0.00010056764581776888
anti-canine coronavirus antibody,0.00010044044545367763
cd8(+) t cell responses,0.00010035172165728675
health surveillance,0.00010027217305162757
late 1800s,0.00010020254677426352
immunological depletion,0.00010011860642308737
immune regulation,9.969921530491071e-05
destruction,9.969415558534886e-05
federally regulated frameworks,9.951271257483017e-05
real-time reverse transcription-polymerase chain,9.943190216661952e-05
part of nonstructural protein,9.939115128338385e-05
crcov infections,9.938151734598764e-05
il13 cytokines,9.928370918841023e-05
coated,9.925395892993507e-05
renilla luciferase genes recfcovrl,9.924795229096598e-05
temperaturesensitive mutant,9.916086892115606e-05
il18 mice,9.903542240269416e-05
sars coronavirus sarscov nucleocapsid protein n protein,9.902493452156391e-05
policies,9.896649237139221e-05
potassium tartrate,9.890985304531396e-05
peripheral consolidations,9.890592126008943e-05
consensus cyaaac sequence,9.88649463468168e-05
heptameric core donor sequences,9.88494814120394e-05
outbreak viruses,9.882099942092562e-05
ros/p38 mapk/stat3 pathway,9.866387088335775e-05
cmi,9.84905125174417e-05
monoclonal anti-canine coronavirus antibody,9.848301897301543e-05
diubiquitin,9.842739028248826e-05
biotinylatedoligonucleotidebased method,9.842236053677928e-05
pro-inflammatory,9.840579274447188e-05
nucleocapsid protein of sarsassociated coronavirus sarscov,9.83390607680333e-05
[35s]methionine-pulse-labeled viral proteins,9.83096654417146e-05
predicting,9.826844197093003e-05
single-bedded rooms,9.826519762812794e-05
ancestral origins,9.823700804666685e-05
green fluorescence protein,9.815482241267936e-05
coronavirus structural protein,9.811178745534321e-05
oligonucleotide probes,9.782729454211034e-05
chinese health officials,9.778031960297012e-05
viral positive neurons,9.746310518990839e-05
l. pneumophila,9.733186622017474e-05
ctype lectin dcsign mutagenesis,9.725969111041975e-05
cd9,9.725376290133692e-05
pentameric ion channels,9.719816328290499e-05
gene upe nucleocapsid n gene,9.712196067713144e-05
non-structural protein 3,9.710182906480683e-05
canine enteric coronavirus,9.705546697889828e-05
rabbits,9.703273761652339e-05
lymphopenia 16 34 interpretation disease,9.694949415329242e-05
study disciplines,9.694567311926843e-05
disease hotspots,9.684718204072939e-05
lipidomics studies,9.67807033675614e-05
nucleotide and protein sequence,9.673504664892736e-05
acute respiratory disease syndrome,9.664009453081767e-05
next-generation sequencing,9.663224801229171e-05
ha3g packaging,9.655634724093707e-05
single-wavelength anomalous dispersion,9.654869249623414e-05
nucleotide positions 4330 and 9230,9.641781537333151e-05
cell surfaces,9.636464553041051e-05
human calu3 airway epithelial cells,9.616683689852966e-05
heterozygous cw0801,9.615465123545677e-05
breeding,9.591636365905227e-05
ade effects,9.586240531918346e-05
cov mouse hepatitis virus,9.58020332700899e-05
diarrhoeic syndromes,9.575513535112059e-05
mers-cov papain-like protease,9.564365972895374e-05
enteric fcov,9.554596389809298e-05
iga,9.544514612319696e-05
ibv nsp14 ddx1,9.538622598353814e-05
inflammasome signaling,9.538597433656184e-05
astrocytoma cells,9.5151904425711e-05
medical institutions,9.512332268961577e-05
aldehyde warhead,9.498423616644069e-05
individualistic perspectives,9.48972310636417e-05
reverse transcriptase-polymerase chain,9.479139993379587e-05
small chain variable regions,9.479001945112191e-05
tcellmediated,9.465762313456695e-05
rat cell line,9.451408688864456e-05
viral core,9.4321365215095e-05
human coronaviruses (hcovs),9.426000189433679e-05
cell homeostasis,9.412480536517786e-05
extra 29-nucleotide fragment,9.410746446534924e-05
diagnostic performance,9.408019250135585e-05
infected cell culture,9.406480774659961e-05
enteropathogenic tgev strains,9.373109796348467e-05
extruded infected cells,9.371203308905492e-05
j. m. rottier,9.359379719936025e-05
helical stems,9.34458691258774e-05
human embryokidney monolayers,9.326719242839685e-05
3a's potassium channel,9.322264229769117e-05
intraalveolar cells,9.31279252298579e-05
strain-specific,9.311183920116598e-05
catalytic cysteine residue,9.302098412641102e-05
107plaque-forming units,9.301040034326127e-05
solublereceptorresistant,9.297861525943731e-05
soluble anti-mhv factors,9.283240050708943e-05
full-length genomes,9.276032994975879e-05
human immunodeficiency virus type 1 reverse transcriptase,9.2748491217199e-05
genomic levels,9.27469924042738e-05
s-specific mabs,9.269035159590566e-05
ace2 thirtyeight,9.268204851922801e-05
complementfixation tests,9.264400244658057e-05
protease polymerase helicase,9.264243789606866e-05
conserved hexanucleotide core acgaac,9.263773647827575e-05
subgenomic rnas substitution,9.259900321381967e-05
mother,9.244462335178788e-05
post-translational modification,9.241727794928221e-05
ibv-infected cells,9.229781988166191e-05
viral double-stranded rna recognition,9.224199580323084e-05
regulate,9.21316079042075e-05
clade 2c viruses,9.209637181084135e-05
fibroblast cell lines,9.194431382498656e-05
rbd located n terminal,9.184030751563118e-05
canine microsomal membranes,9.176529993843703e-05
barrier colony,9.175813999798521e-05
parvovirus,9.172706043245214e-05
non-healthcare workers,9.166641919464731e-05
rdrp nucleotide selectivity,9.15675866091977e-05
hrt 18 cells,9.148058188420892e-05
pipistrellus-bat-coronavirus-hku5,9.130281823769224e-05
endodomain mutations,9.128362222021041e-05
hrct examinations,9.12384149501305e-05
human dpp4 amino acids,9.111706307501578e-05
parainfluenza viruses 1,9.088553431520162e-05
effector memory cell,9.087456880917962e-05
enteric cvlps,9.084450862683947e-05
ciliary,9.078581658703544e-05
non-immune human vl chain repertoire,9.077444366379218e-05
acute respiratory syndrome coronavirus sarscov strains,9.072724949057296e-05
protein epitopes,9.066931486112998e-05
suicide attempt,9.062019680350381e-05
12aminoacid,9.04202113718284e-05
pcrbased assays,9.039140251872142e-05
genomic rna,9.035257186687123e-05
infrared dichroic data,9.034812426725798e-05
"ultraviolet light (uv) at 254nm, heat treatment",9.027098500626393e-05
hepatocellular necrosis sa59r13,9.016394913320718e-05
current,9.015360963556519e-05
cellular proteins yeast,9.010775122993722e-05
immune whey,9.008404812127654e-05
asparagine residues 2249,9.001131531064604e-05
enzymatic cis-trans peptidyl-prolyl isomerase,8.998647422515387e-05
mers-cov infections,8.988713795759953e-05
biosynthesis,8.981135827541803e-05
retinoblastoma,8.966901343965936e-05
revertant viruses,8.962687748556437e-05
endemic infection,8.948738925194439e-05
complementary oligonucleotide primers,8.933899641153541e-05
p40,8.923537274327788e-05
membrane-bound organelles,8.919330717738014e-05
analytical ultracentrifugation,8.911435854147039e-05
viral endoribonuclease endou,8.908051749833912e-05
cytoplasmic viral factories,8.900391461562559e-05
3'-most position,8.893888566261907e-05
virus hcov strain,8.893745540910505e-05
lethal mutants genomes,8.867316740805826e-05
double-stranded segmented rna virus,8.856884562941633e-05
immune mediators,8.853292298495123e-05
singleparticle cryoelectron,8.848603621515684e-05
immunofluorescence testing,8.845377238352902e-05
epidemiologic investigations,8.832905236434638e-05
enzymatic collaboration,8.807910233042856e-05
human blood mononuclear cells,8.80047406882552e-05
coronavirus 3c-like protease,8.799710343415781e-05
rip1,8.796997054978317e-05
hcov respiratory specimens,8.794471523515143e-05
mhv variants,8.780585236470131e-05
log-linear kinetic models,8.773588497601387e-05
live-attenuated coronavirus vaccine,8.772516505449475e-05
zinc,8.770216590625935e-05
negative-strand synthesis,8.767338418281456e-05
renal complications,8.766142843928652e-05
cellular protein response,8.756280421408476e-05
multiplex real-time reverse transcription pcr,8.725964515416705e-05
infectious bronchitis coronavirus,8.716069153873605e-05
naturally occurring flanking sequences,8.71223177697839e-05
kidney tropism,8.709062370829471e-05
a59 and 1hm e2 proteins,8.695357468556588e-05
coronavirus host cell,8.694862943684551e-05
singlestranded nucleic acids,8.68971656010509e-05
cho cell,8.689505516974303e-05
mhv transcriptional promoter,8.680629068781103e-05
recombinant n-terminal domain,8.67756741882171e-05
s1 nuclease digestion,8.677488291848402e-05
primary human respiratory epithelial cells,8.676141853584394e-05
ty-batcov-hku4,8.672960668053995e-05
proinflammatory chemokine response,8.667286544020198e-05
sarshcov tor2,8.665087496478553e-05
chicken kidney tissue,8.662323368626534e-05
calprotectin leukocyte protein l1 myeloidhistiocyte antigen,8.660268935228951e-05
1710nucleotide,8.656912217468442e-05
transcriptional initiation sequence cuaaacu,8.635643207326703e-05
reverse transcription-polymerase chain reaction,8.634117385531481e-05
195kda,8.632747040384778e-05
serum/plasma,8.628584208737042e-05
confocal,8.62698616620986e-05
anti-sars-cov s antibody,8.602240262528612e-05
variation residues snvs,8.590908029624148e-05
genome sequence 30738 nucleotides,8.581630357227987e-05
intraleader open reading frame,8.575973394585657e-05
subcutaneous sc intravenous,8.553301633521309e-05
apical,8.54197712637002e-05
neuroadapted john howard mueller jhm,8.539635672399527e-05
positivestranded rna species,8.527174971095657e-05
human coronavirus oc43 hcovoc43,8.523914578680747e-05
polymerase chain reaction products,8.51521149042418e-05
chicken infectious bronchitis virus,8.515061198401483e-05
rhinolophus bat cov hku2,8.514159772362746e-05
younganimal models,8.513756174064927e-05
radiographic,8.511999648970649e-05
gp 140gp 65 glycoprotein,8.50715880208085e-05
single-nucleotide substitutions,8.500805736160097e-05
dromedary camel populations,8.49464588641533e-05
helper dependent,8.479620580385304e-05
peritoneal effusion,8.475659500229231e-05
spontaneous,8.470599640848129e-05
downregulation,8.469376217635553e-05
cell surface tmprss2,8.452711279107708e-05
ground-glass opacity halo,8.448186757040723e-05
cultures,8.446617386882602e-05
group 1,8.445008348648475e-05
synonymous marker,8.438130890664694e-05
resource poor countries,8.42331336993234e-05
alpaca virus,8.394399307209718e-05
cholesterol-accumulating agents,8.38536309440513e-05
nsp16/nsp10 interaction interface,8.384184070175341e-05
flanking regions,8.383090617487449e-05
pulmonary pathology,8.377623260020316e-05
spike gene sequencing,8.3749521744287e-05
epidemiological investigations,8.364464201947042e-05
quebec enteropathogenic,8.363034475081974e-05
coronavirus nucleocapsid (n) protein packages viral genomic rna,8.360214621817792e-05
nterminal epitope,8.345849941593925e-05
global translation shutdown,8.335406701345562e-05
leader-primed transcription,8.33345831704604e-05
papainlike nsp3 and 3clike nsp5 proteinases,8.329036690729434e-05
antibody titres,8.327799811714016e-05
cysteinecoordinated metal ionbinding domain,8.326789930033171e-05
autophagy pathways,8.320579594643161e-05
human peripheral blood lymphocytes,8.315377796980469e-05
intranasal inoculations,8.31256390534095e-05
natural kittenhood infections,8.285242749126893e-05
genotype,8.282085753170692e-05
new-type ibvs,8.280039673374206e-05
open reading frame orf1,8.266523253007073e-05
apoptotic death,8.265837539407853e-05
g.,8.260178792201224e-05
intermediate cleavage products,8.257944253951134e-05
primary cell types,8.257222447126903e-05
galt gut lamina propria lp,8.252206650922767e-05
antigenspecific iga precursor cells,8.248370137125172e-05
ccvinfected crfk cell lysate,8.241221772390807e-05
s1 domain finally epitope,8.238775140148633e-05
autophagy cargos,8.231287942608455e-05
ace2-expressing cells,8.220791466045388e-05
tenacity,8.220047235631309e-05
pharmacokinetics,8.217904237194214e-05
canine respiratory coronavirus,8.21478809598098e-05
infection-induced apoptosis,8.210491499036257e-05
mutant mceacam1a,8.206731614932723e-05
recombinant deletion mutant viruses,8.206067743337607e-05
radioisotopic-labelled or,8.187553099424968e-05
laboratory diagnostic,8.186359083738208e-05
mature non-structural proteins,8.179465468763148e-05
health care facility,8.178175759968983e-05
diaplex q mers-coronavirus,8.167166645520709e-05
labor,8.144469864345796e-05
protein 1b light chain 3,8.12963048198541e-05
tgev,8.127650084681374e-05
haemorrhagic lesions epithelial barrier,8.118761522373221e-05
translatability,8.116375449628013e-05
454aminoacid protein,8.115446257646326e-05
reverse genetics approach,8.11470287338569e-05
solvent-exposed ace2 residues,8.108930680737883e-05
cellular membrane,8.106644372925259e-05
viral factors,8.096878681362326e-05
atp hydrolysis,8.090485784269855e-05
adjuvanted mers-cov spike protein subunit,8.084736993666345e-05
conduit,8.08454120395643e-05
recombinant 4f4r 6f6r,8.067589694509552e-05
coronaviridae-wide,8.064005106926405e-05
prediction,8.046637414650844e-05
protein receptors,8.040848211952504e-05
predicted oglycosylation site,8.028811618180422e-05
exogenously,8.027886392513349e-05
protein-pseudotyped retrovirus,8.023707367430874e-05
fas,8.022253806693343e-05
linear b-cell epitopes,8.0221893341177e-05
hcov acute respiratory tract infections,8.016255694064327e-05
myelin-reactive autoimmune t cells,8.014120307115277e-05
furin consensus motif 758-rxxr-762,8.010590932546065e-05
290 and 240kda proteins,8.010419051106453e-05
two-dimensional gel electrophoresis,8.007814842419369e-05
epidemiologically clustered,8.001907666623381e-05
ribosomal frameshifting,7.990503722640775e-05
calcium-calmodulin-activated serine/threonine-specific phosphatase,7.986748428968237e-05
cholesteroldependent,7.969070797888064e-05
bovine serum albumin,7.967319193759293e-05
putative replicase complex,7.966713444614593e-05
nasopharyngeal mers-cov rt-pcr tests,7.965475645298114e-05
nucleotide species,7.963969121604556e-05
uncharacterized orfs ucorfs,7.954042521433156e-05
suppressor mutations,7.953907580970885e-05
nterminal orf 1a product p28,7.947699651779318e-05
open reading frame 3c,7.945009240529521e-05
h89,7.924789028142045e-05
nucleotide and amino acid sequences,7.922871376184862e-05
gm-csf,7.917400964452517e-05
mean knowledge score,7.913830206522292e-05
"wuhan, china",7.910448143228886e-05
jhmv infections,7.90658638002571e-05
enteroviruses/rhinoviruses,7.906224944285345e-05
intracellular viral genomic,7.905205935688836e-05
replicative positive-strand genomic rna,7.894451669328752e-05
kit,7.888877720886178e-05
zinc finger 1,7.88454348475933e-05
cytoskeletal proteins,7.874874600702188e-05
naive,7.874558954753826e-05
virus-inoculated cell cultures,7.873966157054049e-05
truncated isg15,7.86803282540753e-05
3a protein forms ion channels,7.864260060278076e-05
putative recombination,7.861753330003897e-05
molecular investigations,7.85377423921164e-05
srr7 s protein,7.842312685108693e-05
nps,7.833137515930176e-05
awareness,7.832184388087714e-05
rna sequence analysis,7.82931119424977e-05
highly conserved viral antigens,7.825846234445785e-05
nmr structure,7.820664260990625e-05
medical advice,7.818469415344892e-05
receptor retinoic acidinducible,7.817334424522041e-05
cterminal dimerization domain ctd residues,7.792005919490425e-05
cap0 rna,7.791624887308451e-05
perinuclear space,7.790423854228084e-05
ccov-iib strains,7.785083884492207e-05
helper virus genomic sequence,7.773148995876702e-05
region of type i,7.768657331022215e-05
cleavage products,7.761273510750204e-05
laboratory response,7.758216671920224e-05
dead box rna helicases ddx3x,7.757251973318105e-05
basic amino acid residues,7.752530222614602e-05
immune pressure,7.7498926554413e-05
reducing,7.739362200594749e-05
serum protein electrophoresis,7.738640084021477e-05
wpre-containing vectors,7.726971771997598e-05
genetic differences,7.726854157818777e-05
sars-cov 3a-induced,7.726842963690894e-05
experimental conditions,7.724802148772291e-05
macrodomain,7.721244520128968e-05
"human cov-229e and -nl-63, feline cov",7.719219011691177e-05
endosomal cysteine proteases cathepsin b,7.705876707456694e-05
hepatitis coronaviruses,7.703170092936232e-05
metalloprotease adamfamily zinc metalloproteases,7.702090475785154e-05
subgenomic mrnas sgmrnas,7.701883696024719e-05
systematic procedures,7.69985974907418e-05
"nonstructural proteins 2, 3 and 16",7.697469909993513e-05
cathepsin proteases,7.696045037323284e-05
nsp10/nsp16 complex structure,7.695277653776595e-05
swine acute diarrhea syndrome,7.677070609695385e-05
global epidemic,7.67698401603867e-05
ibv strain d1466like sequence,7.67564419796729e-05
bovine 4.9kda non-structural,7.665303503304652e-05
interferon therapy,7.657027931311874e-05
neighbour-joining method,7.655562504542915e-05
10 kda ip10 and monocyte chemoattractant protein 1 mcp1,7.649667154812544e-05
post infection,7.649174648039477e-05
commercial vaccines,7.648805684661217e-05
immediate-early transcription factor,7.646035865346037e-05
bioproject accession,7.64563089707624e-05
one-step strand displacement probes,7.644465695628041e-05
ptfe polyvinyl chloride pvc,7.640233141296024e-05
searching,7.636955224426633e-05
nursing students,7.634169964888151e-05
cell blebbing technique,7.623895455497323e-05
hydrophilic cysteinerich cluster,7.622049376457054e-05
systemic fcov infection,7.610739595172869e-05
fusogenic activation,7.608840155193653e-05
l1 myeloidhistiocyte antigen neutrophils,7.605634222119e-05
catalytic functional,7.588289745492398e-05
downstream analysis,7.58691587359229e-05
real time rt-pcr,7.584103514801553e-05
nonessential staff,7.583595935959712e-05
granulocyte colony stimulating factor,7.582888950835092e-05
deep branch,7.581310113384764e-05
p1 and p2 positions,7.572204013920411e-05
kinase activation,7.5721809142987e-05
phosphorylated nucleocapsid protein n,7.567080071096846e-05
macrophage cell line,7.566989714632341e-05
cellular proliferation,7.56386218215935e-05
high-quality solution structure,7.554870577015741e-05
alternative splice variant,7.550983380566938e-05
nterminal domain ntd,7.548112175510863e-05
immunosuppressive drug mycophenolic acid,7.542261664551853e-05
review infection,7.532589316815919e-05
phosporylated,7.531198905444133e-05
reverse genetics analysis,7.530165169028065e-05
genbank accession numbers ef424621,7.523702663405537e-05
mers coronavirus-like particles,7.521765626126355e-05
lamina propria,7.518615323170184e-05
paramyxovirus f,7.518246538592305e-05
green fluorescent protein ra59gfpgp33 p14,7.51200072942492e-05
sars-cov challenge,7.502627063103303e-05
clinical aspects,7.501554785210869e-05
turkey coronavirus spike protein gene,7.501397576404086e-05
dogs,7.498054284406082e-05
disordered putative rna-binding domain,7.484082039461274e-05
aberrant,7.483217777281153e-05
glomerular pathology,7.476589666988566e-05
receptor interference,7.475162053031207e-05
synthetic ligand poly i,7.471010192449031e-05
monocyte/macrophage,7.469356829647898e-05
mild upper respiratory tract illness,7.462829798990359e-05
fruit,7.447548612708743e-05
live-attenuated coronavirus vaccines,7.445752636122843e-05
ibv virus',7.445626566450242e-05
macrophage infection,7.437894298111889e-05
biotinylated recombinant plasmids,7.435963266607426e-05
3clike nsp5 proteinases,7.435193296342091e-05
replicase/transcriptase,7.432746944505e-05
immunoprotection experiment,7.432681364934127e-05
primary embryonic cells,7.429555737185775e-05
n gene trs core sequence,7.422417048526187e-05
blood monocytes,7.42230259130424e-05
mirror,7.419032491396069e-05
lymphocyte subsets,7.413226576988032e-05
hepatic gastrointestinal,7.412157425886013e-05
neutralization antibody assays,7.410642580579457e-05
clinical isolates,7.410382712118398e-05
human promonocyte cell line,7.407733495337328e-05
genetic determinant,7.400707788503189e-05
convertase inhibitor,7.39958819931579e-05
viral inactivation methods,7.398489288656064e-05
healthcare facility,7.39263258067612e-05
mammalian cov species rdrpbased grouping units,7.388608876775435e-05
proteinase k protection assay,7.383549524677091e-05
anti-bcv serum antibody,7.381668056776447e-05
coronavirus isolates,7.378869899075066e-05
t cell epitopes,7.375846716160302e-05
merscovinfected macrophages,7.357568032111276e-05
internal image monoclonal antibodies,7.34437326872684e-05
adaptive evolutionary pathway,7.336094841883165e-05
c-jun n-terminal kinase,7.3357624807239e-05
inoculum,7.33469027521846e-05
global scale,7.333031298775578e-05
cardiologic diseases,7.332610262872124e-05
animal surveillance,7.325435210569401e-05
nuclear factor kappa-light-chain-enhancer,7.309915206347336e-05
covid-19 infections,7.30982783122323e-05
nbased,7.309398076256063e-05
field specimen,7.307549646556942e-05
membrane-anchored sars-cov spike,7.300052554991149e-05
conclusions/significance,7.29552828746523e-05
veterinary diseases,7.292866035785092e-05
necrosis and viral antigen,7.287000195708129e-05
recombinant bacterial expressed proteins,7.286315158567748e-05
hcov-229e receptor function,7.285681674218308e-05
upe and the open rading frame,7.28278541571587e-05
minimal insert region amino acids 310 to 518,7.277422935385126e-05
downstream noncanonical site,7.270872016053546e-05
ubiquitous structural domain,7.263174506224052e-05
recombinant baculovirus-infected insect cells,7.260976536286805e-05
annexin v positive staining,7.247929814829979e-05
neonatal infection,7.24460298366631e-05
envelope envelope glycoprotein,7.240863814810511e-05
epidermal growth factor egf receptor,7.238923709051947e-05
progeny virus,7.230717358764142e-05
non-structural protein genes,7.228291659508637e-05
acute respiratory syndrome sars smediated,7.221361911921822e-05
major clusters 1 and 2,7.215701537051414e-05
dual percoll density gradients,7.204862507552168e-05
temperaturesensitive,7.201323112066032e-05
enhancer factors,7.193120778471039e-05
mers-cov accessory proteins,7.190682471891902e-05
polyinosinic-polycytidylic acid,7.186964073283632e-05
solublereceptorresistant mutant srr7,7.183656366357488e-05
anticoronavirus drugs,7.183156469496522e-05
likelihood phylogeny,7.182707754579684e-05
cov rnadependent rna polymerase nsp12rdrp,7.182665093559174e-05
orf6,7.182457871162088e-05
viral variants,7.172837059962334e-05
proximal convoluted renal tubules,7.172749038866148e-05
anticeacam5 antibody,7.171144249583074e-05
rnaencoded subgenomic mrna,7.154931703060031e-05
chargerich carboxyterminal,7.154798936238326e-05
cd2 cd3 cd4,7.154203288957999e-05
artus biotech standard,7.151724808555015e-05
er-associated degradation,7.141356273345292e-05
real-time rt-pcr assay,7.140637860584597e-05
icu stay,7.140242709554955e-05
mouse hepatitis virus strain a59 mhva59,7.13280570255441e-05
cov genome replication,7.132025333283487e-05
institutional review board,7.130765635779602e-05
carboxyterminal segment,7.130573325590173e-05
oriental house,7.129995380761085e-05
bottlenose dolphins,7.129924537072333e-05
endogenous ddx1 protein,7.124625179986654e-05
roche molecular diagnostics,7.115953792860986e-05
c-terminal p64 fragment,7.091163675781339e-05
mismatching nucleotide,7.082807107604535e-05
protein complex assembly,7.080750420919789e-05
salmonella,7.077550649121025e-05
intravenously,7.075636865817302e-05
colloidal goldmediated immunoelectron microscopy,7.068311228562816e-05
karyopherindependent,7.066414261003828e-05
mers-coronavirus,7.065795936209611e-05
coronaviruses transmissible gastroenteritis virus,7.064602279790735e-05
cultured human and animal cells,7.06297878310081e-05
symptoms neutralizing viral antibodies,7.047137854237511e-05
human coronavirus hcv strains,7.024644665955607e-05
phenotypically mixed,7.009430224022007e-05
open reading frames 1a and 1b,7.0061518224959e-05
post-infection,7.00498988019109e-05
putative packaging signal,7.004326812631478e-05
n-terminal gst-fused sars-cov rdrp,7.003248874529219e-05
recombinant parainfluenza virus piv type 3 vector,6.995858621696204e-05
horizontally transmitted,6.992382500090711e-05
mceacam1a binding,6.983459766411042e-05
realtime reverse transcriptionpcr rrtpcr assays,6.980032397954965e-05
replication complex,6.977816838180096e-05
reservoir-people,6.977061865359313e-05
actual infection,6.970952569006088e-05
human respiratory coronavirus hcv 229e strain lp,6.969851921928566e-05
mhv virions,6.964649233433109e-05
proteinase,6.94847252352829e-05
synthetic transmembrane domain of sars protein e,6.927091988511921e-05
epidemiologic characteristics,6.922798856994481e-05
sars transmission,6.912783975335846e-05
plasma donation,6.912432896226487e-05
virus survival,6.899011406823961e-05
tia1related protein tiar,6.88569509492722e-05
c terminus amino acids 251 to 422,6.881734442302318e-05
variance,6.872530894637426e-05
body weightday,6.86094925914467e-05
human coronavirus vaccine,6.858787206012138e-05
mers-cov-associated infection,6.855214643410172e-05
cleaved glycoprotein,6.85423040211205e-05
coronavirus merscov utilizes dipeptidyl peptidase 4,6.853442463694981e-05
lymphocyte proliferation,6.848497403246375e-05
systemic coronavirus infection,6.847774518022527e-05
inefficient,6.844520525907489e-05
head-to-tail ligation,6.842850491907998e-05
mouse oligodendrocytic n201 cells,6.838125034734428e-05
shortness of breath,6.83568510074459e-05
pdz domain-binding motif,6.823088644618909e-05
papn amino acids,6.821927634112714e-05
papainlike proteinase domain,6.82045131321585e-05
di expression system,6.815541736987414e-05
anchoring matrix recombinant fusion proteins,6.815139827424302e-05
cathepsin l cpl,6.804365089828263e-05
asian leopard cat,6.801594503488003e-05
dclsignmediated virus,6.797781206695704e-05
short antigenic sites,6.788684581787754e-05
doi101016jantiviral201501011,6.781157810965878e-05
region of amino acids,6.780873840989052e-05
feline coronavirus fcov strain fipv,6.780639054341722e-05
protein phosphatase 1 catalytic subunit,6.777997302562672e-05
charged amino acids,6.772872713971269e-05
cd9-dependent cell entry,6.770734404915316e-05
recombinant spike domains s1 of ibv,6.764942096803764e-05
control deutsche forschungsgemeinschaft,6.758457237726763e-05
short oligou stretch,6.754695914940758e-05
ifn signaling ns4b proteins,6.754610282627615e-05
single-stranded rnas,6.753669101218923e-05
receptor-destroying sialate o-acetylesterase,6.753083207933868e-05
s-expressing cells,6.752961258075763e-05
homologue,6.736385766087683e-05
basic building block,6.735915812095702e-05
hcov229e replicase polyprotein residues asn 1302 asn 1305 his 1310 gly 1312,6.735903515038345e-05
multinucleated giant cells,6.73365032766138e-05
ecov-infected mdbk cells,6.72973999920423e-05
extrinsic factors,6.729004147648947e-05
heptad repeat peptide,6.728578948370574e-05
cov murine hepatitis virus mhv nsp12rdrp structure,6.723568108749065e-05
mobile molecular merscov,6.722586342382554e-05
epidemiological details,6.719803625061703e-05
membrane component,6.718123850408902e-05
low-pathogenic human coronaviruses,6.717203919400194e-05
proinflammatory immune response,6.70908410496604e-05
pro-inflammatory cytokines,6.705598606332213e-05
intensive care department,6.704981755074921e-05
open reading frame orf 1b p59nsp14,6.703638938339871e-05
rna-binding protein,6.696262095996911e-05
nested polymerase chain reaction npcr assays,6.69046338642838e-05
melanomadifferentiationassociated gene 5,6.686726544012823e-05
coronavirus endoribonuclease,6.68526888777993e-05
pressures,6.683009279770567e-05
yu,6.6774398737434e-05
oneway hemagglutinationinhibition hi test,6.672872301896931e-05
enteric clinical signs,6.669506189082402e-05
dromedaryalhasakfuhku19d2013,6.669473751467458e-05
endoplasmic reticulum (er)-golgi,6.662948729370883e-05
hiv-1 protease inhibitors,6.6617177598232e-05
protein-mediated,6.656749014979986e-05
csb,6.653897899242636e-05
single-stranded positive-sense rna viruses,6.649453141589648e-05
nsp,6.639455360686258e-05
turkey coronaviruses,6.63405614052173e-05
genotypic relationship,6.633166187357744e-05
adenovirus-based prime-boost vaccine,6.619494666400174e-05
postreceptorbinding events,6.610851061606471e-05
univariate multinomial logistic regression models,6.609188741300396e-05
substrate-induced dimerization,6.608653136357193e-05
notyetidentified proteases,6.605459030782298e-05
rna splicing membrane,6.603228819553324e-05
mycophenolic acid,6.59810770908111e-05
immune-mediated lymphocyte destruction,6.587496580022785e-05
accessory proteins 3 4a 4b,6.58687659789117e-05
immunofluorescence studies,6.58076400530165e-05
merscovneutralizing,6.572914516092696e-05
nucleocapsid gene realtime rtpcr assay,6.572844301719626e-05
parrot/indonesia/bx9/16,6.570464552305854e-05
peripheral posterior lungs,6.564276768850136e-05
polymerase catalytic domain,6.560538540916416e-05
cytotoxicity assay,6.551438714155138e-05
m protein amino terminus,6.550825283837049e-05
hapn protein,6.547929647729176e-05
putative bipartite nuclear localization,6.545113482043385e-05
nspnsp interactions,6.540733113020873e-05
hcovhku1 s1600 glycoprotein,6.539356088719631e-05
circulating human coronaviruses,6.536440821347097e-05
membranebound protein complex,6.527281048419131e-05
oas genes,6.525793349359956e-05
diagnostic test,6.520597561447771e-05
chrcov hku24 betacoronavirus 1,6.514797496023562e-05
protease sites,6.513767364424192e-05
membrane protein m196 amino acids 196 to,6.511455909484891e-05
diagnostic accuracy,6.509733957804902e-05
exclusion highperformance liquid chromatography,6.508816019997526e-05
xenograft mouse,6.494322261853507e-05
lower respiratory tract disease,6.489791399331277e-05
recombinant sarscov n gstn protein,6.478598437949694e-05
prf,6.4768278874029e-05
cell surface aminopeptidase n,6.476595898439944e-05
sars s protein,6.47214911597349e-05
interfering,6.464926888178652e-05
ccv usda strain,6.464556753060651e-05
ubiquitin7amino4methylcoumarin amc,6.462762341848337e-05
reverse-transcription polymerase chain reaction,6.459061541730519e-05
sgmrna production,6.443645276967232e-05
hla,6.439550471228054e-05
viral spillover,6.434056667485538e-05
receptor-binding fragment,6.424203175808176e-05
95bp,6.418618994950808e-05
automatic nucleic acid extraction system,6.41413397836516e-05
chest computed tomographic scan,6.406068133094767e-05
rabvmers,6.399330497721923e-05
fluorescent mhvsgfp,6.389407632373015e-05
cross-protection,6.38407435607256e-05
"hcovs -oc43, -229e, -nl63 and -hku1",6.381468683617909e-05
known virus protein-coding regions,6.379264522389133e-05
aminoterminal region,6.378979832212932e-05
gene 5 products,6.376514142980997e-05
papainlike cysteine proteinase domains,6.37567409005646e-05
membrane-bound replicative organelles,6.37317797341662e-05
adaptive capacity,6.361973988198375e-05
porcine kidney cell line,6.358910703262228e-05
viral genome upstream,6.353800670713553e-05
secondary structural elements,6.352183190358435e-05
viral components,6.348530681868258e-05
state health departments,6.336620819071901e-05
lethal models,6.335712518867745e-05
geo-positioned mers-cov,6.333309454709705e-05
viral amplification,6.332406521712794e-05
neural cells virus populations,6.328279607135175e-05
helical rna packaging,6.325780041114347e-05
dual luciferase reporter assays,6.325110906311026e-05
"virus-encoded, non-structural proteins",6.325101314337562e-05
post-mortem examination,6.316883380465343e-05
nsp1-mediated translational shutoff,6.316726639226712e-05
mhv receptor ceacam1,6.31389580369442e-05
merscovneutralizing antibodies,6.306458476012771e-05
diagnostics,6.306140835839475e-05
infectious bronchitis virus-type pseudoknot,6.301772342698872e-05
mutation multiangle light scattering,6.293780756749288e-05
prophylactic treatments,6.293487308657434e-05
ultrathin sections cores,6.290234557715535e-05
predicted phosphorylation site,6.289603512000272e-05
poly(ethylene glycol)-block-poly(lactide-co-glycolide),6.28529128129384e-05
adverse events,6.285043997112312e-05
antigenpresenting cell,6.283173808867463e-05
adenovirus vaccine,6.282875150390621e-05
anti-m mabs,6.281365827836487e-05
293derived cells,6.280764108329109e-05
green fluorescent protein gfptagged mouse hepatitis coronavirus nonstructural protein 4 nsp4,6.264413491284425e-05
nonconserved glycosylation site,6.260572302059767e-05
cov e protein,6.257121960400589e-05
mouse hepatitis virus mhv nsp10,6.254956368225472e-05
coronavirusspecific antibodies,6.251990269614669e-05
antigenic subgroups,6.246803316835848e-05
sampling date,6.241299021181139e-05
viral mrna cap synthesis,6.23771460656277e-05
membrane-associated replicative organelles,6.232107358822613e-05
microbiologic documentation,6.230992495273913e-05
n-terminus,6.226099701814676e-05
selfmonitored,6.225967778406675e-05
clinical disease,6.221696284420353e-05
c-terminal alternative splice variant,6.215140488791366e-05
rbd domain,6.213025422297317e-05
cjun nterminal protein kinasestressactivated protein kinase,6.210512151154627e-05
human leukocyte antigen hla alleles,6.196445315017135e-05
lipophilic bis(amide) 3e,6.192705735199732e-05
coronavirusinfected cells,6.178309423517503e-05
cov genes,6.173690914264232e-05
electron microscopy analyses,6.17301309556161e-05
peritonitis virus fipv isolates,6.165475196658849e-05
feline infectious peritonitis virus fipv ucd1,6.164824089476203e-05
brsv,6.164652979436479e-05
rrna degradation,6.155408162757468e-05
transcription regulatory sequence motifs,6.15469531875225e-05
technical hindrances,6.154640179367867e-05
replicating,6.149472486426338e-05
p4a,6.148440868969185e-05
basal detrusor tone,6.140703497972385e-05
sars-cov group,6.134328276568355e-05
mhv a59 infectious clone mutant viruses,6.131328600457965e-05
substrate-binding regions,6.131125876146513e-05
genetic drift,6.122922906763607e-05
carboxyl-terminus,6.119208838983917e-05
infection-free herds,6.119190046587861e-05
bfa-resistant guanine nucleotide exchange factor gbf1,6.1143237272384e-05
mutational pressure,6.111742669871985e-05
avirulent serotype i viruses,6.109296777591102e-05
longitudinal serum samples,6.108415462598109e-05
lipid metabolism,6.10580250642602e-05
parental mhv genome,6.0901480043171736e-05
enteric strain,6.085014902027888e-05
threats,6.0826232082760436e-05
predicted nucleophilic cysteine residue,6.0809571756758367e-05
fusion state,6.0749311904340955e-05
chimaera,6.0733553533840376e-05
defective rna drna cd61 61 kb,6.0670354329655216e-05
ependymal cells choroid plexus cells,6.058060675001704e-05
sibs/half-sib kittens,6.054998020475378e-05
quantitative reversetranscriptase rt pcr,6.050096458895959e-05
bifunctional enzyme,6.047738005326096e-05
sfp,6.0473742354795435e-05
receptor binding domain protein,6.043856737841733e-05
canine respiratory coronavirus crcv,6.041435365120092e-05
pseudoparticle neutralization test,6.037973202940807e-05
replicase-transcriptase complex,6.03500441164706e-05
inducible nitric oxide synthase,6.030598895485887e-05
clinico-epidemiological,6.029210136512236e-05
virus-induced apoptosis,6.0269663890673964e-05
nonstructural scov nsp1 protein,6.0208636287412906e-05
doi:10.1186/s12917-015,6.020786697162995e-05
viral respiratory infections,6.0148543917274414e-05
37nt rna,6.0101681539292714e-05
mers-cov real-time reverse transcriptase polymerase chain reaction,6.0074589085021046e-05
microarray studies,6.0061241184032056e-05
inositol-requiring enzyme 1,6.001952025031863e-05
mabs-based antigen capture elisa,5.9953267782615736e-05
molecular diagnostic assays,5.9910591234033784e-05
conserved transmembrane,5.9887724833613416e-05
hla-b* 1301,5.9881893273003206e-05
sars-cov-infected cells,5.958603004348235e-05
factual material,5.950857720024195e-05
ezrin membrane-actin linker,5.946717783246873e-05
ultraviolet light-inactivated virus,5.93672295548532e-05
lawful permanent,5.93384573344872e-05
myeloblastic leukemia,5.898691523461862e-05
rna-synthesizing machinery,5.8981153296994446e-05
mers-cov case algorithm,5.894397574893587e-05
general public,5.8940485580733895e-05
unglycosylated m polypeptide 26k,5.892645476675952e-05
dimeric assembly,5.89148779004054e-05
hrc coiled-coil surface residues,5.8895724205949005e-05
infection virus,5.885443859520842e-05
nucleotide variation,5.8822452279788606e-05
pyogranulomatous-necrotising,5.8790320889509806e-05
subclinical respiratory infection,5.872372851797484e-05
cell lines huh7,5.870516973212389e-05
active cytoskeleton,5.870154291634136e-05
antibiotics intravenous immunoglobulin,5.8695277129334386e-05
methylprednisolone acetate,5.8683696849140464e-05
respiratory tissue,5.866639123293243e-05
vaccinia strain,5.860608683432234e-05
neuronal loss,5.859709055486384e-05
transmembrane serine protease tmprss2,5.8589019035036755e-05
carboxy terminus faces cell cytoplasm,5.8503376731541584e-05
escherichia coli m15 cells,5.849109572954759e-05
nucleoproteins,5.8431307575415234e-05
mhvrspecific monoclonal antibody,5.840015205347139e-05
mers-cov nucleocapsid protein detection assay,5.831432546422954e-05
fecal,5.824182186276488e-05
cov sarscov mpro mutant,5.8184667568148944e-05
t.,5.8163031746360896e-05
cellular lipid,5.813102117807727e-05
porcine aminopeptidase n papn,5.803882432495382e-05
receptordependent pathway,5.8004102578511436e-05
amino acid substitutions r642m,5.7964130532895165e-05
immature and mature human monocytederived,5.7961978857356915e-05
serological diagnoses,5.79264977730537e-05
family coronaviridae coronavirus envelope spike protein,5.787911930509696e-05
ace2 binding,5.782106907800967e-05
left testicular enlargement,5.7816896994048344e-05
sars-cov nucleocapsid,5.781078398836873e-05
coronavirus infectious bronchitis virus,5.7686551111394065e-05
lung proinflammatory cytokines,5.768235675564375e-05
hepatitis a virus 3c protease,5.767013260103497e-05
upe and orf1b genes,5.765716275034431e-05
sgmrna 7 3'-terminal region,5.757383273159143e-05
horizontal transmission,5.753459487448245e-05
travelers/pilgrims,5.7516812389052286e-05
epithelial cell cultures,5.749560659455423e-05
nonnucleoside analog,5.748546978911686e-05
immunopathological,5.745409302669963e-05
docking techniques,5.7437017597772746e-05
monkeys,5.74215993464802e-05
hepatitis c virus ns3 protease,5.7380322677793905e-05
ns8,5.7378536522965065e-05
hepatitis delta ribozyme sequences,5.733867464516627e-05
chronic neuroinflammation,5.729661545260064e-05
allele,5.727725683300951e-05
coronavirus replication machinery,5.726764920916368e-05
heterologous integral membrane protein,5.724057475104462e-05
virus-induced membrane structures,5.7205055213111025e-05
conserved arginine,5.720295703002071e-05
viral peptide-pulsed npcs,5.719118556098761e-05
receptor determinants,5.718501590964125e-05
coronavirus sarscov nonstructural protein 3 nsp3,5.7117948870066174e-05
airliquid interface,5.710961941742347e-05
human ubiquitin ub,5.7063504163145076e-05
anti-sars-cov effect,5.6978240524461244e-05
feline primary macrophages,5.696073666558083e-05
heexpressing di rna,5.685821308118164e-05
agglutinate red blood cells,5.6837058464704233e-05
multifunctional structure,5.681189517350821e-05
authority,5.678512608972978e-05
sn2 position,5.6761880549245275e-05
cultured neural cells,5.674860320127876e-05
oropharyngeal cavities,5.6747766912106836e-05
false-positive,5.667566350488941e-05
virology field,5.660534840347209e-05
mers-cov np capture enzyme-linked immunosorbent assay,5.650501680414685e-05
sars-cov virulence,5.650399469703598e-05
fusion-defective mutants,5.6486049530998356e-05
intratracheally,5.6476103799053255e-05
crowd-sourced epidemiology,5.6470608862583845e-05
drug treatment,5.645446231414483e-05
rb,5.6408063668361774e-05
coronaviral 3clpro cleavage sites,5.6383134213536625e-05
culture supernatants,5.6382408999001784e-05
truncated n protein fragments,5.6355472416371205e-05
cysteinerich region,5.632810448929422e-05
bayesian framework analysis,5.632138197239025e-05
anti-cancer,5.631933765069152e-05
sialic acid recognition,5.629635655704928e-05
colorimetry-based atp hydrolysis assay,5.62821589869347e-05
donor sequence acceptor,5.627276560655763e-05
antagonistic mechanisms,5.6257103738352286e-05
camelid heavy chain variable domains,5.605769117063612e-05
primary infection,5.5968624859860174e-05
ancestors,5.5857342734544884e-05
proinflammatory cytokines interleukin 1 beta,5.584373732966288e-05
multiple recombination sites,5.582656624806695e-05
temperature tsfipv,5.578528834774289e-05
nurses,5.577742569502338e-05
uorfharboring stemloop,5.576866946268258e-05
spike protein evolutionarily,5.576345344281538e-05
phosphatidylinositol 3 phosphate,5.5738151071936245e-05
infectious-bronchitis-virus (ibv)-related variants,5.5711246214117056e-05
recombinant sarscov spike protein sarss,5.568440064845047e-05
hcov-nl63 rna,5.568058029978355e-05
mitochondrial pathway,5.567776588802793e-05
heart diseases,5.564484596140915e-05
evolutionary distances,5.564339913452214e-05
n-terminal gst-fused sars-cov,5.562218958297564e-05
n and second domains sor112,5.560519348926814e-05
coronavirus replication transcription complex,5.559348781837702e-05
gastrointestinal translocation,5.556434141625615e-05
asymmetric five-primer reverse transcription loop-mediated isothermal amplification,5.554428927852036e-05
cd13 tmprss2 cells,5.5534075906884586e-05
recombinant elisa,5.5498333827941116e-05
distended cisternes,5.5478757126480136e-05
parental mhv genomic rna,5.540759181143296e-05
direct sequencing analysis,5.534571217139458e-05
conserved antigenic sites,5.533166691644544e-05
structural or accessory genes,5.529511348440861e-05
somhvr,5.5294065846947635e-05
linear behavior,5.5293449105675264e-05
blood relative,5.527449056329692e-05
extra-respiratory tissues,5.52588303779574e-05
viral spike protein sarss,5.5213234303856415e-05
membrane m protein carboxy tail,5.517367444538908e-05
membraneassociated peptide,5.512903858910733e-05
endosomal pppase,5.511554193631694e-05
wildtype sequence,5.504140856494902e-05
real-time pcr assays,5.502265124503086e-05
tatase activities,5.5014015133538186e-05
open reading frame orf 1 b overlaps orf 1,5.4929568081979456e-05
resistant cc003/unc,5.492551045290074e-05
pro-survival myeloid cell,5.4908590057496336e-05
anchors,5.487427370585557e-05
dromedaryalhasakfuhku132013 ah13,5.486369969870309e-05
proteinspecific monoclonal antibody,5.47893923195221e-05
electrophoretic mobility shift assays,5.470826478015513e-05
virus replication cov nsp5,5.4659581196573744e-05
putative rnadependent rna polymerase,5.4643886610854814e-05
middle east respiratory syndromerelated coronavirus,5.4594722183067294e-05
subjects,5.458966177791231e-05
respiratory cov infections,5.4568922957957304e-05
viral particle,5.456222438482656e-05
vitrotranscription/translation studies,5.4517510087175704e-05
coronavirus nucleocapsid (n) protein,5.449432390920545e-05
hybridized target,5.448496917552499e-05
ezrin dominant negative ferm domain,5.448170785880733e-05
respiratory bcv infections,5.437428488038975e-05
reverse transcription-polymerase chain reactions,5.4336265799833386e-05
polyclonal antibody,5.4295607675466486e-05
sars convalescentphase sera,5.421312681222563e-05
di rnatransfected mhvinfected cells,5.420616218959644e-05
rnase protection assays,5.413723973086245e-05
glycosylated el,5.412925106681011e-05
hcw,5.4120459093509184e-05
slcov 3a dna vaccines,5.411059720707052e-05
orf1ab proteins,5.410358110472017e-05
non-regenerative anemia,5.410239629779769e-05
quaternary arrangements,5.407560588795397e-05
s subunit proteins,5.401199397663552e-05
coronavirus glycoprotein e2,5.400673985286538e-05
susceptible-infected-removed (sir) model,5.399427579452423e-05
carboxy-terminal charge-rich motif,5.398487028826934e-05
lung stemprogenitor cells,5.396561976729609e-05
transcriptional inactivity,5.3943951590491546e-05
immunological selective pressure,5.392933145266885e-05
s2 subunit hr2p,5.392290344226882e-05
2-substituted benzoxazinones,5.392265800326776e-05
coronavirus-like particles,5.3873472876464356e-05
medium-sized hipposiderid bat,5.38679575714822e-05
vitrosynthesized fulllength transcripts,5.3822031165755585e-05
rna-synthesizing enzymes,5.378254198795711e-05
caspases,5.375362332077064e-05
sialic aciddependent binding,5.37130411064028e-05
individual genes,5.356464587741296e-05
receptor-binding site,5.354921991634604e-05
mild encephalomyelitis,5.3477340093582944e-05
bst2s,5.345815792318484e-05
carboxy-terminal amino-acids,5.3433599736185906e-05
ribosome loading region,5.340849644662299e-05
intracistronic slv,5.340612319734956e-05
antiviral activities,5.322849356375846e-05
genome-length sars-cov cdna template,5.3218765194036326e-05
antiviral research,5.31904858619306e-05
zone-interference gel electrophoresis,5.314792740688867e-05
virus neutralization assay,5.31096626009323e-05
protein products,5.301354554189453e-05
motifs of catalytic residues,5.300824484811372e-05
gav,5.2994354037544454e-05
veterinary coronaviral vaccines,5.2971985272593504e-05
mouse hepatitis virus mhv ntd,5.295431107654643e-05
enterotropic mhvy,5.295188460362572e-05
cis rna attenuator,5.292313550361374e-05
subunit dissociation,5.2861650145601656e-05
virusreceptor interactions,5.284987346926606e-05
wang j fu x yang s g lim w hong,5.284855659319507e-05
pathogenic tl/ch/ldt3/03-like virus,5.284648034040327e-05
interleukin2 il2,5.283833101887562e-05
cellular factor,5.280833645796632e-05
heterogeneous nuclear ribonucleoprotein a1,5.280367679245457e-05
eukaryotic rna,5.2788932162177136e-05
coronavirus genera,5.2781470776156456e-05
rna template,5.277075114351964e-05
cross-reactive neutralizing antibodies,5.2701317411045014e-05
acidic endosomes,5.253076800241249e-05
regulators,5.243240991701625e-05
precursor polyprotein,5.24056680239226e-05
aspartic acid residues,5.232511297429105e-05
plasma membrane voltage gated ion channel,5.2195961349035694e-05
sequence conservation,5.217983502028522e-05
quantitative trait locus,5.217907431095582e-05
signal transducer and activator of transcription (stat) 3,5.217736528772142e-05
ib vaccines,5.210516748168363e-05
transcriptionregulating sequences trss,5.209555949141147e-05
viral and cellular membrane fusion proteins,5.208228815925435e-05
brown bats sequence,5.207995742314417e-05
inflammatory monocyte macrophages,5.205794125164621e-05
asynchronously replicating cells,5.199644845357132e-05
speciesspecific coronaviruses,5.181328161474344e-05
reverse transcription (rt)-pcr assays,5.171815924883176e-05
sting-mediated ifn induction,5.1685246031997276e-05
bat slcov 3a dna vaccines,5.157690915231032e-05
sialodacryoadenitis virus sdav,5.156508220953702e-05
mdpp4,5.156277927864736e-05
evolutionary success,5.154931467264764e-05
indices,5.1541411353585445e-05
vl cdr,5.15278548547506e-05
rattus coronavirus hku24,5.1458459524740445e-05
virusblocking activities,5.145834986892093e-05
coronavirus-encoded protein,5.145658695661318e-05
nsp1516q6327,5.1407095048522564e-05
649 nt,5.137330199435934e-05
nterminal domain s1ntd,5.1372927894786216e-05
cell-associated angiotensin-converting enzyme 2,5.1338539680017996e-05
human immunodeficiency virus type-1 and hepatitis c virus envelope proteins,5.123516550999823e-05
ribozyme sequences,5.117679036368381e-05
mers-cov antibodies,5.113896268500528e-05
ccov-iib strains co-circulate,5.113559587069965e-05
iga bcv-specific antibodies,5.1122531967800874e-05
input variables,5.107948747904167e-05
granulomatous disease,5.1073868561100243e-05
interferon-inducible diphtheria toxin-like enzymes,5.104639943061749e-05
cloacal swab,5.099957067851661e-05
npipb3 nuclear pore complex interacting protein family member,5.098501688215252e-05
single-stranded rna of mhv,5.0981040435819066e-05
single genomes,5.09360904540094e-05
stimulatory subunit,5.092382497972917e-05
nonstructural scov nsp1,5.08933749452697e-05
screening method,5.0878577931408415e-05
antibody secreting cell asc,5.087836998435387e-05
ck/ch/ldl/97i-type strains,5.08451064013186e-05
human airway epithelial,5.082314880231899e-05
rna overlay-protein blot assay,5.0817805265737424e-05
3c protease,5.0797686920713584e-05
sarscov sbased immunoglobulin m,5.077023226324809e-05
dominant-negative mutant,5.075562133958988e-05
entry-efficient s gene template,5.0747259893957796e-05
human metapneumovirus f protein,5.073904092665174e-05
single precipitin band,5.0701109131306335e-05
emc s recombinants,5.068141180484161e-05
tissue tropisms,5.060021560114571e-05
single amino acid residue,5.059485098316875e-05
mrna leaderbody junction,5.0535496062201776e-05
19kda receptorbinding species,5.052933184368075e-05
kidney-derived mdbk cells,5.0520746739797714e-05
npc1,5.0507819734021605e-05
murinerestricted,5.0483787113535426e-05
gene-positive specimens,5.0482569620906706e-05
86 nucleotide sequence,5.046820343923874e-05
virus-specific antibodies,5.0464988351761195e-05
type i interferon (ifn) response,5.046130190452261e-05
usingtranscleavage assays,5.044251098697041e-05
respiratory coronavirus 229e,5.035524176963862e-05
chicken respiratory tract s1 derived,5.03272730188362e-05
single-particle cryo-electron microscopy,5.0295745809918115e-05
mild illness,5.0224359912156704e-05
goat and bat receptors,5.016242824448289e-05
response profile,5.016179541265306e-05
hospitalassociated,5.0139964552394704e-05
mers-cov recombinant partial spike protein antibody elisa,5.00885765751971e-05
replication-deficient dis constructs,5.0085581397171115e-05
caco-2 and n2a cells,5.00805203621276e-05
feline coronavirus surface glycoprotein,5.0049519526567845e-05
receptorspecific infection,5.004246071406764e-05
cell-free translation,5.002565194718157e-05
multiple rna viruses,4.99785622310526e-05
th1 and th2 cytokines,4.9972525337983545e-05
restriction enzyme,4.99720093493817e-05
central and western regions,4.996193505414629e-05
species betacoronavirus 1,4.9921956571285234e-05
spike polypeptide,4.989154696583915e-05
trim56 domains,4.986158353892141e-05
antiviral helicase inhibitors,4.985862140131241e-05
crystallography,4.985213766038858e-05
viral replicase/transcriptase complexes,4.983079328762822e-05
anticancer drug,4.9806298491839383e-05
glycoprotein antibodies,4.979759484257612e-05
qualitative differences,4.979475194409421e-05
mers-cov envelope-embedded spike protein,4.973540786995223e-05
human coronavirus 229e hcov229e vector,4.972902721033118e-05
betacoronavirus spike proteins,4.97226488772522e-05
picornavirus,4.9664932681867974e-05
parental virus genome,4.96622771241138e-05
sars-cov frankfurt 1 rna,4.963964406639504e-05
broad-range cov inhibitors,4.9613856890249526e-05
cell survival signaling pathway,4.9600263810758455e-05
feline aminopeptidase n receptor,4.9588571842646925e-05
multifunctional golgiendoplasmic,4.957930639387346e-05
zoonotic transmission coronavirus cov,4.9532715096011254e-05
recombinant receptor-binding domain (rrbd) protein,4.952192187139593e-05
leukocyte transendothelial migration,4.950408991162985e-05
mice ferrets,4.945672914573827e-05
sero-epidemiological survey,4.938956135591283e-05
indiana,4.93483784554524e-05
live-attenuated vaccines,4.933864454281119e-05
epidemiologic risk factors,4.93165243487835e-05
liverresident macrophages,4.9281858361973064e-05
hcov-oc43 genotypes f,4.92524184571079e-05
virus/human/animal network,4.9187245578388146e-05
parental vaccine vector bnsp333,4.918150375456657e-05
receptorbinding s1 subunits,4.916620354695366e-05
immunogold labeling electron microscopy,4.9157024005941424e-05
prokaryotic ribosomes,4.909356032997472e-05
mers-cov antibody response,4.9089606181507324e-05
positive- and negative-strand rna,4.9065617521701876e-05
noncanonical site,4.905291779436395e-05
doi:10.1186/s12917-015-0372-2,4.9047636900913546e-05
replicase nonstructural proteins 2 3,4.898855042399198e-05
continuous mutation,4.8943983621827335e-05
geographical distributions,4.8938438627010836e-05
mhvinduced demyelinating diseases,4.892818059876072e-05
tmprss2positive cells,4.892519122387824e-05
pro-active surveillance programme,4.889813850134529e-05
diarrhea virus pedv,4.885674181057147e-05
traveler-associated secondary cases,4.8846004066675666e-05
pmn,4.8806661276367384e-05
neurotropic virus,4.8786821499258223e-05
culture system,4.8759253736052194e-05
precision,4.8755520160944824e-05
proteinmediated infection,4.872564799156148e-05
cdna encoding sarscov e protein,4.8724645887185224e-05
ribosomes,4.867206877005029e-05
plaque-forming units,4.8667119967516146e-05
structural regions,4.865186524536061e-05
sequence similarity,4.86430338945241e-05
wildtype s protein pseudotyped mlv vectors,4.863767925173936e-05
referral medical laboratories,4.862709805061058e-05
p65,4.8625602375737984e-05
stress responses,4.8600498368425543e-05
asparagine linkage,4.858277490419435e-05
virusspecific cd8 t cells,4.8559239764158337e-05
donor sequence acceptor sites,4.8557841476284644e-05
uninfected population,4.84765569338879e-05
biological forces,4.8475595352079504e-05
mice bcelldeficient mice,4.845151149568552e-05
shelter environment,4.8435138582748073e-05
fragment residues,4.842042537727258e-05
igg2 responses,4.837778992309548e-05
replicationindependent process,4.8375323663281164e-05
neurotropic a59 strain,4.837096322533914e-05
wildtype wt virus,4.833365565926333e-05
anti-viral nab therapies,4.831867594283876e-05
signalling pathway assay,4.8275865493082857e-05
peritonitis coronavirus vaccine,4.820605324448474e-05
interferon immune pathways,4.815896128415685e-05
negatively charged endodomain residues,4.8122880263922807e-05
chemical genetics,4.8097722484033785e-05
canine coronavirus type,4.8062817501879825e-05
c-terminal cytoplasmic domain of 3a,4.8059823398656815e-05
infected epithelial cells,4.804913102414376e-05
plpro domain,4.801515987032466e-05
infrastructure,4.790132868723028e-05
blood lymphocytes,4.7888501429754814e-05
transmembrane matrix,4.783083087731532e-05
olivares l shi d look t gallagher,4.7813345860170206e-05
technological developments,4.7742576449349115e-05
glycosylated integral membrane protein,4.772757471231918e-05
interferon ifndeficient vero cells,4.7723514720539334e-05
cytocidal,4.772201382959771e-05
transcription factors irf-3,4.771736480472973e-05
high-titer neutralizing antibodies,4.7692603241057824e-05
om,4.766516855532407e-05
age-specific,4.761417998463994e-05
cell surface receptor aminopeptidase n binding,4.7605131758250085e-05
serotype-specific neutralization epitopes,4.759125245121848e-05
intrahost single nucleotide variants,4.753307447325707e-05
cellular cathepsin activity,4.75289088694463e-05
recombinant a59 virus,4.752185778895021e-05
membrane-associated replicase complex,4.748553235307907e-05
rsv infections,4.745678874117386e-05
p britton j virol 751235912369 2001,4.7398278309738044e-05
nsp4 proteins,4.739275658911404e-05
virus susceptibility,4.7374408899900746e-05
multivariable cox regression analysis,4.736039066447072e-05
antiinflammatory cytokine,4.730191737498309e-05
mva,4.729098291348247e-05
function proteins,4.728682095039268e-05
synthetic overlapping peptides,4.722114227688119e-05
m.,4.720373656196535e-05
thin-section electron microscopic,4.718938030069093e-05
allergy,4.718550504866283e-05
pan-lysosomal protease,4.712952150918274e-05
coronavirus-based gene delivery vectors,4.703327182471735e-05
hcov229e virus particle,4.703263071006122e-05
interferon subtypes,4.693467318847516e-05
rtd1treated sarscovinfected,4.688123717953266e-05
national veterinary services,4.6879025903252704e-05
healthcare providers,4.684261560681547e-05
renilla luciferasebased cellcell fusion assay svsvcyt,4.680894055073387e-05
nproteinbased western blot assay,4.6807624668968544e-05
chemotaxis eosinophil,4.679416142707944e-05
d1128a mutation,4.6765929975622874e-05
chymotrypsinlike cysteine proteinases,4.667319442567845e-05
sero-surveys,4.6669965917814344e-05
central memory cells,4.664799756931472e-05
crossspecies infections,4.663748694704563e-05
immune differences,4.659867930586712e-05
recombinant baculoviruses,4.6523221239638814e-05
coalescing centrilobular hepatic fatty change,4.646446744952718e-05
cpg suppressed,4.64603204054414e-05
membrane-actin linker,4.645102398721103e-05
southern taiwan,4.6444907358475726e-05
truncated amino acid sequences,4.643926394338262e-05
complementarity,4.643121222134426e-05
normal counterpart,4.642860726347903e-05
synergistic effect,4.639050317996455e-05
coronavirus 229e infections,4.637826190010275e-05
gastroenteritis cov tgev,4.6347010113655236e-05
sars-cov gene,4.632349796862829e-05
human canine,4.6302684866865305e-05
conserved rdrp gene,4.6294612243158096e-05
high-density oligonucleotide array analysis,4.6290645310194e-05
educational interventions,4.628207176367979e-05
stereo-array isotope labeling,4.627445130239068e-05
hace2dependent smediated,4.626842260860121e-05
triton x100resistant microdomain,4.624583262681233e-05
scov replicon system,4.6243549340360945e-05
chest computerized tomography scan,4.6234593657526476e-05
histone deacetylase inhibitor,4.618192368003579e-05
provisional,4.6129753256080725e-05
ksa,4.612882261139777e-05
discontinuous transcription,4.6114863477252156e-05
neutralizing polyclonal antibodies,4.6080193234194656e-05
transmembrane-protein,4.6031950720184606e-05
243ysteart249 (1c3) and 243ysteartdnlseqekllhmv262 (4c7,4.6017152323427916e-05
constitutively,4.596425538970183e-05
immunofocusing,4.596196793544726e-05
antibody-capture elisa,4.5950165036402695e-05
intermolecular disulfide bonds,4.5943512810226734e-05
temporal progression,4.593960296005763e-05
feline s protein sequence,4.5933009538904696e-05
bis-benzylisoquinoline alkaloids tetrandrine,4.5919844739365973e-05
comparative sequence analysis,4.5874377513405913e-05
coronavirus polyproteins,4.58367320736864e-05
viral population,4.5783707072420625e-05
gene therapy,4.577272177964146e-05
hypophosphorylated retinoblastoma protein prb tumor suppressor p53,4.575228730882627e-05
substrate binding site,4.567460837279565e-05
analytical ultracentrifugation analyses,4.5649834681733266e-05
drug-induced disruption,4.5641714692331804e-05
gene transcript,4.5631274372570756e-05
fibrinopurulent bronchopneumonia,4.557336294075729e-05
amino acids 270,4.556428856445281e-05
false-negative,4.5531579986572707e-05
cathepsin l cleavage site,4.546772478216024e-05
equine coronavirus nc99 strain,4.543953511618966e-05
calnexin sirnatreated cells,4.540519033147372e-05
pathogenicities,4.5403659971112386e-05
stakeholders,4.539870745240113e-05
non-structural proteins,4.5390153868832766e-05
scleaving proteases,4.538782774590335e-05
international committee of taxonomy,4.538753033513288e-05
sequence comparisons analysis,4.53829723995852e-05
serine proteinase inhibitors,4.53628764400195e-05
fak focal adhesion kinase activity,4.53622773761062e-05
amino acids in 8a and 8b are,4.534478294407401e-05
adenosine diphosphate adpribose,4.531260381346623e-05
autophagydeficient,4.529913136264996e-05
fluorescence resonance energy transfer,4.5297719293989114e-05
doi:10.1007/s40121-015,4.523743989312485e-05
immunofluorescence antibody ifa assay,4.522430596455921e-05
coronavirus gene product,4.518212540008782e-05
virus replication protein kinases,4.5178385372766244e-05
glycoprotein retention,4.516471565519516e-05
knockdown experiments,4.513963219589093e-05
immunodominant epitopes,4.513361126524457e-05
sars cov (scv) ntpase/helicase,4.511481618576051e-05
peptide vaccine,4.510291666131008e-05
respiratory virus infection,4.510200690252603e-05
standardized nomenclature system,4.505526387713833e-05
predicted nsp12,4.504521319010439e-05
phospholipase a2,4.501694619245834e-05
mouse hepatitis virus-a59,4.501667913743144e-05
damp,4.5009715184150524e-05
protease domains,4.500111458413419e-05
coronavirus replication/transcription complex,4.498614795296829e-05
cellular lipid metabolism,4.4983499128548476e-05
protein intermediates,4.4972612898072615e-05
genetic determinants,4.4966894682210895e-05
proteininduced apoptosis,4.4950852996038036e-05
3cl protease inhibitors,4.4928616586158156e-05
membrane destabilizing transmembrane (tm) hairpin,4.48852349798649e-05
mouse hepatitis virus a59 mhva59infected dbt cells,4.487283253937134e-05
signaling cascades,4.486187057155904e-05
genomic profile analysis,4.4825512765590505e-05
glycopolypeptides,4.479958423281064e-05
brain immune cells astrocytes,4.4626045321373156e-05
nonpharmaceutical preventive measures,4.4622678468918214e-05
no renal impairment,4.457628494238639e-05
bovine-like viruses,4.453785866446843e-05
lymph nodespecific,4.453595413107786e-05
chrcov hku24 nucleocapsid,4.452522718837359e-05
p38 mapk mitogenactivated protein kinase,4.449952042511777e-05
xxxrs motif cleavable,4.444840999316257e-05
complex type glycosylated forms,4.4390916382966065e-05
oligoribonucleotides,4.4381653388905685e-05
england/qatar 1 virus,4.433816535320665e-05
reverse transcription loop-mediated isothermal amplification,4.431201250015964e-05
patient convalescentphase,4.42758065114475e-05
multiple membrane topologies,4.4259725332898484e-05
mhv-induced acute encephalitis,4.4239994063016846e-05
amino acid 9101 da hydrophobic protein hp,4.4205261459054576e-05
porcine epithelial cells llcpk1,4.41967487515972e-05
europe tissue samples,4.414623197564177e-05
virus rna andor antigen,4.409916699516428e-05
escherichia coli cells,4.4071032143068e-05
membrane fusion s2 subunits,4.405114150927481e-05
protein subunits,4.404001035995337e-05
nonisolated in-hospital,4.403521131011659e-05
groupspecific genes,4.402756657867731e-05
mock infected cells,4.402548127954761e-05
vero-to-human transmission,4.40191531716498e-05
transmembrane domain of e protein (etm),4.3986117799429386e-05
lipid composition,4.39450216742778e-05
cellular chromatin,4.3936325688868216e-05
furin,4.393288575990293e-05
adpribosylation factor 1 arf1,4.393067431955477e-05
runde norway,4.391940329932061e-05
primary bone marrowderived,4.39017215248389e-05
coronavirus vaccines,4.38794984388582e-05
murine coronavirus receptor murine,4.3876255400391264e-05
laboratory-confirmed 2019-ncov infection,4.38484121214512e-05
nursing education,4.380774119756438e-05
clinical phase,4.379672203618101e-05
onestep dpcr,4.3791511593027634e-05
putative polymerase gene,4.378551632901712e-05
sarscov nucleocapsid sarscov n protein,4.377255419990254e-05
emc,4.373053019520923e-05
seasonal outbreaks,4.370967153284711e-05
ultraviolet light-inactivated mouse hepatitis virus,4.3708400111021025e-05
magnetic resonance imaging,4.370727588478186e-05
liver pathogenesis m protein,4.37030710398435e-05
conserved core sequence,4.3695995558885284e-05
sequence regions,4.368645220304155e-05
nonmyeloid cells,4.365883298769836e-05
unobstructed catalytically competent active site,4.365305046207118e-05
mhv ntdmurine,4.364010853401168e-05
rat brains mm78,4.363809026951674e-05
trim56 mutants,4.360264316202243e-05
recombinant n protein,4.358506008377934e-05
peripheral blood monocyte macrophages,4.357914475125233e-05
past infection,4.3545910183158766e-05
sars-recovered individuals,4.350647028733753e-05
high s1 gene sequence,4.350111474184264e-05
ifn response,4.3488555278884025e-05
civet sarscov isolates,4.346132031749392e-05
distant downstream site,4.344541355488548e-05
clinico-epidemiological significance,4.342657521811728e-05
group c betacoronavirus,4.341302794988685e-05
gnn,4.339507931893549e-05
endosomal membranes,4.336633439051982e-05
cytokine tumor necrosis factor alpha,4.331993359245013e-05
loop residues,4.33169583065848e-05
fibroblastlike cell line nih 3t3,4.3314883627475185e-05
proinflammatory cell death,4.3307859601754154e-05
iab binding motif,4.3261932962309036e-05
sars-associated service,4.325667992371398e-05
negative-strand,4.323937879068635e-05
200 basepair region,4.323313602373829e-05
bat coronavirus hku4,4.323234038064619e-05
veterinary medical teaching hospital,4.320927115784465e-05
recombinant receptor-binding domain,4.3167420349413536e-05
ceacam5 protein,4.3164645988586986e-05
rrtpcr assay panel,4.3162553854617033e-05
r0 of coronavirus disease 2019,4.315095803206458e-05
neutralizing sars-cov infection,4.3104173465073475e-05
predicted partial amino acid sequences,4.31009350802068e-05
antiviral t cell responses,4.309712468714829e-05
endo-glycosidase h-resistant glycoprotein,4.30777366795428e-05
leader sequence,4.30661283402882e-05
orf1a replicase,4.3031990093527864e-05
virus neutralization test,4.301611393336056e-05
house rats,4.300778223146191e-05
p14 splenocytes,4.300288025068261e-05
vaccine antigens,4.298261333889099e-05
innate immune regulatory,4.2970569530542244e-05
dsmb,4.2967133715088424e-05
rnase l activity,4.296122143350021e-05
modified rna extraction method,4.294296624507915e-05
cho cell line,4.2931251510814426e-05
prototype strain,4.2882889866855116e-05
inflammatory cell infiltration,4.283906730210408e-05
chargerich carboxyterminal region,4.282970798519245e-05
small interfering rna sirna,4.279844199819977e-05
nitazoxanide,4.278795528400939e-05
carboxyl-terminal truncations,4.2780847622587204e-05
ribonucleoprotein (rnp) structure,4.2756315543743304e-05
hr2 region inhibitors,4.27438909486332e-05
field conditions,4.272476674726527e-05
numerically higher,4.2692057906264857e-05
nursing colleges,4.266821070036564e-05
spike transmembrane anchor,4.263202271451868e-05
cns infiltrating bmdm,4.2616668214727244e-05
carboxyterminal endodomain,4.254692216289789e-05
losses,4.252871510998656e-05
mers-cov-specific cellular immune responses,4.2512829618332246e-05
chromatography purification,4.2497399809598084e-05
caveolin1positive area electron microscopy,4.2491969694648983e-05
[(18)f]-fdg)-positron emission tomography/computed tomography,4.246049232685375e-05
catalytic and substratebinding residues,4.24555608540627e-05
aromatic amino acid-nucleobase stacking,4.243435315839289e-05
cterminal transmembrane helix,4.239703406293983e-05
ribavirin r80ae82aexon,4.2389508153660416e-05
aminoterminal domains,4.238254230309212e-05
viral nucleocapsid,4.2380560376718516e-05
primary pig,4.238007428569238e-05
case distribution,4.2377188454054775e-05
ibv nsp9 homodimer,4.2352029482433785e-05
ipc,4.233333372476311e-05
mhv receptor ceacam1 mhvr,4.2278510048804045e-05
coronavirus disease 2019,4.227614138422558e-05
antivirally active proteins,4.2244688190501e-05
porcine delta coronavirus,4.2189462306185e-05
rift valley fever virus,4.2161648616353354e-05
denv type 2 denv2 cinanserin hydrochloride,4.2146855240496125e-05
nickel affinity chromatography,4.2137781478438696e-05
rna-synthesizing activity,4.2096737977715136e-05
interferonstimulated genes,4.206902942821428e-05
intracellular vesicles,4.195556635135479e-05
h-index,4.194807834016577e-05
versatility,4.1916236941489625e-05
reverse-transcriptase quantitative-pcr,4.191241036949546e-05
ace2 amino acids 697,4.1904055727928e-05
transmembrane (tm) domain,4.184273651859648e-05
no deaths,4.18057159766525e-05
rrna degradation assay,4.180053091243376e-05
realtime sarsspecific pcr assays,4.175476785088734e-05
neutralizing mabs and spike protein,4.1729431260305936e-05
vaccine regimens,4.167458513697758e-05
prevention practices,4.1658149577781225e-05
upstream canonical site,4.160500454968974e-05
disease onset,4.159813876570405e-05
phosphoinositide 3-kinase,4.1581414844396635e-05
virus titer,4.1578050355793754e-05
matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry,4.1514139861023935e-05
suppressor residues,4.15024041837612e-05
real-time rt-pcr kit,4.1456228445750256e-05
replication/transcription multi-protein complex,4.143906999614561e-05
sars-cov protein,4.140814370004331e-05
adult wd strains,4.140477619554793e-05
vaccine-induced protective immunity,4.138310245728335e-05
d2 his134tyr change,4.134242919388592e-05
elispot assays flow cytometric analysis,4.125531791582778e-05
alexa488-qsy7 fret-based peptide substrate,4.124178404000562e-05
pathology coronaviruses,4.123689829436076e-05
cis rna slippery sequence,4.115549204531669e-05
-7,4.114221487215345e-05
serum protein free vero cells,4.1137896293453596e-05
carbohydrate side chains,4.112669776021151e-05
no symptoms,4.111912215945378e-05
integral membrane protein,4.1100625667206056e-05
furin sirna silencing,4.1077955866213594e-05
germinal center gc,4.107691591279053e-05
carboxy-terminus of e protein,4.10538319717376e-05
infectious ibv clone system,4.1042563369568645e-05
chronic demyelinating encephalomyelitis,4.1040343830247e-05
cleaved signal sequence,4.1022239801295494e-05
(rt-rtpcr)-based,4.1020666189234586e-05
virus fusion machinery,4.0995665033373324e-05
mhv genomic cryptic transcription consensus sequence,4.093002717818453e-05
sarscov s glycoprotein carboxy,4.092671735593973e-05
histochemistry,4.091328667678517e-05
comparative genomics,4.090149180293048e-05
hyperimmune plasma,4.089026250458426e-05
virus-induced cytopathic effects,4.087500450456812e-05
coronavirus sarscov sarscov gene fragments,4.0839254005840036e-05
spseudoviruses,4.079943643550503e-05
coronavirus macrodomain,4.079027995506035e-05
denoted strain bj232,4.0768463342026734e-05
batcov hku10 spike protein,4.068974002540143e-05
klinikum schwabing munich,4.06820306241554e-05
packaging cell lines,4.0681015672242244e-05
parenchymal abnormalities,4.065730134756766e-05
cpl,4.064263218894652e-05
real-time reverse transcriptase-polymerase chain,4.059994155956254e-05
green fluorescent protein recfcovgfp,4.057603750554038e-05
carbohydrate chains,4.052964896652749e-05
sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis,4.045706736890725e-05
ultrastructural observations,4.043858828396349e-05
type i protein phosphatase,4.043288054770327e-05
five-stranded antiparallel,4.042989234553129e-05
furin consensus motif rrfrr537s,4.038909097077989e-05
enzootic covs,4.032704076270166e-05
acute middle east respiratory syndrome coronavirus,4.030827145642743e-05
lysosomal mhc ii compartment,4.027712332920305e-05
nucleocapsid and orf1a sequences,4.0275372618009835e-05
fusion sites,4.0253383775238865e-05
molecules granzyme,4.02531944430706e-05
vespertilionid bat,4.021566738382338e-05
releases,4.020592074408871e-05
realart hpa coronavirus lc kit artus hamburg germany,4.020383080205649e-05
angiotensinconverting enzyme 2positive,4.020084926155307e-05
enhancer regions,4.018607080751909e-05
pilot study,4.018420072563329e-05
template binding,4.016534743318852e-05
cell endosomes,4.015540734490648e-05
17cl1 cells infection,4.015161839539332e-05
catalyze,4.0140449273022436e-05
intracytoplasmic membranes,4.0134758604885356e-05
intravenous immunoglobulin,4.0126812890965866e-05
sars-cov helicase protein,4.010313756310573e-05
biochemical techniques,4.008720962099367e-05
amino terminus,4.0055258424242355e-05
phylogenetic studies,4.004619135822336e-05
dihydrofolate reductase-deficient cho cell line,4.002519263226021e-05
uvinactivated virus cellcell fusionblocking antibodies,4.002213646062845e-05
genomic position,4.001314186713022e-05
camelidassociated viruses,3.9999247243674055e-05
replicase geneencoded functions,3.9974518449259097e-05
hku9rbd,3.9964172528513664e-05
localizes,3.995247347207819e-05
self-interaction,3.994749186299698e-05
alloy,3.993954724973147e-05
n putative spacer regions,3.992765463117456e-05
acute respiratory syndromelike coronaviruses sarslike covs,3.9885215167601125e-05
actin reorganization,3.985742560929275e-05
iodine-labeled residue,3.9854600645392874e-05
tgev fcov 1 and fcov 2 and tgev antigen,3.984050916263776e-05
evolutionary distinct,3.983430075536402e-05
national institutes,3.982801118462664e-05
sars coronavirus aminoterminal replicase products nsp1 nsp2,3.981472303385214e-05
antiviral nucleoprotein monoclonal antibody,3.979742252081428e-05
protease cleavage,3.9795293024083745e-05
antimhvr monoclonal antibody cc1,3.979212902467117e-05
transduce,3.9778878953918394e-05
coexpressed viral structural proteins,3.97614496327357e-05
coronavirus replication cycle,3.97417927114442e-05
edta,3.965977775930153e-05
bacbased mhv reverse genetics system infection,3.965816401598698e-05
palindromic transmembrane,3.9619550381208485e-05
shortened n-terminal segment,3.961704905831406e-05
inpatient contacts,3.960468021170693e-05
spseudovirus spseudovirus,3.956419042765403e-05
lung infection,3.9559568212946155e-05
antiviral pathway,3.955894283318591e-05
laboratory-confirmed infections,3.953679088730299e-05
coronavirus nsp14,3.947957647355186e-05
raw clinical samples,3.94702076496706e-05
mhv2 spike gene,3.943591276892916e-05
modification site,3.941324286510768e-05
non-permissive temperature,3.940006729394601e-05
seroepidemiological study,3.937897881868118e-05
mers-cov nucleocapsid protein,3.936955635302062e-05
proteins bcl2,3.936220058906777e-05
linkage-specific polyubiquitin,3.933884295533539e-05
creation,3.932881851496123e-05
amplification centers,3.932546381215604e-05
substratebinding sites,3.932029074358818e-05
enteropathogenic cv infect,3.930663444417672e-05
rca,3.930439914026833e-05
5fu sensitivity,3.927632141944013e-05
human serotype 5 and chimpanzee derived adenoviruses,3.9261484574050796e-05
adpribose1monophosphatase adrp activity,3.9247883921550014e-05
upper respiratory samples,3.922783895224675e-05
primary cerebral explant cultures,3.9221538644999876e-05
nps polymerase chain reaction,3.918501680491702e-05
ectopically-expressed plp variants,3.9182460098157746e-05
antibodies recognizing domain,3.916219724045633e-05
endoplasmic reticulum rergolgi retention,3.9159014805510776e-05
amino acid gln-74,3.912621746260708e-05
mers-cov susceptibility,3.911662136366907e-05
highly conserved rna virus proteins,3.911058035364573e-05
experimental feline coronavirus,3.909993451003712e-05
mers-designated icus,3.905653865292373e-05
single-stranded rna genome,3.9046574383324695e-05
epigenome reorganization,3.903832061057836e-05
animal-to-animal transmission,3.901203792602741e-05
sarscov peptidepulsed dendritic cells,3.900628816701215e-05
orthologous receptors,3.899462350725862e-05
one-day-old chickens,3.897581403665459e-05
human leukocytic cell lines,3.8974368014112304e-05
detection methods,3.8911251980333376e-05
lung tissue cytokine,3.883832142087722e-05
human nasal mucosa,3.88214522758584e-05
mutant alb ts16,3.8816654464805174e-05
antiviral defense programs,3.8795528015146374e-05
epidemiologic surveys,3.879367332462153e-05
western immunoblotting analysis,3.8777350015111145e-05
cd4 t cellmediated,3.877518906723227e-05
viral replication sarscov nonstructural protein 9,3.877031708417806e-05
ifitm3,3.874545570828494e-05
coronavirus outbreaks,3.87028272149986e-05
small interfering,3.869347030323491e-05
coronavirus mouse hepatitis virus mhv strain a59,3.8680628656491836e-05
rat roc1 astrocytomaoligodendrocyte cell line,3.86654607271161e-05
short open reading frames,3.863349666465318e-05
acute kidney injury,3.863033436470299e-05
positive rheumatoid factor,3.8629668238165485e-05
membrane proximal cysteine-rich motif,3.862105190726277e-05
endosomal acid,3.8604298681642385e-05
"interferon regulatory factor (irf)-3 and -7, activating transcription factor (atf)-2/jun",3.851983458571077e-05
pepscan analysis,3.8514446480229006e-05
endoribonuclease activity,3.851228412681389e-05
s-nitroso-n-acetylpenicillamine,3.850276925622386e-05
m protein recognition,3.849989781693429e-05
membrane (m) protein gene,3.84900906233227e-05
rrt-pcr assays,3.848170400869553e-05
murine coronavirus polymerase polyprotein,3.8402755711459206e-05
nterminal d1 domain,3.839635313657493e-05
merscov infections additionally,3.8382224772429035e-05
canine aminopeptidase n,3.8370947145406606e-05
lead structure,3.834865218721738e-05
delivery routes,3.832316100252761e-05
infectious aetiology,3.831026655181734e-05
replicationtranscription complex,3.8306306110787016e-05
control partitioning,3.830022913868667e-05
ericov,3.82974108903833e-05
singlestranded positivesense viral genomic rna gene 1 encodes 16,3.828695758773278e-05
ccov infection,3.8282295906833335e-05
polymerase gene sequence,3.8273324398929056e-05
24 putative proteins,3.825898134518059e-05
reticulocyte lysates,3.823265058486589e-05
real-time reverse-transcription polymerase chain reaction,3.8222403459455624e-05
nonoverlappig antigenic domains,3.822120110996237e-05
group 1a,3.821988700038522e-05
chlorpromazine loperamide,3.81999176256982e-05
cellular receptor hcovhku1,3.819844086166802e-05
transmembrane protein,3.818321332213811e-05
class 1 viral fusion proteins,3.818271462887214e-05
interferon induction,3.8149300569921955e-05
virusspecific t cell,3.814651358011237e-05
groupspecific,3.814133270157526e-05
sarscov recombinant murine coronaviruses,3.8126426966696205e-05
receptor-destroying enzyme,3.808084023035707e-05
endo hresistant glycoprotein gp180,3.8057509481123866e-05
retroviral particles pseudotyped,3.804071300640441e-05
nonpermissive bhk cells,3.802654074481888e-05
sarscovsusceptible vero cells,3.7946522128422867e-05
human respiratory samples,3.792092443417776e-05
dipeptide bond,3.791483105857717e-05
caveolar region,3.78978599105202e-05
membrane fusion reactions,3.787541341607961e-05
mebus bovine coronavirus,3.78239958170066e-05
viral reproduction residues,3.7822502072173304e-05
papainlike cysteine proteinases,3.781264076668245e-05
immune enhancement,3.780571210931167e-05
polymerase rna binding site,3.780469473388355e-05
hku39849 hanoi urbani guangzhou gz01,3.776624833934403e-05
e protein ic,3.772871770571065e-05
s1 extracellular domain,3.76859166777361e-05
venezuelan equine encephalitis virus replicon particles,3.766274422468313e-05
4weekold lewis rats,3.764403272756963e-05
fip-associated meningoencephalomyelitis,3.7639731228521754e-05
n-acetyl-9-o-acetylneuraminic acid,3.761714230249551e-05
pig chicken,3.760223852146277e-05
acute respiratory syndrome coronavirus n protein,3.7591481843807834e-05
high sequence depth,3.758099497736308e-05
n-terminal fusion peptides,3.7550353429745686e-05
murine ceacam1a mceacam1a,3.7417181106931295e-05
thrombocytopenia,3.741049396648825e-05
cell surface transmembrane protease/serine,3.738861054815601e-05
putative lung stem/progenitor cells,3.737332168110533e-05
bfa-resistant guanine nucleotide,3.733366097713683e-05
sl-cov,3.732754690662416e-05
subclinical morbidity,3.732339207164867e-05
anticancer,3.732016893918845e-05
structural determinants,3.7317687029232416e-05
medical research center,3.7306540817556935e-05
short aminoterminal ectodomain,3.728579770549278e-05
pre-fusogenic state,3.728557545972435e-05
rna-interaction domain,3.7251120733526807e-05
postchallenge,3.722927712113378e-05
prototype ccov-i strains,3.721412520194812e-05
tf-binding motif,3.721394883722518e-05
oligodendroglial apoptosis,3.719805488478016e-05
epidemiological surveillance,3.719175995810962e-05
nucleocapsid n protein genes,3.717796816066506e-05
nonstructural protein 1 nsp1 nsp5 envelope,3.7173524472015715e-05
protein iga antibody,3.7161968515277586e-05
avian influenza a virus,3.711920557337574e-05
formulation,3.711172488708305e-05
merscov full genome sequences,3.710913528147211e-05
merscovinfected,3.70886316583547e-05
cytokine-induced t cell responses,3.70495134194431e-05
yfv,3.704032107424434e-05
transmembrane pore-forming,3.7000763071526314e-05
sequence divergence,3.698459114526589e-05
viral capping enzymes,3.6983277554893085e-05
coronavirus replicative apparatus,3.697462693271822e-05
"10,668",3.695206775114324e-05
sds-polyacrylamide gel electrophoresis,3.691238133190692e-05
immunochemical characterisation,3.6896192693624905e-05
endosomal infection notyetidentified proteases,3.688130296429089e-05
amount,3.6872372085177965e-05
intestinal cell line caco-2,3.686401221169104e-05
antigen-specific neutralizing antibodies,3.685551944232515e-05
bek1 cultures,3.685455883185282e-05
mhva59infected dbt cells,3.683775058337646e-05
jump barrier,3.683183170870778e-05
cterminal cytosolic domain,3.680746829358206e-05
bovine 4.9kda non-structural protein,3.6798141731702914e-05
virus adhesion,3.678272576784002e-05
thermodynamic,3.678195669776376e-05
coronavirus seroepidemiological studies,3.6760579468651e-05
cov infection ptb,3.671727702638902e-05
disordered conformations,3.6711808366941244e-05
glycoprotein carboxy,3.668180340457079e-05
control precautions,3.667449971262085e-05
activating transcription factor (atf)-2/jun,3.6625893333938686e-05
general caspase inhibitor,3.653998854857409e-05
realtime reverse transcriptionpcr rtpcr assay,3.653840691081504e-05
risk assessments,3.650918675738165e-05
mers-cov transmission,3.6509007083377415e-05
protein-folding vehicle,3.6473422653757e-05
human hepatoma cells,3.6472030967529016e-05
mouse hepatitis virus jhmv,3.6441649401147785e-05
private sector response committee,3.640969029055191e-05
blood monocyte macrophages,3.639956206433809e-05
antisars therapies,3.639869313940111e-05
sars-cov lineage,3.638951726053086e-05
immunofluorescence antibody assay ifa,3.638773979680268e-05
x-,3.637208736222797e-05
mers response task force,3.63419505545872e-05
inability,3.633831506313022e-05
iav subtype h5n1,3.633023676642792e-05
transmission-based precautions,3.632398291297005e-05
dif-positive specimens,3.629401896485044e-05
mouse hepatitis virus mhv mrna 4,3.629151652834311e-05
postfusion paramyxoviruses f proteins,3.626328991301981e-05
antigenic proteins,3.625372300706709e-05
human camel,3.623387764860863e-05
cellular and viral s-adenosylmethionine-dependent methyltransferases,3.619848866755494e-05
replication product,3.6185589671419786e-05
coronavirus spike proteins,3.618064470755222e-05
respiratory human coronavirus nl63,3.616128926268642e-05
guangzhou china,3.615904977516534e-05
protein evolution,3.612020053783729e-05
immobilized cell surface proteins,3.611666318179629e-05
type viral pneumonia,3.6110532290150364e-05
rodents,3.606610499715174e-05
comparative protein expression profiles,3.60501350047334e-05
mitochondrial dna sequences,3.604675717208901e-05
rt-pcr plus nested pcr techniques,3.5981892745748535e-05
simian adenoviral vaccine,3.597552315228439e-05
respiratory stress,3.595108018767486e-05
codon-optimized sars-cov spike protein,3.5931293801860626e-05
hafr-al-batin-1_2013 clade,3.59284325533273e-05
orf1 translation,3.592756090912093e-05
transmissible gastroenteritis virus,3.592576596574291e-05
186 korean people,3.589754789878294e-05
ccov fluorogenic assay,3.58898106384002e-05
spring,3.586797797517269e-05
stagespecific embryonic antigen 1,3.585158931251699e-05
brsv-related clinical outbreak,3.5843607321764834e-05
glycoprotein icsz16s,3.5842459630178996e-05
single nucleotide polymorphisms,3.5823418770879856e-05
neutralizing antibody test,3.5814012420152546e-05
sars-cov vaccines,3.578099086455667e-05
trimeric spike transmembrane glycoprotein,3.5770656350407494e-05
tgevinfected swine testis cells,3.574341429868437e-05
molecular clone,3.574067115334911e-05
purified fragment c,3.5715445325935103e-05
nonessential functions,3.569806431992271e-05
non-vaccinated,3.56961983703396e-05
sedimentable,3.569158036767819e-05
common leader sequence,3.5689505460614916e-05
case detection,3.5644784469638764e-05
capbinding protein,3.562130023427044e-05
clinical respiratory specimens,3.561803033388012e-05
lentivirus pseudotyped,3.561513307601635e-05
respiratory viruses methods,3.559384265563167e-05
major structure proteins,3.555301504792765e-05
protective immunization,3.554749621143798e-05
standardized uptake value,3.553758831212362e-05
ki,3.55361133771635e-05
"predicted transmembrane, domain",3.5524193178158814e-05
lower-affinity interaction,3.5501461803788147e-05
smallmolecule inhibitors,3.54987308072696e-05
ethical principles,3.549363882789289e-05
pkr activation,3.5487102333006815e-05
nsp13associated nucleoside triphosphatase,3.545818037145429e-05
sars-cov,3.537804718398475e-05
data safety,3.536080109989255e-05
membrane-distal region,3.535869785225776e-05
"cd45+, cd3+, cd4+, cd8+, cd19+ and cd16+/56+ cell",3.535773195710809e-05
phage-displayed scfv library,3.534698221849869e-05
longitudinal noninvasive approach,3.533721523597991e-05
nonameric h2d binding domains,3.533487830720017e-05
bottlenose dolphin cov bdcov,3.533370754316247e-05
immunohistologically,3.532037070299079e-05
type i membrane glycoprotein,3.531794220451274e-05
epidemiological screening,3.52930596569785e-05
primary cells,3.528183367035143e-05
mv-susceptible mice,3.5266446633723675e-05
entities,3.525940473085879e-05
rhinolophus blasii rhi bla bat,3.52397384079953e-05
civet sarscov antibody,3.523964626112958e-05
hcov229e severeacute respiratory syndrome,3.5226314544706096e-05
zoonotic sarscov,3.522308106691381e-05
viral rbd fragment,3.519375469677128e-05
organization-recommended singleplex real-time quantitative rt-pcr,3.518070326696607e-05
surfactant protein spd,3.5177932390144956e-05
virus permissive huh7 cells,3.5152187075709306e-05
nsp1mediated shutoff luciferase,3.51420885664187e-05
twisted hinge region,3.5132872404411714e-05
animal sarscov,3.509961060514768e-05
sars-cov infection,3.509210516503211e-05
convenient,3.505649323668476e-05
cellular inducible nitric oxide synthase,3.505465507134015e-05
interferonstimulated response element,3.504967018459718e-05
sliii domain nucleotides 1,3.5048175684694054e-05
monomeric enzyme,3.503297153834861e-05
morbidity/mortality,3.5023946209088587e-05
host-directed antiviral drugs,3.5013366904601365e-05
receptor carcinoembryonic antigen cell adhesion molecule 1 ceacam 1,3.5010117466099624e-05
contagious middle east respiratory syndrome coronavirus,3.500345455989633e-05
microtubular network,3.4991801813679225e-05
papain-like and 3c-like proteinases,3.4982091944987145e-05
lineagespecific singlenucleotide polymorphism snp,3.49813710504562e-05
cov nsp14 exon,3.4954694798826747e-05
ck14 expressing cells,3.491773740218606e-05
differential diagnoses,3.4910246846635224e-05
hcov 229e-based vaccine,3.488206820240626e-05
physical proximity,3.4873694037553065e-05
structureactivity relationship studies,3.4832161795697284e-05
human rectal tumor cell line,3.482750773009572e-05
ceacam1independent,3.4826126312870796e-05
substratebinding residues,3.481971423736179e-05
lipid-mimic detergent dodecylphosphocholine,3.480545308044146e-05
cov lineages,3.478336675913387e-05
liquid chromatographytandem mass spectrometry,3.4762142105914286e-05
protective capacity,3.475306451070526e-05
cov rnadependent rna polymerase,3.474583817278932e-05
cell-to-cell fusion,3.4735570107329725e-05
genetic evolutionary,3.470899584008156e-05
pedvcolorado,3.4699081828129356e-05
sarscov receptor angiotensinconverting,3.469445196098766e-05
acute respiratory syndrome coronavirus sarscov receptor,3.468864693159505e-05
protein ion channel,3.468781289023526e-05
partialduplex rna,3.468199903892705e-05
treatment rates,3.467185216182855e-05
mbl-associated serine protease-2,3.4654156271036764e-05
multi-organ dysfunction,3.463142006836937e-05
viral proteolysis,3.458919669158451e-05
first 20 n-terminal residues,3.458052482586274e-05
amibara s proteins,3.4543034615035764e-05
feline coronavirus type ii strain 79-1683,3.4539904530861185e-05
cough hcov infection,3.453438174729799e-05
virion-associated accessory protein,3.453385360055228e-05
bronchial epithelial,3.452135281544123e-05
s1a domain,3.4520440927670645e-05
deisgylase,3.451264500836721e-05
coronavirus fusion pathway,3.451256511366727e-05
therapeutic antibody,3.450669028167716e-05
hcov229e mutant,3.450113307775381e-05
virus neutralizing antibodies,3.4495540084467635e-05
known rna genomes,3.445234480451498e-05
toll-like receptor (tlr)2 ligand,3.4421360124178966e-05
s-pseudotyped particles infection,3.4358826176071646e-05
2b4 bronchial epithelial cells,3.435870871286523e-05
recognition sites,3.43553003690691e-05
health care institutions,3.4329486043931376e-05
pulmonary sarscov replication,3.430923699734082e-05
coronavirussarscov nucleocapsid n,3.430327591586974e-05
receptordestroying sialateoacetylesterase,3.429803914513053e-05
heparan sulfate,3.4293510914448076e-05
rna cleavage function,3.4289086425070656e-05
betacoronavirus (betacov) genus,3.426412745131908e-05
lymphocytic choriomeningitis virus,3.4260539849656644e-05
non-immunoglobulin component,3.4244728635386035e-05
jeddah virus,3.422589364125645e-05
tgev subgenomic mrnas sgmrnas,3.422369745671599e-05
hepatitis c virus rdrp,3.420038291535315e-05
mhv-a59 orf1a replicase gene products,3.41924301856949e-05
homooligomeric templates,3.417686741740999e-05
signal transport proteins,3.4157452219213104e-05
antibody-binding epitopes,3.413381704955141e-05
human angiotensin i converting enzyme 2,3.413205717556299e-05
block cathepsin lmediated,3.413081438217735e-05
engineering cell lines,3.412410183011595e-05
focal infiltrates,3.4112205596924645e-05
adherent dihydrofolate reductase-deficient cho cell line,3.407990500755578e-05
truncated recombinant nucleocapsid (n) protein antigen,3.4065843163687266e-05
atp1a1,3.402657104032873e-05
pulmonary hemorrhage,3.402490353031247e-05
conserved molecular,3.397291242257229e-05
p166s,3.3951459097932224e-05
polymerization,3.392505944078706e-05
polymerase gene sequence analysis,3.392416862266048e-05
muscle,3.391220430266826e-05
sarscov s2 subunit,3.388908594403308e-05
enzyme-linked immunespecific assay,3.38832613834372e-05
non-structural proteins nsp 4,3.3869949688139005e-05
streptococcal toxic shock syndrome,3.3863275974723594e-05
ifitm-mediated restriction,3.385552107767635e-05
lactate dehydrogenase 23,3.38515395550788e-05
monocyte-associated fcov viraemia,3.379209863173731e-05
viral protein synthesis,3.3786130857623116e-05
parenchymatous organs,3.3769403742755836e-05
diagnosing,3.375519742671285e-05
gastrointestinal tract specimens,3.37234323650892e-05
nuclear factor of activated t cells,3.369874597329755e-05
cytoplasmic vesicles,3.36742632490468e-05
vaccine-mediated protection,3.3647834857535715e-05
catalytic dyad (his-41/cys-145) site,3.362745773715507e-05
mhv subgenomic mrnas,3.362342866195945e-05
poliovirus 3clike proteinase domain,3.361407590053775e-05
bovine cov n,3.360851946009531e-05
nonenteropathogenic mutant virus,3.359073629935331e-05
merscov receptor dpp4 hdpp4tg,3.358505641427941e-05
mock inoculation virus infection,3.357308113332849e-05
coronavirus batscov,3.355637141759317e-05
peak testing,3.355114493501183e-05
ubiquitin-specific proteases,3.351471388363078e-05
arg132 residue,3.349451337327278e-05
referral infectious disease departments,3.348883856243463e-05
ubiquitin-like modifier,3.348812108108532e-05
mrna concentrations,3.3479022184682276e-05
s protein receptor-binding domain,3.3466941240051396e-05
genome-length negative-strand rna,3.346237408079682e-05
bromelin digestion,3.3461523444126284e-05
sls,3.3435931142195474e-05
chronic immunemediated demyelinating disease,3.343026477606569e-05
nucleotide sequences,3.3426801785739074e-05
coronavirus replicase polyproteins,3.341872552801089e-05
wildtype sars cov,3.339939088806932e-05
chronologically,3.339475386052837e-05
human embryonic kidney 293 (hek-293) cells,3.3391822406814415e-05
rnase treatment,3.338372831888932e-05
encephalomyelitis,3.336667949754843e-05
proinflammatory cytokines/chemokines,3.335686237581951e-05
coronavirus antibody,3.3344917080037654e-05
platforms,3.3303284039199316e-05
tcellmacrophage dysregulation,3.330325310741317e-05
bacbased mhv reverse genetics system,3.330162043237675e-05
western immunoblot-negative mabs,3.329421148091589e-05
sars virus replicase surface spike matrix,3.324563878695509e-05
neutrophil chemoattractant activity,3.3245499709704176e-05
nterminal iglike domain,3.3244892490008935e-05
mhv-jhm-induced demyelinating disease,3.3230130662307266e-05
adjacent acidic domain,3.322629830381296e-05
prrsv,3.321697808402114e-05
protein fusogenicity,3.318337977687609e-05
predicted transmembrane domain,3.315614596478251e-05
viral peptides,3.3149630472608064e-05
proteinase domains,3.314688142213681e-05
membrane protein m gene,3.312621141200709e-05
risk prediction model,3.3118660547458016e-05
intracellular virus-specific mrnas,3.311469394031991e-05
loss of function,3.309504883047707e-05
p20c22,3.309083940700071e-05
dimeric papn ectodomain,3.307264712974932e-05
amino-terminal peptide,3.30350050464839e-05
viral proteolytic priming,3.3033295274895694e-05
yeast expression vector ppic35k to construct plasmid,3.3032210222631625e-05
ccov-positive samples,3.29983863681897e-05
hcovoc43 mutant,3.2964401292442694e-05
passaged virus,3.2963999836337166e-05
crcov-positive samples,3.2948427830554604e-05
cellfree membranefusion system,3.293060367801585e-05
sars-cov vaccine,3.292880004200964e-05
proviral factors,3.292454102968332e-05
pleiotropic effects,3.289538542440934e-05
hku7,3.288724225239327e-05
dynamic gene profile,3.2864393194890075e-05
miniature horses,3.2844920432083876e-05
anti-inflammatory elements,3.2825631461405976e-05
pipistrellus bat cov hku5,3.2815420367697815e-05
ace2mediated virus infection,3.280073262817902e-05
hcov229e 015 hcovhku1 013,3.2799455313633424e-05
immune mediated disease,3.2775546355919827e-05
af1521,3.2770164025846995e-05
extracellular domain,3.276379576592267e-05
open reading frame 1b,3.275925213260877e-05
virus detection,3.275222696983149e-05
dromedary camel sera,3.269382208076194e-05
mouse hybridoma antibody,3.268429449332417e-05
epithelial mucosa cells,3.2678981798556714e-05
neutralizing domain,3.26736140497268e-05
3clike proteinase 3clp domain,3.266731985586737e-05
older age hypertension,3.265764924249762e-05
cross-neutralized,3.26473122218529e-05
tmprss2deficient mouse strains,3.264718481546499e-05
ifninducible transmembrane ifitm proteins,3.2636238493022786e-05
scale-manufacture,3.262921585602681e-05
porcine and murine epithelial cells,3.262186891206167e-05
transcription factor 4 (atf4) mrna,3.260889561298062e-05
second open reading frame,3.2577642692582025e-05
bacterial artificial chromosome bac,3.253450926619568e-05
bh3 bcl2 homology domain 3 of bclxl,3.253075303095346e-05
c-type lectins,3.252118515916381e-05
macrophage inflammatory protein,3.2518975240159173e-05
kinase,3.25125914408698e-05
nsp1415q5989 sites,3.248527276451332e-05
correspondence,3.246820729472967e-05
regulatory mechanism,3.2465251913015996e-05
extracellular signalregulated kinase 1 and 2 erk12,3.244170209367594e-05
human coronavirus 229e,3.24311872757473e-05
human cd26dipeptidyl peptidase 4 dpp4,3.241552342516295e-05
nucleocapsid surface,3.2409314238135114e-05
dicistronic rna template,3.240463993318672e-05
rt-pcr assay,3.2373140736421665e-05
sars cov main proteinase dimer,3.236565470745572e-05
positive-sense,3.233559861113635e-05
reverse transcriptionquantitative pcr,3.2316271517699634e-05
followup experiments,3.228373557296086e-05
toxoplasma gondii antibodies,3.225243250973755e-05
antibodylike protein,3.2251016269073504e-05
disintegrin and metalloprotease adamfamily zinc metalloproteases,3.223056964868888e-05
protein-based antiviral agents,3.2217095763200606e-05
coronavirus-mediated pandemic,3.219333822311473e-05
devastating,3.216864538257372e-05
supportive therapies,3.215404994074976e-05
y1188ay1191a protein s,3.215006005113766e-05
neurodegenerative bladder dysfunction,3.214682649700503e-05
rnarna recombination,3.214293840174091e-05
sense rna virus infection,3.2107081509273536e-05
antibody epitope,3.210667694495638e-05
chronic demyelinating encephalomyelitides,3.2083651460657606e-05
abstract haemagglutinating encephalomyelitis virus,3.2082787944669854e-05
predicted sequence aa,3.2040492132315936e-05
threedimensional 3d,3.203030719756057e-05
couples,3.199493336191359e-05
eukaryotic translation systems,3.1993063146451586e-05
radioimmunoprecipitation,3.199115922273755e-05
murine coronavirus mouse hepatitis virus strain,3.1982100078851395e-05
real-time quantitative(q) rt-pcr,3.196022191246449e-05
ubiquitin conjugation,3.1931371450101976e-05
monensin-treated ibv-infected cells,3.192671741250389e-05
epidermal growth factor,3.190820228509521e-05
nacl,3.1832631775701784e-05
hydrophobic substituents,3.182675421086433e-05
3c protein,3.180116347105608e-05
endocytic,3.1800765099611156e-05
epithelial degeneration,3.1776308506246254e-05
prosurvival member,3.177394854317492e-05
ebola outbreak,3.1771550379534006e-05
neuraminidase inhibitors,3.1765138250650496e-05
sars-cov proteins,3.1754902294103875e-05
mrnacoding sequence,3.174680204967752e-05
lesions focal,3.173967954001555e-05
excessive,3.1717170949888524e-05
research designs,3.1714065639843355e-05
sars-like coronaviruses,3.170701823710536e-05
antitumor agents,3.17023168746428e-05
public health response,3.1649369044531616e-05
viral s protein a truncated protein,3.163799484880093e-05
sars-cov np ctd,3.162604622294959e-05
endosomal microenvironment,3.1608629977480656e-05
norway rats,3.160569921914493e-05
bayesian molecularclock models,3.1583896968349394e-05
minimal receptorbinding region,3.157612144681362e-05
immune recognition,3.153630520745427e-05
immunodominant t-cell elispot,3.1535200470586206e-05
dclsignmediated virus infection sitedirected mutagenesis analyses,3.152633161652026e-05
hypophosphorylated,3.152140346253717e-05
multiround infection,3.150309676599468e-05
mouse astrocytes,3.1491826714926883e-05
biological signal transduction,3.1480914758675183e-05
virus replicase polyprotein pp1a,3.147083572647667e-05
linear neutralizing epitopes,3.1452129677723186e-05
cyclic antimicrobial peptide,3.1448544934436e-05
northeast china,3.143058287363967e-05
morphological studies,3.139618899272976e-05
s-mediated cell fusion,3.139542308611947e-05
breathing difficulties,3.137157633283714e-05
viral nuclear import antagonists,3.1350537609773786e-05
luminex xtag rvp fast v1 assay,3.1327548255669894e-05
oncolytic activity,3.127406693682443e-05
inflammatory settings,3.127229595188925e-05
helix sheet,3.126471589855855e-05
growth suppressive factors,3.1262693818799376e-05
treated rat oligodendrocytes,3.125547597337351e-05
solvent-exposed substrate-binding region,3.1243661413384686e-05
human cellular proteases,3.1237580055854754e-05
sarscov batsarscov,3.119998289600082e-05
positions 360 462 472 480 487 609 613 665 743 765 and 1163 the,3.117975550602782e-05
rbd infected cells,3.1175991122165004e-05
reversegenetics study,3.116694359197528e-05
oronasally,3.11613392557215e-05
licl,3.113635375236552e-05
sprotein variant,3.11126468730881e-05
rnaprotein binding assay,3.1101318291305624e-05
rad/spike,3.1093400141167435e-05
monocyte macrophages,3.10584742485267e-05
lymphocytic inflammation,3.10462847307021e-05
multiplespanning transmembrane proteins,3.1042318456243904e-05
viral infection assay,3.103731037682823e-05
normal health,3.102628013390876e-05
presumed crossover region fusion site,3.101450080803087e-05
coronavirus type ii (ccov-ii,3.100402639077574e-05
lethal sars,3.0997998810587015e-05
mouse host cell receptor mouse dpp4 mdpp4,3.099530040519035e-05
nucleocapsid proteins,3.0976955199068994e-05
bnip3-promoter-luciferase reporter,3.095181189761266e-05
tmprss2 ciscleavage,3.094190755635339e-05
imino proton solvent exchange,3.090685212476601e-05
disease-associated,3.0885439747254324e-05
anti-3a n-terminal antibody,3.086394379717909e-05
reverse transcription polymerase chain reaction rtpcr testing,3.0833850080322914e-05
pro-survival myeloid cell leukemia-1,3.081055391483182e-05
long alpha helix,3.078564920800318e-05
secondary structures,3.073550813601235e-05
prosurvival xbp1s protein,3.0727136274080174e-05
human coronavirus 229e nucleocapsid protein,3.071238898893856e-05
european miniopterus bats,3.070172269414014e-05
conductivity,3.067754999529707e-05
cellular binding,3.06608523686768e-05
orf1,3.065902344047115e-05
rn igm elisa,3.0615684466722786e-05
nc95 strain nucleotide sequence,3.060205347750755e-05
ub,3.0589725807111056e-05
molecular target,3.058588362933796e-05
amino acid residues 1029,3.054665030202775e-05
lung cells,3.051919237857688e-05
endonucleolytic cleavage,3.0502367613768586e-05
ucuaaac transcription consensus sequence,3.0500180955318376e-05
subgenomic mrnas rna,3.049143297868103e-05
gene hypervariable region,3.0487729677455923e-05
gav replicase polyprotein precursors,3.04826433979316e-05
carcinoembryonic antigen cell adhesion molecule 1a,3.0475433148362137e-05
immune neutralization,3.0471150768626005e-05
hepatitis virus mhv nonstructural protein 2,3.0460776412645516e-05
strong early/late promoter,3.0459630439234943e-05
replication shedding,3.0403176173133018e-05
overlapping cdna clones,3.0399373432851873e-05
denaturing gel electrophoresis,3.0338693465839514e-05
ccov strains,3.0335927495904176e-05
sars-cov pseudotyped virus,3.0321622389491463e-05
s1 nterminal region,3.0317762635845725e-05
slippery sequences,3.0307136073705184e-05
anticodon structure,3.029683374343466e-05
epistatic,3.0286443838918063e-05
enteric bovine cov bcov strains,3.0281047091246772e-05
coronavirus membrane fusion,3.0279545016977305e-05
monomeric homologue xendou,3.022500586872432e-05
acute tubular necrosis,3.020500803361663e-05
cellular composition,3.0202336722290008e-05
stress response pathway,3.019537412772516e-05
amino acid 543,3.019192606317754e-05
mers-cov deletion variants,3.0115140308766395e-05
central-linker region,3.0097490358408985e-05
co-stimulatory molecules,3.0079485097320994e-05
31-mer peptide,3.0048955744393022e-05
duodenum jejunum,3.004847170026818e-05
oligonucleotides,3.002861040642269e-05
inflammatory cell response,3.0015360997739487e-05
n1347ainfected brains,3.0013516876210935e-05
coronavirus accessory protein orf6,2.9994801267732453e-05
p53mediated antiviral response,2.9992435506238806e-05
antiviral t cell,2.9981489339557112e-05
intestinal mucosal iga antibodies,2.997231779389738e-05
exoribonuclease domain,2.9969241638428465e-05
antigen-specific,2.9960873079779827e-05
nested rt-pcr assay,2.994243094088122e-05
prnt logistic regression,2.9940688422045245e-05
control mers-cov infection,2.9915069533287315e-05
proc natl acad sci u.s.a,2.9911649210349276e-05
massive lymphocyte death sarscov sars coronavirus,2.9875964834053985e-05
human embryo lung fibroblast,2.9850255371999277e-05
karyopherindependent host transcription factors,2.9838743100181504e-05
p38 mapkdependent,2.983842155840225e-05
reservoir/s,2.9806651947598177e-05
pharmacologically active compounds,2.979635538994486e-05
cns pathogenesis,2.9790532306692947e-05
amino acids 1,2.978817332264085e-05
intestinal organoids,2.9787591959318763e-05
chronically ill,2.9776121634621196e-05
reporter merscov expressing gfp,2.976767231579644e-05
compliance,2.976642418233945e-05
pk-dnase method,2.974446548859704e-05
sarscov neutralization antigen,2.9722680029208547e-05
human lung cdna library,2.9716230161328498e-05
chimeric a59jhm recombinant viruses,2.9675199229192178e-05
real-time reverse transcriptase,2.967500051315492e-05
retinoic acid,2.9633984276410294e-05
positive strand rna virus,2.9590346980294695e-05
epidemiological relationships,2.95844974119203e-05
medical students,2.958386314398295e-05
rolling circle amplification rca,2.955510673474769e-05
sarscov rbdlike regions,2.9547179549488565e-05
bcvinfected cells,2.9545488566371634e-05
radioimmunoprecipitation assays,2.9529405936884504e-05
subclass immunoglobulin g2a igg2a antibody,2.952751007124697e-05
principal antigenic determinants,2.9523436085151695e-05
"coronavirus nonstructural integral membrane proteins (nsps) 3, 4 and 6",2.9489656240008252e-05
influenza-like illness,2.945334345220515e-05
h2d,2.9441428010247143e-05
vero-to-human,2.9426845300715193e-05
membrane and envelope proteins,2.94181213808528e-05
virus-like particle formation,2.94173705170724e-05
ill travelers,2.9409233343737266e-05
filovirus glycoproteins,2.938016822115954e-05
virus-induced nlrp3 inflammasome activation,2.9379304281534063e-05
coronavirus-induced encephalomyelitis,2.9369919954700352e-05
histologically cell destruction,2.9359066907068178e-05
innate immune recognition,2.9326657781241514e-05
hrn and hrc coiled-coil surface residues,2.9314607910291907e-05
humans endoribonuclease,2.9311942483056786e-05
trans-cleavage activity,2.9309718513787977e-05
neurovirulent mhvjhm,2.9303827145451752e-05
liver macrophages kupffer cells,2.9302252222449962e-05
cotranslationally oligosaccharides,2.928872705820188e-05
taqman real-time fluorescent pcr,2.926303582590924e-05
asymmetrical,2.9242469198891137e-05
pipistrellus bat cov,2.9240784329645066e-05
chimeric viruses,2.9235952690047918e-05
research activities,2.9226637206941432e-05
lipid bilayer,2.9222789165105875e-05
sera-positive,2.9222352580634084e-05
animal reservoir,2.9186879049388685e-05
recombination analysis,2.9173377827600027e-05
antigen folding pathway,2.9143253413995523e-05
aromatic amino acid-nucleobase,2.913042037362953e-05
murine coronavirus e,2.9121103047107188e-05
full-length rna synthesis,2.908029900522261e-05
protein heptad repeat,2.9077802784295595e-05
thisin vitrointeraction,2.907678257450967e-05
conserved gln residue,2.906456484760726e-05
single-stranded rna,2.9039659277844164e-05
genetic sequences,2.903923465720019e-05
cterminal transmembrane and cytoplasmic tail domains,2.9024310326026634e-05
ibvinfected cells fractionation,2.9000210543109897e-05
icus,2.899688821798832e-05
gene 1 replicase,2.8995959096033715e-05
antiviral strategies inhibitory molecules,2.8992234525890698e-05
transfect,2.8971160277693357e-05
nrs neutralization assay,2.8952664589866114e-05
interleukin-6,2.892758690285747e-05
real-time rt-pcr,2.8927165213037427e-05
stable chinese hamster ovary,2.889613391289104e-05
sars cov s protein near,2.8890902312084692e-05
zone-interference gel electrophoresis assays,2.887503358762432e-05
primaselike protein nsp8,2.88244123418412e-05
type ii transmembrane serine protease (ttsp) member tmprss2,2.8776517261263113e-05
neurological complications,2.876650990744447e-05
phenotypic,2.875063949391265e-05
amino,2.8742160638812558e-05
cb,2.873911493993197e-05
influenza c virus,2.8738353681323705e-05
sars reverse genetic system,2.8734771259615993e-05
acidic amino-acid cluster,2.8726619093363135e-05
plasma membrane coronaviruses,2.8694955815707164e-05
well-characterized,2.8685350103120706e-05
membrane-proximal cysteine cluster,2.868333950737649e-05
real-time quantitative reverse transcriptase-pcr,2.8682325116601946e-05
avianlike origin,2.8666932437092588e-05
"virus, angiotensin-converting enzyme 2",2.866530747507503e-05
protein mutant,2.8634394475959704e-05
lung stem/progenitor cells,2.8633078778717533e-05
immunodeficiency virus type 1derived reporter virus,2.8625287070609242e-05
enzyme activity assays,2.8618087148739888e-05
cell killing,2.861369938786109e-05
murine hepatitis virus mhva59,2.8608429236050947e-05
proinflammatory cytokine tnfa il6,2.8599795538696895e-05
virusinduced ifn,2.8573528774924965e-05
elisabased antibody,2.8567214565607817e-05
46-lrlgsqlsl-54 amino acid sequence,2.8561297953847402e-05
spike protein function,2.852008476224721e-05
genetic factors,2.851509335005574e-05
ribonucleoprotein,2.850555085144779e-05
virus-specific effector t cells,2.848161945333523e-05
alpaca coronavirus,2.8481086986534584e-05
adenoviral-based vaccine,2.8471733861899454e-05
sars-cov n protein,2.8460654989860914e-05
receptor activity,2.8436021426433985e-05
j. gen. virol,2.841925390691985e-05
interleukin6,2.8384324239177748e-05
ards pathology,2.8384310200195505e-05
somhvr somhvr,2.836503312985032e-05
polyubiquitin chains merscov,2.8364805972817076e-05
national guard health affairs,2.8360888124232603e-05
roost,2.8359569619832633e-05
wildtype wt type i interferon receptor,2.835738438260965e-05
mhv-a59 polymerase proteins,2.8349754638915697e-05
polyprotein processing,2.8327062144047688e-05
antigone,2.8297801746395853e-05
mlkl,2.8294278579641327e-05
cholesterol synthesis,2.8289933903377804e-05
oc43 nsp5 proteases,2.8286216678033717e-05
cell-free system,2.82764920881087e-05
major histocompatibility complex mhc antigens,2.8226711825390024e-05
loop-mediated isothermal amplification,2.818184292408709e-05
internally quenched fluorogenic peptides,2.816546537795341e-05
ruminant,2.813368804883882e-05
csn,2.812653301305418e-05
s510 epitope epitope escape mutants,2.8121016834251475e-05
receptorbound mhv2,2.8117611584642788e-05
peritoneal,2.810638381305916e-05
coronaviral genomes,2.8103265289716198e-05
antagonists,2.8101056784693874e-05
lysosomal cathepsin l,2.80933653943929e-05
analytical sensitivities,2.8063583651337715e-05
human angiotensin converting enzyme 2,2.8055530429796252e-05
mhvinfected mice,2.8046654003005437e-05
rnabinding domains,2.803762066235908e-05
cholesterol synthesis/transport,2.8029511240956553e-05
giant replicase gene,2.8007715801411763e-05
confocal microscopic,2.8005445326724546e-05
systemic infection,2.8002780673176085e-05
conserved coronaviral protein rdrp,2.7992736451332608e-05
brsv-related clinical outbreaks,2.7988307251850407e-05
live vaccine,2.7985832140593656e-05
virus transcription,2.7950562222127593e-05
antibiotic resistance/reporter gene dna,2.794735579011379e-05
acute cns infection,2.7939164654681536e-05
healthseeking behaviours,2.7928097615520584e-05
shelter cats,2.7903858971850666e-05
viral binding,2.787908678981104e-05
hvr deletion mutant,2.787175979019483e-05
tgev deletion mutant,2.7871709593875146e-05
native spike protein,2.7863492447677065e-05
macromolecular metabolism,2.7829878378415543e-05
protein of mers-cov,2.781903561069065e-05
fabricius bf,2.7814447280526454e-05
coronavirus envelope proteins,2.7804935535284695e-05
natural nucleotides,2.7785236209601045e-05
respiratory tissues,2.7771955419366976e-05
chromatin immunoprecipitaion,2.7762318913402627e-05
root of members,2.776096121598802e-05
coronavirus structural proteins,2.7759706661025736e-05
transmembrane proteaseserine subfamily,2.7758122220502495e-05
phsensitive endosomal protease cathepsin l,2.7757877864776103e-05
sars coronavirus main protease,2.773715267952399e-05
postfusion paramyxoviruses,2.7678916905892427e-05
g2m phase,2.7637316704323004e-05
deubiquitinating,2.7636460426151864e-05
hipposiderid bat,2.7630686909943007e-05
worldwide,2.7628410927305408e-05
conserved region flanked,2.7616128537725468e-05
crude tissue culture proteins,2.7605908885341152e-05
murine coronavirus s protein,2.760204220937223e-05
immediate-early transcription factor egr-1,2.75987979044413e-05
glyceroltartrate gradients,2.7591458300583004e-05
pulmonary infiltrates,2.757874738426906e-05
recombinase activating gene 1,2.7565134508050214e-05
healthcare-associated mers-cov,2.7560908880459277e-05
antagonistic activity,2.7550263229239904e-05
e3 ligase,2.754732097139571e-05
type i feline coronaviruses,2.753545785197259e-05
doi101038nature02145,2.7521795917593622e-05
angiotensin converting enzyme (ace)-2,2.7516069651119855e-05
resazurin-based cytopathic effect inhibition assay,2.7493872564964052e-05
extracellular signal-regulated kinase,2.749200817543358e-05
sero-positive sars-cov,2.7479786728444593e-05
seroconverted,2.7463031344726573e-05
compensatory fashion,2.7462800060107756e-05
cov e protein ion channel,2.7461888797095597e-05
sitespecific mutations,2.7432213200758813e-05
human cov 229e,2.7429745727517428e-05
nsp67 nsp1213 nsp1314 nsp1415 and nsp1516 precursors,2.741798870447877e-05
brains tumor necrosis factor tnf,2.7381952838470188e-05
molecular dating,2.737915612895027e-05
tissue culture propagated virus,2.7374481040997077e-05
plpro transcleavage assays,2.7371940826748674e-05
smallanimal species,2.736041730676281e-05
nonprocessive,2.7359271748751e-05
mouse hepatitis coronavirus a59,2.7350135677309825e-05
tracheobronchial lymph nodes,2.7346126154370088e-05
chimeric mhv4mhva59 spike glycoproteins,2.7325120342788513e-05
porcine kidney cells,2.732024301943191e-05
lung cdna library,2.7304005622797402e-05
safe,2.7292741456404387e-05
african camels,2.72733706701766e-05
immunopathologic-type lung disease,2.7246791478012327e-05
mtase inhibitors,2.723256728435023e-05
cellular proteases,2.7231558063269384e-05
"human angiotensin converting enzyme ii (ace2)(9,10",2.7226713386658452e-05
multifunctional viral gene product,2.722088988174398e-05
administrative controls,2.7207320509196266e-05
mv,2.720717352760077e-05
protein modified,2.720538556981146e-05
dnazymes,2.72001463216222e-05
monomer-dimer dissociation,2.7176293833878404e-05
cytotoxicity studies,2.7164633701601792e-05
eosinophilic immunopathology,2.7149117651523717e-05
endoplasmic reticulum (er) membranes,2.7145473566580856e-05
4f,2.712804200890338e-05
coronaviral replication,2.7121703485059902e-05
murine hepatitis viruses,2.711729966649854e-05
nuclear import processes,2.7095997851937334e-05
genetic stability,2.7078605345610848e-05
cellular receptor angiotensin-converting enzyme 2,2.7061763177262164e-05
effector and target cells,2.706108088660579e-05
cross-sectional surveillance,2.7059981681215748e-05
archeoglobus fulgidus af1521,2.705490224032287e-05
human cov oc43,2.698166259867255e-05
bronchointerstitial pneumonia,2.696638539003466e-05
phospholipids,2.6951158237543318e-05
t m gallagher j virol 7826822692 2004,2.6938235256677188e-05
receptor-binding ability,2.6931842870828996e-05
sars-cov non-structural protein 10,2.692529733373076e-05
e3 ligase activity,2.6906937574063803e-05
immunofluorescence staining,2.6903941730177194e-05
crossprotective dna vaccines,2.6898330951907554e-05
viral fusion peptides,2.6877320126715647e-05
medical records,2.685287307560844e-05
immune evasion,2.682315430736347e-05
mers-cov s glycoproteins,2.6801717693784065e-05
"crcov-k9, -k37, and -k39",2.6799265773947126e-05
protein-specific antibody,2.679119484382716e-05
carboxy-terminal end,2.677098697479371e-05
mers-cov rna detection kits,2.676102862489115e-05
cellular receptorangiotensinconverting enzyme 2,2.6750856563022727e-05
active dimer structure,2.6707189081563463e-05
single particle cryo-electron microscopy,2.670705292711944e-05
mers-cov real-time reverse transcription pcr,2.664858377012507e-05
polypeptide sequences,2.662447663959377e-05
stem cell transplantation,2.6615670367098677e-05
paramyxoviruses types 1,2.6597427777012072e-05
pneumocytes and bronchial epithelial cells,2.6595015311276632e-05
transcription factor interferon regulatory factor 3 irf3,2.6589359565543348e-05
sarscovinfected mice,2.6583780931414342e-05
proteolytically,2.6577265860607055e-05
enveloped singlestranded positivestrand rna viruses,2.6573868208193714e-05
genus coronavirus,2.657070379963541e-05
haemagglutinationinhibition assays,2.6566018147732374e-05
wild chinese horseshoe bats,2.656575418824795e-05
ibv-infected mammalian cells,2.6554638870046543e-05
a59 membrane-spanning domain,2.6545085245290553e-05
nglycosidasef,2.6536196147999605e-05
cell proliferation assays,2.6533839313998644e-05
aminoterminal end,2.649768201605746e-05
sinusoidal endothelial cells,2.6490876972375062e-05
subgroupspecific open reading frames orfs,2.647855814250637e-05
reverse-transcription-polymerase chain reaction,2.6443634905742995e-05
anti-sars coronavirus igg,2.6441017337240286e-05
probes,2.6437094672753684e-05
doubleknockout,2.6433514075734414e-05
hcov-nl63-negative samples,2.6432642726943103e-05
colonizing,2.641632946135925e-05
ri strains,2.6406370316918302e-05
effector proteins,2.639428846454504e-05
severe illness,2.6393097890094606e-05
human airway epithelial cultures,2.638857771826926e-05
sdav coronavirus,2.6375815123873138e-05
arteriviridae and coronaviridae families,2.637390209425578e-05
complex-type,2.6373345672326314e-05
potassium ion,2.6354007911758436e-05
vulnerability trafficking,2.63527833857518e-05
ari,2.633850935339073e-05
rna stabilization reagent,2.632900716923395e-05
high-income countries,2.6326486218839555e-05
coronavirus proteasedub,2.6284035613294385e-05
cisacting element,2.6240552280340434e-05
groupspecific orfs,2.6236823189365588e-05
proteolysis mass spectrometry,2.6236109053237748e-05
bacteriophage rna polymerase promoter,2.6232506780014545e-05
al(oh)(3)-adjuvanted whole virus sars vaccine,2.6206922950374912e-05
capdependent ribosomal scanning,2.618976332231414e-05
retina,2.6188498009022537e-05
lysosomotropic reagents,2.6176568466417254e-05
putative 3clpro domain,2.6167400868277685e-05
virology phylogeny,2.6166019524408725e-05
flanking regions pp1a residues,2.6164456926431938e-05
nuclear export signal (nes),2.6157855006757384e-05
genome encodes,2.6151825513035612e-05
bovine coronavirus (bcv),2.6121642832438494e-05
peptidomimetic,2.611238442622138e-05
membrane-anchored sars-cov spike (s) protein,2.6082517227546636e-05
serum sars-cov rna rt-pcr,2.6079991417267664e-05
unknown/confirmed aspects,2.6078084623062315e-05
histocompatibility complex class,2.607345699097246e-05
dromedary camel coronavirus uae-hku23,2.607124862194065e-05
hcov-oc43 lineages,2.6054096143542707e-05
positive stranded rna virus,2.604246821778927e-05
genetic basis,2.602654906863132e-05
coronavirus tgev packaging signal,2.5970847458557343e-05
tracheal aspirate/sputum,2.5956822926187175e-05
wildtype spike protein,2.595139536837478e-05
adaptive immune response,2.5889120152208843e-05
cholesterol accumulation,2.5863702878680256e-05
sarscovassociated,2.5862293411262962e-05
hamster dpp4 amino acids,2.5854679509986738e-05
testing positive,2.5848082687382495e-05
nsp12encoded rnadependent rna polymerase,2.5840697689022295e-05
rrbd vaccination,2.582599779436058e-05
nglycosidase f,2.5818388275310255e-05
stem-loop structure,2.5732994771978824e-05
protective antigen,2.572885653952393e-05
protease inhibitors that,2.5715724269155355e-05
compensation,2.5705482525232785e-05
packaging signal and leader,2.567206077826628e-05
recombinant immunofluorescence assay,2.5656645474053428e-05
reproductive number,2.5654615942297863e-05
sars virus nucleocapsid protein,2.5653263129324468e-05
immune cell population,2.5652954016266493e-05
maximum-likelihood phylogenetic trees,2.5636615273002102e-05
m13 phage dna clones,2.5636363863436126e-05
conserved rna virus proteins,2.5630888757183493e-05
horn,2.5611386590477786e-05
insertion mutation,2.5608398404818734e-05
cis-acting rna structures,2.559547746909009e-05
chimeric betacoronavirus murine,2.5578185446648917e-05
sequence elements,2.5577030189905774e-05
non-structural protein 3b,2.5566071205279454e-05
cell surface transmembrane,2.5559806839723038e-05
cxcl2 protein,2.5545157171590403e-05
characteristic heptad repeat regions,2.5527054241602622e-05
p40 tumor necrosis factor alpha,2.551974480482052e-05
supportive therapy,2.5506071931937e-05
kazakhstan bat coronaviruses,2.5502291609076795e-05
standard middle east respiratory syndrome coronavirus,2.5491147377141277e-05
charged endodomain residues,2.548716905899048e-05
blockage,2.5484569296797053e-05
nsp45q2779 nsp56q3086 nsp78q3462 nsp89q3672 and nsp910q3783 sites,2.548203257387209e-05
real-time quantitative rt-pcr assay,2.5480950189792377e-05
soluble ceacam1a receptor,2.545154837268509e-05
jhm spike protein,2.5448691641122512e-05
pro-apoptotic protein,2.543531538635383e-05
cd26/dpp4 receptor,2.5433253965212577e-05
poor induction,2.5428347120636398e-05
active fecv infections,2.5426951515677255e-05
innate defense,2.5401628598313802e-05
membrane anchored plp domain,2.5384098981914058e-05
live virus vaccines,2.5372930986995016e-05
entire cluster,2.5346781235949207e-05
sarscov nsp9,2.5343418214813354e-05
35smethionine residues,2.5335064187298455e-05
cs2,2.5325195666365847e-05
neutrophils tumor necrosis factor alpha interleukin6,2.5313597048635408e-05
ns2h126r replicate,2.5310929025780282e-05
precleaved mers viruses,2.5307884353564422e-05
fecal virus,2.5290472602690953e-05
quantum mechanics simulations,2.5274055991625188e-05
single amino acid reversion,2.5252202991943182e-05
sars coronavirus main proteinase dimer,2.5232401867877397e-05
allogeneic hematopoietic stem cell transplantation,2.5228096492233992e-05
effector genes,2.5217746194053164e-05
scov-specific neutralizing antibodies,2.520934091142047e-05
cln,2.5206182961485845e-05
prcvstimulated th1 gamma interferonsecreting cells,2.5177745086700603e-05
protein degradation,2.5167550449739498e-05
np111 residues,2.515841826734765e-05
avian sequence,2.5143480466932248e-05
generalized lymphatic hyperplasia,2.5143124282530376e-05
chronic enteric infections,2.511681139049264e-05
alveoli,2.5097920995919673e-05
cardiotonic steroids,2.509467829379583e-05
10th fibronectin type iii domain,2.508372642034449e-05
dipeptidyl-peptide receptors,2.507342568878933e-05
evolutionary conservation,2.5072672303245955e-05
speciesspecific cisreplication element,2.506217871124883e-05
non-neutralizing structures,2.505363243256785e-05
tracheobronchial tissue,2.5042127576571217e-05
ecov seroprevalence,2.499841847953794e-05
aac and uuua aau (underlined codon,2.4994658512495023e-05
broad-range polymerase chain reaction,2.4985322046464836e-05
real-time quantitative reverse transcriptase polymerase chain reaction,2.4981366392356925e-05
small interfering rna sirna library screen,2.4971629876770854e-05
hospitals,2.495725168701142e-05
large positivestrand rna viral genome,2.4952857401885683e-05
serinetoglycine,2.4948613816750993e-05
small glutamine-rich tetratricopeptide repeat-containing protein,2.4946305992171737e-05
enteric coronavirus hec,2.4935827788638187e-05
asymptomatic infection,2.4926226620523825e-05
computerised quantification,2.492479818412209e-05
human proteases,2.4924353638397006e-05
melanomadifferentiationassociated gene 5 mda5,2.492299878167157e-05
mesenteric lymph node,2.4909379979491778e-05
co-infection,2.4902917594382516e-05
coronavirusmediated immunosuppression,2.4901968687640546e-05
papain-like,2.4891004985086782e-05
korean ibv isolates,2.4886281225172176e-05
sequencespecific oligonucleotide probes,2.4867706865749467e-05
mhv nsp3,2.4867205894857398e-05
sars cov nucleocapsid protein,2.4865078388594904e-05
human leukocyte antigen (hla) b7 allele,2.4862463081970997e-05
adam families,2.4853768409010118e-05
major immunodominant site aa 528 to 635,2.4853461540517397e-05
cysteine-to-alanine amino acid,2.4838823567745788e-05
gene interaction networks,2.482775421990744e-05
cov species,2.482233480660103e-05
m1,2.4804935315908452e-05
serum neutralization,2.479486551397823e-05
reverse-transcribed-polymerase chain reaction assay,2.4789375572689186e-05
discontinuous and linear b-cell epitopes,2.4788219170616867e-05
herpes simplex virus type 1 glycoprotein d (gd-1) anchor,2.478267633843314e-05
reverse-transcription pcr,2.4771125828531477e-05
quantitative real time pcr,2.4741483576606404e-05
tcell gamma interferon,2.473062515359977e-05
class i viral fusion proteins spike proteins,2.4679492670374365e-05
heat shock protein 90 alpha,2.4676051344438174e-05
virushost interactions,2.4675199096327962e-05
noncrystallographic,2.4670757490662002e-05
cryoelectron,2.4669401147021244e-05
cytoplasm nucleus,2.4666783536578475e-05
byin situhybridization,2.4666531910051138e-05
sarsrelated deaths,2.4662590124477725e-05
janus family kinase jaksignal transducer,2.465285302641053e-05
coronavirus nonstructural integral membrane proteins,2.4650125977436805e-05
cell type,2.4647780751037717e-05
sarscov replicase polyprotein,2.4641903961407945e-05
turkey serum,2.461496466257277e-05
acute respiratory syndrome coronavirus nsp16 protein,2.4612820482211223e-05
operations,2.4612209684086017e-05
alcohol-based disinfectant,2.461061942859651e-05
anticov drug design,2.461056881863866e-05
viral attachment proteins,2.4606766533477495e-05
vesicular stomatitis,2.4602922351889953e-05
colostrum powder,2.4600697945070297e-05
g3,2.4598714190430144e-05
acute respiratory syndrome coronavirus papainlike protease sarscov plpro,2.45986459811521e-05
surface plasmon resonance techniques,2.4593775549791884e-05
amino acid substitution mutation studies,2.4572593725884918e-05
conserved nonmembranespanning hydrophobic domains,2.456837457805267e-05
host galectins,2.4563045787546076e-05
mouse hepatitis coronavirus strain a59,2.4562029449965405e-05
65nt virus genomic leader,2.4553551184252916e-05
gicovoh3 spike gene,2.454037664068666e-05
real-time reverse transcriptase polymerase chain reaction,2.4538704313614732e-05
negativestranded genomic rna replication,2.4519004674842948e-05
respiratory viral coinfections,2.4509358694366044e-05
concentrationdependent,2.449825939894629e-05
proapoptotic activity,2.4497604901649024e-05
coronavirus nonstructural protein 15 nsp15,2.449667699234104e-05
human sarscov receptor,2.449030711596602e-05
two-way repeated measures analysis of,2.4486545933925768e-05
orf8 proteins,2.4481024875168563e-05
compositional constraints,2.4477760087231297e-05
human coronavirus oc43 hcovoc43 bovine coronavirus bcov,2.4468220231022045e-05
coronavirus sarscov 3a protein,2.4463048312064733e-05
human coronavirus transcriptionassociated sequence,2.4457609854196792e-05
aspartic acid,2.4455348399299874e-05
core purification mabs,2.44527164917146e-05
vessels,2.4449968987935334e-05
onestep reverse transcription polymerase chain reaction,2.4445425750492946e-05
monocytes/macrophages,2.442724458829933e-05
southern china,2.4404425424684815e-05
rna structural elements,2.4403128044446838e-05
cterminal dimerization domain,2.438541217131937e-05
sars cov replication,2.438244455735658e-05
alexa488-qsy7 fret-based peptide,2.4373269966626875e-05
nephropathogenic b1648 strain,2.4364986041378593e-05
major neutralization epitopes,2.436417106474614e-05
dromedary strains,2.4324569279773715e-05
glycosidasetreated,2.432164872382241e-05
hostdetermining spike protein,2.4317965686284086e-05
total white cell,2.4307952787816366e-05
uncertainty,2.4287331565742923e-05
primary oviduct epithelial cells,2.4264792870293566e-05
gene transcriptional regulation,2.4250920207000236e-05
canid,2.42426438827087e-05
fcov strains,2.4242412613791444e-05
recombinant protein domains,2.424165579901757e-05
4/91 vaccine recombinants,2.4213584293660357e-05
wildtype mhv,2.4188707982319112e-05
nsp14 amino acid sequence typing,2.4184932832396662e-05
extrapulmonary specimens,2.418004129167858e-05
nucleocapsid (n) protein genes,2.4165994708081196e-05
avian gammacoronavirus,2.4152684702419903e-05
rna products,2.4147728531102996e-05
sedimentation-flotation technique,2.41460007906133e-05
cr3022,2.414143220480075e-05
mrna levels ams,2.410952399623327e-05
5e8,2.4108243885966805e-05
coronavirus-positive macrophages,2.409702965079446e-05
reverse transcription-pcr-hybridization assay,2.4090886542752057e-05
portable fluorescence reading device,2.408988436710892e-05
coronaviridae family members,2.407116663070696e-05
bnip3-promoter-luciferase reporter system,2.406136988212905e-05
hypersensitivity,2.4059528303705986e-05
merscov nsp16,2.4054777716360574e-05
mature proteinase,2.4051420299402294e-05
doi:10.1186/s13550,2.4040023680665976e-05
genetic homogeneity,2.399882184019262e-05
artificial bilayers,2.399286315591749e-05
serumneutralizing antibodies,2.3979209464294005e-05
hematopoietic cells,2.3975227019248682e-05
bioinformatic,2.3972400351938284e-05
controlled genetic background,2.396142031628494e-05
"bat sars-like cov (sl-zc45,",2.3938322578056223e-05
"nucleotides 15,129 to 15,134 (",2.3936131570005453e-05
viruses lp,2.3931691910336675e-05
caspase inhibitors,2.3904039650257768e-05
proteinase consensus cleavage sequence,2.389950794296436e-05
total viral protein,2.3895372882826796e-05
mouse hepatitis virus genomic rna,2.389088566088886e-05
porcine hemagglutinating encephalomyelitis coronavirus,2.3887835247738076e-05
neural cells,2.3886564507529776e-05
stem,2.3884050673987146e-05
virus spread,2.3874312653491373e-05
electrophilic character,2.3873325598565846e-05
african stakeholders,2.384758734573514e-05
monocyte chemoattractant protein 1,2.382861160484076e-05
deubiquitinating protein,2.381162081547393e-05
pathogens bovine coronavirus,2.3808793106088043e-05
anti-coronavirus drug design,2.3806638563554443e-05
cjun nterminal kinase jnk,2.379444292955087e-05
ibv-infected or transfected cells,2.378709305537279e-05
"human coronaviruses (hcovs) -oc43, -229e, -nl63 and -hku1",2.3776540027510252e-05
cell surface entry receptor dipeptidyl peptidase,2.3746041247621596e-05
viral membrane protein,2.3745741203752428e-05
mers-cov rbd-based subunit vaccines,2.3736824160545322e-05
deviation,2.373074772248398e-05
health morbidity,2.3719311935899075e-05
hospital length of stay,2.371739023557562e-05
green fluorescent protein (egfp) gene,2.370289684090812e-05
marek's disease virus,2.3701124243178177e-05
chromatin immunoprecipitation,2.3666219332189574e-05
monocyte-derived infiltrating macrophages,2.3659724199165966e-05
protein nuclear export,2.3653181096247592e-05
genus rheum and polygonum,2.364898184247879e-05
hku4cov 3clpro,2.363306817236399e-05
prcv pneumonia,2.36230208518814e-05
ol,2.3619648729287498e-05
nipah viruses,2.3614758420322117e-05
coronavirus hcov strain 229e infection,2.361475838763724e-05
assembly machinery,2.3606348236024768e-05
coronavirus (cov) envelope (e) protein ion channel,2.3601823065466273e-05
interdomain,2.358840357004288e-05
juxtamembrane domain jmd,2.3586600208989522e-05
type i infections,2.3583211662150142e-05
mhv packaging signal,2.3581731926992427e-05
hamster dpp4,2.3581238859843722e-05
immunofluorescent assay,2.3532430842820592e-05
p38 signaling pathway,2.3507006044953702e-05
replicationcompetent propagationdeficient virus,2.350449269299588e-05
reverse-transcribed-polymerase,2.3497846563830124e-05
modified intracellular membranes,2.349678293818462e-05
homologous human genes,2.347906893131592e-05
septemberoctober,2.3436711652406774e-05
sars-cov mpro,2.342307628537728e-05
neural progenitor cells,2.3417325193276556e-05
transmembrane glycoprotein,2.3416645690519177e-05
n-terminal octapeptide n8,2.3399181549731494e-05
viral envelope protein,2.3398221533806574e-05
neurotropic coronavirus,2.3382203439028364e-05
estimated glomerular filtration rate,2.336051863384579e-05
full-length protease,2.3353348445414085e-05
cathepsin l cpl inhibitors,2.3349737276259385e-05
heteropolymeric,2.3319076377895583e-05
clinical spectrum,2.330098880855261e-05
carboxy-(c-)terminus,2.32971128294729e-05
viral evolution strategy,2.329256777415557e-05
domestic cats,2.3285900092127905e-05
nucleic acid substrate ssya10001,2.3272039555491234e-05
il4,2.321194420926675e-05
methyltransferase,2.3194216965589838e-05
murine coronavirus s trimer ectodomain,2.319091994294576e-05
multivalent merscov s1a,2.3189512771817965e-05
cell-to-cell,2.3184165594999837e-05
29bp deletion fusing orf8ab,2.3179127723657696e-05
negative-strand rna,2.3176393925662363e-05
bronchovascular lung markings,2.3165218114384355e-05
hcov dans des pathologies digestives,2.316347564076133e-05
coronavirus spike protein,2.315979860717859e-05
19 temperature-sensitive (ts) mutants,2.3154983595195535e-05
sars coronavirus nucleocapsid protein dimer,2.3137560607110818e-05
semi-quantitative method,2.3137155507122586e-05
automated nucleic acid extraction,2.3134436352827622e-05
coronavirus-based,2.3123125846953693e-05
non-recombinant and recombinant hcov-oc43 lineages,2.30785143211497e-05
antimalarial effects,2.3027909459433284e-05
virions and infected cells,2.299421232107318e-05
environmental studies,2.299399666423384e-05
clinically diagnosed,2.299015614630788e-05
3a accessory protein,2.2977875493375662e-05
bcov sequences,2.2962616834400304e-05
coronavirus spike proteins receptor,2.2962248785027523e-05
[3h]leucine-labelled ibv-beaudette membrane (m),2.294984310609065e-05
n3,2.294640864178625e-05
runx1b,2.292370653916602e-05
differential aminoterminal polyproteinprocessing pathways,2.2923690810986615e-05
high field,2.2918320485248064e-05
packed cell,2.2901949174210082e-05
peak-years,2.290172709558674e-05
sam,2.289618021697906e-05
paramyxovirus f structures,2.2887531595059394e-05
microrna mir mir30a5p,2.288464153019498e-05
multiple time points,2.287814094470352e-05
todos los pacientes con sospecha,2.286362590729693e-05
michael acceptor inhibitor,2.2861793860682673e-05
shipping fever pneumonia sfp cattle,2.2854246846257785e-05
cellular akt prosurvival pathway,2.2845502144526906e-05
target cell surface tmprss2,2.283809278805003e-05
frame,2.2827399677435265e-05
major viral virulence factor,2.2824635527319027e-05
heterologous viral rna export elements,2.281917974787876e-05
sarscov angiotensin converting enzyme 2 ace2,2.2815987771162862e-05
sars-cov accessory protein,2.2815683821776796e-05
rheum officinale baill,2.2811270772021825e-05
amplification-based diagnostic methods,2.2805227500448506e-05
anomalous behavior,2.2804232002548622e-05
hku1he protein,2.277688121541096e-05
n-acetylglucosamine-like residues,2.2770225217809395e-05
human target cells,2.2752141883095064e-05
hcovnl63 nucleocapsid,2.2751912948376896e-05
cov molecular,2.2749952326684612e-05
pathophysiology,2.2725762714779772e-05
civet covs,2.2725106255547364e-05
p j m rottier j virol 791445114456 2005,2.271753360256033e-05
neutrophils tumor necrosis factor alpha,2.271503380149901e-05
cd45ro,2.2711810387694927e-05
recombinant polypeptides,2.2707189201460883e-05
virus pedv,2.2685827075031892e-05
vaccinia virus mtase vp39,2.2679728111043376e-05
cell surface proteases,2.2670325552478782e-05
civet scov genome,2.2662397775084576e-05
nterminal hydrophobic signal sequence,2.2660668404006473e-05
fibrotic lung disease,2.2654387016401437e-05
control diseases,2.265157963447634e-05
receptorbinding site amino acids,2.2636733651219733e-05
scotophilus bat,2.2628285163058983e-05
hind,2.2597259161329008e-05
glycoprotein-mediated,2.2596734239072217e-05
cellular doublestranded rnabinding protein pact pact,2.2594351004236917e-05
neurological disorders,2.257746377420236e-05
upstream,2.2574995760106665e-05
viral andor cell membranes,2.2570789343257606e-05
retinoic acid-inducible,2.2564250238785852e-05
alveolar macrophages ams,2.256174173195662e-05
renilla luciferase gene,2.2552140359437215e-05
hcov-nl63 infection,2.2546260078148634e-05
n-terminal two-thirds,2.2540985049393563e-05
protein refolding events,2.2519880688318956e-05
jhmv srr7 s protein,2.250908854253292e-05
hcov-oc43 infections,2.2507905111255645e-05
bcov infections,2.2505684315383285e-05
cpg suppressed clones,2.249470651785311e-05
phage-displayed human lung cdna library,2.248312614926687e-05
perinuclear punctate,2.246879101001275e-05
alkaline phosphatase,2.2453731470929115e-05
fusion-defective chimeric proteins,2.2447831176618394e-05
vero e6 cell culture,2.24471158922905e-05
thrush coronavirus,2.244544320016954e-05
p6 p2,2.244167607068539e-05
systematic approach,2.2439793189786452e-05
cellbased cleavage assay,2.2432145366394182e-05
activating transcription factor 4,2.2425507776395112e-05
sl-covs,2.2424666917959372e-05
endoplasmic reticulum (rer),2.2421798719244756e-05
anti-coronavirus activities,2.2402677757842582e-05
aminoterminal part,2.2401178456773018e-05
ibvinfected g2mphasesynchronized cells,2.2380543620048563e-05
cardiovascular diseases,2.237944607025703e-05
emc/2012 strain s-pseudotyped lentivirus,2.2376230169500847e-05
eptesicus fuscus,2.234763559297003e-05
surface levels,2.234685350013431e-05
intrapatient variation,2.2344750436888752e-05
recombinant mers-cov,2.234334415148466e-05
zoonotic coronavirus disease,2.2334104919292394e-05
ace2 ace2,2.232044494194743e-05
2019-ncov,2.2317389666594656e-05
s1 recombinant proteins,2.230473384469717e-05
stain vero e6 cells,2.2300893655760476e-05
white interfacial hydrophobicity scale,2.230009907267298e-05
singlestranded positivesense rna genome,2.22959293478191e-05
multifunctional cellular immunity,2.2282040904396272e-05
control merscov infection,2.226940780355731e-05
human angiotensin converting,2.2236962932449366e-05
viral rna replication andor transcription,2.2230087292692052e-05
bcovs,2.2220477960467612e-05
alphacoronavirus clade bat cov btcovbnm9830,2.2189902652512578e-05
liveattenuated vaccines,2.2181108491208987e-05
sars-coronavirus-host,2.2121420975487163e-05
decreasedfidelity,2.2121027505690356e-05
coronavirus sarscov middle east respiratory syndrome,2.211336956644927e-05
lys63linked polyubiquitin chains,2.210649534954084e-05
mhv discontinuous transcription,2.2097238200858732e-05
glycoprotein vaccine,2.2094091144229922e-05
respiratory distress syndrome,2.208771152892945e-05
host astrocytes,2.2073576407710614e-05
neutralization antibody tests,2.206513227235566e-05
i.p,2.2061413970190478e-05
coronavirus cov nonstructural protein 14 nsp14 is a 60kda protein encoded by the replicase gene that,2.206061770855199e-05
east africa,2.2050054387912282e-05
mucosal immune response,2.2049243652628406e-05
w45,2.2038074418174895e-05
human leukocyte antigen class i,2.2033159004417757e-05
wh-human-1 coronavirus,2.2029380234087677e-05
sarslike cov rs3367,2.201759429798919e-05
dengue virus serotype 2 denv2,2.2016405026505337e-05
ferret coronavirus (frcov) yamaguchi-1 strain,2.20143917307959e-05
cellular receptor cd26,2.201308753550372e-05
bcov amplified product,2.1973329132405556e-05
sarscov life cycle,2.195406234573894e-05
resistant bat cell lines,2.1952871541804447e-05
immunogenicity decrease,2.194318672997632e-05
cl2 infected cells,2.192551343202537e-05
acute respiratory syndromerelated,2.1916393860450298e-05
acute respiratory syndromecoronavirus x domains,2.190443896747948e-05
glycosylation site,2.1873611151677126e-05
eosinophilic immune,2.186701424379218e-05
recombinant vaccinia virus,2.185050467668667e-05
hydrophilic s1 pocket,2.1848027657169674e-05
human embryonic kidney 293,2.1846808711471258e-05
autophagic pathway,2.1841403640015038e-05
intravenous immunoglobulins heptad repeat 2 peptide,2.182041050336497e-05
acute respiratory syndrome-associated coronavirus),2.182006435434718e-05
von frey filament testing,2.1811246142865986e-05
recombinant nucleocapsid protein,2.18082390021851e-05
reproductive tract disorders,2.1808141898385276e-05
nproteinrna binding,2.1799933377503612e-05
biochemical complementation analysis,2.1797820904454437e-05
glycoprotein genes,2.178646794005728e-05
genera,2.178366036749452e-05
standard suspension test,2.1770081160837877e-05
slippery sequence uuua aaa,2.174905802183606e-05
coronavirus mouse,2.1742198500320788e-05
caspases 3 and 7,2.1734626283753064e-05
wtfipv,2.1734258622194575e-05
glycoprotein of sarscov,2.1732607893060713e-05
irf3 plasmacytoid dendritic,2.1730803858640836e-05
immunogenic epitopes,2.1726681339269456e-05
dsrna-binding proteins,2.1708918099708474e-05
rabbit coronavirus hku14,2.169652729452367e-05
recombinant transmissible gastroenteritis coronavirus,2.1693835364960267e-05
3t3 mouse cells,2.168757322058686e-05
homing,2.1683347142461135e-05
serological detection,2.168203505820351e-05
canonical sequence,2.168089776959376e-05
anticeacam5 antibody recombinant ceacam5 protein,2.1677256792561796e-05
c-terminal fc tag,2.1663665420611918e-05
retrospective cohort,2.165894632789661e-05
interferon receptor,2.1654281347544003e-05
recombinant mers s377-588 protein,2.1653219137503002e-05
infecting human cells,2.164741195137442e-05
respiratory epithelial cells,2.164439339851624e-05
indigo sinigrin aloe emodin,2.1636709042924933e-05
human sarscov strains,2.163384866363037e-05
bcov and brsv rna,2.162721176294638e-05
homologous avian,2.1613380118183706e-05
scov nucleocapsid scovn protein,2.1613281073633272e-05
modulating,2.1607956765845327e-05
cs the canonical csb,2.1606323088015637e-05
disulfide-linked homodimer,2.1571915009240828e-05
symmetryassisted reconstruction,2.1564351995975667e-05
antigenic,2.155436478133976e-05
phosphoprotein phosphoamino acid,2.1537293532693998e-05
virusdependent signaling pathways,2.15287799700993e-05
morphological analysis,2.151444689147094e-05
mhvrindependent,2.1509502502976824e-05
enterotropism,2.1499906726774063e-05
human immunodeficiency virus type 1 hiv1,2.1491976760366208e-05
destabilize,2.1483511248162976e-05
solid foundation,2.1459168934927888e-05
eptesicus fuscus) cells,2.1444850191129737e-05
protein plus m protein,2.142285104601245e-05
migration,2.1414366814026065e-05
hiv-1 vpu virus ion channel,2.1370399808765586e-05
polyclonal igg antibody,2.1370106046506897e-05
data surveyed,2.1357433312086386e-05
cyclindependent kinase 6 cdk6,2.135387849229571e-05
race rt-pcr amplification,2.1340289956991823e-05
cov s protein directly upstream of the fusion peptide,2.1326746435895633e-05
nonstructural replicase proteins,2.1306694622454014e-05
national guard hospital,2.1290431349267548e-05
pro-apoptotic bak and pro-survival myeloid cell leukemia-1,2.128694220843527e-05
retinoic acidinducible gene i,2.128257257698199e-05
bst2s antiviral function,2.127292644246128e-05
cov s protein,2.1266313893043573e-05
ribonucleoprotein structure,2.1265360054927202e-05
h. somni,2.1258515352428143e-05
macrophageattracting chemokine,2.1256022988061183e-05
seroepidemiology survey,2.124840360410456e-05
agerelated,2.124418581096576e-05
molten globule state,2.1232966711287974e-05
microglial cellenriched cultures,2.1231002252066213e-05
laboratory-confirmed mers-cov infection,2.12242035978892e-05
bayesian coalescent inference,2.1209157071868736e-05
fever malaise cough,2.118683029198217e-05
mutant proteins,2.116786916944792e-05
human sarscov receptor angiotensinconverting enzyme 2 ace2,2.1158301604206944e-05
nsp9 nonstructural,2.1146987140283734e-05
cathepsin l.,2.113408069754398e-05
recombinant partial nucleocapsid,2.11280511107943e-05
structural and antigenic proteins,2.1124531373250085e-05
immunofluorescence immunofluorescence,2.112323094370243e-05
positive strand rna coronavirus,2.1120682112491983e-05
phage clones,2.1107342289618978e-05
leptomeninx bcells,2.1080955788408825e-05
leaderbody junction,2.1065923033854356e-05
27 coronavirus genome sequences,2.1062978176828744e-05
immunofluorescence analyses,2.106283091993869e-05
nsp1expressing cells,2.104656919861912e-05
transmembrane region,2.1041080264140397e-05
high selectivity index,2.103798195913832e-05
prcvinfected,2.1030955951188106e-05
motif krkte u122,2.1011732267471417e-05
rituximab,2.101101574905508e-05
alpha helical electron microscopic analysis,2.100752030925701e-05
westernblot assays,2.100596689229482e-05
human parkinsons,2.1004523258724874e-05
sn2,2.0996725517188126e-05
phosphate termini,2.099177457010305e-05
coronavirus membrane m protein carboxy tail,2.0987709131691784e-05
genomewide small interfering rna,2.0974322323745585e-05
batsarscov and sarscov genomes,2.0956386588865636e-05
tcovspecific antibodies,2.095537086601278e-05
nucleoside triphosphatebinding,2.0938506231373513e-05
cytoplasm cell cycle analysis,2.0937903616351842e-05
glycan structure,2.0933171631914994e-05
health organization announcement,2.093109694519096e-05
differentiationassociated gene 5 pathways,2.0925310083845076e-05
primary human macrophages,2.092015785209118e-05
hyperimmune polyclonal nucleocapsidspecific antibodies,2.090939308366656e-05
persistence-associated s glycoprotein point mutations,2.0903679971309754e-05
b3,2.0903517817470587e-05
mitogen-activated protein/extracellular signal-regulated kinase,2.089189592344689e-05
embryonic kidney epithelial cells,2.0871958883921155e-05
sars-cov open reading frame,2.0866890636383596e-05
transcription-initiation signal,2.086551302846646e-05
b cell receptor complex,2.0863783630685003e-05
activator nonstructural protein10 nsp10,2.0848932327224813e-05
virus receptor-binding protein,2.0848180141693213e-05
endosomal fusionactivating proteases,2.0847731917552765e-05
epithelzellen durch eine,2.0841595357343265e-05
contemporary coronaviruses,2.084133330349523e-05
melanoma differentiationassociated protein,2.0834659382153985e-05
potassium ion channel activity,2.0822748334164172e-05
virus membranes,2.0810663092006002e-05
hydrophobicity analysis,2.0803762620542773e-05
gene ontology,2.0801129045289014e-05
homologous spike protein,2.0793908492719543e-05
weanling c57bl6 mice,2.0786918738885405e-05
raftassociated,2.0784605391677536e-05
wild type sars-cov,2.0775935064825977e-05
insulated isothermal pcr,2.0763294776215936e-05
cis-acting rna,2.0752207005623892e-05
angiotensin i converting enzyme,2.0736195377968594e-05
infected lung epithelial cells,2.073167242265734e-05
subgenomic mrna transcription,2.0728355338244965e-05
feline coronavirus fcov serotypes 1,2.07209058410093e-05
antiviral doublestranded rnaactivated protein kinase pkr,2.0678845373095556e-05
ppe,2.0667471885255403e-05
acute respiratory syndrome sars coronavirus cov envelope e protein,2.0664011020465523e-05
population-based randomized trials,2.0648903644451435e-05
virus protein-coding regions,2.0644346224509973e-05
interferon-induced proteins,2.0623753601305903e-05
autophagosomes,2.061046679884791e-05
black flying fox brain cells,2.0597095235586445e-05
multisite nucleic acid binding,2.0596048455956564e-05
coronavirus china rattus coronavirus chrcov hku24,2.05841155954504e-05
transfected human embryo lung fibroblast,2.0579685614092047e-05
transgenic,2.057017587367575e-05
targeted recombination system,2.056663049203079e-05
peripheral immunization,2.056233003596622e-05
massachusetts prototype ibv,2.0542480624957138e-05
continuous transcription,2.0541958341090304e-05
nsp16he,2.0524931243642778e-05
mouse hepatitis virus mhv l kuo,2.051475095905669e-05
proinflammatory factors,2.0496786451031954e-05
nucleus of cells,2.0469639916869907e-05
anseriformes birds,2.0469220414434907e-05
protease activity,2.0458121193492412e-05
small size,2.0455110070084842e-05
nonpermissive cell line nih3t3 quantitative pcr,2.0453076368826802e-05
non-structural protein region,2.0409900590894862e-05
anti-severe acute respiratory syndrome,2.0393265338904615e-05
predicted 154-amino acid protein,2.0380084908552192e-05
european hedgehogs erinaceus europaeus,2.037246264319393e-05
melanoma differentiationassociated protein 5,2.0362839041134662e-05
host cell receptor angiotensin-converting enzyme 2,2.0362275385214157e-05
neutralizingantibody,2.0339251528582782e-05
pipeline,2.031180855362027e-05
saudi officials,2.0304704522288955e-05
comparative genome analysis,2.0304251757649793e-05
togaviridae families,2.0299214647524283e-05
maternal antibody,2.029569638856587e-05
side product,2.029294253309561e-05
genotyping,2.0290002421362722e-05
miniopterus pusillus,2.028500673627557e-05
putative gav cysteine proteinase 3clike proteinase 3clpro,2.0243022360853e-05
enteric mers-cov infection,2.022235704936668e-05
injection,2.021677673255457e-05
type ipositive 13 59,2.0214608225374867e-05
receptor functional mimicry,2.021023170372375e-05
3cl proteinase,2.019238565217779e-05
double-stain immunohistochemistry,2.01825161255258e-05
menispermaceae,2.0175628826834437e-05
m protein monomers,2.016155084073458e-05
tender leaf,2.0157049447488978e-05
codonoptimised,2.0156726507887634e-05
wildtype jhm spike sjhmra59,2.0152135260974814e-05
immunodominant site aa,2.014932759467765e-05
bhk,2.014918450518367e-05
glutathione stransferasereplicase fusion proteins,2.013444398922766e-05
virus-induced reorganization,2.0127552126325615e-05
developing neutralizing monoclonal antibody,2.0125230486565924e-05
heterodimerizations,2.0111077778275697e-05
proximal tubular epithelial cells,2.010703460196646e-05
tyr6398leu94 virus,2.010399322461495e-05
alveolar macrophages ams fluorescent antibody,2.0103824531743128e-05
cysteine proteinase 3clike proteinase 3clpro,2.0099902214319247e-05
packageable bovine coronavirus,2.0095810860577488e-05
receptor-associated snps,2.0093207809595163e-05
orthologs,2.0085937491098378e-05
vsars-cov-5prime,2.0084071967134196e-05
anti-mers-cov activities,2.0074079686337723e-05
tertiary rna structure,2.0073092238084587e-05
one-step real-time rt-pcr assay,2.0071731733893067e-05
conserved single-nucleotide,2.0043202714701312e-05
mhv leadercontaining mrnas,2.0032792100639715e-05
stochastic,2.0019897554036895e-05
hku9 robatcov,2.0010779460738697e-05
hcov229e presumably,1.9992202821828147e-05
immunodominant non-neutralizing epitopes,1.999009906148304e-05
herpes simplex virus type 1 glycoprotein d,1.9982615979244994e-05
prototype coronavirus,1.997734563426593e-05
virus propagation,1.9960211292664827e-05
tm domain,1.9952011752046108e-05
palindromic small rnas,1.992887074187489e-05
sars-cov-specific antibody,1.9919444785657836e-05
nsp8 residues p183,1.990189118607077e-05
qatar,1.9898886607331407e-05
respiratory cv infections,1.988811326151125e-05
marmoset animal,1.988569422603562e-05
predicted cleavage site,1.988465897597043e-05
filamentous actin factin,1.988331779328358e-05
convalescent-phase sars,1.9882293918888418e-05
tgev miller m60,1.9880671279343766e-05
coronavirusinduced encephalomyelitis cie,1.9843259242433953e-05
cov polymerase,1.9842570604299766e-05
30base acidic tandem repeat atr,1.9837794414918915e-05
posttranscriptional regulation,1.983290677990074e-05
calicivirus infection,1.983164642289522e-05
memory t cells,1.9821426034909366e-05
chrcov hku24 chrcov hku24,1.9813640571231405e-05
family member,1.980636016609447e-05
antibodies merscov neutralising antibody,1.9790440176602523e-05
drug actions,1.978059244040883e-05
genecoding regions,1.977284978483823e-05
c1,1.9769476798779122e-05
regulatory sequence,1.9766218443799094e-05
multiple sites,1.9765707325782443e-05
reactive consensus pcr primers,1.9748893311015584e-05
rotaviruscoronavirus,1.9744378841239543e-05
betacoronaviruses bovine coronavirus,1.9718069858527925e-05
mouse hepatitis coronavirus strain,1.9696033659527547e-05
pathogenicity and associated virulent factors,1.9687852846251604e-05
bhk cells,1.967757540999362e-05
interleukin 12,1.9669731689961144e-05
caspase dependent y liu y,1.9663513963252167e-05
host death,1.9644088596669596e-05
acute respiratory syndrome sars cov plpro hcovnl63,1.9643901863468828e-05
hcov229e virus,1.9632965459482625e-05
synonymous site,1.963242239986804e-05
sars-cov replication,1.962537212235804e-05
hp concentration,1.9618810822727103e-05
lung alveolar epithelial cells,1.9604924195771742e-05
scandinavian bvdv,1.960162739528271e-05
females,1.9601090996763202e-05
tmprss2 western blot analysis,1.9585395148892282e-05
putative accessory proteins,1.956692148636067e-05
tgev mrnas,1.956545537280976e-05
papain-like proteinase domains,1.955363671621284e-05
extrinsic apoptosis pathway,1.9546290763220408e-05
case recognition training,1.9544981047564093e-05
standardized clinical trial protocol,1.9543545849791872e-05
prosurvival proteins bcl2 bclw mcl1,1.9535827300601646e-05
conserved hydrophobic domain,1.9533650763891797e-05
chinese reference strain,1.952664372132669e-05
proactive surveillance,1.9501558238773382e-05
nonpathogenic neurotropic virus,1.949195383879936e-05
multidisciplinary team,1.9479219230825857e-05
bacteriophage rna polymerase,1.9467877211483206e-05
multiply mutated octapeptide s24,1.9459842844670092e-05
sars cov recombination analyses,1.944555636367808e-05
sequence-independent single primer amplification,1.9441529263251615e-05
small envelope e proteins,1.943744193284737e-05
hrc2,1.9426123421490276e-05
coronaviruses bat viruses,1.9419868842435594e-05
membrane glycoprotein,1.940711432750712e-05
spseudovirus,1.9390715958036684e-05
chronic medical conditions,1.9373102334458255e-05
cellular receptor mceacam1a,1.936522566949979e-05
double-stranded bovine rotavirus rna,1.9360248436381284e-05
n gene coding sequences,1.9342182742189293e-05
civet cat isolates,1.93387121781359e-05
tyrosineprotein kinase 2,1.932014088489838e-05
coronavirus membrane protein,1.929815565669158e-05
pegylated interferon,1.928213755855534e-05
thein vitro-transcribed di rna,1.9266011364836692e-05
coronavirus replicasetranscriptase complex nsp3,1.926058140856354e-05
anticipation,1.923098700959504e-05
mhc class-ii peptide ycileprsg,1.9225008529037776e-05
gene fusion peptide mutations,1.922253955015316e-05
nprotein c terminus,1.922013976235731e-05
phenolic compounds,1.9218238363753765e-05
antibody-phage library,1.9215099711164128e-05
ihc,1.921067413127529e-05
tripartite motif protein 25 trim25 e3 ubiquitin ligase,1.9205607074509918e-05
coronavirus sarscov accessory protein,1.919902116950458e-05
substrate analog,1.9188348127025505e-05
sequesters cell cycle regulatory complexes,1.9187680162460626e-05
canonical receptor,1.9181793125321117e-05
mers-cov entry/fusion inhibitors,1.917981231523371e-05
interleukin-6 mrnas,1.9168264497841672e-05
immune systemmediated damage,1.9166681334566e-05
control mucosal infection,1.9155750349393376e-05
allelic discrimination approach,1.9149818111440154e-05
mutagen,1.914269477314717e-05
type ii transmembrane serine proteases ttsps,1.91374139224366e-05
sars-cov membrane,1.9125475070039565e-05
virus infection assay,1.9125272617980135e-05
effectiveness,1.9120229756386246e-05
repeat pcr polymerase chain,1.9099239259069186e-05
first-line,1.9097111771963155e-05
multicomponent ugi reaction,1.9094166188137342e-05
intercommunicating alleles,1.9090589596928167e-05
coronavirus-infected cells,1.908451610334462e-05
replicating di rna genome,1.9066739782255725e-05
est 2325transepoxysuccinyllleucylamindo3methylbutane ethyl ester,1.904125866519637e-05
environmental origin,1.9039683087358374e-05
ci,1.9035395128035813e-05
caspase activation,1.9029358754197418e-05
avian coronavirus n protein,1.9025563964378895e-05
well-protected hcws,1.9020531754632078e-05
discontinuous transcription i,1.902021097218752e-05
virus-like particle,1.9006328610980492e-05
virus-infected cells,1.9004497370061616e-05
genetically divergent s1 subunit,1.900025924557557e-05
viral conditions,1.8982084544407237e-05
animal movements,1.8978705741927734e-05
expectations,1.897414156117818e-05
infectious sars coronavirus,1.897318373478383e-05
environmental risk factors,1.897111588627643e-05
cellular products,1.8961874549776754e-05
virusplasma membrane,1.8944456640118002e-05
cell cycle delay,1.8936246428990782e-05
risky exposures,1.8934254327558496e-05
nsp1516 precursors,1.8921334362994503e-05
hku14,1.8919617986072573e-05
spike genes orf 3,1.8919066176945027e-05
virus spike glycoproteins,1.8912651457488626e-05
fluidigm dynamic array nanofluidic chip,1.8909023721730395e-05
spatial clusters,1.8906241549309554e-05
broad spectrum inhibitors,1.8882876285132398e-05
requirements,1.8882426012322302e-05
betacoronavirus clade,1.8881126725571793e-05
sequence conservation mutagenesis,1.8879106299229927e-05
hospitalized sars,1.886713352758704e-05
first-line hcws,1.8860324473844707e-05
cross-neutralizing activity,1.8860130700524726e-05
membrane scaffold,1.8855118086818063e-05
proteinbinding domain,1.8850417747972544e-05
tcv n protein,1.884833125993044e-05
salmonella enterica serovar typhimurium,1.884593102140854e-05
mdl28170 and vi sja6017,1.883521482732423e-05
multienzymatic replicase complex,1.8823655655962166e-05
published contextual information,1.8822037479965963e-05
cytopathic mhv infections,1.8819006722083946e-05
sars rna testing,1.8818036355429923e-05
n-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride,1.8810593949615586e-05
sarscovinfected cell lysatebased elisa,1.8807435018278322e-05
sodium dodecyl sulfate-polyacrylamide,1.8794548174976355e-05
virus yield reduction assays,1.87855822954548e-05
bayesian skyline analysis,1.8781222183467613e-05
natural transmission,1.87766917843458e-05
h77,1.8771363314092926e-05
hexameric form,1.8769914606709513e-05
cyanogen bromide,1.8752980492475557e-05
stat1 signal transducer and activator of transcription factor 1,1.87465140115091e-05
camel-to-human mers-cov,1.8738927691403e-05
chimeric construct,1.8731507727093262e-05
conformational feature,1.871835501474116e-05
neutralizing antibody epitope,1.868286553832471e-05
human respiratory disease,1.8670701143996174e-05
membrane proximal cysteine clusters,1.866706057239166e-05
viral neutralization,1.8666488761695952e-05
uv-inactivated virus,1.8659101320839416e-05
anti-sars-cov drug design,1.865662438691544e-05
"mhvr-negative, non-permissive bhk cells",1.865057072605111e-05
pathogenic molecules,1.8642457843824087e-05
viral exposure until,1.8616545975193505e-05
initiation codon,1.8606037718994677e-05
mhv-a59-infected cells,1.8604467089964756e-05
molecular assays,1.8598647898430216e-05
protein receptor-binding domain,1.859763421443508e-05
enzyme immunoassay neutralizing antibody,1.85925235924136e-05
regulatory strategies,1.858810158550189e-05
neurotropic murine coronavirus jhm,1.8557965374614858e-05
amino acid group-specific protein,1.855066537609544e-05
civet sarscov strains,1.8539187484154503e-05
human bronchial epithelial cells 16hbe,1.853646920071522e-05
type ii alveolar cells,1.8532206168534137e-05
cytotoxic tlymphocyte,1.853155925489179e-05
cov rdrp nucleotide,1.8516647467189052e-05
mitogenmediated proliferation,1.8514644541185817e-05
coronaviral proteases,1.8509824542479143e-05
patients lung specimen recombinant protein 3a,1.8503534749150924e-05
mers-cov spike protein,1.849159830723789e-05
peripheral gc,1.8477146275364928e-05
hybridization assays,1.8471185005881162e-05
type of dimer,1.8467826216649517e-05
surface molecule,1.8464165184986652e-05
survive,1.8437796117231404e-05
monomeric subunit pdcov spike,1.8436069458403426e-05
rechallenge,1.843521831798117e-05
economic damage,1.8435085231626843e-05
activator of transcription,1.843333087986996e-05
hill coefficients,1.842913740234986e-05
immune histochemistry,1.8425026377430114e-05
epidemic curve,1.8422226414146984e-05
signaling pathway,1.8418886928743457e-05
western region makkah,1.8418424546593287e-05
stereo- and regio-specifically isotope-labeled amino acids,1.8414920186983394e-05
luciferase assay,1.8409044217088764e-05
protein-related information,1.8398148387960887e-05
chargedresidue substitutions,1.839685264346832e-05
group 2 coronavirus m proteins,1.83653200433407e-05
mononuclear cell infiltrates,1.835980420150073e-05
contrast trypsin,1.834868895326351e-05
antimicrobial functions,1.834318938258164e-05
evolution rate,1.8332804036958706e-05
sars 3cl proteinase,1.832993021144342e-05
lung eosinophilic pathology,1.831845071700817e-05
cellular carcinoembryonic antigenrelated cell adhesion molecule ceacam receptors,1.8306671964620876e-05
sex,1.8305535563612425e-05
transduced cells,1.8298406189081526e-05
humans bats camelids pigs,1.8294541313296875e-05
wild-type n protein,1.82918466158484e-05
gcc,1.8280759827676128e-05
tcell epitopespecific response,1.8271981726808518e-05
manifestationconvalescent,1.8259491457829086e-05
proteinpseudotyped murine leukemia virus mlv vector,1.8258128949021576e-05
advanced infection,1.8240357488640495e-05
spinal cords,1.8237944851877353e-05
full-length spike protein,1.8221321330940267e-05
recombinant native full-length s-protein trimer,1.8216941520460317e-05
glutamate excitotoxicity,1.8210165773540596e-05
jhmv,1.820900674268248e-05
chicken respiratory tract s1,1.8204929015571012e-05
arabian peninsula tunisia morocco france italy germany,1.819992497219031e-05
recombinant vaccines,1.819860564380353e-05
full-length viral genome sequences,1.819744467484185e-05
rnase a-resistant tight n protein association,1.8180179458311827e-05
secondsite revertants,1.817357187986261e-05
type i ifn-dependent genes,1.8171927256691036e-05
40s ribosomal subunits,1.8170060188087435e-05
coatomer protein complex,1.8169711720840684e-05
prrsv-infected pigs,1.8167280139106252e-05
canonical cleavage sites,1.8164278014072834e-05
phylogenetic sister,1.8162624943172336e-05
merscov genomes 21,1.813059189623551e-05
enzyme linked immunosorbent assay,1.8107072866719506e-05
differential diagnosis,1.810310603766458e-05
broadspectrum peptide inhibitors,1.8091028887012794e-05
virus-induced host response,1.8090877793044406e-05
(+)-strand bcov di rna synthesis,1.808083036253002e-05
nucleocapsid protein np of severe,1.806899099377561e-05
endoplasmic reticulum (er)-golgi intermediate compartment,1.8055791372857662e-05
downstream noncanonical motif,1.803992262770215e-05
camel-exporting countries,1.803081886143206e-05
viral genome harbors,1.802776085473339e-05
hotel m contact isolates,1.8026619854258328e-05
german research council,1.8025427558411867e-05
docking approach,1.801804637003938e-05
screening indirect immunofluorescence,1.8007102302368527e-05
nonfatal pulmonary coronavirus infection,1.8001574803497835e-05
coronavirus sarscov bone marrow stromal antigen 2 bst2,1.8001532117998284e-05
ovariectomy,1.799727948871071e-05
e6,1.7996881391081456e-05
hcov229e n  1 hcovnl63,1.7990609968403426e-05
cell epitopes,1.7986243470111307e-05
proline residue,1.797025111549511e-05
nested reverse transcription-polymerase chain reaction,1.7968442282889476e-05
conventional jhm receptors,1.796202977808806e-05
human respiratory syncytial virus,1.794847200320011e-05
human and animal cells,1.7944579811025187e-05
growth factor signaling pathway,1.7937035993103356e-05
virus load,1.7935723566804756e-05
putative fusion domain,1.7931182225477964e-05
subunit vaccine antigen,1.792546256923304e-05
image,1.7925235407281286e-05
anti-sars-cov s2 antibodies,1.7924119497397942e-05
fasl tumor necrosis factor alpha,1.7921973058110128e-05
recombinant s1 protein,1.7921418646760654e-05
virus c/d hemagglutinin-esterase-fusion glycoproteins,1.79115133805768e-05
dodecylphosphatidylcholine micelles,1.790491227900845e-05
tcell response,1.7882874497489087e-05
scientific community,1.7882121827397558e-05
human airway epithelial and calu3 cell cultures,1.7864956519266768e-05
cre recombinase,1.785773788929436e-05
compartmentalise,1.7855009695335803e-05
strand rna viruses autophagosomes,1.7852886333870245e-05
dna vaccination,1.7852600158295627e-05
sarscov virusspecific memory cd8 t cells,1.7849564321372223e-05
degenerative arthritis,1.784687025603481e-05
receptorbinding site amino acids 270,1.7842642363994553e-05
viral envelopes,1.7840490684873134e-05
hrn2 anti-serum,1.7837856141677005e-05
coronavirus cov designated sarscov the virus,1.7810178348999906e-05
laboratory abnormalities,1.7798213401924696e-05
anti-coronavirus drugs,1.7790291235277476e-05
glial glutamate transporter glt1,1.7786484903120263e-05
chicken tracheal organ cultures,1.77754266276417e-05
executioner caspases,1.774658800273733e-05
fusogenic conformational changes,1.774600119015492e-05
amino acid residue sarscov replicase polyproteins,1.7738746859195252e-05
replication-competent mvvac2-mers-s(h,1.7734200874327033e-05
host-to-host,1.7730105911387497e-05
sarscov virusspecific memory,1.7728909806904355e-05
anthropic,1.7728572904919235e-05
lesser,1.7693688200908538e-05
nsp15 mutant mouse coronaviruses,1.7687444940817346e-05
persistence/demylinating-positive strains,1.767691660063921e-05
generation sarscov,1.7669497119354727e-05
serum-free insect cell line,1.7656674213382045e-05
geographical groupings,1.7656581473693283e-05
human coronaviruses hcov nl63,1.765181747494345e-05
noncrossreactive,1.7642411663305097e-05
sarslike cov,1.7632058297034856e-05
enzymatically active nsp10nsp16 complex,1.7630988120153692e-05
sarss,1.762667803001812e-05
no mers-cov receptor,1.7623745774444983e-05
noncanonical templatedependent polymerase,1.7613921115430985e-05
neurotropic coronavirus jhmv infection,1.7607756200019916e-05
polypeptide chains,1.760763947378147e-05
acute renal impairment,1.7606326310342564e-05
sob,1.75923348382132e-05
sars cov s protein,1.75819675279036e-05
viral infection coronaviruses,1.756747822375802e-05
oligodendrocytes astrocytes,1.7555268648486575e-05
contactinhibited confluent nih 3t3 cells,1.753179128051757e-05
molecular approaches,1.7523208207047965e-05
(+)-strand di rna synthesis,1.75149035035677e-05
middle east respiratory syndrome-coronavirus,1.750221204990314e-05
sars-cov igg antibody,1.7498696991663218e-05
viral fusion protein,1.7489905779360595e-05
amino acids 1 to 510,1.748624430198083e-05
laboratory strain fcov fip virus,1.7483902946609814e-05
peripheral blood lymphopenia,1.7476904613124063e-05
16 papainlike protease domains,1.7475169635034004e-05
cell syncytia,1.7468938321087976e-05
p53 tumor suppressor gene,1.7466885552952625e-05
lytic rna viruses,1.7464394578634375e-05
superinfected,1.7458497485961448e-05
hd,1.745766172108834e-05
monoclonal antibodies mab,1.744404027379375e-05
ependymal cells,1.7430369001931798e-05
alzheimers disease parkinsons,1.7427439153025604e-05
fcov type i. seroconversion,1.741762507588982e-05
cytoplasmic reticulovesicular network,1.7400670616651362e-05
mfoldpredicted stemloops,1.739433464038467e-05
eif4e phosphorylation mapkinteracting kinase 1,1.738763706957764e-05
discovery experiments,1.737562455382863e-05
mouse lung,1.7369448365278518e-05
doi101038nm1267,1.7357404559882102e-05
translation studies,1.735458226454964e-05
highly conserved transmembrane domain,1.732276300120616e-05
cell surface acid phindependent,1.7296022007503047e-05
camel vaccine,1.7290770975358864e-05
human and civet sarscov genomes,1.7279055892566574e-05
lung eosinophilic,1.7273394169703956e-05
receptor-binding (s1,1.727065886476876e-05
eukaryotic translation initiation factor 4-alpha,1.725675157487458e-05
vulnerable models,1.7255123929944157e-05
gus,1.7251156910354157e-05
conserved b-and t cell epitopes,1.7239255785106294e-05
viral and cellular determinants,1.7218566316941902e-05
subgenomic viral rna,1.7204166807998946e-05
sarscov plpro inhibitors,1.7191312960649263e-05
fdaapproved compounds,1.717888504191704e-05
chimeric spikes,1.7178146630599407e-05
virus-binding specificity,1.716716117827994e-05
excitotoxicity,1.7165609126933164e-05
pid,1.7160670782909546e-05
endoplasmic reticulum and golgi network,1.712945837089392e-05
neuronal spread,1.712565181415434e-05
templatedependent rna polymerase,1.7125221946860992e-05
hr1hr2 s core fragment,1.7117525226922886e-05
contrast variant,1.7111157481907563e-05
jhmv-specific immunodominant cd4 t-cell epitope,1.7110642822178676e-05
lead molecules,1.710971383822789e-05
chimera,1.7106308072029775e-05
liver replication,1.7101457614730226e-05
genbank kp876546,1.7089458005140997e-05
laboratory-confirmed middle east respiratory syndrome,1.7083964455851153e-05
molecular chaperones,1.705400325431255e-05
recombinant adenovirus 5 (rad5) vectors,1.7021315901809667e-05
attractive,1.701440374666752e-05
activating transcription factor 6,1.7011386299994827e-05
retrovirus pseudotyped viruses,1.7000410649823428e-05
chromatin immunoprecipitation assay analyses,1.6987729030394154e-05
microglia marker fluorescenceactivated cell sorter,1.6979748185867927e-05
spike glycoprotein precursor,1.6966352017213728e-05
pseudovirion infection,1.695462912459184e-05
drug hexamethylene amiloride,1.6930706304363455e-05
cytoplasmic pattern recognition receptor,1.6917749146046742e-05
cd4 tcell populations,1.6911329815388628e-05
rectal tumor 18 cell cultures,1.6907608401907127e-05
synthetic dna vaccine,1.6898374624824055e-05
complementation system,1.6896464236868093e-05
cysteinerich cterminal domain,1.689365920158161e-05
highthroughput testing,1.687969027800403e-05
replication-deficient adenovirus-based vaccines,1.6872654776815982e-05
plasticity,1.6864517254930697e-05
nonrecipients protection,1.685967507361822e-05
oacetylesteraseinactive hku1he mutant,1.6859139504620874e-05
serum igg1 antibody,1.685325466072249e-05
anin vitrocell-to-cell fusion assay,1.685118819149837e-05
amino acid replacement,1.684896240126609e-05
interspecies spillover,1.6847930551469034e-05
strand synthesis,1.6835031055540163e-05
envelope e protein,1.683340599712648e-05
mers-cov spike protein receptor-binding domain,1.68294511815796e-05
falsenegative results,1.682437322207125e-05
subpleural locations,1.6812137124340326e-05
discontinuous,1.6802500975986e-05
coronavirusceacam1,1.6778741235653065e-05
live phecov,1.677548297031277e-05
bottlenose dolphin cov bdcov hku22,1.677513139331154e-05
leave-one-out cross-validation,1.6764602393436217e-05
lung cdna inserts,1.675849765231784e-05
community-acquired infection,1.6756414617155093e-05
viral-specific immune response,1.6755261607209357e-05
liposomes b d zelus j h schickli d m,1.6748272163237344e-05
analytical performance,1.6746943110547684e-05
gene 2 region,1.6743943229433993e-05
convalescent b cells,1.67374267322965e-05
pseudoknot,1.6736801329464258e-05
phosphorylated-n-containing complex,1.6728266989006753e-05
perinuclear region of cells,1.6715879080076506e-05
papainlike protease plpro domain,1.6700628435762365e-05
humanpathogenic rna viruses,1.66999653447633e-05
sarscov surface glycoprotein,1.6688809004419682e-05
mceacam1a,1.667140619086814e-05
membraneassociated glycerophospholipids,1.6671041811933527e-05
receiver-operating characteristic,1.6670643772857693e-05
therapeutic aroma,1.666961702461162e-05
membrane fusion functions(1,1.6665919868453676e-05
virusspecific cd4 t cells,1.665297584012042e-05
subcellular localization analysis,1.6652914762248476e-05
s-protein receptor-binding domain,1.6649320336414593e-05
m protein proliferation,1.6643750860548135e-05
uo126 treatment,1.6643666691735455e-05
cell cycle progression,1.664176926880926e-05
"endoplasmic reticulum (rer),",1.6620764000760243e-05
oropharyngeal swab specimens,1.661833654525843e-05
mhv viability,1.6576137176089222e-05
high sensitivity,1.655645363177366e-05
wildtype protein sequence,1.6547450839011827e-05
shedders,1.6539674774853772e-05
positive predictive value,1.653781608364956e-05
creatine kinase n3 11,1.652566402619231e-05
age-matched controls,1.6506894480833912e-05
variant viruses,1.6506100081028267e-05
antigenic genes,1.650369916651985e-05
genetic clusters,1.6502247047949174e-05
sars-cov 3a protein,1.649733826811474e-05
3 positive gnn,1.6488788730561615e-05
whole-cell patch clamp,1.6487424896443103e-05
human microglial cell line chme5,1.6481122428579644e-05
active replicasetranscriptase complex,1.6478197772332887e-05
lymphocyte subpopulation,1.6455245811224065e-05
immunoblot-negative mabs,1.6447311731348085e-05
hypermutation,1.6445962170276212e-05
immunocytochemical staining,1.6432750857569857e-05
dephosphorylated sars-n protein,1.6422114081412875e-05
trp,1.6412810170539405e-05
nasal epithelium,1.6411458389329806e-05
mhc class ii iab binding motif,1.6407030683214555e-05
evolutionary gap,1.639725300293638e-05
anti-lys48 and anti-lys63 ubiquitin antibodies,1.6379966636313443e-05
g11,1.6379561368167107e-05
bayesian phylogenetic inference approach,1.6371107956112602e-05
"10.254 [1.626-64.666], respectively).",1.6365183781311302e-05
cytoplasmic and nucleolar compartments,1.6362104306965402e-05
secondgeneration replicase,1.6360870839086337e-05
5,1.6355426772312072e-05
reversegenetics system,1.6351925814863896e-05
full-length n gene of sars-cov,1.6348283883910926e-05
pseudostratified hae cell cultures,1.6346909625685405e-05
mouse lungs,1.6332188160069477e-05
deletion mutant,1.632605051369166e-05
recognition membrane,1.6322253587586812e-05
rscovn protein quantity,1.6319222433805903e-05
mhc class-i peptide,1.63181859994606e-05
transmembrane topology,1.6314888387017745e-05
interferoninducible protein,1.6297850748150208e-05
amoy gardens housing complex,1.6295540743920187e-05
post lethal mers-cov,1.6279994067574615e-05
protein monomers,1.62785048346679e-05
covhku1 infections,1.6270136230876123e-05
choroid plexus,1.625772992317842e-05
di rnaencoded subgenomic mrna di rna,1.6253365004323368e-05
secondary infection,1.6252912027805037e-05
patient management,1.6247014545913653e-05
epacspecific,1.6237361301300917e-05
untreated infected cells,1.6232461090325677e-05
sarscovneutralizing serum antibodies,1.6216898960668636e-05
age-related maturation,1.6212449113784916e-05
hydrophilic short epitope tag,1.621244150456071e-05
sarscov orf8,1.620268328567961e-05
enzymelinked immunosorbent assays lymphocyte proliferation assays enzymelinked immunospot assays,1.620081278937696e-05
homogenizing,1.6171107950026534e-05
immunoglobulin g2a,1.6169861516567616e-05
epacspecific inhibitor,1.615721880890171e-05
hydrophobic membrane protein,1.6157176580244223e-05
antibody-based therapies,1.615173619089135e-05
rbd region,1.6147546848509705e-05
animal covs,1.6139115946956723e-05
subgenomic mrna (sgmrna) molecules,1.6136958189268292e-05
fipv and tgev genomes,1.6121034523903915e-05
cterminal pp1ab,1.610843384677608e-05
polyriboinosinic acid,1.6091581838041406e-05
genome features,1.6073357367367646e-05
extracellular medium,1.6061339329577065e-05
ards pathophysiology,1.60575879145437e-05
ck/ch/lsc/99i-type field,1.6050870902779188e-05
sars coronavirus protease,1.6048949544260846e-05
intestinal mucosa,1.604882973262575e-05
disulfide bridges,1.604625478295297e-05
fulllength merscov spike s glycoprotein,1.6036895339803413e-05
tolllike receptor recognition,1.6034823158736425e-05
reverse transcription pcr,1.6029315577665377e-05
rscovn protein expression,1.601962923739943e-05
health authorities,1.601287539787643e-05
anticeacam5 antibody recombinant ceacam5,1.6008221703078476e-05
sars-coronavirus (sars-cov) genome,1.6004883543789287e-05
scissile amide bond of,1.5994053897386784e-05
h2-d restricted decamer peptide epitope,1.599133509394719e-05
nspecific humoral,1.5980632922063805e-05
risk assessment,1.597941337277368e-05
genetic engineering,1.595888780224006e-05
jhmv-infected mice,1.5949086743601464e-05
3clpro cterminal domain nterminal sequence,1.5948700212065664e-05
starvation,1.5943372032926062e-05
vesicular stomatitis virus g protein spseudotyped mlv,1.5917496960443514e-05
crowded settings,1.5914017363449637e-05
chemokine receptor cxcr3,1.59005156720658e-05
proteinprotein interaction assays,1.5894004747894925e-05
okavirus family roniviridae,1.588929382574063e-05
rousettus bat coronavirus,1.5882114727392037e-05
neurotropic human coronaviruses,1.5880822758236012e-05
hipposideridae,1.5878648582808753e-05
180kda spike glycoprotein,1.5876959038120554e-05
"ser190, ser192, thr378 and ser379",1.587502111158652e-05
nucleocapsid n proteins the m,1.586043941896205e-05
cell-surface,1.5857729099930967e-05
reporterreplicase fusions,1.5851360802721295e-05
"3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenyl tetrazoliumbromide",1.5849179332117566e-05
internal organs,1.584501447651615e-05
fluorogenic oligonucleotide probes,1.5825923841662318e-05
angiotensinconverting enzyme 2 ace2 receptor,1.5825355053152923e-05
proapoptotic cjun nterminal kinase jnk,1.5820513789708916e-05
viral rna-processing enzymes,1.580328439913563e-05
temperature-sensitive mutants,1.5797011099644314e-05
bovine coronavirus (bcv)-infected cells,1.5796913089572657e-05
mers-cov infection rate,1.5777091710027273e-05
indopacific bottlenose dolphins tursiops aduncus,1.5738311072938347e-05
cell subsets,1.572581876297355e-05
subgenomic rnas,1.5715785826814073e-05
endosomal acidification,1.570323635124985e-05
serum stimulation,1.5699041602067958e-05
linear,1.5690086479468027e-05
pkr antagonist,1.568641661735633e-05
semi-permissive to infection,1.56841356904725e-05
bat-sars-cov,1.565600765260763e-05
noncompeting,1.56278811035064e-05
scov accessory protein 3a,1.562328365393446e-05
yeast two-hybrid system,1.5622799321338848e-05
sarscov e protein amino terminus,1.5621543612944178e-05
visualization tools,1.5609988666545976e-05
cell protein,1.55982992168318e-05
mhv small envelope e protein,1.5597133595092494e-05
cyclindependent kinase cdk glycogen synthase kinase mitogenactivated protein,1.5595734373179274e-05
failure,1.5595043335804047e-05
recombinant sars virus nucleocapsid protein,1.5591324269585484e-05
human n7mtase,1.5590000466536696e-05
hcov 229e-based vector rna,1.5581722698570535e-05
antiviral inhibitory,1.555954961241197e-05
hrc,1.5559009192198158e-05
subgroupspecific genes,1.555789036698929e-05
second heptad repeat,1.5557073717209488e-05
peptidase4,1.554485821010312e-05
antiviral and inflammatory mediators,1.554001422563048e-05
protease sensitivity assays,1.5539236535061667e-05
socalled earlyphase epidemic,1.5532085313840705e-05
acute respiratory syndrome-cov,1.552943183644446e-05
conserved domain,1.5524148243684827e-05
rfp-bound green fluorescence protein,1.5507342046893256e-05
fluorescent resonance energy transferbased protease assays,1.5502683789198212e-05
transcription regulation,1.5499602377854918e-05
antagonistic mechanism,1.5497769044628934e-05
selective agent,1.548704315922992e-05
urbani strain,1.5483557837397217e-05
viral ancestors,1.548197169380115e-05
mouse hepatitis,1.545803064527117e-05
kinaseregulated processes,1.5447988702852753e-05
analytical ultracentrifugation method,1.5439484728862957e-05
aminoacyl-trna synthetases,1.5437727943137634e-05
orf1a realtime reverse transcriptase pcr rtpcr,1.5416982171783952e-05
green fluorescent proteinnanotrap pulldown methodology,1.541697273646248e-05
lightcycler sarscov quantification kit,1.540062327863095e-05
c-terminal tail of protein,1.5390034616366116e-05
real-time polymerase chain reaction,1.5379406162374e-05
predicted polypeptide products,1.5364325865886775e-05
protein level,1.5362939535092415e-05
framework,1.535104424126658e-05
organellelike structures,1.5348382033922586e-05
iga production,1.534629188710457e-05
essential function,1.5335095786581803e-05
gfppscontaining sarscov,1.5319687498009883e-05
cellular carcinoembryonic antigenrelated,1.53143360005097e-05
cellular stress response,1.5311147604706482e-05
nucleocapsid (n) protein,1.530631034335617e-05
cov viral replicationtranscription machinery,1.530285378849933e-05
10fn3 intrabodies,1.5300221965211947e-05
14clabeled virus,1.5296403470594846e-05
myeloid cells,1.5294701901298737e-05
mutant replicon genomes,1.5291392251732173e-05
bcov orfs ns49,1.5278098351102092e-05
critical factors,1.52759594962272e-05
lysosomotropic agent,1.527571264624376e-05
elongation factor 1alpha,1.5273453948816922e-05
neuronal cell,1.5270191970201475e-05
spry domain,1.5268409322375914e-05
human interleukin 8,1.525253635293251e-05
sarscov nucleocaspid protein np amino acids 216 to 225,1.5246917920296292e-05
electron microscopic studies,1.5240062485756708e-05
isogenic recombinant mhva59 viruses,1.5234231919202474e-05
negatively-charged lipid membranes,1.522788546150506e-05
mouse hepatitis cov a59,1.5220506193114699e-05
cells coimmunoprecipitation,1.521807444223752e-05
groupspecific open reading frames orfs,1.5217295562497777e-05
multiple ground-glass opacities,1.5192843766663069e-05
methylate mrna cap-0,1.5188357849332036e-05
regulations,1.517316508436102e-05
endoplasmic reticulum erderived doublemembrane vesicles,1.5169130892388704e-05
middle east respiratory syndrome coronavirus merscov infection,1.5161757637575586e-05
co-immunoprecipitation assay,1.5152176135784441e-05
conserved viral,1.5147622907172074e-05
known coronavirus,1.5139675365113074e-05
human and bovine macrophage and,1.5139537118827109e-05
stemloop sl signaling domains,1.5134414999110883e-05
single cluster,1.5132639099462557e-05
nonstructural protein ns4,1.5118871212172437e-05
coronavirus cov lung,1.5097684557845813e-05
polyadpribose polymerase,1.5094653519104429e-05
defective-interfering (di) particles,1.5094644251397756e-05
(246)vtrfygarsssa(257,1.5091319232344176e-05
active duty,1.5088492010639431e-05
ineffective,1.5079170017285016e-05
cytotoxic t cell responses,1.5074457869735133e-05
peptideloaded dendritic cells,1.506750218983603e-05
host-cell proteins,1.5064024757323409e-05
histocompatibility complex mhc antigens,1.5063923652655833e-05
extracellular signal-regulated kinases 1/2,1.5059668659485607e-05
outer structural proteins,1.505501076042696e-05
chicken kidney tissues,1.5046986026550861e-05
g1 cyclins cyclins d1,1.5042955610572314e-05
histidine-tagged recombinant sars-cov n (rsars-n,1.5042921334132316e-05
characteristic inflammatory cells,1.5040861580603692e-05
clinical scanner modified,1.5038409292641384e-05
viral enzyme complex,1.5038036772231106e-05
cd4 t cell-induced autoimmune murine,1.5037664737218609e-05
copicoated vesicles,1.5032903196252002e-05
leschenaults rousettes,1.5030436338902022e-05
hcov-229e e protein derived peptide,1.5027369442244992e-05
adult patients,1.502712609692787e-05
open reading frames ns5a ns5b ns5c ns6 ns7 ns8 ns9,1.5026381113190902e-05
proteins viruses,1.5024815041378628e-05
molecular libraries,1.501608132328807e-05
acute respiratory syndrome-coronavirus nucleocapsid,1.5012550636655998e-05
co-immunoprecipitated,1.5003910592098471e-05
bactrian camel,1.4991234577543463e-05
pulmonary neutrophil infiltration,1.4973257747396523e-05
papain-like coronavirus cysteine proteases,1.4972477837422328e-05
spatiotemporal cluster analyses,1.4967971590224372e-05
infectious bursal disease virus,1.4959167099390408e-05
convalescentphase plasma,1.4959031720613842e-05
a59-de-cat-infected mice,1.4956963489798846e-05
neuronal response,1.4953465747704483e-05
reduction assay,1.4936677834787139e-05
infiltrating,1.4929451459501428e-05
respiratory rna virus infections,1.4926121398193506e-05
s-pseudotyped lentiviral,1.4920358241735474e-05
retrovirus,1.4917367465620459e-05
pulmonary lymph nodes,1.4910587036926381e-05
j774a.1 macrophage cell line,1.490835860634096e-05
host cell type,1.4905223357754362e-05
trypsin-generated n-terminus,1.4891645412163708e-05
inflammation stress response,1.4881235733787327e-05
prognostic,1.4878958478328653e-05
sars-like coronavirus (sl-cov),1.4876248846174103e-05
pathogen sarscov,1.487386109428596e-05
mhvr,1.4867379859026638e-05
pn,1.4863358102363578e-05
wildtype wt mice,1.486114637107391e-05
protective efficacy,1.4861080334097986e-05
lowpathogenicity,1.485888387054022e-05
neurodegeneration,1.4853668631556389e-05
avian infectious bronchitis coronavirus,1.4842955597901481e-05
nonredundant nsp5 primary sequences,1.484274339650224e-05
biological facilities,1.4835926372200793e-05
cdc200301157,1.4815734432283853e-05
lysosomal proteases,1.4815694005923579e-05
qprobe,1.4814659163909471e-05
proteasomal,1.4806081768526061e-05
reverse transcription-quantitative pcr,1.4795936095767687e-05
hisg15,1.4772796149436008e-05
coronavirus-associated illnesses,1.476408884002359e-05
cp1,1.475762726586503e-05
fcov membrane (m),1.4756856606774724e-05
korean ccv strains,1.4755466975956424e-05
immunoglobulin fc domain,1.4753473033526338e-05
synthetic di rna midi-hd,1.474043005963778e-05
nterminal region,1.4721881137013304e-05
consensus,1.4714337434055124e-05
class i enveloped viruses,1.4703722487504995e-05
geographical distribution,1.4693777932419439e-05
avian-origin h7n9 influenza virus outbreak,1.46921011785464e-05
ubl,1.4683974356782072e-05
hand gp3341specific cells,1.4682236892338554e-05
human coronaviruses nl63 hcovnl63,1.468184557141195e-05
coronaviridae research,1.4680720811769317e-05
antigen-presenting cells,1.4673563455804309e-05
healthy subjects,1.4672537250908645e-05
membrane curvature,1.466958714817495e-05
oligosaccharideoligonucleotide foldlike fold,1.4661495914636859e-05
ubiquitin-independent proteasome,1.4659891553702587e-05
sars-coronavirus isolates,1.465482654677185e-05
fulllength hexameric forms,1.4652711227793417e-05
detection amplification,1.4647078684816569e-05
wild-type,1.4646923532836324e-05
secondary transmission,1.4645277558178072e-05
biomedical research centre,1.4637200238927868e-05
antimerscov activity,1.4632985201838608e-05
hcov-nl63-related viruses,1.461909876433642e-05
sequencing cdna clones,1.4608861842990672e-05
antiviral tcell response,1.4601771083975612e-05
interferon-inducible diphtheria toxin-like,1.4599425570450564e-05
48s,1.4586519594354929e-05
aspartic-acid side-chains,1.458264129485721e-05
1-step quantitative real-time reverse-transcription pcr assays,1.4576486249288717e-05
multiple sequence alignment,1.456374892026704e-05
open reading frame9b,1.4559073439825614e-05
field-deployable system,1.4551380409054732e-05
gcn2 protein,1.4549189647223057e-05
phosphorylation site,1.454773750735784e-05
viral target cells,1.4534190162339932e-05
ceacam1a dependence,1.4531920724069463e-05
diagnostic sensitivities,1.453169127655829e-05
unvaccinated controls,1.4522000913637964e-05
classification,1.4520625972234916e-05
middle east respiratory syndromeassociated coronavirus,1.4516487287238937e-05
microtubulemediated transport,1.4513897461116986e-05
human rectal tumor (hrt)-18 cells,1.4507204204419608e-05
monoclonal antibody therapy,1.4499488688874985e-05
pancoronavirus reverse transcriptase,1.4497842385851995e-05
structural comparisons,1.449507517115274e-05
cterminal antigenic sites,1.4493398280480195e-05
endosome,1.4488289827493308e-05
virus-positive animals,1.4482417749040367e-05
major immunodominant antigen,1.4482024864638585e-05
control virus replication,1.4467993526142196e-05
cellular glycoprotein,1.4466429030899855e-05
viral genomic rnas,1.4466150299846308e-05
protective interventions,1.446442279512196e-05
host protein,1.445860395787547e-05
molecular evolution analyses,1.4451154004650913e-05
haemorrhagic lesions,1.4432323854447955e-05
ibv-beaudette membrane,1.4428251268099563e-05
raccoon dog strains,1.4412663030984244e-05
truncated orfs,1.4410148466560302e-05
northern sweden,1.4407635781399674e-05
hammerhead ribozyme self-cleavage,1.4404133718864682e-05
wholegenome,1.4401016153611406e-05
baculovirus insect cell,1.4386584876157714e-05
neutral,1.437774258024662e-05
decrease,1.4373015606917393e-05
coronavirus ribouncleoprotein complex,1.4363818833450403e-05
hamster rat cat dog monkey and human cell lines,1.4361781235874586e-05
immunoglobulin gene sequence,1.4358026021046773e-05
viral accessory proteins,1.4354990474524274e-05
retarded,1.4351717318882932e-05
mutation filtering scheme,1.4347901055908287e-05
assembly pathway,1.4347817212773167e-05
laboratory-confirmed mers-cov,1.4346398411575916e-05
rat oligodendrocytes,1.434499403642344e-05
african bat virus,1.4342902800277391e-05
conserved domain flanked,1.4340882853934825e-05
cxr,1.4325757551896014e-05
host species,1.4324827869646565e-05
acute tcell lymphopenia,1.432366735020097e-05
multiple effector cytokines,1.431163446277654e-05
sars-cov membrane protein,1.4309816232205157e-05
cloned bronchial epithelial cell line,1.4303452005814647e-05
reversetranscriptase rt polymerase chain,1.4290460066990017e-05
quantitative reverse transcription,1.4279087473090964e-05
cov infection,1.4268038318564569e-05
immunodominant site,1.4267184294919314e-05
nuclear factor kappa-light-chain-enhancer of activated b cells,1.4264093240005104e-05
viral gene product,1.4256316750797283e-05
antiviral vaccine,1.4239384592925874e-05
hcovs respiratory infection,1.4232765139659265e-05
ace2 mrna levels,1.4228299472025767e-05
elisa-positive cases,1.4226334173964991e-05
sambinding site,1.4221621392787054e-05
double-stranded rna (dsrna),1.4220536761705647e-05
viral polypeptide cleavage function,1.4219729848391036e-05
cord blood samples,1.4209662380957264e-05
clinical epidemiological,1.4196831888044205e-05
brsv-,1.418988819856331e-05
virus binding,1.4184955252117848e-05
wild-type e protein sequence,1.4184259469850065e-05
hypophosphorylated retinoblastoma,1.4182616566107536e-05
core sequence,1.4176134720225728e-05
coronavirus replicative structures,1.4174316210323515e-05
cterminal superfamily 1 helicase,1.4170176595970137e-05
nsp12rdrp,1.4169915677920338e-05
preventive behavior,1.416886239329422e-05
chloramphenicol acetyltransferase cat gene,1.4168678637599608e-05
subunit vaccines,1.4166484527270229e-05
caspase-dependent pathway,1.4162986858204543e-05
nonstructural protein nsp subunits,1.4154453413050209e-05
standard protocols,1.415368374020006e-05
inoculated tissue culture cells,1.4153384861585084e-05
viral family,1.4153135074493721e-05
body transcription regulatory sequence,1.4153030426590863e-05
r80ae82aexon,1.4145910397784297e-05
mhvinduced demyelination,1.4145709433630608e-05
immunoglobulin g2a igg2a antibody,1.413894036106502e-05
cellbased virus escape assay,1.4133701952186888e-05
parvovirus infection,1.4129866405628607e-05
signal transduction,1.4124360284954642e-05
death rate,1.410808882676917e-05
sars-cov encodes several,1.4102084220071448e-05
parp-mediated inhibition,1.4097743992383349e-05
substrate-recognition pocket,1.4090385633386473e-05
ibv-beaudette spike propolypeptide,1.407689189184192e-05
structural arrangement,1.4071991757086534e-05
sequence type (st) 42,1.4067098194278098e-05
mx1,1.406204480516059e-05
multifocal nodular consolidations,1.4055553934409466e-05
fibronectin type iii domain,1.4039162603379202e-05
amino acid positions 109 118 119 158 227 589,1.4017915440965653e-05
kupffer cells,1.4012993089377982e-05
cov rdrp nsp12,1.4007593517835438e-05
mrnas coding,1.4006429363935176e-05
reverse transcription-polymerase chain,1.4002902748846094e-05
viral replication covs,1.3997900966240289e-05
e protein pdz-binding motif (pbm),1.3992774639628922e-05
translation initiation factor,1.3986180022796456e-05
coronavirus antigen,1.3986088271207519e-05
mouse-adapted sars-covs,1.3980598248610171e-05
antinucleocapsid monoclonal antibody,1.3974144065935966e-05
vacuolar proton,1.3970662917269378e-05
king saud medical city,1.3967986266359797e-05
biosecurity routines,1.3964531049005694e-05
chinese batborne cov,1.3957866618505048e-05
alpha,1.393965307913721e-05
p28induced g0g1 cell cycle arrest,1.3933881513546037e-05
tissue culture assays,1.3930571496245532e-05
late phases,1.3921620413943951e-05
respiratorysyncitial virus,1.392100794661578e-05
firstgeneration tests,1.3914511356643995e-05
transmembrane protease serine 2 tmprss2,1.3914199183699678e-05
proteasedependent cell,1.3910744719331664e-05
ruminant pestivirus,1.388881454260667e-05
3clpro expression constructs,1.3887830862002713e-05
ibv-infected,1.3881884905993513e-05
wild-type hcov-229e protein forms,1.386930586957718e-05
sars-associated cov (sars-cov) strain,1.3860334531108965e-05
structural domain,1.3848066974451914e-05
longdistance communication pathways,1.38469483723956e-05
g-quadruplex binding,1.382692340984417e-05
hypervirulent strain,1.3824279628953227e-05
transfected and infected cells,1.3817674027271046e-05
sars-associated lymphopenia,1.3803293224886586e-05
8,1.3798401535334214e-05
massachusetts type strain,1.37963290609278e-05
bat sarslike covs,1.3794482640665864e-05
mammalian positivestranded rna viruses,1.3794390009715253e-05
mers-cov rates,1.3792308059089535e-05
enveloped coronaviruses covs,1.378107430962979e-05
gammacoronavirus,1.3764013897089336e-05
mers-cov neutralizing antibodies,1.375979009102938e-05
clathrinmediated endocytosis pathway,1.3759217134348541e-05
backbone sequences,1.375433711844576e-05
endosomal cysteine proteases,1.3753063812842279e-05
korea hospital,1.374520539763154e-05
peripheral activation events,1.3739569694282907e-05
hcov-229e wild-type protein,1.3736901897496736e-05
interspecies transfer,1.3706472197211706e-05
sars-cov 3cl protease inhibitors,1.369991576602214e-05
innate immune,1.3694644872166147e-05
ribosomal rna,1.3691952581095416e-05
cov murine hepatitis virus mhv,1.3691880710896664e-05
deathinducing signaling complex,1.3691626176732151e-05
s-adenosylmethionine binding pocket,1.3682089736410237e-05
replicase/transcriptase gene,1.3661471568469524e-05
sl5,1.3660921870584953e-05
carcinoembryonic antigen-related cell adhesion molecule 1a,1.3659472208560906e-05
coronavirus s protein,1.3656288516758288e-05
alphacoronavirus alphacov,1.3654339697124583e-05
wheat germ cell-free protein,1.3643456341284215e-05
glutathione-s-transferase (gst) pulldown assay,1.36408897763138e-05
coronavirus-induced upr,1.3637691987402204e-05
adenoviralbased vaccine,1.3627428455956703e-05
geographic area,1.3622206634306726e-05
immunologically,1.3614580079717725e-05
hlaa2 sarscovinfected,1.3612488106036051e-05
chimeric spike protein mutants,1.360368109738107e-05
recombinant sarscov nucleocapsid proteinbased,1.3598275643886078e-05
conformational neutralizing,1.3594806429134473e-05
healthcare-associated outbreaks,1.3594163101886513e-05
promonocyte cells,1.3590967638060767e-05
mhv2,1.3588490929958875e-05
bacterially expressed hcv 229e 3c-like proteinase,1.3582586424470727e-05
rhinolophus shameli,1.3582572554266585e-05
genomic features,1.3579604628224807e-05
capforming enzymes,1.3577220266089646e-05
endosomallysosomal pathway,1.357504037511561e-05
hcov229e seroconversion,1.3566907487248078e-05
canonical dilysine signal,1.3560840789464052e-05
reaction turnover,1.3552563883119853e-05
nucleocytoplasmic shuttling,1.3549779454963928e-05
caspase-independent cell death,1.3542659146718195e-05
infection-limiting pathway,1.352522662152127e-05
triple crossover,1.3520992868962608e-05
murine hepatitis coronavirus,1.3515931026374035e-05
innate antiviral signaling,1.349873138243718e-05
potencies,1.3494008425015666e-05
lsec,1.3493079821956554e-05
crna products,1.3491878244110103e-05
proinflammatory cytokines tumor necrosis factor,1.3490964585195609e-05
lymphatic hyperplasia,1.3490869324358755e-05
bortezomib,1.3482782239932302e-05
deoxynucleotides,1.347780339613228e-05
condensing ceacams,1.3465688448911148e-05
ribosome leaky scanning,1.3452505204190984e-05
small nonstructural ns proteins 3a,1.3449530595678152e-05
glycopolypeptides no. 2,1.3448491195170896e-05
tolllike receptor 3,1.3447739138917554e-05
donor and acceptor splice sites,1.3441981698834732e-05
replicasespecific antibodies,1.344176118216877e-05
human cd26dipeptidyl peptidase 4,1.343494925750906e-05
coronavirus mouse hepatitis virus strain a59,1.3433881476677613e-05
amino acid sequence homology,1.3431837515951468e-05
public health laboratories,1.3428138600626506e-05
rbcvneutralizing activity,1.3416513895991382e-05
mhvinfected cns,1.3412927974322044e-05
spongiotic lesions,1.3412281906972178e-05
lelys,1.3403793372934586e-05
hcov-hku1 infection,1.339829448326327e-05
encephalomyocarditis virus internal ribosome entry site (ires) region,1.3397663776073376e-05
anti-immune strategies,1.3397222206995838e-05
gillespie algorithm,1.3393402972060194e-05
c and d strains,1.3383951336776875e-05
c2,1.337562496734527e-05
pseudotype assay,1.3374275445545354e-05
hemagglutinin-esterase-fusion glycoproteins,1.3363277125494392e-05
stat1 complex,1.3358114530220192e-05
gene silencing,1.3357341588809326e-05
mhv production,1.3346087988126724e-05
long open reading frame,1.3338368165793725e-05
acute respiratory syndromerelated coronavirus sarscov,1.3338247431622636e-05
cores,1.3333862653398619e-05
adpribose1phosphatase nsp3b,1.3317657787299903e-05
protein microarrays,1.3315069103399152e-05
rafmekerk signaling pathway,1.330961704783477e-05
virion structure,1.3305470861986651e-05
preventive strategy,1.3305366764218417e-05
sars-cov-s protein,1.3300860137795254e-05
beaudette strain,1.3296107031098844e-05
pulmonary coronavirus,1.3283965338747816e-05
blood vessels distant,1.327820152547083e-05
rousettus bat coronavirus gccdc1,1.3272332825687069e-05
theta isoform,1.3270692447967457e-05
affinity-purified polyclonal antibodies,1.3268318276540195e-05
glutamyl-prolyl-trna synthetase,1.3267497968797962e-05
native sars-cov s protein,1.3253579458429573e-05
positivestrand rna genome,1.3253046018046727e-05
deisgylating cellular proteins,1.3248968060225202e-05
protein 8b/8ab-induced degradation,1.3244288493640151e-05
genomewide sirna,1.3220305505671629e-05
genomic data,1.3219123554252477e-05
s-gene sequences,1.3190222390770371e-05
january,1.3178819371450917e-05
recombinant mhv strains,1.3173776101467015e-05
il-11-induced stat 3,1.3151146630277825e-05
12monthold mice,1.313614393863002e-05
pulmonary host,1.3133249867880143e-05
reintroductions,1.3130916699514152e-05
infectious bronchitis virus ibv,1.3116816490297745e-05
native envelope trimeric s glycoprotein,1.3110520418012739e-05
recombinant human singlechain variable region fragments,1.3107718700526721e-05
sl-cov s protein,1.3101454681216967e-05
sars cov proteinase,1.3096219581269208e-05
virus-specific cd4 t-cell epitope,1.3083801789069364e-05
subunits s1 residues,1.3082101166984521e-05
bdcov hku22positive,1.307034892507983e-05
hydrogen bonding networks,1.3058589184602278e-05
unfolded protein response,1.3044312471733229e-05
fusion linker,1.3038049213344257e-05
a59 background genes,1.3028217470958503e-05
fp5,1.3016851599411835e-05
beta-coronavirus viral loads,1.3009590699430103e-05
cell growthcell cycle regulation,1.2998979090600827e-05
rb phosphorylation,1.2992343413979311e-05
coronavirus genome nsp7,1.2991017349930493e-05
betacoronavirusconserved nh2proximal,1.2974334604172797e-05
colonic carcinoma cell line,1.2967507274614805e-05
coronaviral polyadenylation,1.296214120487104e-05
"enterovirus 3cpro (6b, 6c and 6d",1.2960263842183584e-05
non-structural protein (nsp) 10 gene,1.2959483465807326e-05
clinical laboratory,1.2955096416796155e-05
innate antiviral resistance,1.2954723829599565e-05
cleavage sites,1.2953630184434155e-05
known protein sequences,1.2948748421173956e-05
subgenomic mrna coronavirus,1.2937793828131825e-05
whole-genome expression profiling,1.29362610080302e-05
virus cell,1.2934773200016483e-05
charged residue r227,1.2921110981237633e-05
case-patients 2,1.2914094288884475e-05
sequences,1.2912729374797107e-05
peripheric catalytic sites,1.290632384651446e-05
endosomal cysteine proteases cathepsin l ctsl,1.2905205806892449e-05
shelter intake,1.2886296299810073e-05
tissue localization,1.2885059807009925e-05
human polyclonal igg antibody (,1.2871969525355638e-05
human fetal intestinal organ,1.2857745499320329e-05
coronavirus spike glycoproteins,1.2856363615342084e-05
natural stopover site,1.2854163533534088e-05
aminopeptidase n receptor,1.284202812715256e-05
pp1ab-specific monoclonal antibodies,1.2833932667772193e-05
site-specific infrared dichroism,1.282336195266511e-05
monoclonal antibodies j.7.2,1.2811657264029118e-05
transfected vero e6,1.280714144074605e-05
usual-spreaders,1.2806809991654118e-05
mammalianlike and avianlike parent viruses,1.280579814897619e-05
proteinpseudotyped virus,1.2790770688333192e-05
poorly conserved structural proteins,1.2778972816203341e-05
crcov proteins,1.277655319813934e-05
greater,1.2763320047857123e-05
health-care workers,1.2759716226164903e-05
consensus intergenic sequence,1.275949161384936e-05
chronic respiratory illnesses,1.2755260443123306e-05
n7mtase of rna life,1.2753131911999009e-05
bovine coronavirus human coronavirus,1.274992611474821e-05
subgenomic rna sgrna transcription,1.2744302239832595e-05
delta inulinbased polysaccharide,1.2741008042471261e-05
fractionation experiments,1.273457552742584e-05
endodomain cysteine-rich motifs,1.2732283552295233e-05
mers-cov-associated publications,1.273007139978007e-05
neurotropic variants,1.2729753653264033e-05
q-s (q3462s3463) dipeptide,1.27295302924197e-05
reverse transcriptionpcr rtpcr assays,1.2711949252449852e-05
two-residue interdomain linking sequence,1.2706217362555982e-05
acidic ph-dependent mhv mutant oblv60,1.2695566057732068e-05
acute respiratory syndrome sars infections,1.2689098543772817e-05
gadd153knockdown cells,1.2684430918505218e-05
consensus transcriptional initiation sequence ucuaaacu,1.26829295016812e-05
ck/ch/ldl/97i-type virus,1.266534547044475e-05
real-time polymerase chain reaction mers-cov tests,1.2652956597226873e-05
infiltrating neutrophils,1.2637532597896542e-05
mers-cov recombinant partial spike protein antibody,1.2633926372558196e-05
amino-terminal signal peptide,1.2633443930694736e-05
neurological system process,1.2630362455831778e-05
octapeptide interface inhibitor,1.2618119541680354e-05
realtime pcrbased virus cell entry assay,1.261408412412026e-05
residues 527 to 651 sudm527651,1.2613802115013711e-05
sars-cov receptor human angiotensin converting enzyme-2,1.2609593352579873e-05
major neutralizing sites,1.2608292532981617e-05
replicase nonstructural proteins nsp3,1.2605112915082583e-05
group-specific accessory genes,1.259788566251611e-05
g1 cyclincdk complexes,1.2591240263133582e-05
cellular response,1.258500194491311e-05
protein fragment,1.2577502923941423e-05
host-damaging role,1.2574277242952032e-05
th1-related cytokines,1.257300741500471e-05
sars-cov s2 trimers,1.2567622240404232e-05
lactic acid bacteria,1.2564581652347906e-05
in situ hybridization assays,1.255990194749962e-05
high-throughput sequencing,1.255604355840182e-05
multiple classifiers,1.2552392493718732e-05
phylogenetic conservation,1.2549141819388452e-05
host antiviral restriction factors,1.2546188665908352e-05
ubiquitin proteasome,1.2544224533435483e-05
rna virus proteinase,1.2536469866338215e-05
axillary lns,1.2535724031639056e-05
coronavirus sialodacryoadenitis virus sdav,1.2530299592517058e-05
neutralization activity,1.2527359146274088e-05
serine protease-2,1.2527306605670696e-05
sars-cov genomic rna,1.25242450073223e-05
inter-family recombination,1.2520419868983869e-05
pcv and tgev infected bronchiolar epithelium and,1.2519890395175843e-05
intramolecular,1.2505733023589828e-05
feline infectious peritonitis viruses,1.2499067590404922e-05
gliatropic coronavirus,1.249761715338999e-05
addavax-adjuvanted s377,1.2494259059582e-05
interconnectedness,1.2491947962511937e-05
sars-coronavirus target cells,1.2489668892863175e-05
noncanonical base pair near a35,1.247880511116912e-05
588-fc elicited higher-titer neutralizing antibodies,1.2473277849842415e-05
subneutralizing,1.2463908652702496e-05
p-sg-qpcr test,1.246233946040684e-05
negatively,1.2459905486703256e-05
recombinant soluble rbrfc protein,1.2457798398567534e-05
traffic,1.2446699397600299e-05
pachypus coronavirus hku4,1.2446192695567152e-05
endoplasmic reticulum erresident glucosidases,1.2435799153131212e-05
anti-sars drugs,1.2434726772737942e-05
n-terminal cys/his rich domain,1.2413851888190384e-05
p8,1.2392817870545475e-05
nonviral rnas,1.2389398390709381e-05
5a,1.2383441538356873e-05
trim25mediated rigi,1.2369724585155725e-05
betacoronaviruses sarsrrfbatcov,1.235543900079731e-05
s protein encompassing,1.2354924984304707e-05
intrasliv chimeras,1.2353067895134326e-05
viral spike s proteins,1.2351561566224187e-05
gfp moiety,1.2327697660460587e-05
single strain,1.2303537909850703e-05
zoonotic merscov,1.2296854748580964e-05
transcription factor interferon regulatory factor 3,1.2295932192886671e-05
blood donors,1.229164057797675e-05
hcov 229e-based vectors,1.2283869552177039e-05
accessory 3abc genes,1.2283147952031248e-05
oasrnase l pathway,1.2282793713747554e-05
human coronavirus genome,1.2282661543409291e-05
mouse system,1.2277603849701823e-05
therapeutic entry,1.2264645216268258e-05
increasing,1.2263310389613623e-05
ssrnabinding site,1.2260048766728663e-05
conserved n-terminal transmembrane domains,1.2254984387264732e-05
persistently infected glial cells,1.2252882085125993e-05
influenza b infection,1.2246562516893718e-05
balbc mice h2d,1.2243564007237479e-05
viral proteinase,1.2239427391160956e-05
galanthus nivalis agglutinin,1.2231663965875675e-05
lung epithelial cells,1.2229999165178567e-05
receptor dipeptidyl peptidase 4 dpp4,1.2225125192488231e-05
rna proofreading,1.222476619425064e-05
nuclear translocation,1.2219052701112305e-05
rt-pcr components,1.2215669933217173e-05
transcription base,1.2207234823452365e-05
recombinant spike domains s1,1.2207121967886713e-05
viral proteins coronaviruses,1.2206436711189898e-05
dynamic light scattering,1.220533651904205e-05
geographic origin,1.2205117457437645e-05
viral nonstructural proteins nsp,1.2204744177968723e-05
fms-like tyrosine kinase 3,1.219341444015476e-05
unique extra domain,1.2193327032769034e-05
immunofluorescence analysis,1.2192323113811905e-05
doi:10.1007/s11033-014-3019-7,1.2192287837355387e-05
long hydrophobic domain,1.2188081968754413e-05
coronavirus gene,1.2185014260942388e-05
g1/s phase transition regulator cyclin d1,1.2184207104016757e-05
reverse transcriptase polymerase chain reaction testing,1.2177617162371559e-05
ethiopian dromedaries,1.2174009832417264e-05
monocyte-macrophage cell,1.2168290130886903e-05
m396 crossreactivity sequence,1.2166722351027396e-05
liver derived genomic rna,1.2165881131600591e-05
coronavirus disease,1.216166474050865e-05
fluorescent resorufin,1.2160210815720269e-05
north china,1.2148826042264532e-05
high prevalence areas,1.214654762386193e-05
balbc mouse lung,1.214215685540315e-05
oligonucleotide attachment sites,1.2140349279452782e-05
3clpro-interacting cellular protein(s,1.2139465409836845e-05
membrane m protein carboxy,1.2139010315975813e-05
rna transcripts,1.2136382003115138e-05
immune pathologies,1.2127553849004391e-05
reagent,1.2114059858147457e-05
multivariate logistic regression analysis,1.2108459582307801e-05
ribosomal frameshift site,1.2079188122538044e-05
serum immunoglobulin,1.207745920043491e-05
cytoplasmic ribonucleoprotein complexes,1.20750615648115e-05
hipposideros lekaguli,1.2066176566810627e-05
national circulation,1.2065439588691495e-05
hku4,1.206467207152844e-05
replicase/transcriptase subunits,1.2064524508695135e-05
vaccinia virus expressing epitopes,1.2061234953245085e-05
glycopeptide derivatives,1.2060701059545455e-05
gln-4995/ala-4996,1.2059643515579671e-05
acute respiratory syndromecoronavirus sarscov nucleocapsid protein n enzymelinked immunosorbent assay,1.2056796603161903e-05
non-health-care workers,1.2050622477558929e-05
minimally lethal virus,1.2047202477724564e-05
b. bronchiseptica,1.2045863656706506e-05
insertion,1.2034997218459927e-05
heat-inactivated dccov uae-hku23,1.2027835671206174e-05
real-time electronic isolation flagging system,1.2019934021724882e-05
"interferon-inducible transmembrane (ifitm) proteins 1, 2 and 3",1.2018983299860334e-05
hlaa2restricted tcell epitopes,1.2013631845041982e-05
coronavirus-characterized sera,1.2012223962279587e-05
primary viral pneumonia,1.2011965935649504e-05
cell surface serine proteases extracellular trypsin,1.1989119556553444e-05
viral genomic rnp complexes,1.198645542941968e-05
fulllength spike protein,1.1975184243789553e-05
sars coronavirus (sars-cov) spike protein,1.1966660353682418e-05
subgenomic mrna coronavirus n proteins,1.1962595369338977e-05
bwcov sw1,1.196074202964239e-05
cell cycle regulatory complexes,1.1948411701818765e-05
packaging signal,1.194075172606375e-05
murine hepatitis virus mhv feline,1.1934919581109422e-05
infectious laryngotracheitis virus,1.191972131137474e-05
4.7-kda nonstructural protein,1.1903361631986161e-05
rabv infections,1.1896080737949088e-05
amino acid 547,1.1888633945454496e-05
innate antiviral signalling pathways,1.1882236309766057e-05
genetic studies,1.187511394142101e-05
protein pseudotyped mlv vectors,1.1874741000032528e-05
iondependent,1.1870826298251218e-05
phosphorylated nucleocapsid protein,1.1868549328768904e-05
countries/territories,1.1867266656872932e-05
recombinant s fragment residues 1 to 565 to sarscovsusceptible,1.1853010208278314e-05
function(s,1.1852425995472492e-05
small cov envelope e protein,1.1851903635494364e-05
antigenic structure,1.1836962017552067e-05
nsp14 proofreading enzyme,1.1836669287506664e-05
specific-pathogen-free chickens,1.183179361345651e-05
alphacoronavirus genus,1.1828544849736216e-05
exponential modeling analyses,1.1825992192473517e-05
a59-de-he-infected mice,1.1821058409863705e-05
similarityassisted rdrp strand switching,1.1815874837707892e-05
fipvs,1.1812056004805255e-05
iga-antibody-secreting cells,1.1810637104252185e-05
infective doses,1.1809860721266241e-05
acute selflimited infection,1.1804246452146967e-05
caspasedependent pathway,1.1795799370548986e-05
28s and 18s rrnas,1.1786771876910846e-05
feline aminopeptidase n,1.1786671920698414e-05
hospital-based paediatric population,1.1783308151642931e-05
nucleocapsid antigen capture enzyme-linked immunosorbent assays,1.1782854432638996e-05
giraffe giraffa camelopardalis,1.1774576819781295e-05
enveloped virushost cell pair,1.1772950187946928e-05
c-terminal hydrophilic part,1.1764130633641318e-05
disease dynamics,1.1761957581071977e-05
microvillous border,1.1760685943697118e-05
decanoylargvallysargchloromethylketone,1.174555061832822e-05
pattern recognition receptors melanoma,1.174420953014391e-05
epidemiologically-linked household contacts,1.17415636082122e-05
enteric ccov-iia,1.1737084757898121e-05
cellular isgylation,1.1736463856664924e-05
coronavirus scov 7a protein,1.173105991950039e-05
coronavirusbased vectors,1.1719969794088489e-05
local dependence,1.1711567245514815e-05
sars coronavirus sarscov nonstructural protein 3 nsp3,1.1699455762437489e-05
b cell,1.1692248558927185e-05
host rna,1.1682650114614534e-05
salmonella typhimurium,1.166942864279984e-05
encephalomyocarditis virus internal,1.1662484879461578e-05
coronavirus genus boundaries,1.1658960388277232e-05
interferon cytokine,1.1648155310541794e-05
ptb cytoplasmic,1.164297290901132e-05
cricket paralysis virus crpv,1.1635670931625286e-05
ts mutant-infected cells,1.1631412883800574e-05
covs sialic acid moieties,1.162273541586036e-05
n1347ainfected brains tumor necrosis factor tnf,1.1618466442601394e-05
quantitative real-time reverse transcription-pcr,1.1603892626789767e-05
evolutionary origins,1.1598222272998287e-05
orf 3b protein,1.1589967611484767e-05
consensus cleavage sequence,1.1589739761097811e-05
reverse transcriptase-pcr,1.1589188032014411e-05
rna quantifications,1.1583470822289876e-05
loops,1.157411287322404e-05
low alanine aminotransferase,1.1566672146856256e-05
laboratory outcomes,1.1559429457096269e-05
debilitated progeny,1.1553608634405249e-05
nsp16 residues,1.1553553075897405e-05
nascent negative rna strand,1.1528574391045043e-05
serum neutralizing antibodies,1.1524509623056608e-05
cell cycleregulatory proteins,1.1515664556967611e-05
rational attenuation,1.151537649576333e-05
developing sars,1.1513923384277477e-05
mers-cov disease,1.1505114737984205e-05
cellular deubiquitinating enzymes,1.1502375678535279e-05
n-terminal acidic domain,1.1499659608829048e-05
groupspecific orfs orf3a,1.1497242914742105e-05
clinical use,1.1493831950012385e-05
recording,1.1490342039464699e-05
noncytopathic sindbis virus replicon,1.149007574917846e-05
gst,1.1485342748914834e-05
ectopically expressed proteins,1.1483076604128548e-05
defense mechanisms,1.1481501581265267e-05
intercellular membrane,1.1473753256622253e-05
middle east respiratory syndrome-cov,1.1472472254896658e-05
co-circulating,1.1465123665580209e-05
metabolic processes,1.145902072001797e-05
tgev rna packaging,1.1448793504823871e-05
upper respiratory tract specimens,1.1439729170893525e-05
sars genechips,1.143477761918229e-05
heavy and light chain sequences,1.142783391937184e-05
peptide-directed secretion,1.1424872187646949e-05
hepatotropic,1.142198828936017e-05
sars-cov nsp16/10 complex,1.1421510691319065e-05
monoclonal antibody 6d11c1,1.1420466057900286e-05
ace2 residues residues 31 35,1.1400431937121018e-05
hela-epithelial carcinoembryonic antigen-related cell adhesion molecule 1a) cells,1.139714270676692e-05
neutralizing activities,1.139323110774868e-05
wild type mers-cov kor/knih/002,1.138145243390504e-05
mvvac2covsh,1.1363264090652525e-05
standardized data collection,1.1362221633701662e-05
transient infection,1.135712059329765e-05
lysine k aspartic acid,1.1348748822186383e-05
anti-viral nab,1.1347798141477312e-05
hyperammonemia-associated encephalopathy,1.1345953320594973e-05
recombinant measles vaccine,1.1345444614911766e-05
non-native 3d structure,1.1342352937530934e-05
receptor-associated sars-cov pseudovirions,1.133857419931201e-05
rna-positive alimentary samples,1.132906802108599e-05
priming components,1.1328334648000753e-05
il29 tumor necrosis factor alpha ccl5,1.1326119533291857e-05
mouse hepatitis cov mhv,1.1322679208764682e-05
standardized real-time pcr assays,1.1321717136962937e-05
recombinant and plasmaderived,1.1321241257516127e-05
coronavirus double membrane vesicles,1.1318730016406524e-05
forms pentameric ion channels,1.1313004502969734e-05
immunodominant antigen,1.1312471054189054e-05
experimental fip,1.1311180882108481e-05
chaperna,1.1291480561877893e-05
cov crossspecies transmission,1.1284543274889018e-05
bovine cov n protein,1.1277541010855453e-05
small multifunctional protein,1.1257491537042308e-05
enteric tract cells,1.1248273635818084e-05
pkr-like er protein kinase,1.124375174324971e-05
alpha and betacoronavirus spike proteins,1.1237969489333522e-05
protein ion channel activity,1.123638641107401e-05
anti-s and -m monoclonal antibodies,1.1235418389565132e-05
transmissible gastroenteritis virus genome css2,1.1233273148627607e-05
cleared,1.1222184713038925e-05
700-nucleotide tgev-specific rna,1.1219342409423944e-05
amino acids 14,1.120154750899131e-05
replication-associated proteins,1.120112789053906e-05
ubl domain residues 785 to 787,1.1200253279462993e-05
glial reactivity,1.1200077456899308e-05
bs,1.1196656589684724e-05
cellular unfolded protein response,1.119537946942147e-05
differentiated airway epithelial cells,1.1192011464709203e-05
neutralization antibody assay,1.118648032256472e-05
ligandbinding domain,1.1185372560230144e-05
central hydrophobic cavity,1.1182305053911136e-05
virusinfected cells,1.1176160468750419e-05
translocon subunit,1.1173225498002622e-05
laboratory tests,1.1172799879507807e-05
polypeptide segments,1.1161595748277496e-05
tmprss2,1.1155588811121922e-05
bioproject accession prjna601736,1.1150980809163823e-05
immunoelectron microscopy analyses,1.1146105133311126e-05
stat1 transport,1.1144064698638156e-05
international significance,1.1135176122552299e-05
sarsunique domain,1.1134245074005486e-05
peerreviewed case reports,1.1133875768974165e-05
cellular networking,1.1126568865066789e-05
mink lungderived cells,1.1119543109161544e-05
central china hubei province,1.1114734667943899e-05
nonconservative amino acid,1.1110251728132053e-05
mbl,1.1108900864472046e-05
murine astrocytes,1.1107464448121447e-05
type i interferon ifni system,1.1101061619275393e-05
human airway epithelial cell cultures primary lung fibroblasts primary lung microvascular endothelial cells,1.1100992720096436e-05
sars-cov infected cells,1.108864971703939e-05
sarsrelated cov open reading frame 8 orf8,1.1087301387086236e-05
non-health-care,1.1084908078615508e-05
coronaviruses (covs) circulating,1.107038846181754e-05
alpha motif domain,1.1062326362519304e-05
oligonucleotide strategy,1.1055470997399968e-05
mrna coding sequence body transcriptionregulating sequences trss,1.1038711802214181e-05
host transcription factor runx1b,1.1033704023460712e-05
polyfunctionality and human leukocyte antigen,1.1028927085031302e-05
glial activation,1.1026233197740221e-05
positive-strand rna viruses,1.1018270532728784e-05
left ventricular hypertrophy,1.101295684797785e-05
valine substitution,1.1008827980855843e-05
ace2binding site,1.0996334161968873e-05
twostep furin,1.0991470106456598e-05
mouse fibroblast cell,1.0989439831305916e-05
korean peninsulas,1.0982900247219826e-05
chemical crosslinking experiments,1.0981990708135663e-05
protein-protein interactions,1.0975261726843763e-05
viral activation,1.097355235704329e-05
chemokine receptor 3 cxcr3,1.0965943985124404e-05
acute phase,1.0959177068087109e-05
transmembrane serine proteases,1.0957670228351368e-05
competitive binding assays,1.0949350685403915e-05
receptor-mediated transduction,1.0944429638755078e-05
nonnucleoside analog inhibitors,1.0941091296394568e-05
hamster kidney bhk21 cells,1.092782286211762e-05
aa 120 of prcv n protein,1.0925445584013488e-05
surface plasmon resonance experiments,1.0920283877831526e-05
synthetic interferon,1.0918863126680691e-05
perturbation,1.091857348119569e-05
cellular membrane compartments,1.0913373297095453e-05
merscov s1 protein,1.0898165357873928e-05
acute lymphoblastic,1.0897299657010229e-05
hematopoietic tissues,1.0875862116506929e-05
carbohydrate,1.087282648616057e-05
inflammatory alterations,1.086743345102394e-05
sars coronavirus nucleocapsid,1.0863982206376812e-05
sarscov receptor human angiotensin i converting enzyme 2 hace2,1.0863898569307423e-05
tumor necrosis factor receptor,1.0863457376502885e-05
vector system,1.0861865634977906e-05
relocalized,1.0840595391773804e-05
ptec,1.0830793390715433e-05
mers-cov-positive hcws,1.0826968220323887e-05
diarrhoetic dogs,1.0821861500284683e-05
discontinuous sucrose,1.0821097661621327e-05
rabies virus particles,1.0820053503439104e-05
transmembrane proteins,1.082000841625837e-05
body temperature,1.081540479970026e-05
membraneassociated tails,1.079564899685154e-05
bernhardnocht institute,1.0789362954781113e-05
antibiotic-resistant cell,1.078682847548794e-05
replication cycle of sars-cov,1.0780942850100459e-05
mhvs,1.0780329778460863e-05
porcine kidney epithelial line pk15,1.0777477259228808e-05
postchallenge control,1.0773598382396837e-05
viral replication progeny virus,1.0771146007509196e-05
serum anti-n immunoglobulins,1.076619556790854e-05
evolutionary conserved viral,1.0762235597606885e-05
ectopically-expressed,1.075483345890441e-05
betacoronavirus named sars-cov-2,1.075419508535394e-05
nonisotypeswitched memory,1.0752234526532492e-05
protective,1.0748889411446872e-05
adverse effects,1.0742902389696588e-05
domestic rabbits,1.0725596338589984e-05
molecular diagnostic methods,1.0711337247285648e-05
viral expression,1.0706388457801359e-05
virus replicase polyprotein pp1a orf,1.0700010524943245e-05
electrondense granulofibrillar material,1.0688729903234072e-05
ready-to-use real-time rt-pcr kit,1.0680847626245544e-05
p100 transcriptional co-activator protein,1.0679852465276815e-05
serine proteases tmprss-2 or -4,1.0661257326680355e-05
log-likelihood ratios,1.0652389314121048e-05
473 intrahost single nucleotide variants,1.0632945875728447e-05
viral genome sequences,1.0630998801971992e-05
middle eastern respiratory syndrome,1.062809775814316e-05
mechanical ventilation,1.0619149228124162e-05
replicative organelles,1.0613297996139824e-05
lethal disease,1.0600674787375616e-05
np21 residues 21,1.0593122072063266e-05
oligoadenylate synthetase oasrnase l pathway,1.0583709208866671e-05
amino acids 351 to 403 domain,1.058347713807838e-05
nucleocapsid protein gene,1.0573507933192024e-05
human primary intestinal epithelial cells,1.057188015674509e-05
human alveolar epithelial cells,1.0558734088205135e-05
geographical region,1.054993955112678e-05
adenovirus 9 human parainfluenza virus 1,1.054048510310316e-05
genome-length replicative intermediate,1.053522516486179e-05
authentic sarscov,1.0531580600031568e-05
upe and orf-1a regions,1.052667516433938e-05
viral virulence proteins,1.051795117682595e-05
feeding,1.0512602790497109e-05
bone marrow chimera experiments,1.0511623388321295e-05
rna interference,1.0506860464121959e-05
influenza-like illnesses,1.0506191024475007e-05
"interferon-inducible transmembrane proteins 1, 2, and 3 (ifitm1, 2, and 3)",1.0505975957808091e-05
undiluted pvp-i product,1.0502855719242873e-05
sab301 mean,1.0502379542923678e-05
niaid-sponsored virus pathogen database,1.0501238547139094e-05
purified virus,1.0498160047360839e-05
gene trs core sequence csn,1.0496212967309092e-05
predominant products p220,1.0466696202369327e-05
membrane fractions,1.0461382110987102e-05
cov in noncaged animals,1.0460644052548492e-05
ubamc,1.0455701833444841e-05
middle east respiratory syndrome-related coronavirus,1.0451814286322515e-05
diarrhoea-causing organism,1.0447720768582012e-05
virion membrane m proteins,1.0444405063031814e-05
cytoplasmic n molecules,1.0439936706409345e-05
allele-specific motif matching,1.0438261164643863e-05
protective asc,1.0437994271170743e-05
ace2binding domain,1.043709387596898e-05
proteinbased vaccines,1.0420247979345827e-05
positively charged helical groove,1.0418980035797183e-05
cation-selective channel,1.0409392437153928e-05
mixed neural cell cultures,1.03918321800226e-05
g0g1,1.0367649002946958e-05
urbani mutational repertoire,1.0362703412320084e-05
neutralization antibodies,1.0358338379754572e-05
endosomal acid phdependent proteases,1.0337102932742195e-05
leucine rich repeat domain,1.0333107401476516e-05
coronavirus-induced acute encephalitis,1.0327582376906392e-05
tcells,1.0324690923973328e-05
helicase activity,1.0321836649509552e-05
scovinfected cells,1.0317241806641028e-05
glycoprotein of coronaviruses,1.0314582264892936e-05
receptor-binding (s1) and fusion (s2) domains,1.031233373859696e-05
protease inhibitor ki  06,1.0311075420107995e-05
anti-nucleocapsid (anti-n) antibody,1.0305158301180568e-05
scientific data,1.0304636870153428e-05
proteomic datasets,1.0300724558430528e-05
monovalent cations,1.0296626178824442e-05
type i interferon protein,1.0294279724048481e-05
america grading system,1.0281037792531395e-05
strategy,1.026986573299196e-05
world health organization website,1.0265603573515562e-05
exon activity,1.0265214847255572e-05
scv proteins,1.0261646314493909e-05
parental regions,1.0258942822665574e-05
c strains bootscan,1.0252606419267123e-05
cysteine-rich motifs,1.024909747784716e-05
renilla luciferase,1.0241841542149368e-05
160-kda protein,1.0241478294123524e-05
animal-to-human,1.0236663255434129e-05
structural similarities,1.0229677843210972e-05
neutrally charged glutamine q,1.0223671305479596e-05
anti-serum,1.0214502199296284e-05
transmembrane and cytoplasmic domains,1.0214125288764709e-05
ifninducible transmembrane ifitm proteins ifitms,1.0211032401670701e-05
major human coronaviruses hcovs,1.0210158001292113e-05
continuous screening,1.0187741303237474e-05
nprotein fragments,1.0176170699922934e-05
replicating virus,1.0161210858897891e-05
ibv s proteins,1.0159763382831685e-05
methylotrophic yeast ppastoris gs115 the,1.0157948189498647e-05
cterminal region amino acids aa 362 to 412 and middle region aa 153 to 178,1.0157337997936906e-05
nucleocapsid (n) proteins,1.0153430203023298e-05
anti-apoptotic effect,1.014902430246491e-05
coronavirus rnas,1.0148515905921834e-05
structural superposition,1.0142659647347019e-05
analytical ultracentrifuge,1.0124419298909765e-05
conserved negatively charged amino acids,1.0123827201293023e-05
ribosome profiling,1.0121066219462773e-05
sds,1.0109082717483864e-05
specific nucleotide sequence,1.010604898617313e-05
mhv transcription consensus sequence,1.0100292424360781e-05
base composition signature,1.0088116804984178e-05
internal position 27,1.0085624364552638e-05
cytokine secretion,1.008460063883583e-05
nextgeneration subunit vaccines,1.008293300097434e-05
proteasemediated cell surface pathway,1.0080394068491282e-05
coronaviral polyprotein 1a/1ab (pp1a/1ab,1.007772021989241e-05
somhvr coimmunoprecipitation,1.007049764949007e-05
real-time reverse transcription-polymerase chain reaction,1.0069466626590222e-05
adrenal glands,1.0067408561945106e-05
abl kinase inhibitors,1.0063156996566861e-05
entire protein-coding region,1.00568600259312e-05
detergentresistant membranes,1.0056809841121421e-05
viral rna-dependent rna polymerase,1.004788420402687e-05
substrate-binding loop,1.0047713461403255e-05
neutralization assays,1.0046107598264723e-05
nendou activity,1.003875952343815e-05
structural proteins spike membrane envelope and,1.0027886072970358e-05
type ii transmembrane serine protease family,1.0023576393587457e-05
fipv-specific antibodies,1.0018238171624776e-05
mhvrspecific monoclonal antibody cc1,1.001801193175996e-05
flanking nonstructural protein,1.001123462167211e-05
virusinfected or noninfected cells,1.000324716153079e-05
delta inulinbased polysaccharide adjuvant,9.995432195133879e-06
viral properties,9.986762300947769e-06
antiviral drug screening,9.984357175030781e-06
acetyl groups,9.973528061347776e-06
golgispecific brefeldin aresistant guanine nucleotide exchange factor 1 gbf1,9.970787180898354e-06
disseminated intravascular coagulation,9.958714244631448e-06
self-reported infection,9.956845592755204e-06
replicationtranscription sites,9.954335026023681e-06
postmortem lung tissues,9.944958549837256e-06
aminoterminal ectodomain,9.942616526100069e-06
cutoff score,9.940485795542366e-06
c-terminal phosphorylation cluster,9.93419726697847e-06
"n-(6-oxo-5,6-dihydrophenanthridin-2-yl)(n",9.934089758781721e-06
cell-culture-adapted strains,9.93096670597173e-06
atiie brain virus,9.924569123215626e-06
antiviral stress,9.917974817175967e-06
sucrose gradient,9.912990875210529e-06
coronavirus sarscov receptor,9.912935314821984e-06
core replicase domains,9.907973830917371e-06
ground-glass opacity,9.904135436011127e-06
aroma,9.893121387363843e-06
merscov plpro constructs,9.883879561430791e-06
chronic infections,9.876144984854277e-06
potyviruses,9.870781333885233e-06
protein myd88,9.864417528552996e-06
endoplasmic reticulum.,9.862766917649508e-06
proinflammatory chemokine,9.857018022349886e-06
viral tropism,9.842148020357556e-06
p65 transcription factor,9.841933605594967e-06
protein orf5,9.84190127743783e-06
sensitivity test panel,9.838982640976993e-06
sarscovinduced,9.838591761063148e-06
cytokine interleukin4 il4,9.819574751712264e-06
lowph shock viral rna replication,9.8195137313667e-06
g-stretches,9.817098721356545e-06
immune system process,9.816850444843854e-06
respiratory parents,9.790162617467887e-06
downstream restriction factors,9.788818637196326e-06
sud-m subdomain,9.784810840112745e-06
randomized control trial,9.781277439244867e-06
multifocal chest radiograph,9.771166537689684e-06
p1glu substitution,9.768705447056997e-06
escherichia coli maltosebinding protein mbp,9.763897009021992e-06
acute respiratory syndrome sars coronavirus cov sarscov spike dna vaccine,9.763169763458226e-06
immunosuppression,9.760111790408053e-06
interstemloop domain,9.758696813365655e-06
7b,9.750013023374764e-06
recombinant adenovirus serotype 5,9.746911290318874e-06
intrinsic disorder,9.741277572520753e-06
antemortem confirmatory test,9.738677866456938e-06
human gastrointestinal tract,9.735459671750573e-06
leukocyte antigen class i,9.733870337145625e-06
aldehyde cm-ff-h,9.726929115493745e-06
laryngotracheitis virus,9.725639069000663e-06
bulged stemloop,9.724346663431863e-06
retrovirus human immunodeficiency virus type 1 hiv1,9.719443900279742e-06
viral subpopulations,9.717272953334016e-06
cl2,9.716864798544206e-06
real-time reverse transcription polymerase chain reaction,9.71614795672775e-06
evolutionary pathway,9.705072467564694e-06
intestinal villi,9.695661572139032e-06
hcov229e binding and receptor,9.683543760439457e-06
3a protein 7a protein,9.681108387407176e-06
overall structure,9.655813454184986e-06
human airway epithelia,9.647846881730666e-06
type 2 nitric oxide synthase,9.64623435324619e-06
genechipbased genome,9.64539677131095e-06
alveolar type2 and type1like pneumocytes,9.642911866782661e-06
anticoronaviral drugs,9.641187287195545e-06
registry,9.638108175540797e-06
acute respiratory syndromeassociated coronavirus,9.6374796651408e-06
bcv s1specific primers,9.636918628659832e-06
intravenous immunoglobulin therapy,9.633079153891457e-06
mammalian secretory,9.632374537990078e-06
prospective,9.62698264674235e-06
amino acids 14 to 762,9.621027618456016e-06
gene 7,9.617058087486079e-06
helical oligomer,9.61689511036183e-06
monomeric homologue,9.614312466278034e-06
tgev fulllength cdna clone,9.613676674704885e-06
sephacryl s1000 sizeexclusion chromatography ultracentrifugation,9.59652262786581e-06
nt 239 to 310 and slvi nt 311 to 340,9.585038119827514e-06
cellular cyclindependent kinase cdk,9.575964100812094e-06
highmolecularmass glycoprotein,9.571109935836386e-06
small ibv proteins,9.564743293713666e-06
protective neutralizing antibodies,9.560865378466108e-06
receptornegative cells,9.556937243789953e-06
uvinactivated sarscovimmunized mice,9.540884755191128e-06
virus-induced cell-cell fusion,9.5195022629106e-06
z1thiophen2ylethylideneaminothiourea,9.514103227940197e-06
neisseria meningitidis,9.512074564440254e-06
histopathologic,9.505665410254439e-06
non-coronaviral targets,9.504238660492215e-06
rnase l murine coronavirus mouse hepatitis virus mhv nonstructural protein 2 ns2,9.503830995475067e-06
cellular function,9.500903727617018e-06
tmprss2expressing cells,9.493809915042734e-06
self-association,9.493644301112924e-06
viral n gene,9.488388615043158e-06
perinuclear punctate staining,9.485417425229676e-06
mannose-rich-type oligosaccharide,9.481813909941486e-06
third transmembrane tm domain,9.480264618183704e-06
carboxyterminal domain of n protein n3,9.473804196711569e-06
regulatory t cells tregs,9.466249869684699e-06
th1based cellular immune,9.461583390518107e-06
interferon ifndependent signaling,9.459974896022034e-06
membrane anchoring,9.459015846367923e-06
mrna coding sequences,9.458894945124076e-06
netherlands human coronavirus,9.457545194155602e-06
hypervariable s1 region,9.449560688838659e-06
tgev m protein,9.445672843173362e-06
ubiquitinlike ubl,9.437070857360008e-06
compartmentalization,9.424412077052597e-06
mixed parallelantiparallel,9.42146414835087e-06
sialoglycans,9.421383014251634e-06
negative charges,9.412476732055861e-06
enveloped positivesense rna viruses,9.406506235201705e-06
package genomic rna,9.394136900762033e-06
n-terminal transmembrane domains,9.386808855770975e-06
cyclophosphamide,9.373751372072423e-06
noncanonical rna polymerase,9.367301325207909e-06
sarscoronavirus structural proteins methods,9.359375862037381e-06
nlrp3 inflammasome,9.358976156414614e-06
innate immune response cytokines chemokines,9.349340181901657e-06
viral titers proinflammatory cytokine,9.331434278728751e-06
elisabased iggplusigm antibody,9.329524785523676e-06
group 2c betacoronavirus,9.327687445980592e-06
endemic coronaviruses,9.32308213612645e-06
singlestranded rna,9.306294927179189e-06
rn igg elisa 947,9.301821089627052e-06
binding conformation,9.30025882763827e-06
phosphoinositol 3kinase pi3kserinethreonine kinase,9.292723250616323e-06
i.m,9.290298681823499e-06
coronavirus protein e homologous sequences,9.28256740611343e-06
lamp-n chimera,9.279529318971555e-06
tripartite motif protein 56 trim56,9.27658079465538e-06
bcells,9.263418270085049e-06
dpp4 receptor,9.2594127203157e-06
philippines,9.249626849951435e-06
autopsy study,9.247119083876054e-06
aerosol-generating procedures,9.246859651207392e-06
k v holmes j virol 77 830840 2003 recombinant viruses,9.245555568943347e-06
co-stimulatory molecule cd86,9.241125875614211e-06
human monoclonal anti-m antibody,9.23830115841491e-06
statistical incongruence,9.236520509847405e-06
clustered sars-cov s2 trimers,9.234725664592321e-06
tgev subgenomic rnas,9.227280643866087e-06
fusion peptide inhibitors,9.22431010059312e-06
infective viruses,9.21995604599242e-06
secrete,9.21709279935787e-06
coronavirus ccov strain,9.214496937615794e-06
endoplasmic reticulum golgi,9.208909986599303e-06
nsp9 mutations,9.208113562321648e-06
fluorescent resonance energy transferbased protease,9.207916134192735e-06
postfusion conformation,9.207571635386558e-06
rna viral polymerases,9.199716076192734e-06
eukaryotic proteins,9.195654136672757e-06
enterocyte cultures,9.175283114726791e-06
viruscell membrane fusions,9.166251414109402e-06
viral antagonists,9.164959606712011e-06
relevant,9.161756266646858e-06
subgenomic-length negative-strand rnas,9.157709466775663e-06
trimeric membrane-fusion s2 stalk,9.154155166372382e-06
alveolar epithelial type ii cells,9.144998927918632e-06
nsp1-mediated rna cleavage,9.139602427044519e-06
replicationcompetent sars coronavirus antibodymediated infection,9.137622484905943e-06
transmembranous region,9.134298149022516e-06
protein-angiotensin-converting enzyme 2,9.130242177356767e-06
progenitor oligodendrocytes central glial 4 cg4 cells,9.129545035289752e-06
diarrhea-recovered calves,9.120101443044866e-06
antiviral intervention,9.115142933075642e-06
r667a sars-covpp mutant,9.114791826700982e-06
replicase subunit nonstructural protein 3 nsp3,9.110539026025643e-06
continuous open reading frame,9.09681134497917e-06
purified protein components,9.086500813081417e-06
pharmacological,9.070449458630456e-06
cov subgroup group,9.068505796903183e-06
nsp10nsp14mediated,9.062899768145892e-06
spinal cord tissues,9.055893668043854e-06
hypervariable n-terminal domain,9.054202095723096e-06
nonlethal chronic demyelinating disease,9.046087772783824e-06
multiple point mutations,9.04191856895286e-06
hybridized genechips,9.041570806737616e-06
receptor-binding and fusion core domains,9.032269886164089e-06
m e,9.02411888816729e-06
cellular stress responses,9.023853186533623e-06
viral factories,9.023050476031571e-06
mers-cov-specific antibodies,9.017885522250606e-06
compound-based forward,9.002685301772416e-06
transcription regulating sequences trss,9.001244090216537e-06
mammalian cell line,8.997509925575173e-06
mhv-specific cd8+ t cells,8.996437855156354e-06
pathogenic covs,8.991806218376523e-06
intestinal infection,8.988383202982075e-06
positive test,8.986583593321246e-06
murine central nervous system cns,8.98602860847112e-06
coronavirus nsp6,8.981531614521067e-06
intracellular aggregates,8.967163804218586e-06
inflammatory chemokine,8.9661240635692e-06
carboxyterminal region,8.965072360749557e-06
dihydroxychromone derivatives,8.94541890543914e-06
secondary cleavage site,8.934007112799593e-06
chinese hamster ovary (cho) cells,8.930831151223442e-06
infection-induced,8.928988592022365e-06
acute respiratory syndrome sars coronavirus sarscov infection,8.921928965339992e-06
protein amino terminus,8.918762821343113e-06
respiratory tract cells,8.914777504853046e-06
cov emergence,8.908909706096485e-06
case histories,8.907397683577268e-06
coronavirus ubl domain,8.892820883543678e-06
protein accumulation,8.88393896354729e-06
medically,8.870016858680476e-06
deterrent,8.867289262112322e-06
central nervous system disease,8.862411671033909e-06
alanine 2841,8.857656934708727e-06
small animals,8.84289119829184e-06
panel of cells,8.836444650229105e-06
n-dimethylamino)acetamide hydrochloride,8.832942485432423e-06
viral evolution,8.799664571318813e-06
mutant molecules,8.797866981385178e-06
quantitative reverse transcriptionpcr,8.797656805815724e-06
feline immunodeficiency virus,8.786495558936252e-06
cell physiology,8.783843562518014e-06
amino acid (aa) sequences,8.777290161322736e-06
revertant variants,8.77619281106056e-06
coronavirus cns infection,8.772295210802337e-06
respiratory complications,8.77111820627769e-06
fusion protein heptad repeat regions,8.770767821524515e-06
genome cdna fragments,8.766155365532597e-06
orf5b,8.751501545267782e-06
sds polyacrylamide gels,8.741448485218486e-06
lactam bridge constrained analog,8.740869163059575e-06
merscov 4a,8.73305246136293e-06
perinuclear region of mhvinfected cells,8.732837829189776e-06
oligodendrocyte,8.729032643193631e-06
bat cell lines,8.71920196475246e-06
prb tumor,8.716401379729635e-06
three-dimensional structure,8.715669843150804e-06
porcine intestine,8.712989446571809e-06
protein-expressing cultured cells,8.71140265579292e-06
antiviral pharmacologic classes,8.708903768460752e-06
histidinetagged,8.706286111339166e-06
protein dimerization,8.696885098876043e-06
electrospray ionization tandem mass spectrometry,8.692164134253456e-06
type ii pneumocytes,8.687796564539305e-06
non-structural protein products,8.680297634630964e-06
lysosomal damage,8.676814549265624e-06
homologous recombination,8.673641663078138e-06
codon-optimised spike glycoprotein,8.672681401488915e-06
cytoplasmic host,8.670573612608121e-06
major hydrophobic domains,8.665068074272404e-06
viral replicative,8.653916476321667e-06
primary porcine kidney cells,8.64413613405071e-06
human galectin,8.633643875781695e-06
recombinant sarscov,8.625279196714669e-06
disease origin,8.618206603656315e-06
gastrointestinal complications,8.609780303228292e-06
exchange protein,8.602050829270546e-06
posterior density regions,8.601442785814473e-06
lung tissues,8.597825172260768e-06
infectioncontrol,8.596090039987822e-06
intracellular site,8.593616321204757e-06
airway proteases,8.59334311326103e-06
cap1 rna,8.593148625582248e-06
enzyme-linked immunospot,8.591192191186781e-06
spd,8.582049371109425e-06
merscov plpro chiefly,8.581378986323794e-06
oviduct epithelial cells,8.579434016055712e-06
wild and synanthropic birds,8.576090195717217e-06
stat1 nuclear import recombinant,8.575170306921316e-06
chicken embryonic tissues,8.574783100701e-06
sars-cov spike s2 sequence,8.56071122594581e-06
receptor glycoprotein human angiotensin converting enzyme 2 hace2,8.560229700419056e-06
reporter gene assays,8.55608281255069e-06
primer extension analysis,8.55371298223178e-06
inhibitory subunit,8.549136774187898e-06
coronavirus sarscov open reading frame 3a protein,8.545753779778526e-06
plasma membrane monoclonal antibodies,8.540391158915703e-06
csa,8.539284431625572e-06
adpribose1monophosphate,8.536811574022884e-06
full genome sequences,8.529153608681025e-06
cellular trna,8.522765177712464e-06
prcvdex pigs,8.516886353251347e-06
primary mouse,8.502956443035571e-06
catalytic mechanism,8.50148332726172e-06
gammacoronavirus infections,8.493504430104515e-06
sb 203580treated cells,8.48561781608894e-06
competitive inhibition elisa,8.459951090670347e-06
argentinean strains,8.458857569816623e-06
human ciliated airway epithelial hae cell cultures,8.45375994918766e-06
non-canonical cleavage sites,8.453587499552838e-06
inventory of pro,8.453000309847007e-06
nucleoprotein molecule,8.444036591395659e-06
human galectin galactosebinding lectin,8.418871384801226e-06
glycoprotein s protein,8.405209300849942e-06
hematologic malignancy patients,8.400841119339471e-06
multiple proteins,8.394791888904864e-06
cell-invading molecular machinery,8.387769986440354e-06
human intestinal tract,8.386278544676622e-06
medial golgi compartment,8.384792156642004e-06
s1 specificity,8.376257034400424e-06
viral protein behavior,8.373355723240827e-06
biological pattern,8.365327482779002e-06
quasispecies,8.352588409122058e-06
rhinolophus sinicus,8.347197759188853e-06
sarscov receptor angiotensinconverting enzyme 2,8.337421838181038e-06
membrane associated s protein,8.336982609529375e-06
heparan sulfatedependent,8.333856859336656e-06
nsp10 monomer structure,8.33267105255707e-06
genome copies,8.319801864958101e-06
nosocomial infections,8.318036563617577e-06
nycteris sp. bat coronavirus,8.310457864351583e-06
hku1s1,8.301049748639967e-06
animal cells,8.29606847833641e-06
aidsrelated complex,8.291136110969228e-06
s.,8.289304559012626e-06
k v holmes j virol 7194999504 1997,8.284213945673436e-06
mrna translation,8.284126922059148e-06
exchange assay,8.283639968192445e-06
nucleocapsid spike membrane,8.279169136755279e-06
immunofluorescence antibody,8.278435441218442e-06
apcov infection,8.277001376924801e-06
multiple viral rna binding motifs,8.26877452947476e-06
zoonotic receptor binding domain,8.268339471134437e-06
middle-east respiratory syndrome,8.24704010327406e-06
recombinant mouseadapted sarscov rma15,8.229501149724204e-06
fipvfecv hybrid viruses,8.226138739600656e-06
detection strategy,8.22363616702062e-06
catalytic n-terminal domain,8.216678825189455e-06
vaccination regimen,8.210612611273575e-06
human alveolar epithelial a549 cells,8.19857160957125e-06
sister relationship,8.197383612005752e-06
doublestranded rnabinding domain,8.190025591280134e-06
protein e forms,8.18491543259346e-06
carboxyl-terminal domains,8.175273352349952e-06
"sars_cov, sars 3c-like protease",8.171700616512582e-06
purified recombinant 3clpro pp1a residues 2832,8.16803742511665e-06
rt-qpcr-positive,8.163415704246902e-06
nk cells macrophages,8.163228644115558e-06
antibodymediated,8.15682408392665e-06
spike polypeptide of,8.155884499258746e-06
tissue culture replication assay,8.155346176205396e-06
cyclindependent kinase 6,8.155166191018513e-06
cell typespecific,8.153802878132675e-06
nucleic acid binding,8.152053562638138e-06
cns infections,8.144438638292816e-06
peripheral immune tolerance,8.127015266047766e-06
copy number,8.1239697584892e-06
pge374/viral recombinant vector,8.123676691891408e-06
flaviviruses yellow fever virus yfv,8.119859472621765e-06
healthcare-associated transmission,8.105563783370528e-06
plaquepurified mersma clone,8.1014188265896e-06
human camel and horse receptors sensitized cells,8.095826342833186e-06
sarscoronavirus cov cholesterol,8.089066862911136e-06
nonessential group-specific accessory genes 3 and/or 5,8.088355015637394e-06
borate gel electrophoresis,8.087664614746837e-06
"fas, fas-associated death domain",8.078634259818063e-06
autologous,8.07814876096752e-06
base-paired stem,8.072967256581718e-06
potassium sensitive,8.070225157375299e-06
coronaviral cell,8.06826641210716e-06
shelter,8.052619868709794e-06
intestinal enteroid,8.05026663799415e-06
cov e,8.041823813274694e-06
mouse hepatitis virus strain 3,8.040665408309854e-06
human merscov receptor dpp4,8.034929562498073e-06
cholesterol-rich microdomains,8.024401597447644e-06
human airways,8.022146173380709e-06
supporting lysosomal,8.021956778436848e-06
genome mutation,8.020995813350341e-06
human betacoronaviruses,8.02020498614899e-06
ergolgi membrane,8.015938927440522e-06
neurotropic mhva59,8.015368624303227e-06
hcovnl63specific,8.011271261461256e-06
pretransmembrane region,8.010949382515431e-06
endemic human virus,8.008431740539299e-06
sequential bayesian method,8.005527504215829e-06
cd8+ t cell responses,7.999003594244206e-06
airway epithelial cell,7.997693982263032e-06
sprotein trafficking,7.9937024314653e-06
conserved coronavirus double membrane vesicles,7.989584648126823e-06
dietary treatment,7.989044237495016e-06
acute respiratory syndrome coronavirus sarscov viruslike particles,7.986308617580873e-06
viral glycoproteins ultracentrifugation,7.978595716015864e-06
3-iodobenzyloxy-substituted derivative 5e,7.975554491351969e-06
sars-cov e protein,7.966423087412692e-06
crystal packing,7.956157554471243e-06
mhv-induced demyelination,7.947976989792988e-06
hydrophobic anchor sequence,7.944792412478249e-06
hcov-oc43 adaptive evolution,7.943314433659977e-06
ipv,7.942783578839024e-06
sarsconvalescent,7.935664055549612e-06
highorder rna structures,7.933307236850217e-06
18-day-old embryos,7.92938368243635e-06
sars-cov-specific accessory proteins,7.926599995737916e-06
negative pressure pretreatment,7.926480402594062e-06
membrane microdomains,7.924220988567444e-06
endocytosis,7.923011043632214e-06
cd8 t cell,7.920220083920652e-06
recombinant modified vaccinia virus,7.908113272902528e-06
assembly rna,7.903659270986507e-06
novel monoclonal antibodies,7.900858758412587e-06
non-overlapping viral sequences,7.899794890951332e-06
infection control reversetranscriptase pcr,7.892159833584312e-06
picornavirus autoprocessing element,7.88709585254404e-06
3c-like protease,7.880840083939639e-06
canonical dilysine,7.87556065439648e-06
lines,7.874916999516344e-06
antigenic study,7.85260115464964e-06
infectious cloning system,7.844442373481511e-06
mhva59 gene 1encoded polyprotein,7.840701002478253e-06
extramembrane domains,7.838283493909414e-06
neighbors,7.837325655361165e-06
putative genetic lineages,7.837271682457569e-06
epidemiologic pictures,7.834100766834328e-06
carcinoembryonic antigen family member,7.834018591749307e-06
primates,7.833715474679976e-06
molecule nonpeptide inhibitors,7.829915400060605e-06
short oligoribonucleotides,7.829040257559246e-06
cellcell membrane fusions,7.82338265737126e-06
twostep screening method,7.820693525023266e-06
neurotropic spike genes,7.808479246717718e-06
membrane destabilizing transmembrane,7.80499672442871e-06
predicted stemloop iv homolog,7.802201299033743e-06
south korea mers-cov outbreak,7.798362422052552e-06
multifunctional glycoprotein,7.791690782316585e-06
neurovirulent mouse hepatitis virus mhv,7.789691764545026e-06
extract treatments,7.784872992208742e-06
mouse hepatitis virus mhv rna,7.776926260696529e-06
surface glycoprotein,7.763661659806922e-06
reverse transcription-loop-mediated isothermal amplification,7.754085296050356e-06
pantropic ccovs sequence,7.74621199683356e-06
balayage,7.729863964668069e-06
positive-strand coronavirus genome,7.72533990996809e-06
licensed kinase inhibitors,7.714204145598329e-06
recombinant vaccine antigens,7.714093532491655e-06
high death,7.698300184253558e-06
p9,7.69702170500796e-06
live rdna vectors,7.695854769228959e-06
immunodominant cd4 t-cell epitope,7.693755773565744e-06
merscov requires receptors,7.689069356910454e-06
pathogenic strain,7.688396928427294e-06
pneumocytes and ciliated epithelial cells,7.68466147855046e-06
colostrum-deprived calves,7.683678522777895e-06
ctla4hingesars800 dna vaccine,7.668692579358133e-06
viral proteases papainlike protease plpro,7.666206516165369e-06
antiviral heptad repeat peptides,7.658412740705173e-06
hku24 chrcov hku24,7.65634244498197e-06
sarscovspecific memory,7.650649472703597e-06
rhinolophidae,7.643304210048475e-06
rna synthesis,7.640883252416047e-06
enzymatic cis-trans peptidyl-prolyl isomerase function,7.637153668007259e-06
m proteinmrna 1,7.634745416580004e-06
translated short open reading frames,7.63288577278687e-06
modified vaccinia virus,7.629433011232276e-06
cathepsin lmediated,7.626233760025893e-06
hong kong special administration region,7.624022458460014e-06
wildtype sarscov mpro,7.619850546575473e-06
bronchiolar lavage specimen,7.613144004841241e-06
endoplasmic reticulum/golgi,7.611217342485916e-06
reverse complementary sequence,7.610082413256731e-06
negativestrand rna,7.604071265578084e-06
upper-respiratory tract disease virus,7.592936525933018e-06
virus replication recombinant sarscovs,7.590359150242258e-06
vacuolar proton pumpatpase,7.589880635842953e-06
major histocompatibility complex class i/ii-restricted t cell,7.585662139138532e-06
real-time pcr method,7.5844218535068545e-06
mutant plp2,7.58189379576601e-06
molecular docking approach,7.58071959511214e-06
mutant-infected cells,7.577783753723954e-06
cterminally adjoining polypeptide segments,7.575284384085555e-06
coronavirus n protein inhibitor,7.563394707438457e-06
infection mass spectrometry,7.563314686867369e-06
cd8 tcell epitopes,7.560175224757048e-06
clinical chemistry,7.558546374754578e-06
crossreactive region,7.5555442314735574e-06
sentinels,7.5511528216854e-06
uk,7.550303095842184e-06
experience,7.538842050114682e-06
1766 passengers,7.530688257618404e-06
amino acid synthetic polypeptide,7.525005127865277e-06
deleterious side effects,7.512953221497103e-06
chlorpromazine,7.5057247113799006e-06
angiotensin-converting enzyme-2,7.503662561871064e-06
nipah virus,7.502340775864638e-06
hcd26/dipeptidyl peptidase-4 (dpp4) transgenic,7.497445656260518e-06
cysteine-rich amino acid clusters,7.495108388900578e-06
130-kda and 140-kda proteins,7.489205763970054e-06
recombinant mv expressing merss,7.478494936486654e-06
prrsv replication,7.469596264354654e-06
transgenic hdpp4 mice,7.447568616819163e-06
physicochemical,7.447416233670512e-06
ataxia-telangiectasia mutated,7.446230067972512e-06
serotype i feline coronavirus fcov strain black,7.4457583614717296e-06
quantitative test assays,7.4386477583405005e-06
recommendations,7.428826268042688e-06
ubiquitinlike interferon ifnstimulated gene 15 isg15 protein,7.424124562796088e-06
transcriptional level,7.4113160736561395e-06
"recombinant ibv expressing proteins 8a, 8b and 8ab",7.410766454286472e-06
cellular membrane fusion proteins,7.405976121208754e-06
sars pseudoknot,7.40482457530874e-06
peritonitis virus,7.3990466039111055e-06
rocatccinduced neuronal,7.396729804836426e-06
antigenspecific neutralizing antibodies,7.396637200066107e-06
viral neutralizing antibodies,7.391445409946683e-06
coronaviridae families,7.387291009230058e-06
motifs v and vi and,7.37761630012783e-06
peak prevalence,7.371765934133057e-06
respiratory cov prcv,7.369422652594073e-06
intraviral protein,7.3642010111716556e-06
nterminal receptorbinding subunit s1,7.362050180928566e-06
endosomal cathepsin l,7.361181832558466e-06
pulmonary epithelial cell necrosis,7.360684709207352e-06
mhv e protein ion channel,7.352112983884126e-06
pkr phosphorylation,7.3476771984337694e-06
mechanism-based irreversible inhibitors,7.33840476226937e-06
small-interfering rna,7.332519348222895e-06
antiviral reagents,7.329755573523412e-06
four-point scale,7.327820796904659e-06
civethuman sarsrcovs,7.323345110814648e-06
long g-stretches,7.320332156761019e-06
economical,7.319093352243709e-06
eukaryotic translation initiation factor 2,7.312819435793522e-06
homodimeric solution structure,7.312077094529473e-06
food safety,7.30663807621184e-06
lethal coronavirus,7.3062859985249445e-06
protease cleavage site(s),7.304624865634461e-06
coronaviruses fipv,7.29883516887047e-06
antiapoptotic proteins,7.296841622617044e-06
drug administration,7.29487682989718e-06
intracellular precursor protein gp170,7.290720414509254e-06
mitogen-activated protein (map) kinase,7.2850206034665635e-06
tripartite motif protein 25,7.284637103706004e-06
antiviral treatments,7.278129500038698e-06
sars-cov papain-like protease,7.276802893568535e-06
nucleocapsid ii,7.258006141436345e-06
virus and infected cells,7.255575920223956e-06
community-based public hospitals,7.253669064819173e-06
exited,7.253123643887405e-06
high-throughput screening,7.248351081165061e-06
pentapeptide aldehydes,7.237378048941899e-06
coronavirus ns genes,7.2333775303157464e-06
nsp5 structurefunction determinants,7.227716923934479e-06
mutant ubl domain,7.226514834775027e-06
rigid sequence,7.22442282720944e-06
ecov-induced cell death,7.212594382971183e-06
animalhuman zoonotic,7.208717682309778e-06
intracellular viral rnp complexes,7.207738674746139e-06
open reading frame orf 3b orf,7.2071408541875655e-06
virus-infected chicken kidney,7.205797418563788e-06
free energy analyses,7.199683893904326e-06
amino acid 219,7.198298765224359e-06
systematically,7.195777711617331e-06
asc differentiation,7.1945072985906745e-06
global left ventricular systolic dysfunction,7.194334060438432e-06
gene expression profile,7.188569450799109e-06
envelope membrane protein,7.162714761076024e-06
enteric virus surveillance system,7.1518696342600305e-06
live-attenuated virus vaccines,7.151857299160467e-06
genome-wide gene,7.149586373438802e-06
hydrophobic virusreceptor interface,7.145933399702155e-06
evolutionary inference,7.1425940832626885e-06
downstream consensus sequence,7.14049619599477e-06
tetratricopeptide repeat 2,7.135596616534689e-06
camel merscov vaccine,7.1324400407548e-06
brain lysates,7.1247458874867634e-06
south korean outbreak methods,7.123094006662669e-06
avian coronavirus spike proteins,7.101397274114182e-06
immunohistochemical peroxidase technique,7.098253486326122e-06
motif ligand 2,7.096450860745537e-06
rna-processing enzymes,7.094463278398192e-06
rm,7.093925591088574e-06
folded properly trimerized,7.093333981616975e-06
chemical inhibitors,7.092601699455909e-06
mhv hypercholesterolemia,7.088228652128371e-06
transcriptionregulating motif,7.0879556829951635e-06
compassionate use,7.0837317100173986e-06
cholesterol depletions,7.0832325752060995e-06
evolutionary constraints,7.08000302758108e-06
sl4,7.064861068752582e-06
open reading frame 3,7.060263816410598e-06
pan-coronavirus inhibitors.,7.059218030010773e-06
heptanucleotide slippery sequence,7.053640572514942e-06
sars-cov-2 pneumonia,7.050230243893093e-06
isogenic recombinants,7.044640890041977e-06
clathrinmediated endocytosis,7.043464935243616e-06
sars-associated cytokines,7.029873748131799e-06
antiparallel fashion,7.0287793636952685e-06
university medical center,7.026320078850185e-06
sampling occasion,7.0258819335104715e-06
cellular signaling pathways,7.023184138308537e-06
processed,7.0231311210058e-06
endosomal cholesterol,7.023118272381319e-06
nmr chemical shift perturbation,7.020416596277168e-06
p-sg-qpcr,7.016378834469151e-06
s4r,7.015844978074725e-06
transmission electron microscopic tem studies,7.010583619842529e-06
recombinant vaccinia virus dna,7.0082285043354015e-06
gc,7.0032180212284145e-06
neuroinvasive neurotropic,7.002136859805058e-06
sars-cov-infected caco-2 cells,7.001737589416811e-06
recsars-cov reporter virus,7.0004708539651595e-06
55 kda nucleocapsid protein,6.999864381449538e-06
eonycteris bats,6.996266828979799e-06
cdna fragments,6.992895010506573e-06
preclinical research,6.978936162435556e-06
alphacov,6.975854462308751e-06
spike protein s1 fragment,6.974196940614025e-06
highly basic nucleocapsid (n) protein,6.958487313321979e-06
mhvinduced,6.956979032729145e-06
adaptive mediators,6.954448670880062e-06
neurontoneuron spread,6.953608078985111e-06
plasma therapy,6.948312632335773e-06
putative open reading frames,6.939760178414857e-06
multiple signaling,6.938203460757432e-06
laboratory-confirmed,6.9364262237661524e-06
chemoattractant protein1,6.929436537792971e-06
sf9 cell-produced full length,6.921064934595012e-06
tripartite motif protein 56,6.920373299228804e-06
faecal material,6.907658860713837e-06
nterminal hydrophobic peptide,6.903742519019657e-06
subgroup 2b sarscov,6.899073695954507e-06
nucleocapsid phosphoprotein,6.8972508078019166e-06
lipopolysaccharide,6.894540717522809e-06
host/pathogen,6.8890745404425995e-06
classical anti-tgev neutralization test,6.888479665479468e-06
bd,6.8765270299068e-06
risk factor funding french,6.8750389713348375e-06
genome encapsidation,6.866680383502298e-06
sars-cov 3clpro inhibitors,6.858387488742444e-06
haematological,6.850269152258195e-06
copies/reaction,6.848435330899743e-06
kinome protein kinases,6.846709998047848e-06
cell fractionation studies,6.839186144017849e-06
receptorinduced temperaturedependent virus,6.837400455598938e-06
contrast substitution,6.819694265934216e-06
helper virus rna,6.819250410053188e-06
factor interferon regulatory factor 3,6.812609745231487e-06
vertical transmission,6.806805140776531e-06
swc3a monocytesmacrophagesgranulocytes cell frequencies,6.797655321938625e-06
cation-selective ion channels,6.791825218487835e-06
full length non-structural protein 3b,6.791727030230283e-06
amino acids 184,6.791336081794273e-06
lyra11,6.791154464406154e-06
sputum samples,6.790031198327783e-06
sail protein,6.784562247273469e-06
preattachment,6.775879188044546e-06
helical stemloop structures,6.7735427071627265e-06
sars-like cov,6.769787428675317e-06
wildtype wtexon,6.763829083455873e-06
in-practice assay,6.758604484805719e-06
multiple logistic regression,6.757670698387872e-06
gap,6.749440085134681e-06
hnrnpa1specific monoclonal antibody,6.7457151950450975e-06
yetunknown n7specific mtase,6.742788964983565e-06
membrane permeabilizing activity,6.717006676206328e-06
prospective hospital-based study,6.710273597908118e-06
humanadapted sarslike coronavirus,6.709901971078401e-06
ciliated lung epithelial cells,6.7078653166472185e-06
predisposing,6.702929111613463e-06
recombinant immunofluorescence assay testing,6.6923966114971424e-06
nosocomial settings,6.691119437029044e-06
viral genome replication/transcription,6.688805803559576e-06
mediastinal lymph nodes,6.68539198162264e-06
rna-binding groove,6.68401233466353e-06
viral sarsunique domain sud,6.672538797853932e-06
p28,6.66845610710487e-06
post-translational level,6.663072634287687e-06
selection pressure,6.659304874299708e-06
punctated perinuclear,6.656216294587258e-06
children studies,6.650862495255737e-06
human coronavirus virus hcov,6.650754775019096e-06
hybridization permeabilized cells,6.646809554962112e-06
putative kdke catalytic tetrad,6.625828416065232e-06
control groups,6.622336072861841e-06
stage infection,6.621558047953394e-06
central triplestranded coiled,6.612879364736309e-06
fluorogenic peptide assays,6.612366904688327e-06
baby hamster kidney cells,6.604312546276183e-06
respiratory viral infection,6.596239351904516e-06
membraneinteracting capabilities region,6.5955520966906544e-06
protein expression systems,6.595345995573395e-06
repeat domain,6.589795154810264e-06
tl/ch/ldt3/03,6.584087507745269e-06
contig assembly,6.579596370752227e-06
detergent-resistant membranes,6.578993676130676e-06
orf7b protein resides,6.578864113615871e-06
tl/ch/ldt3/03-like virus,6.5785922599355885e-06
scov nucleocapsid rscovn protein,6.5713960895879645e-06
t2-cell stabilization assays,6.57092297527971e-06
molecular replacement,6.570872519352684e-06
sars cov entry inhibitors,6.57020369945391e-06
prrsvprcv dualinfected pigs,6.5692640591121515e-06
fcov c1je genomic rna sequence,6.562665972852662e-06
multiple kinases,6.560418123933095e-06
histidine-tagged fusion protein,6.558550943383797e-06
microarray analysis,6.551874085375549e-06
freeze substitution methods,6.5483730736816505e-06
igg antibody test,6.536021954468073e-06
selective packaging,6.525741704541045e-06
green fluorescence protein (gfp)-fused s protein of scotophilus,6.524373189466169e-06
ccl2monocyte chemoattractant protein 1 mcp1,6.522395209299567e-06
np,6.51978117428932e-06
acute respiratory syndromerelated coronavirus sarscov vaccines,6.509092325133952e-06
comprehensive study,6.495756760005634e-06
coronavirus nsp3 tm domain,6.4950661819605395e-06
mers-cov receptor-binding domain,6.4750969649981416e-06
mers-cov rna transcripts,6.47291610878046e-06
municipal hospital,6.469218983654057e-06
chimeric s constructs,6.4681711732413795e-06
real-time rt-pcr (rrt-pcr) assays,6.467837151239945e-06
e2 glycoproteins partial endoglycosidase,6.464478678839795e-06
amino acid sequencing analyses,6.4506985761367906e-06
prokaryotic-expressed recombinant nucleocapsid protein,6.449284921771343e-06
viral regulatory strategies,6.445242454154558e-06
commercial assay,6.440466710465185e-06
ppsp.fp2 probe,6.438682276900881e-06
coronavirus spike glycoprotein,6.435035854570971e-06
fulllength n protein,6.4336075994305696e-06
rna-dependent rna polymerase (rdrp) gene,6.41808044764361e-06
endosome-lysosome fusion,6.417795617548621e-06
seasonal respiratory tract viruses,6.415684731744396e-06
realart hpacoronavirus assay artus assay was 1,6.4145685432589535e-06
genetic manipulation,6.39769988281546e-06
cp therapy phase,6.39706797212142e-06
cv challenge,6.393264747308926e-06
catspecific subgenomic mrna,6.38929425810237e-06
confocal microscopy assays,6.371645766766939e-06
sars-cov frankfurt-1,6.364626370067996e-06
concerns,6.363807305706022e-06
surveillance capabilities,6.363484022390857e-06
75 polymorphic nucleotides,6.362231229684321e-06
endoribonuclease endou,6.356562199487831e-06
cw0801 hla allele,6.353130683990615e-06
ts mutant cv fipv,6.348589532042098e-06
btm,6.3424759435111915e-06
hcovoc43 rocatcc,6.338731977433835e-06
spike protein-derived peptide,6.33582478591855e-06
core exon domain,6.324337408715281e-06
protein sequence,6.321936464657643e-06
c57bl6 genetic,6.312669855209806e-06
tertiary structure,6.304100903332055e-06
retinoic acid-inducible gene 1,6.3017189146683225e-06
metabolic derangements,6.295563655095295e-06
cell-permeable agent,6.290176790879661e-06
sarscov receptor human angiotensinconverting enzyme 2 hace2,6.284578944016014e-06
cell culture silac,6.2785165274107445e-06
reverse genetics systems,6.278308530408412e-06
hapn,6.2687069915009635e-06
sarscov n gene,6.261704061421797e-06
acute respiratory syndrome cov sarscov s2 domain,6.260141166429987e-06
adenosine deaminase,6.252192090946382e-06
leaderless genomic rna,6.251733980092867e-06
hcov-229e,6.250680652763294e-06
crcov antibodies,6.2464345392482e-06
gp3341specific cells,6.245997903007837e-06
ion channel activity,6.2277037450027715e-06
acute respiratory syndrome sars coronavirus sarscov,6.227007116776915e-06
membrane-associated proteins,6.2237991374217396e-06
intersubunit,6.21521909925137e-06
non-denaturing purification,6.209352452860569e-06
fecv shedding,6.2001068250194e-06
putative fusion peptide,6.194357142976404e-06
threedimensional structure homology,6.1864465916780845e-06
image-derived input function,6.186148152323108e-06
pyrin domain-containing 3,6.184861277039716e-06
piglet,6.181421584457474e-06
sars-cov 3clpro expression constructs,6.178338769876911e-06
fusionactive subunit,6.1726101413853985e-06
biosecurity advices,6.171656373842213e-06
metadata-driven,6.168846104297189e-06
nsp4 glycosylation site n176,6.166262004031768e-06
fcov spike gene mutations,6.163362095753744e-06
middle east coupled,6.160471564259153e-06
single agent,6.159190444735017e-06
merscovsusceptible species,6.154249997019586e-06
raccoon dogs,6.143431750535467e-06
"single-stranded, positive-sense rna",6.140151496581104e-06
viral nucleoprotein,6.139262353361977e-06
monoclonal suspension cho cell line,6.1330888007088436e-06
n195spike recombinant baculovirusinfected sf9 cells,6.128793727560073e-06
internal sequence domain,6.128681272671368e-06
bax protein,6.123109569290235e-06
dc,6.119244318588554e-06
acute respiratory syndrome sars coronavirus cov virions,6.10543604045532e-06
single nucleotide substitution,6.103210098015169e-06
point-of-care testing,6.102335337644796e-06
papainlike protease plpro,6.101105887104935e-06
sars cov spike glycoprotein peptide,6.092206788635893e-06
sars-induced cytokines interleukin-6,6.091170142795973e-06
pancaspase inhibitor,6.081814786700933e-06
sarscov genes open reading frames orfs,6.077908795425517e-06
orf6 protein microarray analysis,6.077120386830489e-06
highestaffinity antibody fragment,6.075718318928622e-06
hm5,6.0704413326688e-06
principal steps receptor binding,6.06390322012631e-06
phosphorylationdependent,6.0595074379800035e-06
nonpermissive baby hamster kidney cells line bhk21 transduced cells,6.057510776550061e-06
mouse bone marrowderived macrophages,6.043008055839464e-06
tails fisher exact test,6.035189593538699e-06
experimental autoimmune encephalitis,6.030680861493767e-06
9b,6.029841258865679e-06
mucosaderived cell lines,6.02402140618785e-06
c-terminal s2 subunit,6.022148045822508e-06
evolution mechanisms,6.0193753495885555e-06
type i fcov replication,6.0177649244999905e-06
helper-independent,6.013907457272651e-06
immunofluorescence-classified,6.010178125057264e-06
companion animals,5.999259282911606e-06
mhcii,5.996547985720274e-06
cellular protein levels,5.994707981261626e-06
leadership,5.991159083642345e-06
acute 229e infection,5.988041263292007e-06
janus family kinase jaksignal transducer and activator of transcription stat,5.985560690008536e-06
sarscov papainlike protease plp,5.985450359015264e-06
fulllength cdna clone,5.977828763444347e-06
positive-sense single-stranded rna molecule,5.970725787897352e-06
glycan array screen,5.955818093577958e-06
s-pseudotyped particles,5.9520570879538565e-06
fallwinter,5.936712128779307e-06
dsrna-independent stress response pathway,5.933927411849352e-06
c-terminal domain,5.929916562670789e-06
signaling transducer,5.923259742684402e-06
sarscov predicted replicase protein,5.917767958448188e-06
nonlinear n epitope,5.917564854063761e-06
tg mice,5.916014486535095e-06
virusinduced interferon,5.912570568550422e-06
mixed consolidation,5.907586116177183e-06
incidence risk,5.907057641255994e-06
phylogenetic markers,5.903869715204024e-06
hcv ires,5.903819810845409e-06
60-nucleotide leader sequence,5.8986371192772265e-06
virtual screening platforms,5.892577004371861e-06
dendritic cellspecific icam3,5.887802560562482e-06
liveattenuated vaccine,5.887087562380337e-06
3cl protease inhibitor ki  06,5.883309403715427e-06
sars-cov infection pathway,5.8683114777769785e-06
fulllength homotrimer,5.866935712369793e-06
hostdirected,5.863196019820405e-06
fcov-positive cats,5.861431640152504e-06
acute respiratory syndrome sars pseudoviruses,5.8590447250943684e-06
immunoprecipitations,5.856024000437637e-06
bootscan analysis,5.855338017724097e-06
nationally recommended therapy,5.851093669973447e-06
coronavirus genome sequences,5.843825749016094e-06
cns igd b cell,5.842885620872923e-06
linear ranges,5.830402195486835e-06
canonical rnadependent rna polymerase rdrp,5.817489592812755e-06
coronavirus sarscov replicase gene,5.812533565779074e-06
fas/fc chimera,5.810524625540647e-06
newborn mice,5.805078339165944e-06
singlestranded rnas ssrnas,5.800547549414683e-06
tp29,5.7965491853694685e-06
heparan sulfate proteoglycans,5.795542236725193e-06
fragments residues,5.792170190598436e-06
amino acids 270 to 510,5.791998602941997e-06
hdcs,5.787899191082108e-06
cov replication cycle,5.786827153674139e-06
vacuolar-h+ atpase (v-atpase) g1 subunit,5.77642122546782e-06
asite codons,5.770911614145642e-06
noneneveloped viruses,5.767026855399663e-06
human and canine coronavirus spike protein sequences,5.757713466178694e-06
shake flask culture,5.749788919512824e-06
hypervariable region 3 site,5.7488471301895715e-06
dna fragmentation,5.745927460528487e-06
lkr,5.745639187676707e-06
ccov life cycle,5.744073713753792e-06
repeat atr,5.73747808030044e-06
wildtype particles,5.731323706244307e-06
recombinant modified-vaccinia-virus-ankara (mva-s)-vaccination,5.73015904903858e-06
tissue samples,5.727361109367986e-06
rat small intestine epithelial cells,5.726014568815867e-06
c6,5.718628470046978e-06
endocytic internalization,5.716585700064897e-06
receptor-binding edge,5.709235051006462e-06
y195,5.704850991739886e-06
rna extraction methods,5.701014446947101e-06
dromedary camel herd,5.698655621310555e-06
virus-host interaction,5.695062657904127e-06
anti229e antibodies,5.693628924108805e-06
muscarinic receptor agonist,5.692721130818836e-06
amino acid aa residues 324,5.692265710459963e-06
16 replicase subunits,5.688933208837133e-06
operation-level suckling,5.681503023582957e-06
instrumental,5.681209625440414e-06
acute respiratory distress,5.679688804905477e-06
endoplasmic reticulum rer,5.6777670299105196e-06
disease outbreak,5.673731849231707e-06
nlrp3 inflammasome activation,5.659205515472285e-06
induced-fit reorganization,5.656866576964749e-06
genomic cryptic transcription,5.6553562645983905e-06
restriction fragment length polymorphism,5.653670399853997e-06
macrophages kupffer cells,5.648961186816894e-06
bdcov hku22,5.639872391000154e-06
generalized immunosuppression,5.636045506254864e-06
phylogenetic tree,5.623921550869231e-06
kinases,5.618936452697475e-06
cartilage damage,5.608844876498106e-06
h1n1 infection,5.599349702341847e-06
nexocexo conformation,5.596972215463878e-06
dna electroporation,5.59262363079744e-06
nosocomial outbreak,5.589493527541073e-06
indigenous middle eastern,5.587711925189857e-06
[35s]methionine-pulse-labeled,5.586269946752743e-06
coronavirusinfected mice,5.584888799097336e-06
multiple sequence alignments,5.582862071831107e-06
sucrose gradient sedimentation,5.575425927230359e-06
infection ward,5.570825856612804e-06
mers-cov-np-specific monoclonal antibodies,5.568644829466148e-06
hku4 merscov 4a protein,5.558408257046643e-06
non-immunosuppressive derivatives,5.5551159634799974e-06
glycoprotein amino terminal heptad repeat,5.545384030735867e-06
abelson abl kinase inhibitors,5.541267298340097e-06
transmembrane-protein gene,5.540772306740423e-06
genetically diverse slcov sequences,5.539762906806104e-06
affymetrix hgu133a microarray,5.515008028200626e-06
viral infectivity assays,5.51046546077095e-06
anti-mers-cov antibodies,5.507573688051085e-06
adenovirus transduction,5.490700516371272e-06
immunoelectrophoresis tests,5.489105330618763e-06
lower respiratory tract specimens,5.488512050535625e-06
th2 cells,5.474201487090409e-06
cellular metabolism,5.46881695814848e-06
feline infectious,5.467866253046409e-06
uorf auginitiating codon,5.467050453565323e-06
subcutaneous regimens,5.45683706657458e-06
therapeutic neutralizing antibodies,5.454186549559499e-06
virion envelope proteins,5.450869935499054e-06
coronavirus vaccine,5.441969679407033e-06
hcov229e single amino acid revertants,5.428944703376286e-06
mers-n-specific immune responses,5.423343662744108e-06
sarscov receptor human angiotensin i converting enzyme 2,5.419629497520119e-06
o-inoculated calves,5.419159053967652e-06
palindromic sequence,5.417345069190133e-06
putative origin,5.405241119497905e-06
red marine alga griffithsia sp.,5.4049807237340375e-06
sarscov plpro inhibitors 6mercaptopurine 6mp,5.4044358838628014e-06
mers-cov subunit vaccine,5.402481885991107e-06
epithelial barrier,5.401593187521254e-06
homooligomerization,5.400514626888959e-06
nsp8mediated tatase,5.388373379247535e-06
human-pathogenic coronaviruses,5.3783882673217225e-06
next generation matrix,5.378326336529528e-06
rnasynthesizing activity,5.371129970270536e-06
cxcr2 signaling,5.361223203938092e-06
coronavirus replicase gene products,5.357906051775492e-06
pulmonary epithelial cells,5.352606181948211e-06
hcovoc43 hcovhku1,5.348763488228559e-06
sars-cov intranasal infection,5.348217950826663e-06
amino acid aa,5.346109851994386e-06
hcovoc43 infection,5.340807400982526e-06
cerebral cortex,5.338343048584512e-06
retroviral pseudotypes,5.331149373837626e-06
bnip3 promoter,5.331111998307889e-06
nonpeptidic inhibitor,5.326924112705044e-06
cathepsin activity,5.3257900887130945e-06
mapk kinase 3,5.3199013679633095e-06
gammacoronavirus infectious bronchitis virus,5.3143033602974835e-06
quaternary rearrangements,5.302582594453629e-06
n-terminal domain,5.301431569224715e-06
camels alveolar epithelium,5.30091576392674e-06
swedish,5.2930097537097e-06
onestep singletube,5.292565824272648e-06
rna unwinding activity,5.281598911321428e-06
lymphatic tissue,5.275847160971799e-06
translating mrnas merscov nsp1,5.274066413220253e-06
partial sequence analysis,5.269930203486645e-06
phylogenetically analysed,5.2690801927672384e-06
negativestrand synthesis,5.261848952759675e-06
virus assembly site,5.2579757341705126e-06
contents,5.257007687347125e-06
avoidance measures,5.252898801931125e-06
multifunctional,5.250904005776787e-06
intestinal cells,5.245741404800727e-06
intranasal doses,5.243799163929297e-06
alphacoronavirus porcine transmissible gastroenteritis,5.239841662212044e-06
human embryokidney cells,5.239026192498327e-06
intensive interventions,5.237454896725331e-06
middle-east respiratory syndrome coronavirus,5.230309917740695e-06
ribonucleoprotein (rnp) complexes,5.227768466526113e-06
catalytic subunit nsp16,5.2237790435962055e-06
replicative-intermediate rna,5.221258226158188e-06
co-detection,5.219992336730546e-06
mers-cov pseudoviruses,5.2162449269136655e-06
interleukin28ab il28ab,5.215668110877719e-06
bovine virus diarrhoea virus,5.211385622229564e-06
human alveolar cells,5.19961346036859e-06
middle east respiratory syndrome-associated coronavirus,5.196134826593648e-06
macrodomain catalytic point mutant virus,5.187645203701777e-06
attachmententry receptor,5.180493597020548e-06
sarshcov,5.179246304774287e-06
nasal mucosal immune system,5.173754444278798e-06
ccov-iia strains,5.16457718494715e-06
nucleotide changes,5.155936347466619e-06
cterminal regions,5.155134057400997e-06
systemic disease,5.153563520730785e-06
alpha and beta t cell receptors,5.151623627286146e-06
cov antiviral therapeutics,5.147928602696876e-06
heat-inactivated sars-cov-infected vero e6 cell lysate,5.138795486085485e-06
recombinant coronavirus vaccine,5.13764188007608e-06
mhvrnegative cells,5.135098025912546e-06
plp2,5.131480834148207e-06
endoplasmic reticulum ergolgi membrane,5.12790862127019e-06
laboratory cats,5.127293965394128e-06
interdomain interactions,5.124682170808849e-06
retinoblastoma protein prb,5.116966886886787e-06
tracheal-lung wash fluid,5.112575526346913e-06
seroepidemiologic survey,5.111589435608871e-06
sars-cov replication cycle,5.107549694933356e-06
mitogen-activated protein,5.103683360559293e-06
human polyclonal igg antibody,5.099602087678984e-06
buffalo coronavirus,5.089477275956024e-06
replication/transcription complex,5.087877224223333e-06
nucleotide covariation,5.0875081226293815e-06
il17:foxp3 expression,5.08652725646748e-06
papain-like protease,5.083879909056121e-06
binding pocket,5.0774467682520475e-06
human dipeptidyl peptidase 4 receptor,5.073917951454036e-06
experimental evidence,5.068805240042128e-06
metadata-driven comparative genomics statistical analysis,5.067057089410628e-06
clone viruses,5.060814164885369e-06
monkey model,5.0586326273535245e-06
serological assays,5.05554533297361e-06
coronavirusinduced,5.051843845681347e-06
subgenotypes,5.050174458515698e-06
regulatory genomic clusters,5.049959634187922e-06
hypothetical 78-amino acid protein,5.043493780026811e-06
physically,5.041438282622966e-06
corrected sedimentation coefficient,5.032662125608336e-06
enterohaemorrhagic escherichia coli o157h7 infection,5.029546593168321e-06
acute respiratory syndrome sars virus studies,5.021798667296819e-06
full-length misg15 protein,5.013365883099541e-06
hcov229e infection surfactant protein,4.996217252723142e-06
interferon regulatory factor,4.982921917030708e-06
n-terminal and c-terminal segments,4.980880987535445e-06
mers-cov-infected rats,4.97985793277952e-06
ns129 protein,4.976531133916834e-06
sucrose gradient ultracentrifugation,4.968723503105433e-06
coronavirus sarscov bone marrow stromal antigen 2,4.966779043833144e-06
instantaneous,4.966512197293191e-06
inflammatory cell infiltration edema,4.963964880712964e-06
sequence motifs cx2cx5hx6c,4.958913615893529e-06
autophagosome,4.95575981853468e-06
mir-155,4.947877612846907e-06
predicted transmembrane,4.946453380202774e-06
transmissible gastroenteritis virus antiserum,4.945289766919848e-06
adenovirus-based vaccines,4.943904564668787e-06
genomic mechanisms,4.943310900710815e-06
cellular rna-binding proteins,4.941310408733848e-06
intermediate,4.940765437673784e-06
hepatitis virus mhv infection sarscov protein,4.9401484534831135e-06
human rhabdomyosarcoma cell line,4.929935677826857e-06
dtt,4.920098233345973e-06
intransp1,4.915302524583574e-06
anti-viral medication,4.910153355411315e-06
cov he receptorbinding,4.90898572274645e-06
hospitalized saudi,4.908755285455374e-06
isg15 pathway,4.903966185871311e-06
106-kda non-structural protein 12,4.900079805331976e-06
bacterial and viral rnadependent rna polymerases,4.898210526227634e-06
dibasic endoplasmic reticulum,4.8939498745152156e-06
open reading frame orf 5b,4.8920763715754785e-06
newborn gastric sample,4.882303047088631e-06
clinico-epidemiological information,4.878176610197373e-06
discontinuous epitopes,4.870304527328846e-06
inoculation mild bronchointerstitial pneumonia,4.865349673823229e-06
human peripheral blood mononuclearcytes,4.862481765407538e-06
prime-boost vaccination protocol,4.856202789084138e-06
presentation system,4.845881913890882e-06
antigen immunization,4.838727214607879e-06
protein oligomerization,4.837508151442015e-06
e protein ion channel,4.8317848720661256e-06
bats-hosts-reservoir-people transmission,4.831200016108201e-06
positive strand rna viruses,4.828897915454208e-06
single residue substitution,4.823936179574614e-06
mouse ferret hamster,4.819929283125048e-06
peripheral gc formation,4.815209858953126e-06
dna vaccine gene segment,4.81254537083587e-06
indeterminate,4.8098502898311476e-06
human erythrocytes,4.8065077902938e-06
survival rate,4.803316945439321e-06
protein expression virus protein,4.797154657814961e-06
high-efficiency n-binding site,4.793487834348406e-06
hlaa2 positive online database analysis,4.789551332112852e-06
yettobeidentified,4.789376233306673e-06
free charges,4.7858461517635166e-06
consensus transcription initiation signal ucuaaucuauc and uuuaaucuu,4.7828039248681635e-06
antiviral host factor,4.77999547988463e-06
reverse silac measurements,4.778031835606811e-06
endoplasmic-reticulum and golgi-complex,4.776976470781177e-06
extracellular signal-regulated kinase (erk) 1/2 and c-jun n-terminal kinase,4.769113029173494e-06
v202i substitution,4.765433101450583e-06
viral protein processing machinery,4.7619086418235155e-06
recombinant partial nucleocapsid (n) proteins,4.744116154927652e-06
inflammatory cells,4.737168324002391e-06
zinc metalloproteases,4.735213976141945e-06
amsterdam 57 and amsterdam 496,4.730684069404576e-06
hcovnl63 replicase gene,4.724933572866033e-06
clinical fip tgev,4.724731951206621e-06
coreceptor,4.72381520854729e-06
sarscov nonstructural protein 1,4.722243800567563e-06
proteinaseresistant,4.721631517042192e-06
cpg,4.720258839546401e-06
rhabdovirus infections,4.719980463476751e-06
mild upper respiratory tract infections,4.717982453919503e-06
alphacoronavirus transmissible gastroenteritis virus tgev nsp1,4.717236616059305e-06
mhv-jhm-derived di rnas,4.716127804165018e-06
therapeutic approach,4.712466204478863e-06
coronavirus-induced encephalitis,4.711022871599669e-06
functional subunits,4.705208686305303e-06
regulates,4.703495746582861e-06
s450650based elisa,4.701049980038089e-06
memory cd8 t cell,4.696674220157747e-06
herd-level,4.694567043715381e-06
review precautions,4.689814623202378e-06
virus-like particles,4.687624736229676e-06
total rectal swab positives,4.685709116631906e-06
cns infection,4.678696448398247e-06
drug concentrations,4.678557746078883e-06
no effect,4.676567662013069e-06
hamster nonsusceptible,4.675357699953517e-06
mutant genotype,4.673310924292771e-06
clinical manifestation,4.6664355769472744e-06
sars-cov neutralizing antibodies,4.666091034161849e-06
p150 nsp4,4.6630171371703145e-06
ibv-induced jnk,4.648505968355629e-06
automatic rna extraction,4.648334168914198e-06
destabilizing effect,4.646203880036993e-06
cell-based receptor binding assay,4.640686705980283e-06
antigenic relatedness,4.6293741470514535e-06
nsp7nsp8nsp12 complex,4.627913935962118e-06
enzymatically active dimer,4.625255904980036e-06
sarscov helicase nonstructural protein nsp 13,4.6176840081590316e-06
coronaviral diseases,4.6162532775766185e-06
adjuvanted recombinant ssol protein,4.609113005076404e-06
irf7 interferon regulatory factor 7,4.606250633173564e-06
cat sars-cov-like,4.603858320581406e-06
wildtype replication,4.596373792857285e-06
digestive system,4.592436663166493e-06
nterminal region amino acids,4.589168282878998e-06
hcovhku1 infection,4.586449234891263e-06
network analysis,4.577511951642172e-06
cytotoxic tcell response,4.571745618496106e-06
viral n protein no green fluorescence,4.570497587976331e-06
laboratory features,4.561191594461566e-06
human ciliated airway epithelium,4.559597611644965e-06
hcovoc43 genotypes,4.552203427300803e-06
nested reverse transcriptase pcr,4.546550380236263e-06
malabsorptive diarrhea,4.54517768044825e-06
hcov229e replicase geneencoded nonstructural protein 13 nsp13,4.544927592052304e-06
ibv strain h120-vaccinated,4.532837741529762e-06
golgi plasma membrane budding,4.530351646226356e-06
picornaviral 3clike protease,4.529515954771874e-06
intracellular or extracellular proteases,4.527254513711023e-06
human sarscov 3a,4.525099984206394e-06
er stress-related genes,4.5233140828734015e-06
mucosal secretions,4.515972322026127e-06
coronavirus e proteins,4.513895177883263e-06
mers-cov amino-acid sequence,4.5133039036620925e-06
l.,4.505901393266619e-06
coronavirus-induced demyelinating encephalomyelitis,4.5031720245831564e-06
cloned genome fragment,4.500288593957078e-06
bufalin,4.499855626965708e-06
gnotobiotic calf,4.494556870167499e-06
rjhm,4.4913662011584735e-06
sars-cov accessory proteins,4.462449569324979e-06
cleavage events,4.461291382105098e-06
epac1 inhibitors,4.460230241311388e-06
x1,4.44657780800029e-06
molecule inhibitors,4.434334097173895e-06
economic problems,4.4257339112731754e-06
u937 monocyte cells,4.422297190083405e-06
long disordered regions,4.40323774407306e-06
immune compromised,4.399185660942912e-06
human coronavirus replicase gene,4.396747282086771e-06
betacoronavirus structural elements,4.394883469955071e-06
human cd26/dpp4 receptor,4.386477143455752e-06
fluorescence,4.383847458973904e-06
predicted secondary structures,4.380621422061212e-06
bcl2 family coimmunoprecipitation,4.373601680977489e-06
newly-emerged middle east respiratory syndrome coronavirus,4.360324429351469e-06
automated method,4.358581783365501e-06
n-terminal p12 fragment,4.358184594103361e-06
rdeacetylesterase domain,4.350884753398922e-06
ion fe(2+),4.347805842534059e-06
locations,4.345745470199414e-06
cellular membrane sterols,4.3439395523074115e-06
nucleotide positions 106 to 136 partial deletion,4.339226008383733e-06
replication/transcription,4.335924548914142e-06
seroprevalence study,4.332313509814633e-06
disulfide-bonded form,4.32596667289738e-06
post-transcriptionally,4.322050534344373e-06
regions of fusion proteins,4.31112504709691e-06
enzyme-linked immunosorbent assays,4.309629758315826e-06
host-range restriction,4.305208783805259e-06
regulatory t cells,4.282461429071886e-06
protein binding,4.280559714961471e-06
nddedvvtgd,4.277140349272952e-06
sds-polyacrylamide,4.267882579088353e-06
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",4.2626558646581275e-06
subclinical virus infection,4.262501394667681e-06
caulis polygoni multiflori,4.2571544029562325e-06
wildtype mice,4.246266824337799e-06
viral control,4.245382436232541e-06
multivariable logistic regression,4.238704379356209e-06
spike protein gene sequence,4.235313301734687e-06
putative antigenic epitopes,4.234775327089024e-06
murine coronavirus mhv-a59,4.218022867004579e-06
phecov challenge,4.215336109812505e-06
lysates,4.205137915899816e-06
npas positive samples,4.200817958859055e-06
respiratory syndrome virus,4.191692052623791e-06
antiviral role,4.185349169603661e-06
international research collaboration,4.176552940455153e-06
epidemic strain,4.175177153908025e-06
global village,4.1741480586194445e-06
munia cov hku13 mucov,4.1706128321708e-06
endogenous cytoplasmic protein,4.166866518948317e-06
gulf cooperation council,4.165187772310699e-06
cov molecular biology,4.1480350219764424e-06
bat sars-like coronaviruses,4.14371018815549e-06
antigen-capture elisa,4.141551962754454e-06
viral testing,4.141326714067483e-06
uvinactivated viruses,4.140427539982382e-06
chimeric and truncation mutants,4.1282061896264825e-06
entire nucleotide sequences,4.123068713954917e-06
proteins 3b,4.115557754931094e-06
sarscov membrane,4.1107437241609245e-06
polypyrimidine tract-binding protein,4.109560263352127e-06
lethally pathogenic,4.101911434021971e-06
30-base acidic tandem repeat,4.100560155396019e-06
conserved neutralizing epitope sp11431157,4.099837311428088e-06
acute respiratory syndrome-related coronavirus,4.099823846600674e-06
putative recombination strains,4.074321682893148e-06
membraneanchored s2 subunit,4.062201244549351e-06
reproducible,4.059110130936762e-06
balbb mice,4.057636120685724e-06
airway epithelia pneumocytes,4.055455150781461e-06
bilateral infiltrates,4.049374353049924e-06
regional comparisons,4.041568502218828e-06
k v holmes j virol 7194999507 1997,4.033018602978353e-06
viral genome equivalents,4.019917309185722e-06
human respiratory pathogens,4.01495899707212e-06
intracellular precursor protein,4.01225220979745e-06
aminoterminal ubiquitinlike domain,4.008395049972648e-06
coronavirus hku1 cov,4.0075237334367325e-06
am2 virus,4.005420293197281e-06
cytolytic molecules,4.003806119898613e-06
bat alphacoronaviruses,4.000655476238929e-06
human isg15,3.997711700103037e-06
cov hku1,3.993888590847805e-06
sequence arg-arg-phe-arg-arg,3.9859400835235325e-06
birds gammacoronaviruses,3.984926015555901e-06
recurrent,3.983702359277457e-06
real time quantitative rt-pcr,3.980181881907503e-06
hiv-1 virus,3.971022061403114e-06
papainlike protease 1,3.967316230779438e-06
polya tail coronavirus nucleocapsid n protein,3.966836848841533e-06
rna recombination system,3.96664636929536e-06
jnk,3.96514042952929e-06
bacterial and mammalian cells,3.963187170505724e-06
acute atrophic enteritis,3.961949499224308e-06
hr2 q159lr654hh716de1035d,3.959080911672539e-06
nucleotide (nt) and amino acid (aa),3.9553030624161705e-06
immunoglobulin gene sequence analyses,3.95261151009822e-06
direct sequencing,3.950374241485859e-06
known n protein binding site,3.945769755812525e-06
il-11-induced stat 3 phosphorylation,3.944899037567452e-06
clinical laboratories,3.943950085130177e-06
reverse transcription recombinase polymerase amplification,3.939132445931323e-06
coronavirus s proteins,3.928776142538883e-06
habitats,3.92802835840256e-06
rapid immunochromatographic assay,3.923759079398187e-06
acetylesterase enzymatic activity,3.91514603111421e-06
nodular lesions,3.909223863825951e-06
putative heptad repeat 2 (hr2) sequence,3.90533919667274e-06
sars-cov harness,3.899399268684082e-06
signatures,3.889833406451023e-06
rcov infection,3.888854019265874e-06
deubiquitinating enzyme inhibitor ubiquitin aldehyde,3.881198055634205e-06
single-nucleotide substitutions predicted,3.876589599885779e-06
positive candidate cellular protein,3.8710112148990654e-06
mouse hepatitis virus a59,3.867461873669867e-06
nuclear polyhedrosis virus acnpv,3.865680725139468e-06
recombinant his6tagged sars cov nucleocapsid protein,3.859831124953126e-06
virulent coronavirus,3.8555299623666524e-06
mouse hepatitis virus a59 strain,3.853910214511182e-06
charged residue,3.841550625746823e-06
american rbcv lsu,3.838596282824952e-06
electron microscope,3.83841842084764e-06
betacoronavirus lineage,3.832545822586704e-06
interferon-inducible transmembrane (ifitm),3.831626080700206e-06
dna duplexunwinding,3.829898228011478e-06
ccov envelope,3.826993942414584e-06
non-sars-associated hcovs,3.826601558820847e-06
enzymelinked immunosorbent assays elisas western blot assays,3.825970900792264e-06
cell surface cpl,3.825541716444956e-06
homologous sequence regions sudm527651,3.819271346429914e-06
mannose-rich-type oligosaccharide side-chains,3.818716540483152e-06
amino acid aa residues,3.818462210237618e-06
multi-organ failure,3.816347654279003e-06
coronavirus genotypes,3.815121314296158e-06
primary cell type,3.806839255070906e-06
genomic mutations,3.804513293102869e-06
translation product deduced,3.7948641035463894e-06
membrane fusion proteins,3.789494695893482e-06
mers spike pseudotyped virus,3.7831554470114035e-06
adpribose1monophosphate appr1p,3.7827855297137243e-06
murine glycoprotein receptor ceacam1a,3.7804527848661957e-06
transcriptional response,3.7781482581167015e-06
spike envelope glycoprotein,3.7622584908422006e-06
sarsrrfbatcovs,3.745783877123508e-06
endoplasmic reticulum er retrieval,3.745543546438152e-06
acute respiratory syndrome-coronavirus,3.7387727356969433e-06
oronasal inoculation,3.733099304842795e-06
murine coronavirus receptor murine ceacam1a,3.7328385558456386e-06
epithelia undifferentiated cells,3.7251169594750927e-06
ecov challenge studies,3.719395320145475e-06
sars-coronavirus homolog,3.7146606512942473e-06
two-hybrid analysis,3.7138538473015743e-06
perlman j virol 791133511342 2005,3.7126942458439928e-06
interferon regulatory factor (irf)-3/7,3.7077235866981003e-06
virus bunyamwera delnss,3.7071479930790536e-06
cellular bases,3.690023830420949e-06
o-acetylated sialic acids,3.6844385580848385e-06
ciconiiformes pelecaniformes,3.677682474918812e-06
calprotectin leukocyte protein l1 myeloidhistiocyte antigen neutrophils,3.6758421795004176e-06
hexameric endoribonuclease,3.670735297681239e-06
high inhibition panel,3.6639658218208643e-06
hcov-nl63 virus,3.6611639716219632e-06
t cell response,3.66062299200579e-06
recombinant rdrps (sars-cov nsp12,3.659885277098791e-06
nickel-affinity chromatography,3.6538668164067624e-06
alphacoronavirus mutants,3.653529251552321e-06
overlapping cdna fragments,3.650243057273518e-06
nascent protein,3.6487998415806096e-06
s gene sequence,3.638398596326349e-06
liver damage,3.6350384987386043e-06
monophasic unfolding curve,3.6335064418524438e-06
proinflammatory cytokines il6,3.632628859059363e-06
masked palm civets,3.6259184201622477e-06
chymotrypsinlike protease 3clpro rnadependent rna polymerase pol helicase,3.625525207563478e-06
diagnostic testing,3.6198932686602114e-06
wildtype recombinant virus rwtfipv,3.617265463461774e-06
mouseantisarscovnmab,3.606502095704728e-06
glutathione-s-transferase (gst),3.605974815203742e-06
chromosome associated proteins,3.597454734600105e-06
merscov hujordann32012,3.597352784761502e-06
bst2,3.591920890440656e-06
orf 2a 30kda protein,3.5906099282588185e-06
stressinduced,3.5795857677699815e-06
phosphotungstic acid,3.5740553967704732e-06
colonystimulating factor 1 receptor csf1r,3.5727424515091113e-06
porcine blood leukocytes,3.5725176505026573e-06
northern italy,3.5718860547220296e-06
arterivirus infections,3.571341481361358e-06
lys48-linked polyub chains,3.562194768089847e-06
open reading frame 1a (orf1a) rna transcripts,3.5537918338213286e-06
cns glutamate,3.549265046801123e-06
fibrotic response,3.5488188964983325e-06
public health officers,3.547366718910288e-06
viral nucleocapsid (n) protein,3.5360543469216825e-06
hydrophobically-modified derivative,3.5263447090992726e-06
jmd,3.52501174669347e-06
peptidelipid,3.5161873557882813e-06
murine cov mouse hepatitis virus,3.5142009934922725e-06
receptordestroying,3.5121901510904813e-06
short interfering rna,3.5034200132606963e-06
mapkinteracting kinase 1,3.501794320004029e-06
virological similarities,3.4985194158468558e-06
helix-specific antibodies,3.496678088228814e-06
viral life cycle,3.4870542874435542e-06
cytokinesis,3.4836777796284664e-06
g2,3.483454613876094e-06
hamster mice,3.4791551710176316e-06
orf7a and orf7a/cd4 chimeras,3.4768374515013735e-06
sliii domain nucleotides 1 to 84 and sliii domain nucleotides 85,3.4764549368862435e-06
individual samples,3.4687277776899373e-06
international collaboration,3.4686651992460372e-06
retinoic acid inducible gene,3.467714524382011e-06
hcov229e sprotein 229es,3.464618649618485e-06
filtration experiments,3.462278544164521e-06
sizeexclusion chromatography,3.4514412379018987e-06
infection consortium,3.4381056954310434e-06
mutant middle east respiratory syndrome coronavirus,3.436802374229172e-06
vaccine virus genomes,3.434899297504493e-06
oral salmonella-tpa-s-dna,3.4336982136451943e-06
enzymatically inactive mutant,3.4254793164731564e-06
neurovirulent a59 recombinants,3.4254029870389383e-06
http://www.biomedcentral.com/collections/annualupdate2016,3.4239549297052198e-06
ifn-mediated effector responses,3.4209792234817183e-06
peak viral replication,3.4193835334166425e-06
elrpositive chemokines,3.417060079482434e-06
distantly related arterivirus,3.4152440576542406e-06
cell-mixing experiments,3.4107673828029386e-06
autophagy-sensitive conditions,3.408942060713758e-06
health care contacts,3.4002889524747163e-06
conformational flexibility,3.4000750061573275e-06
ub-like interferon-stimulated gene product 15,3.3992666027542557e-06
viral immunotherapy,3.3988397382624844e-06
roche lightcycler sars cov quantification kit roche assay,3.398140954176572e-06
receptor aminopeptidase,3.3933483897938696e-06
contact screening,3.390571261837316e-06
natural course,3.384165311935342e-06
punctate perinuclear,3.382043397259685e-06
geographical differences,3.3801372573573454e-06
transcriptional initiation sequence ucuaaacu,3.372936687980163e-06
longitudinal studies,3.3614966406722384e-06
intrapatient,3.35950241042445e-06
mrna destabilization function,3.3581944982779124e-06
s-adenosyl-l-methionine (adomet)-dependent (guanine-n7)-methyltransferase,3.3526983370456355e-06
covs transmissible gastroenteritis,3.3490810192315603e-06
replication process,3.3466441605883745e-06
green monkey kidney epithelial cell lines vero vero e6,3.343019698393818e-06
viral kinetics,3.3305762182685156e-06
sarscov immunohistochemistry,3.328217755943946e-06
natural infection antibodies,3.3263665595931886e-06
spike protein fusion core,3.3208174632204373e-06
tyrosineprotein kinase 2 abl2,3.30939353192275e-06
biosecurity,3.307236923536896e-06
temporally,3.2993250275712934e-06
appr1pasedeficient hcov229e mutant,3.2958801337994376e-06
genotype/subtype,3.294983887814023e-06
transgenic tg mice,3.294905472817828e-06
subgenomic rna transcription,3.288102584512339e-06
lethal coronaviruses,3.285110883209584e-06
toric hexamer,3.2848562670278894e-06
host genetic variant,3.2784207022644464e-06
fulllength 179residue protein,3.270204846177085e-06
cell-based assays,3.2681368611183317e-06
cellular cyclophilins,3.26543571045247e-06
sarscov recombinant infectious clone,3.261523686464403e-06
poly(adp-ribose)-binding protein,3.258748662611139e-06
n-terminal sequencing,3.2544984934054157e-06
matching,3.2526352417648774e-06
molecular diagnostics,3.250142628283263e-06
synergy,3.2470803087752176e-06
wildlife analyses,3.2433430647619145e-06
gene subgenomic messenger rna,3.240590111898392e-06
deubiquitination activity assays,3.2401964032706813e-06
sialic aciddependent fashion virus binding assays,3.2377212273699064e-06
virus res.,3.2288562449442785e-06
nglycosidase enzyme the sarscov 3a,3.2231085440506625e-06
interferon ifn gene,3.222246778984506e-06
poly(adp-ribose,3.2174360952303003e-06
naturally occurring mutations,3.210788861067113e-06
slippery sequence,3.207733149949438e-06
bat sars-like coronavirus,3.2055861326414444e-06
multiplex reverse transcriptase polymerase chain reaction rtpcr,3.1958300151080137e-06
macromolecular synthesis analysis,3.194855037465574e-06
murine carcinoembryonic antigen cell adhesion molecule 1a,3.1937995143582237e-06
mc,3.186865170749031e-06
hcov-nl63 nucleocapsid protein,3.1822753617272768e-06
healthy,3.1694530217139434e-06
putative polymerase-encoding gene,3.164758520020243e-06
cyclindependent kinase cdk inhibitor p21cip1,3.1617991264808085e-06
aminoterminus(n)-sl-s2-carboxyterminus(c,3.1551849657831564e-06
virusspecific t cells,3.1482781602263238e-06
antiviral immune responses,3.143878121329053e-06
time-dependent contact,3.1325337347428448e-06
extracellular viral,3.1171278083914354e-06
secretions,3.1149604889666197e-06
hrp,3.1079977417497075e-06
spike protein s1 fragment membrane protein,3.103737933792185e-06
apical mers-cov inoculation,3.1017264885609254e-06
ifn-dependent genes,3.099533581428862e-06
coronavirus (cov) causing severe acute respiratory syndrome,3.09921258814188e-06
reporter protein,3.093864885622015e-06
putative viral polymerase gene,3.0917137205994738e-06
palmitoylated s protein cysteines,3.082059255115743e-06
viral replicase proteins,3.081481822850546e-06
mers-cov active circulation,3.078061812497202e-06
vaccinia virus-based sars-cov,3.0759167359262986e-06
unprocessed intermediate polyprotein,3.0750144266630627e-06
site-directed mutagenesis studies,3.0611484905033533e-06
ib-like avian coronavirus,3.0590390953295525e-06
neurotropic mouse hepatitis virus jhmv,3.0581774496347487e-06
g1,3.0424097121311876e-06
non-structural accessory proteins,3.042022668593795e-06
permissivity,3.0328393574674105e-06
serum antibodies,3.029333975577092e-06
endoplasmic reticulum golgi intermediate compartment,3.0231870094037437e-06
major immunodominant site,3.019410780792095e-06
monocyte-derived-dendritic cells,3.0107323356666233e-06
smallangle xray scattering,3.009145526668797e-06
east respiratory syndrome coronavirus,3.006943010956684e-06
replicase 1a/1b gene products,3.006650373379837e-06
identities,3.000686739129308e-06
quantitative reverse-transcriptase polymerase chain reaction,2.9975366002174764e-06
nucleolus nucleoli,2.9783458878563e-06
single pcr reaction,2.971779676830115e-06
polymerase-like domains,2.9698929956456676e-06
highpathogenicity,2.9643655127972157e-06
human lung cdna libraries,2.9537962235318943e-06
bimodular envelope proteins,2.952826994007065e-06
lactogenic immunity,2.9495736469060762e-06
intracellular rnp complexes,2.9478865527628863e-06
sars-cov plpro,2.9478175357860086e-06
primer-probe energy transfer,2.9458355281816855e-06
unfolded protein responses,2.9393676671506e-06
doi:10.1186/s12871-016-0198-x,2.934809666340587e-06
spike-mediated membrane fusion,2.9341194014954867e-06
mersrelated covs,2.932064612380442e-06
serum proinflammatory cytokines,2.9271158819968047e-06
virus type,2.9252718334246235e-06
indirect immunefluorescent tests,2.902508475642015e-06
acid ampa receptor antagonist,2.90078092666645e-06
cv structural protein genes,2.890739096383268e-06
comprehensive update,2.8888295325545336e-06
janus nterminal kinase signaling pathway,2.887472481878881e-06
spike protein of sars-cov,2.886779297668317e-06
accessory proteins 3a and 3b,2.8847746915928368e-06
alternative protein products,2.870794490830585e-06
ifn-stimulated genes,2.8675459763906296e-06
ifn-independent,2.8670532408786055e-06
furin inhibitor,2.8616745595947757e-06
human angiotensin converting enzyme ii,2.8605112351304174e-06
immune escape,2.8603650492372356e-06
mitigated,2.859749531802172e-06
thp-1 monocytic cell line,2.858952704886177e-06
hemagglutination iha test,2.855358363871879e-06
point substitutions predicted,2.8411017483751053e-06
vida frecuentemente,2.8401210699566265e-06
human immature dendritic cells,2.838303797785649e-06
human lung,2.8361097264347928e-06
full-length nsp13 helicase of sars-cov,2.825137418378037e-06
1a and 1a/1b polyproteins,2.8243450920045044e-06
known coronavirus proteins,2.811964700915004e-06
hlaa2 donors,2.809666412668149e-06
prospective population-based pri.de study,2.8036514542978268e-06
cell culture-based infection models,2.7998672508733376e-06
pro-apoptotic function,2.798049712290716e-06
oligosaccharideoligonucleotide foldlike,2.78661279967952e-06
abstract human coronaviruses,2.7732209491168195e-06
rna transcribed,2.772340022242021e-06
genomic positive-stranded rna,2.7670445760318678e-06
coronavirus immunity,2.766234024357906e-06
viral hepatitis,2.7656720514995648e-06
cysteine acylation,2.760447364764093e-06
depressed general condition,2.75870027957848e-06
octamerbinding transcription factor 4,2.7570898343307846e-06
ouabain,2.756158029417048e-06
tolllike receptor 7 tlr7,2.753735721416674e-06
cellular palmitoyl acyltransferases pats,2.751772954632701e-06
nterminal domain ntd residues 45 to 181,2.742123006409306e-06
direct enzymelinked immunosorbent assay,2.734134162912408e-06
endonucleolytic rna cleavage,2.7203356420634334e-06
professional antigen presenting cells,2.717207314975163e-06
highly labeled,2.7158529886935314e-06
transcription regulatory sequences trss,2.709543468049681e-06
diagnostic protocols,2.706598729549662e-06
cov populations,2.7063519068497158e-06
eukaryotic initiation factor 4f,2.6999619994966e-06
12-nucleotide-long sequence,2.6996635794086217e-06
crimean-congo haemorrhagic fever virus,2.6987756858156763e-06
coronavirus nsps,2.6951418041118484e-06
subgenomic rnp complexes,2.6937136779148363e-06
antiviral mediator,2.6915383966628104e-06
apoptotic cell population,2.690983343249769e-06
viral host,2.6865333408182396e-06
virally,2.6776246837244515e-06
vero e6 cell line sarscov,2.677219018340282e-06
structure-based substitutions,2.674254824650653e-06
human pathogens,2.662443783198793e-06
beaudette full-length cdna,2.6601533389132094e-06
cal type viruses,2.657895996005325e-06
cleavable spike glycoprotein,2.653306518860738e-06
protein sarss,2.652983909906e-06
type i interferon alphabeta interferon,2.6502357419288513e-06
cellular endocytosis,2.6340475122529483e-06
maps,2.6283652345990115e-06
lateral flow platform,2.6268513291721863e-06
intestinal biopsy specimens,2.61666021769966e-06
viral positive,2.615421571673538e-06
protein synthesis,2.6123989305065464e-06
2amino35methyl3oxo12oxazol4ylpropranoic acid ampa receptor antagonist gyki52466,2.6116336029587492e-06
mir30a5psocs axis,2.606938812541117e-06
e3-specific monoclonal antibodies,2.605154389789219e-06
recombinant ibv s1 proteins,2.600519021331748e-06
vm,2.597740450399165e-06
genetic property,2.590339487674022e-06
prionailurus bengalensis,2.580883127247974e-06
bronchovascular bundles,2.578423766813461e-06
protein e oligomerization,2.574167267871682e-06
cell-free protein synthesis system,2.5680906123294372e-06
immune dysregulation,2.5678162450036352e-06
trimeric units,2.563115550530936e-06
ib,2.5617323790102696e-06
sarscov nucleoprotein,2.559074470006128e-06
cterminal tail,2.558980219299501e-06
proteolytically stable core fragment,2.5570695674264174e-06
host-species and 36 coronaviruses,2.5552068805007566e-06
distributions,2.5534777034179797e-06
animal-to-human transmission,2.5371975101625495e-06
30 cell lines,2.5335052956871273e-06
serum rna extraction procedure,2.5214518333012604e-06
super molecular assembly,2.5160135255778878e-06
virion polyproteins pp1a,2.5139456921963256e-06
earlystage sarscov human,2.508944040164576e-06
mouse fibroblast cell lines,2.5064268737793108e-06
bak knockdown cells,2.5016022097907397e-06
viral-induced encephalomyelitis,2.497184034692517e-06
goblet cells crypt,2.4970488330641585e-06
nuclear localization signal,2.492391119025435e-06
hindlimb paralytic disease,2.490917405840229e-06
coronavirus s glycoproteins,2.4893780258796323e-06
ifn-inducible genes,2.486905727422541e-06
ifni response,2.486896387066927e-06
ser5-phosphorylated rna polymerase,2.483044650899728e-06
small molecule inhibitors,2.4779317993675533e-06
coronavirus mouse hepatitis virus-a59 (mhv-a59),2.4756877413638567e-06
dromedary 229e viruses,2.475563582831032e-06
cinanserin,2.4745246006021643e-06
3b,2.4709439494113654e-06
coronavirus cov spike s protein is,2.459685324354855e-06
multiplex pcr,2.4590720484511345e-06
intermediate cleavage product,2.4568477260589315e-06
cholesterolrich microdomains,2.4543863865701986e-06
classical swine fever virus ires,2.4501631582994806e-06
viruscell,2.4488219862221218e-06
macrophage chemoattractant,2.4419916594863384e-06
sars cov further,2.436607398622771e-06
interferon restricted a59,2.436172819972101e-06
middle east respiratory syndrom coronavirus,2.429279748396694e-06
temperature-sensitive mutant,2.4255234942191357e-06
sarscov plpro processes,2.4208856212371864e-06
danish herds,2.4157315528191805e-06
human 293t cells,2.415156249312639e-06
lu,2.405262132067274e-06
duallabeling experiments,2.400009999280564e-06
viral transcriptionregulatory sequence trs region,2.3973249153456273e-06
logistic regression models,2.392800681091524e-06
fecal material,2.391817217955101e-06
tylonycteris pachypus coronavirus hku4 pipistrellus pipistrellus coronavirus,2.3876929154761823e-06
virological surveillance,2.3871852363030773e-06
epithelial colonies,2.384371253354157e-06
lung leukocyte,2.3843699178685006e-06
hemagglutinating encephalomyelitis coronavirus,2.3824240525770266e-06
sars-related rhinolophus bat cov hku3,2.379276641585097e-06
domain rbd,2.3684463401622966e-06
random analysis,2.3679414850160757e-06
antipsychotics,2.3656549382096177e-06
lymph node cells,2.362610333422589e-06
rt-iipcr assays,2.3597578225279535e-06
nts,2.349318462072349e-06
homologous rechallenge studies,2.3442098415098477e-06
canine coronavirus (ccv),2.3379877081561173e-06
small open reading frame,2.3332057645682254e-06
plp2 cleavage site,2.3287368150485973e-06
orthologous entry receptor dipeptidyl peptidase 4,2.3259933906565503e-06
pan-coronavirus inhibitors,2.3255994260351795e-06
aminoterminal portion,2.32402238902782e-06
patienttostaff,2.3153373634986184e-06
conserved domains,2.3030137434004206e-06
chymotrypsinlike protease 3clpro rnadependent rna polymerase pol helicase spike,2.3006991800863616e-06
pl1pronegative mutant,2.2905817579365744e-06
linear dynamic,2.2898631452733624e-06
g332a virus,2.2898413113167066e-06
stat1,2.288405404819406e-06
rtpcrs,2.286901485417202e-06
critically ill,2.2867992048452588e-06
electron microscopical analyses,2.282024739462795e-06
cell cycle uvirradiated mhv,2.2816249360041874e-06
human angiotensin converting enzyme 2 (ace2) receptor,2.2749554978073266e-06
ym1expressing,2.272857214218711e-06
nested polymerase chain reaction npcr assay,2.272007264778356e-06
fd filamentous bacteriophage,2.2689804364164374e-06
mixed population,2.2670346842562957e-06
sarscov gfp sarscov gfp,2.263795126794813e-06
cd8 tcell priming,2.2600398226267466e-06
methyltransferase inhibitors,2.253542435261836e-06
acute respiratory syndrome-like coronaviruses,2.2532222074255575e-06
solution structure,2.252889942973066e-06
proliferative response,2.2383211760647798e-06
multifunctional nature,2.2381229073832595e-06
occurs,2.2370947450367303e-06
cell mediated,2.2286828959975133e-06
internal,2.2282922588400733e-06
immune function,2.2220425018748266e-06
replicasetranscriptase,2.2204533759491476e-06
nonhuman primate,2.2089289068925806e-06
feline coronoviruses-specific antibodies,2.2070734419817774e-06
long periods,2.2014438548307994e-06
hepatitis virusa59,2.20027420608926e-06
camel pastoralists,2.199703294850371e-06
virus neutralization tests,2.1993577286042327e-06
compositional constraint,2.191436634498645e-06
egfr ligands amphiregulin,2.1781665584629537e-06
tgevderived vectors,2.176365342208398e-06
proapoptotic gene bnip3,2.1757930616382225e-06
local health departments,2.174436821062124e-06
mers-cov igg,2.1641435987758137e-06
40s ribosomal subunit,2.163482851768347e-06
anthraquinone compound,2.161807502202377e-06
immunolabeled,2.148702816043456e-06
drug imatinib,2.143737258002057e-06
src kinase inhibitors,2.143593032914129e-06
gastric,2.140353150292392e-06
speciesspecific,2.1371220238008957e-06
sinonasal inflammation,2.1352619688230215e-06
alpha and betacoronavirus s1ntds,2.1319553416949784e-06
virus-specific cd4(+) t cells,2.131595869785619e-06
recombinant hcov-hku1 nucleocapsid,2.129372039845113e-06
http://covdb.microbiology.hku.hk,2.1265991589640813e-06
feline cells,2.1258868898667278e-06
human type i interferon,2.1231706854879373e-06
viral membrane proteins,2.116191074486113e-06
merscov hosts,2.1142248539504043e-06
hcov229e spike glycoproteins,2.1086914874011654e-06
cellular mrnas,2.102903270790715e-06
esterase domains,2.1012302325505785e-06
viral nucleocapsid core,2.100300579405505e-06
virus surveillance,2.098284314605297e-06
immune cell infiltrations,2.0982544928571075e-06
karyopherin alpha 2,2.0973733323833157e-06
surveillance approaches,2.0918607464096424e-06
structural functions,2.08740437644148e-06
translational control,2.08359858207576e-06
global transport,2.082846583526482e-06
virus neutralizing vn antibodies,2.0820388460980087e-06
sarscov helicase,2.082006935901733e-06
cytoplasmic tail domains,2.0805140272448573e-06
mhv-jhm amino-terminal proteins p28,2.0764822718163798e-06
cysteinerich domains,2.069830677388206e-06
peptidases,2.05538622194784e-06
peptide neutralization interference assay residues,2.0491079882993878e-06
primary demyelination,2.04556513007774e-06
nterminal gene 1 protein,2.0351088915462367e-06
significantly higher,2.0250150675998973e-06
fibrous connective tissues,2.013103662043217e-06
double-stranded dna unwinding activity,2.010491014553945e-06
pseudo-center of symmetry,2.000890806494517e-06
neutralizing anti-s antibodies,1.996864510227922e-06
coronavirus-inoculated calves,1.996655014836924e-06
ecov s1-based,1.994793484909333e-06
11-nucleotide sequence,1.994748876597117e-06
chronic demyelinating diseases,1.9935743807533177e-06
viral propagation,1.9933162611350984e-06
12 mature nonstructural proteins nsp5,1.992696351223834e-06
heparan sulfate substitutions,1.988741491183321e-06
sars covinfected vero e6 cells,1.988579648131061e-06
nucleotide composition,1.9747004824804656e-06
rna genomes,1.9655568200325497e-06
clinical knowledge,1.96258665762838e-06
cellular unfolded protein,1.960266075226742e-06
u48g sl2 mutant rna,1.9542037478362193e-06
balb/c macrophage cultures,1.951797386347093e-06
acute sars-cov infection,1.9474265038273978e-06
virus-host interactions,1.9422982309436766e-06
low copy number,1.939379710038939e-06
infectious sarscov,1.936352332809091e-06
treatment regimens,1.933067754335973e-06
filter binding assay,1.9222409197944562e-06
rearranged cellular membranes,1.9213094361082555e-06
viral spike proteins,1.9179465133284103e-06
type iii ifns,1.916870836595092e-06
mitochondrial translocation,1.9124660739879953e-06
lung kidney,1.9046306968484322e-06
bovine coronavirus bcv genome,1.89620904928266e-06
tatase activity,1.8790480500147578e-06
cuban bovine coronavirus sequences,1.8776588002058738e-06
doi:10.1186/s13029-016-0049-7,1.8764171550586272e-06
coiledcoil trimer,1.8762811350847611e-06
bananin iodobananin vanillinbananin,1.871371797144735e-06
dna complemented palindrome,1.8633197298090303e-06
conserved residues,1.8583409699336223e-06
membrane-bound transcription complex,1.8545469849821192e-06
putative coronavirus polymerase gene,1.853633889661167e-06
kinase inhibitor h89,1.8517053552818977e-06
hla-b* 4601 allele,1.8487187011926068e-06
pv,1.8416591316886314e-06
neuroadapted jhm strain,1.8411150353198816e-06
subgenomelength rnas,1.8397005050800293e-06
tgev and sarscov n proteins,1.8314383098699792e-06
nonstructural protein 1 nsp1,1.8188418231877184e-06
contactinhibited confluent nih,1.8168114750178594e-06
recombinant scovn rscovn protein,1.809683956148896e-06
correlates,1.809125585854271e-06
transcription consensus sequence,1.808148654561792e-06
monocyte chemoattractant protein 1 mcp1,1.8027285521318266e-06
sars-cov nucleocapsid protein,1.7899154055248283e-06
s-dependent membrane,1.7779592041014748e-06
myd88independent,1.7756960734400493e-06
ifitms,1.7667877289545074e-06
central players,1.7582060579563083e-06
cov virulence,1.7492150032503986e-06
inner mitochondrial membrane,1.7426142225952323e-06
orf7a expression,1.7387663919920472e-06
cov he,1.7378282457134245e-06
viral restriction factors,1.7348380975757517e-06
betacoronavirus-b,1.7295812298159908e-06
hcov-nl63 infections,1.7294924883936215e-06
coronavirus papainlike protease,1.7266661916136222e-06
fcov nsp7nsp8 complex,1.7265260270455396e-06
impaired,1.7205815445627336e-06
sequence microheterogeneity,1.7148269184538948e-06
prioritization,1.7144030503141047e-06
major histocompatibility complex class i-restricted epitopes,1.7106991492691424e-06
protective antigens,1.6981286547721746e-06
pi,1.6919955762337052e-06
mhv spike s protein,1.6795071801536143e-06
mhv4 rbd s4r,1.6728580471187088e-06
unaltered,1.666663209190692e-06
q6327n,1.6651338583294333e-06
rnaprocessing enzymes,1.6639023488254689e-06
iav,1.663644455492736e-06
eukaryotic positive-stranded rna viruses,1.6619872001207834e-06
66-nucleotide leader,1.659929454449748e-06
mers-cov hr1-derived peptide,1.6549749201789274e-06
rna-binding controls,1.6521674994337552e-06
binding specificity,1.650911805664863e-06
highly polarized calu3 cells,1.6362610317265039e-06
kidney epithelial cell lines vero vero e6,1.6352759825319644e-06
viral cysteine,1.633440568545889e-06
non-immunosuppressive cyclosporin a-analog,1.6306305931113954e-06
systematic mutagenesis,1.6234365364376477e-06
caspase-6-mediated cleavage,1.6179637157941836e-06
interior,1.617749952053549e-06
replicative-intermediate,1.6093401351846047e-06
healthcare-associated infection,1.604863832814967e-06
38 monoclonal antibodies mabs,1.6010630631733338e-06
renilla luciferase-encoding sars-cov replicons,1.592480889810293e-06
truncated spike protein sequence analysis,1.591031695475616e-06
carboxypeptidase-like activity,1.5873779911932776e-06
coronavirus ribouncleoprotein,1.584717641695061e-06
3clpro cleavage site-like motif,1.5819442048733368e-06
small angle x-ray scattering,1.581448310352598e-06
protein e arbely z granot i,1.5781987798276288e-06
mouse hepatitis virus infection,1.5777838580835355e-06
spinoculation,1.5736253959126394e-06
elisa western blot analysis immunofluorescence,1.5717658766413323e-06
sars-cov antibody binding assays,1.5706319896934972e-06
bovine enteric coronavirus,1.570073697424295e-06
luciferase reporter,1.5682296104424438e-06
descriptive statistical analyses,1.5629386906692154e-06
immunoreactivity assays,1.557579994745266e-06
residues k45 d129 k169,1.5460373649851776e-06
human respiratory virus pathogens,1.5351374195066346e-06
papainlike proteinases,1.531981527932885e-06
human anti-sars monoclonal antibody,1.5305714363329373e-06
coronavirus poly(a,1.5234951488765758e-06
availability of,1.5180313812870113e-06
acute-onset heart failure,1.5128819760413341e-06
rbd-specific humoral,1.510133315729342e-06
group-specific genes,1.5091593254198457e-06
densely populated regions,1.4994520065359734e-06
wide-spectrum anti-cov drugs,1.4857880198779565e-06
virusspecific isotypeswitched asc,1.4789792348901279e-06
sars-covs,1.4750800051244836e-06
16 viral nonstructural proteins nsp,1.4723068116584543e-06
protein sequence analysis,1.4702210698172595e-06
infectious challenge,1.469509792969221e-06
international sars outbreak,1.4673384853932366e-06
cv vaccines,1.465253471516284e-06
mammalian cov,1.4648706096981103e-06
terminal 17 amino acids,1.4634692639141006e-06
airspaces bronchiolitis obliterans,1.451864094185434e-06
subpopulations,1.4510888224720827e-06
virus tropism,1.4496285790765477e-06
packaging signal n protein,1.448573803774051e-06
subcellular fractionation studies,1.443708164424515e-06
healthy eclectus,1.437491537903998e-06
decreasing,1.430060638627098e-06
global gene expression profiling,1.423851282576259e-06
antiviral protective asc,1.4188422761295064e-06
chronic inflammation,1.4129964270894214e-06
proinflammatory cytokine tumor necrosis factor alpha,1.4051884720411728e-06
mhv fulllength,1.4026549916159147e-06
bronchial epithelial cell line 16hbe,1.3986201318908761e-06
proteolytically resistant domains,1.3962275935982286e-06
human kinome protein,1.3961082274503868e-06
peritonitis virus fipv,1.3950969065146161e-06
wildtype sarscov infection system tgg,1.3927782555239342e-06
m1m2 macrophage,1.3796746707189045e-06
one-step rrt-pcr assay,1.3793239613877351e-06
real-time quantitative reverse transcription polymerase chain reaction,1.3690283729915289e-06
transmissible gastroenteritis virus cluster,1.3648154387816756e-06
major neutralizing epitopes,1.3533076818724954e-06
socalled groupspecific genes,1.353142935860467e-06
cytotoxic t lymphocyte (ctl) epitopes,1.3527825099631495e-06
hace-2 tg mice,1.343870829204649e-06
sars-cov rdrp elongation,1.3332387258242458e-06
sarscov orf6 expressing cells,1.3312147836991592e-06
mers-cov rna,1.3307188567446061e-06
immunomodulatory factors,1.3093498914751117e-06
pretransfer mers-cov testing,1.305263433568512e-06
protein-driven,1.3032511745802203e-06
mhv and tgev receptor glycoproteins,1.300556104220839e-06
virus hijacks caveolin-dependent,1.297135979790023e-06
argininerich,1.294102644456119e-06
hibatcov hku10,1.2886115685642494e-06
dendritic and epithelial cells,1.2818598649472658e-06
incidence rate ratio,1.2751784662887488e-06
sarscovinfected vero e6 cells,1.2748406056248044e-06
ac22 mice,1.2739979836000386e-06
ordinary differential equations,1.272050841655231e-06
bilateral peripheral posterior,1.2706180984810253e-06
viral replicative machinery,1.267681421782197e-06
cq,1.2593916467476274e-06
purine-containing rna sequences,1.2534399601076956e-06
sarscov nsp16,1.2521048839909878e-06
methyltransferases,1.2480492267603398e-06
s1n330 receptor-binding site (s1n330-iii),1.244420688669858e-06
pbmc and thp-1 cells,1.2439165553610225e-06
modified vaccinia virus ankara,1.2435811953553186e-06
regulatory sequences,1.2426840886363901e-06
small envelope e glycoproteins,1.2400574681216224e-06
ribosome pause sites,1.2394959142360464e-06
systematic,1.2374857864843806e-06
molecular dynamics procedures,1.233482901661826e-06
down-regulated,1.2322921212564436e-06
postmedial golgi compartment,1.2291547972012748e-06
structural signature,1.226026865519313e-06
r.,1.2085838283262948e-06
human respiratory viral pathogens,1.207313234437668e-06
maternal vaginal,1.206101358020006e-06
receptor-binding,1.20059868869483e-06
s-adenosyl-l-methionine (sam)-dependent methyltransferases,1.197796998302396e-06
standard donation criteria,1.1889509356382963e-06
mva-mers-n expressing recombinant n protein,1.1883184066999423e-06
structurebased optimization,1.1861871515910546e-06
mouse ceacam1a mceacam1a,1.1806072340682994e-06
sarscov receptor angiotensinconverting enzyme 2 ace2,1.1713852081290697e-06
transcriptional profiles,1.1604063714192858e-06
structure-based drug design,1.1595701050078852e-06
broad-spectrum antiviral drugs,1.1534484188911408e-06
structural protein production,1.1516055484998171e-06
anti-mceacam1a antibodies,1.1511605378179384e-06
recsars-cov reporter virus expressing renilla luciferase,1.1498548465278109e-06
di2 sequence,1.1436815582025122e-06
pseudotyped vesicular stomatitis virus,1.1396931621885784e-06
semi-conserved ile (i95) residue,1.1340121188743368e-06
tissue cultureinfective,1.1286289554185956e-06
six-helix bundle conformation,1.1105112119084205e-06
viral entry/fusion inhibitors,1.109978836789844e-06
mink lung epithelial cells,1.103894918442115e-06
hla-b* 4601,1.098974443354792e-06
coronavirus rna capping,1.0929005792088902e-06
western blot assay,1.0876666317947765e-06
isg15usp18 pathway,1.0857082804642435e-06
fas-associated death domain,1.084709896868933e-06
brain infection,1.0846950611741033e-06
spearmen's coefficient,1.0830424909778542e-06
serologic assays,1.0821841739084556e-06
semiquantitative analysis,1.080417197834967e-06
upe and open reading frame 1a orf1a realtime,1.0788026652695038e-06
reca-like subdomains,1.0738641757232522e-06
lysine-flanked isotopically labeled etm peptide,1.073703249381306e-06
nucleolar-cytoplasmic distribution,1.0606775558044167e-06
double-membrane vesicles,1.0592277948402944e-06
control mers-cov,1.0572048342490863e-06
human mers-covs,1.0537711666862392e-06
solidphase binding assay,1.0482646084509753e-06
monocyte-derived dendritic cells,1.0424827202966313e-06
center,1.0424494396309545e-06
electron micrograph northern blot,1.041530401569581e-06
integrity,1.0407382061917131e-06
super-spreader specimen,1.040623058362637e-06
full-length nucleocapsid protein,1.0395806773115305e-06
hydrophobic n-terminal signal sequence,1.038399960218343e-06
nucleotide identities,1.0380820735241825e-06
kd  17 nm 10fn3 intrabodies,1.0280755005877636e-06
nsp13associated deoxynucleoside triphosphatase,1.0274782716823466e-06
infectious mhv,1.024066178733085e-06
sarscovspecific antibody assays,1.0218024827915963e-06
pvp-i gargle/mouthwash,1.017938252651121e-06
cell surface receptor aminopeptidase n,1.0169509838408324e-06
hcov 229-e,1.016281395722773e-06
primary cell cultures,1.0134911002057253e-06
catalytic domain,1.0131163116684065e-06
surveillance activities,1.0091885553312838e-06
superspreader,1.0088391505679092e-06
cellular extracts mutations,1.0070889518532702e-06
di rnachloramphenicol acetyltransferase cat,1.0007484476356998e-06
active immunity,9.971657967196438e-07
cleavage site 1,9.935642067970555e-07
gamma interferon,9.931693749512154e-07
sars-coronavirus (sars-cov) infection,9.9221653398474e-07
e gene upe nucleocapsid n gene,9.897903726631796e-07
[(18)f]-fdg-pet,9.87482514213906e-07
rbv sarscov,9.856630030316014e-07
quantitative real-time pcr,9.842350867568735e-07
oglycosylation,9.773443504637415e-07
transmembrane oligomer,9.73602638200872e-07
broad-spectrum activity,9.71498658836826e-07
intestinal homogenate,9.654066998370189e-07
ubline molecule isg15,9.604132671906537e-07
hmpv,9.597367899702168e-07
virus-neutralizing antibodies,9.579990930965736e-07
hku5cov,9.57441038599328e-07
chimaera s genes,9.46538167524383e-07
orf3 protein product,9.457176746084555e-07
ccl3,9.423955374345901e-07
mers-cov s protein epitopes,9.392406494143546e-07
maternal igg1 antibodies,9.37257568926447e-07
merscov spike glycoprotein,9.346671066632347e-07
human airway epithelial cell cultures,9.297376074505113e-07
nonstructural replicase proteins nsp1,9.287879039902357e-07
gene mutation analysis,9.238110668268217e-07
protein receptor aminopeptidase,9.234861244390013e-07
pcp2,9.079611776804573e-07
firefly luciferase luc gene,9.054343940702346e-07
rrbd protein,9.036059125761506e-07
co-phylogenetic reconciliation analysis,9.011633521407329e-07
pulmonary infiltration,8.917587580768686e-07
aa macrophages infection,8.684100804649572e-07
papn amino acids 283 to 290,8.679333907679569e-07
dairy,8.627065339713921e-07
cytoplasmically,8.602873021714831e-07
ubiquitin chains,8.466744381098484e-07
hrn,8.456460634718095e-07
thermal denaturation,8.397910295461742e-07
viral replicationtranscription complex,8.336152177022631e-07
258-nucleotide rna fragment,8.265554958556386e-07
nonstructural ns proteins 3a,8.243864991802782e-07
human angiotensinconverting enzyme 2 hace2,8.17650914155906e-07
hematological measures,8.148293427316581e-07
non-pruritic erythematous nodule,8.120327547676999e-07
membrane rearrangement,8.071185542189717e-07
extracellular signalregulated kinase erkmitogenactivated,7.946745459432199e-07
respiratory epithelium,7.938242351090081e-07
triton x100 tx100,7.876148624357372e-07
purified recombinant viral proteins,7.820322084854993e-07
s-based elisa,7.819111733649335e-07
c-terminal 209 amino-acid region,7.812594480391685e-07
murine coronavirus mouse hepatitis virus strain a59,7.731992943272551e-07
reverse transcriptase-polymerase chain reaction,7.696119914551043e-07
bredavirus,7.691889901393546e-07
ptb and tiar,7.68503274030955e-07
iga bcv antibodies,7.674518012187959e-07
normal limits,7.666536159774776e-07
sarscovimmune splenocytes,7.658069252677299e-07
subclinical sarscov infection,7.656309224372082e-07
sars coronavirus (cov),7.649192045491338e-07
chinese horseshoe bat,7.510299818342394e-07
critical aspects,7.476407362965521e-07
hla-a2.1 positive human peripheral blood mononuclearcytes,7.431724104005822e-07
immunoprecipitate radiolabeled proteins,7.408297647771665e-07
group-specific protein,7.387560142971635e-07
pathogenicity factors,7.356646599362126e-07
orfx deletion mutant,7.297304516997131e-07
allelic discrimination assays,7.249087465128593e-07
operating,7.172255989581098e-07
bovine coronavirus bocv strains,7.138191601070921e-07
rosette-like structures,7.025832485334917e-07
receptor-binding domains,6.988609652546915e-07
transmembrane m glycoproteins,6.979026645845381e-07
antibiotic-resistant cell lines,6.919541315469379e-07
spatiotemporal cluster,6.847157926029791e-07
immunofluorescent analyses,6.845517326460981e-07
rna-binding activity,6.825236972174393e-07
nterminal 547 amino acids,6.813390306431795e-07
whole genome sequences,6.785628790717342e-07
sadenosyllmethionine adometdependent rna,6.697233803844992e-07
high-yield monoclonal suspension cho cell line,6.696911290920572e-07
viroporin,6.67988545364999e-07
virus-infected l cells,6.584506405299218e-07
immortalised feline cell line,6.581360315370029e-07
sz16s mutant viruses,6.541267009102083e-07
evolutionary distance,6.526457340657491e-07
p65-bound enhancers,6.519965785533908e-07
tgev replication,6.50102763191459e-07
ethiopian dromedary camels,6.462522756749901e-07
nonisotypeswitched igd,6.416192076013421e-07
dsrna-encircling ring structure,6.396744703211089e-07
tryptophanyl residue(s),6.388767733693152e-07
suckling mice,6.314644868723395e-07
papainlike cysteine proteinases pcp1,6.300600912298591e-07
rad/spike administration,6.282414925708264e-07
mouse-adapted,6.247024233030162e-07
structure-assisted optimization program,6.220139130125519e-07
cdk6,6.191409082597617e-07
preventive medicine database,6.156122441583279e-07
hybridoma clones,6.060714436355412e-07
animal origins,6.033943562914258e-07
sar analysis,6.014035166139067e-07
virusspecific memory cd8 t cells,5.956299081629862e-07
trimer of dimers,5.93295250803893e-07
yeast twohybrid system,5.932185331203469e-07
type i interferon system,5.916702377792489e-07
ligand-binding pockets,5.805129639312247e-07
bottlenose dolphin,5.800224870333301e-07
coronavirus nonstructural protein 9,5.758627909666295e-07
anti-pure virus or anti-crude virus animal serums,5.754072486733203e-07
mhv-a59 infection,5.695091922450822e-07
coronavirus-host,5.680014737035683e-07
hepatic dysfunction,5.674919142509245e-07
interneurons,5.647363617484811e-07
rabv particles,5.646994507074247e-07
experimental validation,5.599673249059856e-07
peritoneal membranes,5.560374471631356e-07
retrospective study,5.546958203993601e-07
coimmunoprecipitated,5.546578460112412e-07
fractionated proteins,5.50203875787862e-07
bhk-r2 cells,5.493237159003291e-07
s978,5.486744463522241e-07
mouse antisera,5.440840666559881e-07
roc analysis,5.405863264045824e-07
alanine glycine andor phenylalanine residues,5.351235171755308e-07
asparagine residues,5.255454049581894e-07
coronavirus pedv,5.24820953547975e-07
spillover hosts,5.209364363845428e-07
26 kda matrix protein,5.120412963238312e-07
apcs,5.117758233870651e-07
endoribonucleolytic activity,5.110835893543143e-07
pandemic agents,5.109171005498768e-07
vaccines stimulated gamma interferon,5.093691254805359e-07
third transmembrane,5.059491413592214e-07
structurebased,4.994914405022702e-07
sa4,4.942124325926036e-07
hla peptide binding predictions,4.933603935486149e-07
zinc finger cchc-type and rna-binding motif 1,4.842452497338168e-07
serological antibody,4.836637722099464e-07
linkage-specific polyubiquitin (polyub) chains,4.769374269492665e-07
salt bridges,4.7198044912251004e-07
systematic comparison,4.6987297497964543e-07
docking model,4.677626469962946e-07
abdominal organs,4.656275607633803e-07
agp and anti-fcov antibody,4.570846617344582e-07
merscov fusion core,4.5390646816657106e-07
co-immunoprecipitation techniques,4.478607621791314e-07
nonsynonymous substitutions,4.4492974305805915e-07
coronavirus non-structural protein 1,4.44388922412814e-07
mild respiratory symptoms,4.3882598171067404e-07
state,4.32956143683755e-07
sars-cov chemical inhibitors,4.229136209870119e-07
prototypical gammacoronavirus,4.2133193442629215e-07
single tube real-time reverse transcription pcr,4.211661835726585e-07
electro-mobility shift assays,4.1664752868588715e-07
antiviral state,4.153439764048354e-07
polyacrylamide gel electrophoresis,4.1471656537939456e-07
full-length s-protein trimer,4.1394854618626026e-07
neural network,4.1093287308020733e-07
spike-protein gene,4.0891432758712634e-07
nakatpase,3.973046203491683e-07
cov rdrp nucleotide selectivity,3.954922884516931e-07
utr,3.9154802361444735e-07
hcov-nl63-negative group,3.8948963434030795e-07
lamp chimeras,3.87995514670706e-07
fever growth retardation,3.879334986069357e-07
nsp4 glycosylation site,3.858811252257128e-07
antiinflammatory effects,3.818998542319228e-07
global promoter,3.749607328535048e-07
avian gamma-coronaviruses,3.68614750076836e-07
anti-apoptotic protein b-cell lymphoma 2,3.670069130517154e-07
intermolecular disulfide bridge,3.6654370160069007e-07
transmissible gastroenteritis virus tgev zfc,3.6520202483102286e-07
type iii interferon,3.6185628435944887e-07
mammalian dpp4 orthologs,3.5974868078090334e-07
regulatory transcription,3.562526248174786e-07
ribonucleoprotein complex,3.5443886099977886e-07
unglycosylated m polypeptide,3.4947393901897413e-07
high frequency,3.4907308361890337e-07
gargle/mouthwash,3.422425040028104e-07
spike-specific mabs,3.3050372425503766e-07
post-translation modification,3.284544768816911e-07
host galectin,3.2772365992770655e-07
over-expression,3.262077859872545e-07
erk,3.185656751747693e-07
protein/rna interactions,3.1819507053965696e-07
healthcare system,3.1341527481674683e-07
nuclear/nucleolar localization,3.0702038380564154e-07
interferon responses,3.056870129918122e-07
reverse transcription recombinase polymerase,3.019814992443666e-07
genotype-specific fluorogenic assays,3.014596149736063e-07
rtd1,3.0138263554541843e-07
viral rna complexes,2.967168209508661e-07
crownlike structure,2.9513074348112304e-07
gene mutated fcovs,2.922306285260863e-07
quiescent 17cl1 cells,2.920501505329097e-07
biochemical studies,2.905469600558846e-07
antiviral function,2.893709068781912e-07
ires40s binary complex,2.811264142765519e-07
monocytesmacrophages,2.809673134079652e-07
anti-coronaviral agents,2.7222031884155267e-07
column-based manual rna extraction method,2.706189221041875e-07
multinucleate cells,2.676878804581681e-07
clostridium botulinum neurotoxin b,2.6271069708890187e-07
signature,2.5541352554388e-07
sars-covs and sars-like covs,2.476399139131622e-07
murine brain,2.4530508371711696e-07
animals nuclear,2.4521248971043463e-07
t helper epitope,2.3950818742227154e-07
immunoglobulins,2.3376861265347422e-07
caspase9,2.3102218562903737e-07
catalytically incompetent,2.3043752345979882e-07
protein production,2.2513000646893446e-07
research networks,2.1861252264008243e-07
aerosolized contamination,2.136549096983193e-07
computational,2.1198843741362273e-07
cauliflower mosaic virus 35s,2.1016448257249655e-07
core-glycosylation,2.0341666762558035e-07
genomic rna sequence,2.027284117029317e-07
sgs,2.0019943834161422e-07
structure-based design,1.9888037914704308e-07
yonsei university medical center,1.9874661833985584e-07
neuronal expression,1.9032636908312154e-07
ubiquitinlike domain,1.8897822279383787e-07
coupled-transcription translation system,1.8723596337441405e-07
mouse angiotensinconverting enzyme 2 ace2 receptor,1.8567859970277096e-07
older patients,1.8423013684250915e-07
recombinant viruses transcribing subgenomic mrna,1.7988766348591305e-07
hospital contacts,1.793423126566314e-07
scv helicase,1.728429404293647e-07
medications,1.6499705073797285e-07
lipid microdomains,1.6436205267643347e-07
partial nsp1coding region,1.638558761298733e-07
cryo-electron microscopy,1.6011492511495939e-07
sequencing analysis,1.461998258851233e-07
hemagglutinating encephalomyelitis phe,1.439543462159542e-07
parallel experiments,1.4333476239897538e-07
cis-acting rna elements,1.4269859956697535e-07
anti-annexin a2 antibodies,1.4129394113279374e-07
100foldhigher,1.3854407765400487e-07
neurologic diseases,1.3250166654489077e-07
omani camel sera,1.3161716029383205e-07
viral surface glycoproteins,1.313577176269505e-07
ribonucleoprotein complex electrostatic potential distribution,1.3094147070791596e-07
glyceraldehyde 3-phosphate dehydrogenase,1.3030075850779688e-07
viral-induced neuroinflammation,1.3027445548901687e-07
coronavirus terminal genome regions,1.2923317310511398e-07
p38 mapk pathway,1.2883966904208888e-07
casein kinase iimediated,1.2483867352826674e-07
neutralizing effects,1.2426655654796556e-07
colonystimulating factor 1 receptor,1.2204717669394083e-07
mavs,1.2030125718828462e-07
sarscov receptor human angiotensinconverting enzyme 2,1.1790698700357001e-07
c terminus of orf6,1.129852656717629e-07
chemokine homing receptors,1.0460944451891536e-07
infectious-bronchitis-virus,9.963512462826128e-08
hcov co-circulent avec une,9.90590962450237e-08
sting-traf3-tbk1 complex,9.460712537952514e-08
apoptotic cell,9.419555722155438e-08
transiently transfected cells,9.404651354886831e-08
rscovn protein production,9.34617258126867e-08
c-terminal cleavage site,9.02906245032262e-08
thr378 and ser379 sites,9.01250527468033e-08
j storz j med virol 44152161 1994,8.916777784612987e-08
infectious cdnas,8.532983995053347e-08
turkey pox virus,8.492309854010126e-08
indirect immunofluorescence test,8.411956437470205e-08
sarscovinduced tissue damage,8.315459535707765e-08
carcinoembryonic antigenrelated cell adhesion molecule 5,8.057793457959257e-08
lopinavir/ritonavir,7.894047224740379e-08
cd19independent factors,7.558429070367215e-08
isg15,7.558377963740667e-08
kq6,7.15727570480451e-08
conserved epitope,7.001018147181646e-08
naturally-occurring flavonoids,6.99524228214152e-08
infectious peritonitis viruses,6.976148792998219e-08
double mutation,6.917001600905525e-08
pulmonary sars-cov,6.472724415352568e-08
psg16,6.249067818435938e-08
serotonin antagonist,6.234342192107417e-08
polyadenylation,6.205424677341857e-08
rcovinfected alveolar epithelial cells,5.8677672569054044e-08
two-domain ub-like protein,5.742407785628531e-08
coronavirus n protein,5.461652632729957e-08
sustainability,5.298450640315753e-08
conventional polymerase chain reaction,5.1994707555090726e-08
surface plasmon resonance sedimentation equilibration analysis,5.1228627482002866e-08
primary coronavirus assembly subunits,5.0769595440674116e-08
non-intervention,4.920379475555842e-08
mbl-associated serine protease-2 (masp2) gene,4.847897619730608e-08
korean health care settings,4.743785211113466e-08
continuous cell lines,4.2752050274060786e-08
mature receptor-binding and transmembrane fusion subunits,4.1705377225114675e-08
baculovirus-infected insect cells,3.756556626457434e-08
oral salmonella-s-dna-control,3.5881733817952315e-08
mhv fipv middle east respiratory syndrome,3.12912098260399e-08
coronavirus spike protein sequences,3.113621665470601e-08
hemagglutinin activity,2.4882351232816088e-08
promonocytes,2.2280070316687743e-08
avian nephritis virus 1,2.139248858458838e-08
homologous viral strains vaccine,1.901591701400912e-08
hrn2 anti-sera,1.8719928260142772e-08
multiple renal cortical infarcts,1.7759195625972763e-08
respiratory coronavirus oc43,1.5785183356671572e-08
real-time quantitative pcr technology,1.5515802400081485e-08
mutated viral,1.5090247518255184e-08
cellular uptake,1.4510019211657415e-08
automated veterinary hematology analyzer,1.4286000706492529e-08
secretory immunity,1.32758516077661e-08
human respiratory infections,1.3226379827690282e-08
murine coronavirusinduced,1.0963649110856083e-08
genetic traits,9.819075155690778e-09
cns immune responses,8.968140846284572e-09
recovery process,8.805644452392694e-09
microsomal membrane vesicles,7.753722483945301e-09
cellular oncoprotein mdm2,7.460252459042825e-09
nuclear magnetic resonance nmr spectroscopy,6.8413334440838e-09
hcovhku1 genome,6.343530289367896e-09
high-throughput performance,4.717579309082898e-09
upper respiratory tract infection,4.377739489486407e-09
hku4 hr2-derived peptides,3.1422262386100053e-09
mitochondrial aif,2.7701929719158054e-09
serine proteases tmprss-2,2.7672269234842693e-09
two-dimensional fluorescence difference gel electrophoresis,2.741228197648374e-09
reporter gene detection,1.819102875354776e-09
human respiratory secretions,1.6335539896393348e-09
hyperphosphorylation,1.5530343023570264e-09
rna dependent rna polymerase,1.155117864236195e-09
contagious upper respiratory tract infections,1.0962263448343509e-09
nonproductive infection,8.916291851612072e-10
higher-order rna structures,8.584141634784698e-10
housing conditions,8.017106724222686e-10
inner core protein,4.5128989161697196e-10
n910dioxo910dihydroanthracen2ylbenzamide,3.3361359882604274e-10
multiple specimens,2.2413294380302167e-10
innate immune signaling,1.5122811565905386e-10
interaction domain,7.13842789803237e-11
murine,0.0
cea,0.0
mouse hepatitis virus,0.0
human,0.0
neisseria,0.0
interactions,0.0
mouse,0.0
iglike domains,0.0
murine coronavirus,0.0
domains,0.0
nterminal domain,0.0
ceacam1,0.0
family members,0.0
family,0.0
receptors,0.0
carcinoembryonic antigen cea,0.0
carcinoembryonic antigen,0.0
murine ceacam1 proteins,0.0
virus receptor,0.0
crystal structure,0.0
virusbinding residues,0.0
exploration,0.0
isoforms,0.0
sceacam1a14,0.0
murine sceacam1a14,0.0
residues,0.0
murine ceacam1,0.0
proteins,0.0
mhv,0.0
soluble,0.0
neutralizing activity,0.0
human ceacam1,0.0
architecture,0.0
structural,0.0
functional,0.0
virus,0.0
carcinoembryonic antigen cea family isoforms,0.0
carcinoembryonic,0.0
homophilic,0.0
heterophilic,0.0
coronavirus,0.0
atomic structure,0.0
ceacam1 proteins,0.0
domain,0.0
activities,0.0
binding,0.0
protomers,0.0
his41,0.0
rna viruses,0.0
cellular proteinases,0.0
coronavirus polyprotein,0.0
chymotrypsin,0.0
s1,0.0
cys144,0.0
viral and cellular proteinases,0.0
glutamine,0.0
asymmetric unit,0.0
coronavirus mpro,0.0
mpro selfprocessing,0.0
loop,0.0
protein,0.0
kda transmissible gastroenteritis,0.0
p1 glutamine,0.0
molecular,0.0
enzyme,0.0
sequence,0.0
arrangement,0.0
mutagenesis,0.0
substrates,0.0
study,0.0
transcleavage activity,0.0
active site,0.0
variations,0.0
low,0.0
viral main proteinase mpro a protein,0.0
classical chymotrypsin fold,0.0
side chains,0.0
resolution,0.0
mutual,0.0
p2 leucine residues,0.0
chymotrypsinlike fold,0.0
substrate binding,0.0
viral,0.0
trans,0.0
mpro,0.0
structure,0.0
orientation,0.0
dimers,0.0
nterminus,0.0
cellular,0.0
leucine residues,0.0
subsites,0.0
molecular modelling,0.0
extra domain,0.0
residue loop,0.0
data,0.0
sars,0.0
enzyme 2 ace2,0.0
outbreak,0.0
functional receptor,0.0
ace2,0.0
sproteinbinding site,0.0
sars coronavirus sarscov,0.0
humans,0.0
human cells,0.0
affinity,0.0
sarscov spike sproteinbinding site,0.0
palmcivet ace2,0.0
bound,0.0
human angiotensinconverting enzyme 2,0.0
efficiently,0.0
palm civets,0.0
human ace2,0.0
human angiotensinconverting enzyme 2 ace2,0.0
severity,0.0
spike sproteinbinding,0.0
site,0.0
civet ace2,0.0
compare,0.0
isolated,0.0
sprotein residues,0.0
sarscov,0.0
adaptation,0.0
severe,0.0
civets,0.0
sprotein residues 479,0.0
molecular interactions,0.0
angiotensinconverting,0.0
residues conserved,0.0
giant,0.0
nsp8 rdrp,0.0
nonstructural protein 12 nsp12,0.0
transcription,0.0
rdrp domain,0.0
catalytic residues,0.0
rnas,0.0
nsp12,0.0
palm,0.0
complementary oligonucleotides,0.0
coronaviruses,0.0
fidelity,0.0
distant,0.0
nonstructural protein 12,0.0
nsp8,0.0
genome,0.0
rdrp activity,0.0
membranebound enzymatic complex,0.0
rna templates,0.0
homology,0.0
synthesis,0.0
origin,0.0
rna,0.0
catalytic palm subdomain,0.0
cterminal domain,0.0
rdrps of rna viruses,0.0
cognate membranebound enzymatic complex,0.0
coronavirus rdrps,0.0
cellular dnadependent rna primases,0.0
rnadependent rna polymerase,0.0
subgenomesize,0.0
primers,0.0
cognate,0.0
primerdependent,0.0
polarities,0.0
sars coronavirus,0.0
reaction,0.0
domain conserved,0.0
replication,0.0
detectable,0.0
fever,0.0
human peripheral blood mononuclear cells,0.0
cytotoxic,0.0
immunemediated,0.0
peripheral blood mononuclear cells,0.0
induced,0.0
patients,0.0
epithelial cells,0.0
patient sera,0.0
cells,0.0
immune cell adhesion,0.0
autoabs,0.0
acute respiratory syndromeassociated coronavirus sarscov infection,0.0
sera,0.0
pathogenesis,0.0
type2 pneumocytes,0.0
antis2,0.0
autoab production,0.0
autoantibodies autoabs,0.0
cell,0.0
epitopes,0.0
mechanism,0.0
crossreactive epitopes,0.0
sarscov spike protein domain 2 s2,0.0
antiepithelial cell,0.0
preabsorption,0.0
viral effect,0.0
cytotoxicity,0.0
blood mononuclear cells,0.0
level,0.0
cell cytotoxicity,0.0
cytotoxic injury,0.0
autoimmune responses,0.0
treatment,0.0
crossreactive,0.0
days,0.0
adherence,0.0
protein domain,0.0
nonsarspneumonia,0.0
sarscov infection,0.0
binding assays,0.0
correlated,0.0
igg,0.0
onset of,0.0
pneumonia,0.0
detection,0.0
throat,0.0
fecal samples,0.0
alternative,0.0
extensive,0.0
laboratoryconfirmed sars,0.0
selfcollected samples,0.0
beijing china,0.0
nasopharyngeal aspirates,0.0
patient,0.0
pressure,0.0
quantify,0.0
reverse transcriptase polymerase chain reaction rtpcr,0.0
laboratory confirmation,0.0
selfcollected throat,0.0
china,0.0
laboratoryconfirmed,0.0
context,0.0
hospital resources,0.0
viral loads,0.0
occasional,0.0
rates,0.0
onset,0.0
detect,0.0
reverse transcriptase,0.0
illness,0.0
symptoms,0.0
weeks,0.0
acute respiratory syndrome,0.0
positive,0.0
detected,0.0
clinical illness,0.0
institution,0.0
sarscov rtpcr,0.0
identification,0.0
crystals,0.0
crystalline,0.0
development,0.0
inhibitors,0.0
sarscov mpro,0.0
catalytic site,0.0
structurebased inhibition studies,0.0
target,0.0
compounds crystals,0.0
viral polyproteins,0.0
crystallographic twofold,0.0
group,0.0
processing,0.0
sars virus,0.0
conformation,0.0
orthorhombic space group p21212,0.0
proteinase mpro,0.0
ph 65,0.0
monomer,0.0
orthorhombic space,0.0
virus life cycle,0.0
biologically active,0.0
specific,0.0
coronavirus sarscov,0.0
membrane,0.0
orientational,0.0
bind,0.0
lysine residues,0.0
host cell,0.0
inhibited,0.0
preparation,0.0
homopentameric,0.0
virus morphogenesis,0.0
pentameric,0.0
apoptosis,0.0
lipid bilayers,0.0
c,0.0
consistent with,0.0
transmembrane,0.0
tm,0.0
reconstituted,0.0
peptide,0.0
double mutants,0.0
mutants,0.0
membrane destabilizing transmembrane tm hairpin,0.0
drug amantadine,0.0
c and n termini,0.0
homooligomerize,0.0
topology,0.0
e protein etm,0.0
amantadine,0.0
sodium,0.0
parameters,0.0
lipid,0.0
sodium conductance channel,0.0
organization,0.0
small envelope protein e,0.0
activity,0.0
moderate,0.0
antiinfluenza drug amantadine,0.0
improve,0.0
solubility,0.0
transmembrane pore,0.0
e,0.0
flanked,0.0
small envelope protein,0.0
transmembrane tm,0.0
involvement,0.0
homopentameric model,0.0
nonstructural protein nsp15,0.0
p4332,0.0
viral rna synthesis sars fulllength,0.0
escherichia coli,0.0
peg,0.0
uridinespecific endoribonuclease,0.0
human coronavirus,0.0
amino acids,0.0
apoenzyme,0.0
crystallized,0.0
nonstructural protein,0.0
mutation,0.0
nterminal hexahistidine tag,0.0
homogeneity,0.0
abolish,0.0
human coronavirus nsp15 gene,0.0
precipitants,0.0
unitcell,0.0
cloned,0.0
viral replication,0.0
gene,0.0
expressed,0.0
viral rna,0.0
aetiological agent,0.0
tag,0.0
nanodrops,0.0
diffraction,0.0
h229e human coronavirus nsp15 gene,0.0
viral rna synthesis,0.0
substitution,0.0
cleavage,0.0
amino acid,0.0
enzymatic,0.0
rapid,0.0
amino acid positions flanking,0.0
protease cleavage site,0.0
experimental approach,0.0
acute respiratory syndrome coronavirus sarscov 3clike protease 3clpro,0.0
intolerant,0.0
p2 position,0.0
occupied,0.0
specificity,0.0
p2,0.0
substrate,0.0
replicase polyproteins,0.0
highthroughput,0.0
antisars drug development,0.0
position,0.0
mixed peptide,0.0
acidic amino acids,0.0
proteases,0.0
substitutions,0.0
acidic residue substitution,0.0
investigating,0.0
p3,0.0
amino acid positions,0.0
hydrophobic residue,0.0
matrixassisted laser desorptionionization timeofflight mass spectrometry malditof,0.0
electrostatic repulsion,0.0
coronavirus sarscov 3clike protease 3clpro,0.0
amino acid position,0.0
hydrophobic pocket,0.0
synthesized,0.0
replacement,0.0
proteolytic processing,0.0
batch,0.0
acidic residue,0.0
automated analysis,0.0
peptidebased sarscov 3clpro,0.0
enzymatic cleavage,0.0
design,0.0
amino acid substitutions,0.0
bulky,0.0
highthroughput screening method,0.0
susceptibility,0.0
sarscov 3clpro cleavage site,0.0
recombinant sarscov 3clpro,0.0
investigated,0.0
comprehensive,0.0
synthetic peptidebased sarscov 3clpro inhibitors,0.0
